title,url,time_published,summary,ticker,relevance_score,ticker_sentiment_score,ticker_sentiment_label
Vertex Pharmaceuticals  ( VRTX )  Outpaces Stock Market Gains: What You Should Know,https://www.zacks.com/stock/news/2037604/vertex-pharmaceuticals-vrtx-outpaces-stock-market-gains-what-you-should-know,2023-01-10 22:50:18,"In the latest trading session, Vertex Pharmaceuticals (VRTX) closed at $288.75, marking a +1.95% move from the previous day.",VRTX,0.699089,0.408977,Bullish
"Healthcare Stocks, a Star Last Year, Are Stumbling Out of the Gate",https://www.barrons.com/articles/healthcare-stocks-performance-2023-51673386289,2023-01-10 21:32:00,"Healthcare Stocks, a Standout in 2022, Are Going Nowhere in ...",VRTX,0.159569,0.084772,Neutral
Moderna  ( MRNA )  Reports 2023 Business View & Pipeline Updates,https://www.zacks.com/stock/news/2037482/moderna-mrna-reports-2023-business-view-pipeline-updates,2023-01-10 16:55:00,Moderna (MRNA) expects to record a minimum of $5 billion in revenues from COVID vaccine sales in 2023. It also expects to incur around $4.5 billion as R&D expenses in 2023.,VRTX,0.099476,0.058298,Neutral
2 Growth Stocks That Could Help Set You Up for Life,https://www.fool.com/investing/2023/01/10/2-growth-stocks-that-could-help-set-you-up-for-lif/,2023-01-10 13:15:00,Regularly investing in both up and down markets can help you build a resilient portfolio over time.,VRTX,0.218817,0.066001,Neutral
"Want $1 Million in Retirement? Invest $300,000 in These 3 Stocks and Wait a Decade",https://www.fool.com/investing/2023/01/10/want-1-million-retirement-invest-in-these-stocks/,2023-01-10 10:50:00,Don't let your retirement planning fall by the wayside in the current market.,VRTX,0.174083,0.165706,Somewhat-Bullish
6 Favorite Biotech Bets For 2023,https://www.forbes.com/sites/moneyshow/2023/01/09/6-favorite-biotech-bets-for-2023/,2023-01-09 15:48:07,"Biotechnology has often been among the most popular sectors in the MoneyShow Top Picks report, our annual survey of the nation's leading newsletter advisors. This year's report is no exception. here's a six-pack of favorite biotech ideas for the coming year.",VRTX,0.040519,0.004001,Neutral
3 Revolutionary Stocks I'd Buy Right Now Without Hesitation,https://www.fool.com/investing/2023/01/09/3-revolutionary-stocks-id-buy-without-hesitation/,2023-01-09 13:00:00,The current market is still full of wonderful opportunities for investors of all trading styles.,VRTX,0.082393,-0.068319,Neutral
2 Healthcare Stocks That Could Make You Richer,https://www.fool.com/investing/2023/01/08/2-healthcare-stocks-that-could-make-you-richer/,2023-01-08 14:45:00,The healthcare industry presents opportunities for both growth and value investors.,VRTX,0.114137,0.216302,Somewhat-Bullish
2 Risky Cathie Wood Stocks to Buy Today And Hold For 5 Years,https://www.fool.com/investing/2023/01/07/2-risky-cathie-wood-stocks-to-buy-today-and-hold/,2023-01-07 13:15:00,Both are hoping to use the latest gene editing technology to make the lucrative therapies of tomorrow.,VRTX,0.051441,0.168463,Somewhat-Bullish
"Looking for Growth in 2023? Where to Invest $5,000",https://www.fool.com/investing/2023/01/07/looking-for-growth-in-2023-where-to-invest-5000/,2023-01-07 11:15:00,"Over time, some of last year's losers could win big.",VRTX,0.113597,0.107355,Neutral
These Stocks Jumped 100% and 30% Last Year. Here's Why They're Still a Buy.,https://www.fool.com/investing/2023/01/07/these-stocks-jumped-100-and-30-last-year-heres-why/,2023-01-07 10:30:00,These stocks look cheap if you take a long-term view.,VRTX,0.125789,0.093353,Neutral
2 Under-the-Radar Biotech Stocks to Buy in 2023,https://www.fool.com/investing/2023/01/06/2-under-the-radar-biotech-stocks-to-buy-in-2023/,2023-01-06 13:45:00,These biotechnology stocks are pushing ahead with promising innovations.,VRTX,0.089129,0.038419,Neutral
"CRISPR, Genetics And AI - Why 2023 Could Be Biotech's Year",https://www.investors.com/news/technology/biotech-stocks-how-crispr-genetics-and-ai-could-drive-a-2023-inflection/,2023-01-06 13:00:00,"Biotech Stocks: How CRISPR, Genetics And AI Could Drive A 2023 ... Investor's Business Daily ...",VRTX,0.028155,0.050109,Neutral
"Biogen Names Priya Singhal as Executive Vice President, Head of Development - Biogen  ( NASDAQ:BIIB ) ",https://www.benzinga.com/pressreleases/23/01/g30291349/biogen-names-priya-singhal-as-executive-vice-president-head-of-development,2023-01-05 12:30:00,"CAMBRIDGE, Mass., Jan. 05, 2023 ( GLOBE NEWSWIRE ) -- Biogen Inc.",VRTX,0.029765,0.01348,Neutral
Cathie Wood Is Buying These Top Growth Stocks -- and Both Could Make You Rich Over Time,https://www.fool.com/investing/2023/01/04/cathie-wood-is-buying-these-top-growth-stocks/,2023-01-04 11:00:00,Wood is bargain hunting now. And these buys may pay off big in the long run.,VRTX,0.057079,0.18099,Somewhat-Bullish
3 Must-Have Stocks to Buy in 2023,https://www.fool.com/investing/2023/01/04/3-must-have-stocks-to-buy-in-2023/,2023-01-04 10:52:00,There's too much to like with these stocks to pass them by.,VRTX,0.121959,-0.011767,Neutral
"Where to Invest $100,000 in 2023",https://www.fool.com/investing/2023/01/04/where-to-invest-100000-in-2023/,2023-01-04 10:30:00,The holidays are over. Let's put our money to work.,VRTX,0.100729,0.262556,Somewhat-Bullish
10 Top Stocks That Can Make You Richer in 2023,https://www.fool.com/investing/2023/01/04/10-top-stocks-that-can-make-you-richer-in-2023/,2023-01-04 10:06:00,A new year brings new opportunities for investors to build their wealth on Wall Street.,VRTX,0.040934,-0.011912,Neutral
Vertex Pharmaceuticals  ( VRTX )  Dips More Than Broader Markets: What You Should Know,https://www.zacks.com/stock/news/2034849/vertex-pharmaceuticals-vrtx-dips-more-than-broader-markets-what-you-should-know,2023-01-03 22:50:20,"Vertex Pharmaceuticals (VRTX) closed the most recent trading day at $286.02, moving -0.96% from the previous trading session.",VRTX,0.657184,0.1032,Neutral
3 Top Healthcare Stocks Defying the Bear Market,https://www.fool.com/investing/2023/01/03/3-top-healthcare-stocks-defying-the-bear-market/,2023-01-03 15:45:00,These healthcare companies look poised to continue their runs.,VRTX,0.101154,0.140074,Neutral
3 Stocks to Buy for 2023 That Are Practically Money Machines,https://www.fool.com/investing/2023/01/03/stocks-to-buy-2023-practically-money-machines/,2023-01-03 10:52:00,"If money makes the world go round, these three stocks could have it really spinning.",VRTX,0.139669,-0.010145,Neutral
Investing Action Plan: Brace For A Blue Wave Of Earnings,https://www.investors.com/research/investing-action-plan/stock-market-investing-action-plan-tesla-chevron-microsoft-and-a-blue-wave-of-earnings/,2023-01-20 23:40:00,"A mixed week for the stock market is no surprise after a strong start to January. Tech stocks staged a nice show, leaving the Nasdaq composite comfortably above its 50-day line, while the Dow turned and undercut its 50-day average and the S&P 500 ended clinging to support.",VRTX,0.035929,0.048587,Neutral
"The Best Stocks to Invest $5,000 In Right Now",https://www.fool.com/investing/2023/01/20/the-best-stocks-to-invest-5000-in-right-now/,2023-01-20 15:23:00,It's still a great time to be a long-term investor.,VRTX,0.235252,0.283609,Somewhat-Bullish
2 Healthcare Stocks You Can Buy and Hold for the Next Decade,https://www.fool.com/investing/2023/01/20/2-healthcare-stocks-you-can-buy-for-next-decade/,2023-01-20 14:15:00,The healthcare industry isn't going anywhere.,VRTX,0.131164,0.135572,Neutral
Futures Fall Ahead Of Housing Data,https://www.investors.com/market-trend/stock-market-today/dow-jones-futures-rise-ahead-of-housing-data-netflix-surges-on-subscriber-growth/,2023-01-20 13:56:00,"Dow Jones futures fell modestly Friday morning ahead of housing data, threatening to extend a three-day losing streak. China's markets rallied heading into their Lunar New Year break, giving a boost to global markets. Netflix ( NFLX ) stock surged more than 6% after the company's ...",VRTX,0.100518,0.097882,Neutral
Futures: Market Rally Breaks Key Levels,https://www.investors.com/market-trend/stock-market-today/dow-jones-futures-netflix-jumps-on-subscribers-after-market-rally-breaks-key-levels/,2023-01-19 23:39:00,"Dow Jones Futures Rise, Netflix Jumps On Subscribers After Market ... Investor's Business Daily ...",VRTX,0.127999,0.04177,Neutral
Market Rally Suffers Key Losses; Netflix Pops On Subscribers,https://www.investors.com/market-trend/stock-market-today/s-and-p-500-nasdaq-break-key-levels-watch-these-5-stocks-netflix-subscriber-growth-strong/,2023-01-19 21:47:00,"S&P 500, Nasdaq Break Key Levels, But Watch These 5 Stocks ... Investor's Business Daily ...",VRTX,0.131643,0.042341,Neutral
CRISPR Therapeutics Stock: Bull vs. Bear,https://www.fool.com/investing/2023/01/19/crispr-therapeutics-stock-bull-vs-bear/,2023-01-19 15:07:00,Should investors buy this risky biotech stock as the company moves toward bringing its first major treatment to market?,VRTX,0.048133,0.076101,Neutral
Stocks Lower After Jobless Claims; Netflix Earnings Due,https://www.investors.com/market-trend/stock-market-today/dow-jones-futures-fall-ahead-of-jobless-claims-netflix-earnings-due/,2023-01-19 15:00:00,Dow Jones Falls 225 Points After Jobless Claims. Netflix Earnings Due Investor's Business Daily ...,VRTX,0.111358,0.100033,Neutral
3 Unstoppable Stocks to Keep Buying in 2023,https://www.fool.com/investing/2023/01/19/3-unstoppable-stocks-to-keep-buying-in-2023/,2023-01-19 10:30:00,These companies have what it takes to drive long-term share performance.,VRTX,0.102449,0.147652,Neutral
"Incyte Clears Technical Benchmark, Hitting 80-Plus RS Rating",https://www.investors.com/ibd-data-stories/incyte-clears-technical-benchmark-hitting-80-plus-rs-rating/,2023-01-19 08:00:00,"On Thursday, Incyte ( INCY ) hit a key performance benchmark, with its Relative Strength ( RS ) Rating jumping into the 80-plus percentile with an upgrade to 82, an increase from 78 the day before. X When looking for the best stocks to buy and watch, one factor to watch closely is relative ...",VRTX,0.350564,0.0,Neutral
Vertex Pharmaceuticals Stock Meets 80-Plus Relative Strength Rating Benchmark,https://www.investors.com/news/vertex-pharmaceuticals-stock-meets-80-plus-relative-strength-rating-benchmark/,2023-01-19 00:10:00,Vertex Pharmaceuticals Stock Meets 80-Plus Relative Strength ... Investor's Business Daily ...,VRTX,0.468029,0.0,Neutral
Vertex Pharmaceuticals  ( VRTX )  Stock Moves -0.68%: What You Should Know,https://www.zacks.com/stock/news/2041007/vertex-pharmaceuticals-vrtx-stock-moves--068-what-you-should-know,2023-01-18 22:50:19,"Vertex Pharmaceuticals (VRTX) closed at $309.86 in the latest trading session, marking a -0.68% move from the prior day.",VRTX,0.633079,0.179865,Somewhat-Bullish
Here's How Much You Would Have Made Owning Vertex Pharmaceuticals Stock In The Last 10 Years,https://www.benzinga.com/news/earnings/23/01/30471499/heres-how-much-you-would-have-made-owning-vertex-pharmaceuticals-stock-in-the-last-10-years,2023-01-18 20:32:09,"Vertex Pharmaceuticals VRTX has outperformed the market over the past 10 years by 10.51% on an annualized basis producing an average annual return of 20.7%. Currently, Vertex Pharmaceuticals has a market capitalization of $79.26 billion.",VRTX,0.980595,0.386944,Bullish
IBD Stock Of The Day Vertex Stacks Up Billions In Sales Potential,https://www.investors.com/research/ibd-stock-of-the-day/vrtx-stock-finds-support-as-billions-in-potential-sales-stack-up/,2023-01-18 17:50:00,VRTX Stock Finds Support As Billions In Potential Sales Stack Up Investor's Business Daily ...,VRTX,0.399734,0.257529,Somewhat-Bullish
Cassava Sciences Stock Shows Big Jump In Its Relative Strength Rating,https://www.investors.com/research/stock-upgrades-cassava-sciences-shows-rising-relative-strength/,2023-01-18 15:35:00,Cassava Sciences Stock Shows Big Jump In Its Relative Strength ... Investor's Business Daily ...,VRTX,0.331765,0.0,Neutral
Why Vertex Pharmaceuticals  ( VRTX )  is a Top Growth Stock for the Long-Term,https://www.zacks.com/stock/news/2040735/why-vertex-pharmaceuticals-vrtx-is-a-top-growth-stock-for-the-long-term,2023-01-18 14:45:03,The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.,VRTX,0.493128,0.385329,Bullish
"Futures Rise; Tesla, Moderna Lead Early Movers",https://www.investors.com/market-trend/stock-market-today/dow-jones-futures-market-rally-pauses-tesla-jumps/,2023-01-18 13:19:00,Dow Jones Futures Rise On Bank Of Japan Surprise. Tesla ... Investor's Business Daily ...,VRTX,0.115011,-0.019007,Neutral
5 Reasons to Buy Vertex Pharmaceuticals Now,https://www.fool.com/investing/2023/01/18/5-reasons-to-buy-vertex-pharmaceuticals-now/,2023-01-18 11:00:00,"Vertex shares are extending last year's gains, and that trend probably isn't over.",VRTX,0.109705,0.074032,Neutral
Vertex Pharmaceuticals Meets 80-Plus Relative Strength Rating Benchmark,https://www.investors.com/ibd-data-stories/vertex-pharmaceuticals-meets-80-plus-relative-strength-rating-benchmark/,2023-01-18 08:00:00,Vertex Pharmaceuticals Meets 80-Plus Relative Strength Rating ... Investor's Business Daily ...,VRTX,0.514619,0.251969,Somewhat-Bullish
Stocks Showing Improving Market Leadership: Regeneron Pharm Earns 80 RS Rating,https://www.investors.com/ibd-data-stories/stocks-showing-improving-market-leadership-regeneron-pharm-earns-80-rs-rating/,2023-01-18 08:00:00,Stocks Showing Improving Market Leadership: Regeneron Pharm ... Investor's Business Daily ...,VRTX,0.297661,0.0,Neutral
Market Rally Pauses As Tesla Jumps; 3 Stocks Rising Late,https://www.investors.com/market-trend/stock-market-today/market-rally-pauses-tesla-keeps-rebounding-united-airlines-moderna-microsoft-in-focus/,2023-01-17 22:48:00,"Market Rally Pauses, Tesla Keeps Rebounding. United Airlines ... Investor's Business Daily ...",VRTX,0.127321,-0.01987,Neutral
VRTX: The No. 1 Biotech Stock to Buy for 2023,https://stocknews.com/news/vrtx-gild-biib-uthr-the-no-1-biotech-stock-to-buy-for-2023/,2023-01-17 14:02:08,VRTX: The No. 1 Biotech Stock to Buy for ...,VRTX,0.59616,0.432445,Bullish
Stocks Showing Market Leadership: Cogent Biosciences Earns 91 RS Rating,https://www.investors.com/ibd-data-stories/stocks-showing-market-leadership-cogent-biosciences-earns-91-rs-rating/,2023-01-17 08:00:00,Stocks Showing Market Leadership: Cogent Biosciences Earns 91 ... Investor's Business Daily ...,VRTX,0.343279,0.135398,Neutral
3 Biopharma Stocks That Could Help Make You a Fortune,https://www.fool.com/investing/2023/01/16/3-biopharma-stocks-could-help-make-you-a-fortune/,2023-01-16 13:30:00,"All three are protected by sales of in-demand products, with more on the way.",VRTX,0.095707,0.206849,Somewhat-Bullish
2 Stocks Down More Than 25% to Buy Right Now,https://www.fool.com/investing/2023/01/16/2-stocks-down-more-than-25-to-buy-right-now/,2023-01-16 10:30:00,These companies are set for a new era of growth.,VRTX,0.04882,0.085964,Neutral
3 Dirt Cheap Stocks to Buy in January,https://www.fool.com/investing/2023/01/14/3-dirt-cheap-stocks-to-buy-in-january/,2023-01-14 11:15:00,Bargains can easily be found as the new year gets underway.,VRTX,0.150827,0.009507,Neutral
Is It Too Late to Buy Vertex Pharmaceuticals Stock?,https://www.fool.com/investing/2023/01/14/is-it-too-late-to-buy-vertex-pharmaceuticals-stock/,2023-01-14 11:00:00,Vertex is heading for a new phase of growth.,VRTX,0.131643,-0.014711,Neutral
5 Potentially Explosive Stocks to Buy in 2023,https://www.fool.com/investing/2023/01/13/5-potentially-explosive-stocks-to-buy-in-2023/,2023-01-13 10:30:00,These stocks all dropped in the double digits last year. But their future prospects are brilliant.,VRTX,0.036812,0.125244,Neutral
VRTX: 3 Biotech Stocks to Help Boost Your Portfolio in January,https://stocknews.com/news/vrtx-biib-jazz-3-biotech-stocks-to-help-boost-your-portfolio-in-january/,2023-01-12 16:51:03,"President Joe Biden signed an executive order last year and launched a national initiative to invest more than $2 billion in the U.S. biotechnology sector. Additionally, the U.S. Department of Energy ( DOE ) is committed to taking key steps to advance the Biden-Harris Administration's National ...",VRTX,0.347127,0.309412,Somewhat-Bullish
Want to Get Richer? 3 Top Stocks to Buy Now and Hold Forever,https://www.fool.com/investing/2023/01/12/want-to-get-richer-3-top-stocks-to-buy-now-and-hol/,2023-01-12 14:40:00,Expect these stocks to boost your portfolio in the long run.,VRTX,0.095138,0.182077,Somewhat-Bullish
2 Top Healthcare Stocks to Buy for the Long Haul,https://www.fool.com/investing/2023/01/12/2-top-healthcare-stocks-to-buy-for-the-long-haul/,2023-01-12 13:28:00,This space is rife with opportunity for investors.,VRTX,0.275867,0.357298,Bullish
1 Top Growth Stock Set to Crush the Market Again in 2023,https://www.fool.com/investing/2023/01/12/1-top-growth-stock-set-to-crush-the-market-again/,2023-01-12 12:45:00,This company's long-term thesis looks impeccable.,VRTX,0.239305,0.362794,Bullish
4 Growth Stocks to Buy and Hold Forever,https://www.fool.com/investing/2023/01/12/4-growth-stocks-to-buy-and-hold-forever/,2023-01-12 10:52:00,These stocks could be huge winners for patient investors.,VRTX,0.129168,-0.013296,Neutral
History Says Bull Should Bet On This Pharma Giant,https://www.forbes.com/sites/greatspeculations/2023/01/11/history-says-bull-should-bet-on-this-pharma-giant/,2023-01-11 19:58:52,Shares of Vertex Pharmaceuticals (VRTX) have been in recovery mode since suffering a rapid fall from their Dec. 8 record peak of $324.75.,VRTX,0.835133,0.374039,Bullish
"Biotech Stock Roundup: REGN Down on Eylea Data, CINC Surges on AZN Offer & More",https://www.zacks.com/stock/news/2037977/biotech-stock-roundup-regn-down-on-eylea-data-cinc-surges-on-azn-offer-more,2023-01-11 16:10:00,Updates from Regeneron (REGN) and CinCor Pharma (CINC) are the key highlights from the biotech sector during the past week.,VRTX,0.043186,0.034665,Neutral
2 Growth Stocks You May Regret not Buying Right Now,https://www.fool.com/investing/2023/01/11/2-growth-stocks-you-may-regret-not-buying-now/,2023-01-11 14:37:00,"At their beaten-down valuations, these stocks have the potential to deliver some impressive returns.",VRTX,0.064797,0.161274,Somewhat-Bullish
2 Unstoppable Growth Stocks to Buy in 2023 and Beyond,https://www.fool.com/investing/2023/01/11/unstoppable-growth-stocks-to-buy-2023-and-beyond/,2023-01-11 13:44:19,"These healthcare companies' revenue and earnings have grown, and they expect more growth.",VRTX,0.145437,0.192334,Somewhat-Bullish
Should You Invest in the iShares Biotechnology ETF  ( IBB ) ?,https://www.zacks.com/stock/news/2037707/should-you-invest-in-the-ishares-biotechnology-etf-ibb,2023-01-11 11:20:09,Sector ETF report for ...,VRTX,0.136113,0.07192,Neutral
3 Top Healthcare Stocks to Buy for January,https://www.fool.com/investing/2023/01/11/3-top-healthcare-stocks-to-buy-for-january/,2023-01-11 10:52:00,These healthcare stocks have a lot going for them in the new year.,VRTX,0.119235,-0.151018,Somewhat-Bearish
2 Supercharged Stocks to Buy Right Now That Could Soar in 2023,https://www.fool.com/investing/2023/01/11/2-supercharged-stocks-to-buy-right-now-that-could/,2023-01-11 10:10:00,These stocks have been solid performers despite the macroeconomic uncertainties in 2022.,VRTX,0.152499,0.198508,Somewhat-Bullish
Vertex Pharmaceuticals  ( VRTX )  Stock Moves -0.46%: What You Should Know,https://www.zacks.com/stock/news/2046584/vertex-pharmaceuticals-vrtx-stock-moves--046-what-you-should-know,2023-01-30 22:50:17,"In the latest trading session, Vertex Pharmaceuticals (VRTX) closed at $319.98, marking a -0.46% move from the previous day.",VRTX,0.631282,0.227774,Somewhat-Bullish
Tech Futures Sell Off With Fed Meeting In Sight,https://www.investors.com/market-trend/stock-market-today/dow-jones-futures-fall-with-fed-meeting-in-sight-tesla-stock-upgraded-to-buy/,2023-01-30 13:15:00,Dow Jones Futures Fall With Fed Meeting In Sight. Tesla Stock ... Investor's Business Daily ...,VRTX,0.107495,0.15199,Somewhat-Bullish
"Ring Therapeutics Announces Appointment of Industry Veteran Christopher Wright, M.D., Ph.D. as Chief Medical Officer, Head of Translational Research",https://www.benzinga.com/pressreleases/23/01/g30620489/ring-therapeutics-announces-appointment-of-industry-veteran-christopher-wright-m-d-ph-d-as-chief-m,2023-01-30 13:00:00,"CAMBRIDGE, Mass., Jan. 30, 2023 ( GLOBE NEWSWIRE ) -- Ring Therapeutics, a life sciences company founded by Flagship Pioneering to revolutionize gene therapy with its commensal virome platform, today announced the appointment of Christopher Wright, M.D., Ph.D. as Chief Medical Officer, Head of ...",VRTX,0.052226,-0.021839,Neutral
Biotech Stocks Can Be Worth It If You Can Take The Bumpy Ride,https://www.investors.com/stock-lists/ibd-50/biotech-stocks-reward-shareholders-who-handle-the-bumpy-ride/,2023-01-27 19:56:00,Biotech Stocks Reward Shareholders Who Handle The Bumpy Ride ... Investor's Business Daily ...,VRTX,0.142144,0.0,Neutral
"The Best Stocks to Invest $20,000 in Right Now",https://www.fool.com/investing/2023/01/27/the-best-stocks-to-invest-20000-in-right-now/,2023-01-27 14:53:00,These healthcare giants have plenty of room left to run.,VRTX,0.115048,0.168665,Somewhat-Bullish
Futures Fall After Inflation Data: Intel Plunges On Earnings,https://www.investors.com/market-trend/stock-market-today/dow-jones-futures-dip-after-inflation-data-intel-plunges-on-earnings/,2023-01-27 14:24:00,"Dow Jones futures fell slightly Friday after key inflation data, with the early release of the Personal Consumption Expenditures price index. Meanwhile, Dow Jones chipmaker Intel ( INTC ) was down nearly 10% on an earnings miss.",VRTX,0.104569,0.152172,Somewhat-Bullish
3 Healthcare Stocks to Buy and Hold for the Next 10 Years,https://www.fool.com/investing/2023/01/27/3-healthcare-stocks-buy-and-hold-for-next-10-years/,2023-01-27 11:50:00,These companies have the therapies to boost revenue for a decade.,VRTX,0.135347,0.0,Neutral
"Tech Futures Rally After GDP, Jobless Claims",https://www.investors.com/market-trend/stock-market-today/dow-jones-futures-fall-ahead-of-key-economic-data-tesla-stock-surges-on-earnings-musk-comments/,2023-01-26 13:58:00,Dow Jones Futures Rise After Key Economic Data. Tesla Surges On ... Investor's Business Daily ...,VRTX,0.092748,0.095934,Neutral
"Futures Fall As Boeing, Microsoft Report Earnings",https://www.investors.com/market-trend/stock-market-today/dow-jones-futures-fall-200-points-as-boeing-microsoft-drop-on-earnings-tesla-earnings-due/,2023-01-25 13:57:00,"Dow Jones Futures Fall 280 Points As Boeing, Microsoft Drop On ... Investor's Business Daily ...",VRTX,0.101367,0.099187,Neutral
Xencor Hits 80-Plus Relative Strength Rating Benchmark,https://www.investors.com/ibd-data-stories/xencor-hits-80-plus-relative-strength-rating-benchmark-2/,2023-01-25 08:00:00,"Xencor ( XNCR ) saw a welcome improvement to its Relative Strength ( RS ) Rating on Wednesday, with an upgrade from 68 to 82. X When looking for the best stocks to buy and watch, one factor to watch closely is relative price strength.",VRTX,0.366061,0.0,Neutral
Stocks Flashing Renewed Technical Strength: PTC Therapeutics,https://www.investors.com/ibd-data-stories/stocks-flashing-renewed-technical-strength-ptc-therapeutics-3/,2023-01-25 08:00:00,"The Relative Strength ( RS ) Rating for PTC Therapeutics ( PTCT ) entered a new percentile Wednesday, with a rise from 80 to 83. X When looking for the best stocks to buy and watch, keep a close on eye on relative price strength. IBD's unique rating tracks market leadership with a 1 ( worst ...",VRTX,0.338582,0.0,Neutral
Stock Upgrades: Inhibrx Shows Rising Relative Strength,https://www.investors.com/ibd-data-stories/stock-upgrades-inhibrx-shows-rising-relative-strength/,2023-01-25 08:00:00,"When looking for the best stocks to buy and watch, focus on those with rising relative price strength. One stock that fits that bill is Inhibrx ( INBX ) , which had its Relative Strength ( RS ) Rating upgraded from 80 to 88 Wednesday.",VRTX,0.331765,0.0,Neutral
"Krystal Biotech Clears Technical Benchmark, Hitting 90-Plus RS Rating",https://www.investors.com/ibd-data-stories/krystal-biotech-clears-technical-benchmark-hitting-90-plus-rs-rating/,2023-01-25 08:00:00,"Krystal Biotech Clears Technical Benchmark, Hitting 90-Plus RS ... Investor's Business Daily ...",VRTX,0.318897,0.12787,Neutral
Stocks Generating Improved Relative Strength: Ligand Pharmaceuticals,https://www.investors.com/ibd-data-stories/stocks-generating-improved-relative-strength-ligand-pharmaceuticals-2/,2023-01-25 08:00:00,Stocks Generating Improved Relative Strength: Ligand ... Investor's Business Daily ...,VRTX,0.316846,0.0,Neutral
Stocks With Rising Relative Price Strength: Sage Therapeutics,https://www.investors.com/ibd-data-stories/stocks-with-rising-relative-price-strength-sage-therapeutics-4/,2023-01-25 08:00:00,"Sage Therapeutics ( SAGE ) saw a positive improvement to its Relative Strength ( RS ) Rating on Wednesday, with an upgrade from 88 to 92. X When looking for the best stocks to buy and watch, one factor to watch closely is relative price strength.",VRTX,0.310843,0.125315,Neutral
Stocks Showing Market Leadership: Keros Therapeutics Earns 92 RS Rating,https://www.investors.com/ibd-data-stories/stocks-showing-market-leadership-keros-therapeutics-earns-92-rs-rating/,2023-01-25 08:00:00,Stocks Showing Market Leadership: Keros Therapeutics Earns 92 ... Investor's Business Daily ...,VRTX,0.28387,0.116532,Neutral
Vertex Pharmaceuticals  ( VRTX )  Gains As Market Dips: What You Should Know,https://www.zacks.com/stock/news/2043609/vertex-pharmaceuticals-vrtx-gains-as-market-dips-what-you-should-know,2023-01-24 22:50:22,"In the latest trading session, Vertex Pharmaceuticals (VRTX) closed at $313.57, marking a +0.56% move from the previous day.",VRTX,0.642187,0.232041,Somewhat-Bullish
GILD: 1 High-Yield Dividend Stock You Can Count on in 2023,https://stocknews.com/news/gild-uthr-vrtx-biib-1-high-yield-dividend-stock-you-can-count-on-in-2023/,2023-01-24 14:55:48,GILD: 1 High-Yield Dividend Stock You Can Count on in ...,VRTX,0.100308,0.159969,Somewhat-Bullish
Futures Down: Economic Data Due; 6 Earnings Reporters,https://www.investors.com/market-trend/stock-market-today/dow-jones-futures-fall-as-6-key-earnings-movers-report-microsoft-earnings-due/,2023-01-24 13:27:00,Dow Jones Futures Fall As 6 Key Earnings Movers Report. Microsoft ... Investor's Business Daily ...,VRTX,0.086713,0.092599,Neutral
Futures: Stocks Extend Gains; 10 Stocks To Buy And Watch,https://www.investors.com/market-trend/stock-market-today/dow-jones-rallies-250-points-what-to-do-now-10-best-stocks-to-buy-and-watch/,2023-01-23 21:50:00,Dow Jones Rallies 250 Points. What To Do Now. 10 Best Stocks To ... Investor's Business Daily ...,VRTX,0.100308,0.093551,Neutral
"AbCellera Biologics Clears Key Benchmark, Hitting 80-Plus RS Rating",https://www.investors.com/research/abcellera-biologics-clears-key-benchmark-hitting-80-plus-rs-rating/,2023-01-23 16:00:00,"AbCellera Biologics ( ABCL ) saw a positive improvement to its Relative Strength ( RS ) Rating on Monday, rising from 77 to 81. When looking for the best stocks to buy and watch, keep a close on eye on relative price strength.",VRTX,0.240489,0.0,Neutral
"Futures Rise Ahead Of Key Economic Data, Earnings Reports",https://www.investors.com/market-trend/stock-market-today/dow-jones-futures-rise-ahead-of-key-economic-data-earnings-reports-amd-jumps-on-upgrade/,2023-01-23 13:28:00,"Dow Jones futures rose Monday ahead of a busy week of key economic data and as the dollar dropped to an eight-month low. A big week of earnings news includes results from Tesla, due out Wednesday. Advanced Micro Devices ( AMD ) jumped more than 2% after a Barclays upgrade to overweight.",VRTX,0.098862,0.097438,Neutral
Should You Invest in the VanEck Biotech ETF  ( BBH ) ?,https://www.zacks.com/stock/news/2042463/should-you-invest-in-the-vaneck-biotech-etf-bbh,2023-01-23 11:20:08,Sector ETF report for ...,VRTX,0.133841,0.071297,Neutral
Stocks Showing Improving Market Leadership: ACADIA Pharmaceuticals Earns 84 RS Rating,https://www.investors.com/ibd-data-stories/stocks-showing-improving-market-leadership-acadia-pharmaceuticals-earns-84-rs-rating/,2023-01-23 08:00:00,Stocks Showing Improving Market Leadership: ACADIA ... Investor's Business Daily ...,VRTX,0.355588,0.0,Neutral
Stocks Flashing Renewed Technical Strength: Xenon Pharmaceuticals,https://www.investors.com/ibd-data-stories/stocks-flashing-renewed-technical-strength-xenon-pharmaceuticals/,2023-01-23 08:00:00,Stocks Flashing Renewed Technical Strength: Xenon ... Investor's Business Daily ...,VRTX,0.33628,0.0,Neutral
Better Biotech Buy: Bluebird Bio or CRISPR Therapeutics?,https://www.fool.com/investing/2023/01/22/better-biotech-buy-bluebird-bio-or-crispr-therapeu/,2023-01-22 14:00:00,Last year paved the way for a potential breakthrough this year for both gene-editing biotech companies.,VRTX,0.053509,0.033004,Neutral
5 Stocks Near Buy Points With Big Growth Potential,https://www.investors.com/news/bp-stock-baidu-lead-5-stocks-near-buy-points-with-big-growth-potential/,2023-01-21 14:10:00,"BP stock, the U.K.-based oil giant, and Chinese search and AI play Baidu lead this weekend's watch list of 5 stocks near buy points. Both BP and BIDU stock have rallied on China's emergence from Covid, as well as their own growth initiatives. BP ( BP ) has a host of major oil and gas projects ...",VRTX,0.167904,0.111288,Neutral
3 Smart Stocks to Buy if a Recession Is on the Way,https://www.fool.com/investing/2023/01/21/3-smart-stocks-to-buy-if-a-recession-is-on-the-way/,2023-01-21 11:55:00,Their products will enjoy strong demand regardless of what happens with the economy.,VRTX,0.169676,-0.112219,Neutral
CRISPR  ( CRSP )  to Report Q4 Earnings: What's in the Cards?,https://www.zacks.com/stock/news/2052338/crispr-crsp-to-report-q4-earnings-whats-in-the-cards,2023-02-09 14:48:00,"Devoid of marketed drugs, investors' focus will be on CRISPR Therapeutics' (CRSP) pipeline, specifically its lead candidate exa-cel, in its fourth-quarter earnings.",VRTX,0.24289,0.127886,Neutral
GILD: 1 Dividend Stock You'll Be Thankful to Own in 2023,https://stocknews.com/news/gild-vrtx-biib-uthr-1-dividend-stock-youll-be-thankful-to-own-in-2023/,2023-02-09 13:53:09,GILD: 1 Dividend Stock You'll Be Thankful to Own in ...,VRTX,0.074345,0.079659,Neutral
2 Biotech Stocks That Could Make You Richer,https://www.fool.com/investing/2023/02/09/2-biotech-stocks-that-could-make-you-richer/,2023-02-09 13:00:00,Patience will pay off with these two stocks.,VRTX,0.046816,0.055113,Neutral
Better Bull Market Buy: CRISPR Therapeutics or Vertex Pharmaceuticals?,https://www.fool.com/investing/2023/02/09/better-bull-market-buy-crispr-therapeutics-vertex/,2023-02-09 10:56:00,Both stocks should be winners if gene-editing therapy exa-cel wins regulatory approvals.,VRTX,0.108712,0.182907,Somewhat-Bullish
Wall Street Expects This Stock to Jump 70% This Year. Here's Why It Could Happen.,https://www.fool.com/investing/2023/02/09/wall-street-expects-this-stock-jump-70-this-year/,2023-02-09 10:30:00,CRISPR shares are ripe for a rebound after dropping 46% last year.,VRTX,0.063594,0.183244,Somewhat-Bullish
2 Top Biotech Stocks Defying the Bear Market,https://www.fool.com/investing/2023/02/08/2-top-biotech-stocks-defying-the-bear-market/,2023-02-08 19:00:00,These stocks soared in the double digits last year.,VRTX,0.129866,0.122099,Neutral
AMGN: 5 Biotech Stocks That Could Make You Rich in 10 Years,https://stocknews.com/news/amgn-vrtx-uthr-jazz-exel-5-biotech-stocks-that-could-make-you-rich-in-10/,2023-02-08 18:54:11,"Despite the lingering macroeconomic headwinds, mergers and acquisitions in the biotech industry are getting back to normal levels as larger companies are making acquisitions to realize their growth plans and gain access to innovative technologies.",VRTX,0.146173,0.199949,Somewhat-Bullish
"Vertex  ( VRTX )  Beats on Q4 Earnings & Sales, '23 View Encouraging",https://www.zacks.com/stock/news/2051745/vertex-vrtx-beats-on-q4-earnings-sales-23-view-encouraging,2023-02-08 15:53:00,Vertex Pharmaceuticals' (VRTX) four-quarter 2022 earnings and sales beat estimates. VRTX also issues better-than-expected revenue guidance for 2023.,VRTX,0.190868,0.071258,Neutral
What's Going On With Vertex Pharmaceuticals  ( VRTX )  Stock Wednesday? - Vertex Pharmaceuticals  ( NASDAQ:VRTX ) ,https://www.benzinga.com/news/earnings/23/02/30811202/whats-going-on-with-vertex-pharmaceuticals-vrtx-stock-wednesday,2023-02-08 14:24:54,Vertex Pharmaceuticals Incorporated VRTX shares are trading lower by 1.44% to $304.10 Wednesday morning. The company on Tuesday reported fourth-quarter financial results. Vertex Pharmaceuticals reported quarterly earnings of $3.76 cents per share which was above the analyst consensus estimate of ...,VRTX,0.774534,0.376085,Bullish
Futures: AI Frenzy Intensifies; Three Earnings Winners,https://www.investors.com/market-trend/stock-market-today/dow-jones-futures-ai-arms-race-fortinet-enphase-uber-jump-on-earnings/,2023-02-08 13:22:00,"Dow Jones Futures Fall, AI Arms Race Intensifies. Fortinet, Enphase ... Investor's Business Daily ...",VRTX,0.09239,0.037774,Neutral
Dow Jones Futures Fall; 6 Big Earnings Movers,https://www.investors.com/market-trend/stock-market-today/dow-jones-futures-fall-chipotle-dives-on-earnings-uber-surges-on-upbeat-outlook/,2023-02-08 13:22:00,Dow Jones Futures Fall. Chipotle Dives On Earnings. Uber Surges ... Investor's Business Daily ...,VRTX,0.058259,0.0,Neutral
1 Beaten-Down Stock That Has a Lot to Prove in 2023,https://www.fool.com/investing/2023/02/08/1-beaten-down-stock-that-has-a-lot-to-prove-in-202/,2023-02-08 13:05:00,"This biotech looks like a high-risk, high-reward play.",VRTX,0.054114,0.09076,Neutral
Here's What Key Metrics Tell Us About Vertex  ( VRTX )  Q4 Earnings,https://www.zacks.com/stock/news/2051382/heres-what-key-metrics-tell-us-about-vertex-vrtx-q4-earnings,2023-02-08 10:35:00,"Although the revenue and EPS for Vertex (VRTX) give a sense of how its business performed in the quarter ended December 2022, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.",VRTX,0.114137,0.078661,Neutral
Vertex Pharmaceuticals  ( VRTX )  Q4 2022 Earnings Call Transcript,https://www.fool.com/earnings/call-transcripts/2023/02/08/vertex-pharmaceuticals-vrtx-q4-2022-earnings-call/,2023-02-08 06:00:38,"VRTX earnings call for the period ending December 31, 2022.",VRTX,0.00457,0.158843,Somewhat-Bullish
"Stocks Rally On Powell, AI Arms Race; 5 Earnings Movers Late",https://www.investors.com/market-trend/stock-market-today/dow-jones-futures-market-rallies-on-powell-microsoft-ai-arms-race-fortinet-enphase-jump-on-earnings/,2023-02-07 22:22:00,"Dow Jones Futures: Market Rallies On Powell, Microsoft AI Arms ... Investor's Business Daily ...",VRTX,0.106188,0.045702,Neutral
Vertex Pharmaceuticals  ( VRTX )  Q4 Earnings and Revenues Beat Estimates,https://www.zacks.com/stock/news/2051205/vertex-pharmaceuticals-vrtx-q4-earnings-and-revenues-beat-estimates,2023-02-07 22:15:04,"Vertex (VRTX) delivered earnings and revenue surprises of 6.52% and 0.50%, respectively, for the quarter ended December 2022. Do the numbers hold clues to what lies ahead for the stock?",VRTX,0.140896,0.09672,Neutral
Why Vertex Pharmaceuticals  ( VRTX )  Stock Is Moving During Tuesday's After-Hours Session - Vertex Pharmaceuticals  ( NASDAQ:VRTX ) ,https://www.benzinga.com/news/earnings/23/02/30781665/why-vertex-pharmaceuticals-stock-is-moving-during-tuesdays-after-hours-session,2023-02-07 21:52:03,Vertex Pharmaceuticals Incorporated VRTX shares are trading marginally lower by 0.82% to $306.00 during Tuesday's after-hours session. The company reported worse-than-expected fourth-quarter EPS results. Vertex Pharmaceuticals reported quarterly earnings of 76 cents per share which missed the ...,VRTX,0.807885,0.344555,Somewhat-Bullish
Vertex Offers Upbeat Guidance After Profit Beat,https://www.investors.com/news/technology/vrtx-stock-vertex-earnings-q4-2022/,2023-02-07 21:11:00,"VRTX Stock: Guidance Upbeat After Quarterly Profit Beat, Sales In ... Investor's Business Daily ...",VRTX,0.904419,0.360358,Bullish
Vertex Pharmaceuticals Battles Back With A Boost To 81 RS Rating,https://www.investors.com/research/vertex-pharmaceuticals-shows-rising-price-performance-with-jump-to-81-rs-rating/,2023-02-07 15:45:00,"On Tuesday, Vertex Pharmaceuticals ( VRTX ) hit an important performance benchmark, with its Relative Strength ( RS ) Rating moving into the 80-plus percentile with an upgrade to 81, a rise from 73 the day before. Keep in mind it hit a roadblock as it tried to break through a pivot point.",VRTX,0.241684,0.108691,Neutral
Futures Mixed Ahead Of Powell Speech,https://www.investors.com/market-trend/stock-market-today/dow-jones-futures-fall-ahead-of-powell-speech-bbby-shares-crash-on-proposed-equity-offering/,2023-02-07 13:23:00,Dow Jones Futures Fall Ahead Of Powell Speech. BBBY Shares ... Investor's Business Daily ...,VRTX,0.051386,-0.1985,Somewhat-Bearish
Morning Bid: Powell's state of the union,https://www.reuters.com/markets/us/global-markets-view-usa-2023-02-07/,2023-02-07 11:03:35,"A look at the day ahead in U.S. and global markets from Mike Dolan. While U.S. President Joe Biden gets set to deliver his second ""State of the Union"" address late on Tuesday, world markets will be more in thrall to what his Federal Reserve Chair makes of an increasingly confusing economic picture.",VRTX,0.063091,0.0,Neutral
3 Top Stocks to Buy If There Is a Market Pullback,https://www.fool.com/investing/2023/02/07/3-top-stocks-to-buy-if-there-is-a-market-pullback/,2023-02-07 10:55:00,All three of these stocks performed well as the market fell in 2022.,VRTX,0.122894,0.025144,Neutral
3 Nasdaq 100 Stocks to Buy Hand Over Fist in February,https://www.fool.com/investing/2023/02/07/3-nasdaq-100-stocks-to-buy-hand-over-fist-february/,2023-02-07 10:06:00,The growth-focused Nasdaq 100 is home to three exceptional deals.,VRTX,0.091743,0.032409,Neutral
Vertex Pharmaceuticals Battles Back With A Boost To 81 RS Rating,https://www.investors.com/research/vertex-pharmaceuticals-shows-rising-price-performance-with-jump-to-81-rs-rating/,2023-02-07 08:00:00,Vertex Pharmaceuticals Shows Rising Price Performance With Jump ... Investor's Business Daily ...,VRTX,0.241684,0.108691,Neutral
Futures: Key Powell Speech On Deck; 4 Earnings Movers,https://www.investors.com/market-trend/stock-market-today/dow-jones-drops-ahead-of-key-powell-speech-pinterest-plunges-on-earnings/,2023-02-06 22:00:00,Dow Jones Drops Ahead Of Key Powell Speech. Pinterest Plunges ... Investor's Business Daily ...,VRTX,0.060312,-0.237122,Somewhat-Bearish
"Biotech Stocks' Q4 Earnings Due on Feb 7: VRTX, INCY and EXEL",https://www.zacks.com/stock/news/2050425/biotech-stocks-q4-earnings-due-on-feb-7-vrtx-incy-and-exel,2023-02-06 15:30:00,"Let us take a look at what is in store for some of the biotech stocks VRTX, INCY and EXEL, which are scheduled to report on Feb 7.",VRTX,0.214937,0.0,Neutral
Stocks Slide To Start Week; Tesla Rallies After Musk Verdict,https://www.investors.com/market-trend/stock-market-today/dow-jones-futures-fall-200-points-tesla-stock-rallies-on-musk-verdict-twitter-comments/,2023-02-06 15:14:00,Dow Jones Falls 175 Points As Tesla Stock Rallies On Musk Verdict ... Investor's Business Daily ...,VRTX,0.055751,-0.17193,Somewhat-Bearish
Ready to Buy the Dip? Consider This Gene Editing Stock,https://www.fool.com/investing/2023/02/06/ready-to-buy-dip-consider-this-gene-editing-stock/,2023-02-06 13:15:00,"CRISPR Therapeutics shares had a rough 2022, but the stock might soon surge back.",VRTX,0.056275,0.201059,Somewhat-Bullish
3 Cathie Wood Stocks Wall Street Thinks Can Soar 60% to 129%,https://www.fool.com/investing/2023/02/06/3-cathie-wood-stocks-wall-street-thinks-can-soar/,2023-02-06 10:55:00,Cathie Wood is bullish about these stocks. And so are Wall Street analysts.,VRTX,0.050254,0.187282,Somewhat-Bullish
Is a Recession on the Way? Here's What the Top 7 Indicators Say.,https://www.fool.com/investing/2023/02/06/recession-on-way-heres-top-7-indicators-say/,2023-02-06 10:52:00,"If these indicators were in a Magic 8 Ball, they'd probably say, ""Ask again later."" ...",VRTX,0.104911,0.098653,Neutral
PTC Therapeutics Joins Rank Of Stocks With RS Ratings Over 90,https://www.investors.com/ibd-data-stories/ptc-therapeutics-joins-rank-of-stocks-with-rs-ratings-over-90-2/,2023-02-06 08:00:00,"PTC Therapeutics ( PTCT ) saw a welcome improvement to its Relative Strength ( RS ) Rating on Monday, with an upgrade from 88 to 91. When you're researching the best stocks to buy and watch, be sure to pay attention to relative price strength.",VRTX,0.31482,0.12658,Neutral
Penny Stocks & What To Watch in the Stock Market This Week 2/6-2/10,https://pennystocks.com/featured/2023/02/05/penny-stocks-what-to-watch-in-the-stock-market-this-week-2-6-2-10-2023/,2023-02-05 18:23:25,"Whether you're trading penny stocks or higher-priced stocks, knowing what's going on in the stock market this week can give you an edge. Following last week's January/February Fed meeting and surprise earnings from some of Wall Street's top holdings, volatility is undoubtedly here to stay.",VRTX,0.063425,0.0,Neutral
Stock Market Investing Action Plan: Nasdaq's Best January in 22 Years,https://www.investors.com/research/investing-action-plan/stock-market-investing-action-plan-nasdaq-best-january-in-22-years/,2023-02-03 23:28:00,"January provided a hospitable start to 2023, giving investors a reminder of what upward stock market momentum feels like. Friday's jobs report rattled hopes for a dovish Fed, and Jerome Powell may further that message on Tuesday.",VRTX,0.038592,0.176377,Somewhat-Bullish
Stock Market Investing Action Plan: Nasdaq's Best January in 22 Years,https://www.investors.com:443/research/investing-action-plan/stock-market-investing-action-plan-nasdaq-best-january-in-22-years/,2023-02-03 23:28:00,"January provided a hospitable start to 2023, giving investors a reminder of what upward stock market momentum feels like. Friday's jobs report rattled hopes for a dovish Fed, and Jerome Powell may further that message on Tuesday.",VRTX,0.038592,0.176377,Somewhat-Bullish
Vertex  ( VRTX )  to Report Q4 Earnings: What's in the Cards?,https://www.zacks.com/stock/news/2049772/vertex-vrtx-to-report-q4-earnings-whats-in-the-cards,2023-02-03 19:02:00,"On Vertex Pharmaceuticals' (VRTX) Q4 earnings call, investors will likely focus on the sales performance of its cystic fibrosis medicines and updates on its non-CF pipeline candidates.",VRTX,0.29887,0.156806,Somewhat-Bullish
3 No-Brainer Growth Stocks to Buy in 2023,https://www.fool.com/investing/2023/02/03/3-no-brainer-growth-stocks-to-buy-in-2023/,2023-02-03 19:00:00,These stocks all fell by double digits last year.,VRTX,0.053509,0.0,Neutral
"Dow Jones' Rebound Fades; Tesla Revs Up On Record China Sales, Surprise EV Tax Credit",https://www.investors.com/market-trend/stock-market-today/dow-jones-falls-teslas-record-china-sales-meme-investor-cohen-buys-struggling-nordstrom/,2023-02-03 18:56:00,Dow Jones' Rebound Fades. Tesla Revs Up On Record China ... Investor's Business Daily ...,VRTX,0.136113,0.0,Neutral
Why Editas Medicine's Shares Jumped This Week,https://www.fool.com/investing/2023/02/03/why-editas-medicines-shares-jumped-this-week/,2023-02-03 17:10:58,The gene-editing biotech's shares have had a strong two-week run.,VRTX,0.235823,0.038082,Neutral
2 Unstoppable Growth Stocks to Buy in 2023 and Beyond,https://www.fool.com/investing/2023/02/03/2-unstoppable-growth-stocks-to-buy-in-2023-and-bey/,2023-02-03 14:37:00,These companies should be able to carry their momentum well beyond this year.,VRTX,0.275867,0.170308,Somewhat-Bullish
"ABBV: The 5 Best Stocks to Invest $1,000 in Right Now",https://stocknews.com/news/abbv-vrtx-musa-mcft-pnrg-the-5-best-stocks-to-invest-1000-in-right-now/,2023-02-03 14:16:57,"The cooling inflation, historically tight labor market, China's move to reopen its economy, and signs of easing energy market stress have all contributed significantly to the improvement in investors' sentiment in recent weeks. The S&P 500 index's 8.9% rise in 2023 shows optimism in the stock ...",VRTX,0.10234,0.157717,Somewhat-Bullish
"BioRestorative  ( NASDAQ: BRTX )  Ramps Up Production In Anticipation Of Positive Phase 2 Results - Biomarin Pharmaceutical  ( NASDAQ:BMRN ) , BioRestorative Therapies  ( NASDAQ:BRTX ) ",https://www.benzinga.com/general/biotech/23/02/30706675/biorestorative-nasdaq-brtx-ramps-up-production-in-anticipation-of-positive-phase-2-results,2023-02-03 14:03:30,"Chronic lumbar disc disease ( cLDD ) is a debilitating condition affecting millions of people worldwide. It is characterized by back pain, stiffness, and restricted movement due to damage to the bony discs in the lower back.",VRTX,0.167322,0.0,Neutral
Nasdaq 'Power Trend' Igniting Demand For These Tech Stocks,https://www.investors.com/etfs-and-funds/mutual-funds/best-mutual-funds-bet-on-5ech-stocks-including-11-semiconductor-stocks/,2023-02-03 13:01:00,Tech Bounces Back: The Best Mutual Funds Bet On These 11 ... Investor's Business Daily ...,VRTX,0.104455,0.028871,Neutral
Is Editas Medicine Stock a Buy Now?,https://www.fool.com/investing/2023/02/03/is-editas-medicine-stock-a-buy-now/,2023-02-03 11:15:00,Layoffs and a thin clinical-stage pipeline aren't very encouraging.,VRTX,0.060236,0.201386,Somewhat-Bullish
Strength Seen in CRISPR Therapeutics AG  ( CRSP ) : Can Its 7.2% Jump Turn into More Strength?,https://www.zacks.com/stock/news/2049303/strength-seen-in-crispr-therapeutics-ag-crsp-can-its-72-jump-turn-into-more-strength,2023-02-03 08:52:00,CRISPR Therapeutics AG (CRSP) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might help the stock continue moving higher in the near term.,VRTX,0.110973,0.113164,Neutral
Ultragenyx  ( RARE )  Expected to Beat Earnings Estimates: What to Know Ahead of Q4 Release,https://www.zacks.com/stock/news/2048469/ultragenyx-rare-expected-to-beat-earnings-estimates-what-to-know-ahead-of-q4-release,2023-02-02 15:00:53,Ultragenyx (RARE) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.,VRTX,0.088799,0.038143,Neutral
2 Surefire Stocks to Buy in 2023 and Hold for at Least the Next Decade,https://www.fool.com/investing/2023/02/02/2-surefire-stocks-to-buy-in-2023-and-hold-at-least/,2023-02-02 14:53:00,These stocks are growing steadily and have a solid history of enriching shareholders.,VRTX,0.179788,0.160078,Somewhat-Bullish
3 No-Brainer Stocks to Buy in February,https://www.fool.com/investing/2023/02/02/3-no-brainer-stocks-to-buy-in-february/,2023-02-02 10:52:00,Going with these stocks should be an easy decision.,VRTX,0.13459,0.254695,Somewhat-Bullish
Legend Biotech ADR Shows Rising Price Performance With Jump To 82 RS Rating,https://www.investors.com/ibd-data-stories/legend-biotech-adr-shows-rising-price-performance-with-jump-to-82-rs-rating/,2023-02-02 08:00:00,Legend Biotech ADR Shows Rising Price Performance With Jump ... Investor's Business Daily ...,VRTX,0.360752,0.0,Neutral
Vertex Pharmaceuticals  ( VRTX )  Stock Sinks As Market Gains: What You Should Know,https://www.zacks.com/stock/news/2047963/vertex-pharmaceuticals-vrtx-stock-sinks-as-market-gains-what-you-should-know,2023-02-01 22:45:23,"In the latest trading session, Vertex Pharmaceuticals (VRTX) closed at $317.27, marking a -1.8% move from the previous day.",VRTX,0.751437,0.351941,Bullish
VRTX: 3 Biotech Stocks to Get in on Before It's Too Late,https://stocknews.com/news/vrtx-biib-jazz-3-biotech-stocks-to-get-in-on-before-its-too/,2023-02-01 16:33:13,The rising prominence of personalized medicine and an increasing number of orphan drug formulations are spurring the growth in the biotech sector.,VRTX,0.22792,0.174237,Somewhat-Bullish
A New Bull Market Could Arrive in February: 3 Stocks to Buy Now,https://www.fool.com/investing/2023/02/01/new-bull-market-february-stocks-to-buy-now/,2023-02-01 10:52:00,The bulls could be about to take over again. And these stocks are poised to be big winners.,VRTX,0.108712,0.175046,Somewhat-Bullish
"This Clue Helps Spot The Best Stocks To Watch, Including These 11",https://www.investors.com/research/best-stocks-to-watch-in-top-ranked-industry-groups/,2023-01-31 20:16:00,Stock market history shows the best stocks to buy and watch often hail from the top-ranked industry groups. It's a telltale clue to help jump-start your search for potential big winners.,VRTX,0.163354,0.132066,Neutral
Stock Market Eyes Fear Gauge Ahead Of Fed; This Biotech Nears Major Breakout: AMD Could Sink Chips,https://www.investors.com/market-trend/stock-market-today/stock-market-firm-but-fear-gauge-rises-amd-could-sink-chips-mcdonalds-caterpillar-sell-off/,2023-01-31 16:57:00,Stock Market Eyes Fear Gauge Ahead Of Fed. This Biotech Nears ... Investor's Business Daily ...,VRTX,0.173333,0.055519,Neutral
Vertex Pharmaceuticals  ( VRTX )  Earnings Expected to Grow: What to Know Ahead of Next Week's Release,https://www.zacks.com/stock/news/2047037/vertex-pharmaceuticals-vrtx-earnings-expected-to-grow-what-to-know-ahead-of-next-weeks-release,2023-01-31 15:00:51,Vertex (VRTX) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.,VRTX,0.102231,0.129563,Neutral
3 Things About CRISPR Therapeutics That Smart Investors Know,https://www.fool.com/investing/2023/01/31/3-things-about-crispr-that-smart-investors-know/,2023-01-31 15:00:00,The gene-therapy specialist's near-term outlook is quite bullish.,VRTX,0.124164,0.295726,Somewhat-Bullish
"Got $1,500? These 2 Stocks Could Be Bargain Buys for 2023 and Beyond",https://www.fool.com/investing/2023/02/19/got-1500-these-2-stocks-could-be-bargain-buys-for/,2023-02-19 15:00:00,These companies are raking in profits and growing at a speed that outpaces the competition.,VRTX,0.165598,0.251568,Somewhat-Bullish
2 No-Brainer Growth Stocks to Buy Right Now,https://www.fool.com/investing/2023/02/19/2-no-brainer-growth-stocks-to-buy-right-now/,2023-02-19 14:45:00,Don't let these incredible businesses pass you by.,VRTX,0.18343,0.192826,Somewhat-Bullish
A Recession Could Be More Likely Now: Here's What Investors Should Do,https://www.fool.com/investing/2023/02/18/recession-more-likely-now-what-investors-should-do/,2023-02-18 11:55:00,There's one strategy that's the best approach of all.,VRTX,0.107978,0.081309,Neutral
3 Top Stocks to Buy and Hold for the Next Decade and Beyond,https://www.fool.com/investing/2023/02/18/3-top-stocks-to-buy-and-hold-for-the-next-decade-a/,2023-02-18 10:50:00,The sky is the limit for these stocks.,VRTX,0.165409,0.016827,Neutral
Beat the Dow Jones With CRISPR Therapeutics Stock,https://www.fool.com/investing/2023/02/17/beat-the-dow-jones-with-crispr-therapeutics-stock/,2023-02-17 19:00:00,"If approved, CRISPR's first product may deliver blockbuster sales.",VRTX,0.059488,0.0,Neutral
These 2 Biotech Stocks Could Soar in the Next Bull Market,https://www.fool.com/investing/2023/02/17/these-2-biotech-stocks-could-soar-in-the-next-bull/,2023-02-17 15:23:00,They're both at the cutting edge of gene-editing technology.,VRTX,0.057907,0.131023,Neutral
Chances of a New Bull Market Fading? 2 Great Stocks to Buy Anyway,https://www.fool.com/investing/2023/02/17/chances-new-bull-market-fading-stocks-to-buy/,2023-02-17 10:55:00,These two stocks are unstoppable leaders.,VRTX,0.095899,0.410401,Bullish
Is Exact Sciences or Editas Medicine the Better Growth Stock to Own in 2023?,https://www.fool.com/investing/2023/02/16/is-exact-sciences-or-editas-medicine-the-better-gr/,2023-02-16 16:00:00,Which of these rebounding biotech stocks is the better buy right now?,VRTX,0.067158,0.126842,Neutral
Moderna  ( MRNA )  to Report Q4 Earnings: What's in the Cards?,https://www.zacks.com/stock/news/2055420/moderna-mrna-to-report-q4-earnings-whats-in-the-cards,2023-02-16 15:10:00,"Investors focus will likely be on Moderna's (MRNA) pipeline, especially with its late-stage pipeline candidates, when it reports fourth-quarter earnings.",VRTX,0.050572,-0.061496,Neutral
2 Monster Stocks to Buy Hand Over Fist in 2023,https://www.fool.com/investing/2023/02/16/2-monster-stocks-to-buy-hand-over-fist-in-2023/,2023-02-16 11:07:00,A pandemic favorite and a healthcare growth stock each have something to add to the long-term investor's portfolio.,VRTX,0.288893,0.252785,Somewhat-Bullish
"Robinhood, Merck And 2 Other Stocks Insiders Are Selling - Merck & Co  ( NYSE:MRK ) , Robinhood Markets  ( NASDAQ:HOOD ) ",https://www.benzinga.com/news/23/02/30922910/robinhood-merck-and-2-other-stocks-insiders-are-selling,2023-02-15 13:03:58,"The Nasdaq closed higher by around 0.6% on Tuesday, also recording losses for the week. Investors, meanwhile, focused on some notable insider trades. When insiders sell shares, it indicates their concern in the company's prospects or that they view the stock as being overpriced.",VRTX,0.421485,0.132811,Neutral
4 Healthcare Mutual Funds to Buy in the Post-Pandemic Period,https://www.zacks.com/stock/news/2054428/4-healthcare-mutual-funds-to-buy-in-the-post-pandemic-period,2023-02-15 10:34:00,"FBTIX, PHSYX, JNGLX and VGHCX are four healthcare mutual funds that can lend solidity to one's portfolio today and provide big returns in the foreseeable future.",VRTX,0.050572,0.064481,Neutral
3 Prime Healthcare Takeover Targets,https://www.fool.com/investing/2023/02/14/3-prime-healthcare-takeover-targets/,2023-02-14 12:10:00,These three companies are attractive targets for their potential.,VRTX,0.080055,0.11394,Neutral
3 Growth Stocks With More Potential Than Any Cryptocurrency,https://www.fool.com/investing/2023/02/13/3-growth-stocks-with-more-potential-than-crypto/,2023-02-13 14:15:00,Setting your portfolio up for robust long-term returns doesn't have to be complicated.,VRTX,0.101154,0.199151,Somewhat-Bullish
2 Top Healthcare Stocks to Buy for the Long Haul,https://www.fool.com/investing/2023/02/13/2-top-healthcare-stocks-to-buy-for-the-long-haul/,2023-02-13 13:30:00,"The healthcare industry is booming, and this presents no shortage of opportunities to invest in promising businesses.",VRTX,0.263942,0.293654,Somewhat-Bullish
3 Unstoppable Growth Stocks to Buy for 2023 and Beyond,https://www.fool.com/investing/2023/02/13/3-unstoppable-growth-stocks-to-buy-2023-and-beyond/,2023-02-13 10:50:00,The future looks really bright for these businesses -- and their stocks.,VRTX,0.116631,0.141776,Neutral
2 Top Stocks to Buy in February and Hold Forever,https://www.fool.com/investing/2023/02/13/2-top-stocks-to-buy-in-february-and-hold-forever/,2023-02-13 10:25:00,These healthcare giants are profitable and have wide moats.,VRTX,0.297301,0.315938,Somewhat-Bullish
"The Best Stocks To Invest $5,000 in Right Now",https://www.fool.com/investing/2023/02/12/the-best-stocks-to-invest-5000-in-right-now/,2023-02-12 10:50:00,The time is right for each of these great stocks.,VRTX,0.108466,0.220102,Somewhat-Bullish
These Cheap Growth Stocks Could Supercharge Your Portfolio,https://www.fool.com/investing/2023/02/12/these-cheap-growth-stocks-could-boost-portfolio/,2023-02-12 10:30:00,All of these players are cheap today considering their growth potential.,VRTX,0.04912,0.046963,Neutral
3 Surefire Growth Stocks You Can Buy Right Now,https://www.fool.com/investing/2023/02/11/3-surefire-growth-stocks-you-can-buy-right-now/,2023-02-11 19:31:00,Maybe there's no such thing as a sure thing. But these stocks could come close.,VRTX,0.173333,0.254048,Somewhat-Bullish
2 Biotech Stocks That Could Help Set You Up for Life,https://www.fool.com/investing/2023/02/11/2-biotech-stocks-that-could-help-set-up-for-life/,2023-02-11 18:13:00,The two companies have seen similar share growth over the past year.,VRTX,0.098054,0.200652,Somewhat-Bullish
This Growth Stock Crushed the Market Last Year. 5 Words from the CEO Suggest There's More to Come.,https://www.fool.com/investing/2023/02/11/this-growth-stock-crushed-the-market-last-year-5-w/,2023-02-11 10:30:00,Vertex climbed 31% last year even as the overall market fell.,VRTX,0.114137,0.21069,Somewhat-Bullish
Stocks Pull Back; Google Dives On AI Flop: Weekly Review,https://www.investors.com/news/stock-market-pulls-back-treasury-yields-jump-google-dives-on-ai-flop/,2023-02-10 15:20:00,Stocks Pull Back. Google Dives On AI Flop: Weekly Review Investor's Business Daily ...,VRTX,0.050786,0.049996,Neutral
Could CRISPR Therapeutics Stock Help You Become a Millionaire?,https://www.fool.com/investing/2023/02/10/could-crispr-therapeutics-stock-help-you-become-a/,2023-02-10 13:30:00,"The gene-editing business has loads of potential, but is it enough to make you rich?",VRTX,0.064104,0.220439,Somewhat-Bullish
3 Stocks That Could Soar Whether There's a New Bull Market or Not,https://www.fool.com/investing/2023/02/10/stocks-could-soar-new-bull-market-or-not/,2023-02-10 10:52:00,These stocks could enjoy their own bull markets regardless of what the overall market does.,VRTX,0.110717,0.1722,Somewhat-Bullish
2 Top Stocks to Buy Without Hesitation in 2023,https://www.fool.com/investing/2023/02/10/2-top-stocks-to-buy-without-hesitation-in-2023/,2023-02-10 10:35:00,These healthcare giants have a long track record of enriching investors.,VRTX,0.270202,0.264824,Somewhat-Bullish
Is Vertex Pharmaceuticals Stock a Buy Right Now?,https://www.fool.com/investing/2023/02/10/is-vertex-pharmaceuticals-stock-a-buy-right-now/,2023-02-10 10:17:00,"The drugmaker outperformed the broad market by a mile in 2022, but could there be further gains?",VRTX,0.198493,0.282742,Somewhat-Bullish
ImmunoGen Allows Vertex Pharma Use Its Technology For Conditioning Agents For Use With Gene Editing - Immunogen  ( NASDAQ:IMGN ) ,https://www.benzinga.com/general/biotech/23/03/31126063/immunogen-allows-vertex-pharma-use-its-technology-for-conditioning-agents-for-use-with-gene-editi,2023-03-01 16:27:02,"ImmunoGen Inc IMGN announced a global, multi-target license and option agreement that granted Vertex Pharmaceuticals Incorporated VRTX rights for ImmunoGen's ADC technology to discover targeted conditioning agents for use with gene editing.",VRTX,0.363388,0.385475,Bullish
VRTX: 2 Bargain Stocks to Buy For 2023 And Beyond,https://stocknews.com/news/vrtx-kr-2-bargain-stocks-to-buy-for-2023-and-beyond/,2023-03-01 16:16:59,"U.S. inflation remains alarmingly high despite the Fed's relentless efforts to tame it. Although inflation has shown signs of slowing over the past few months, Fed officials have indicated further rate hikes ahead.",VRTX,0.362254,0.348355,Somewhat-Bullish
Here's How Much You Can Make From Investing Your Tax Return Every Year,https://www.fool.com/investing/2023/02/27/heres-how-much-you-can-make-from-investing-your-ta/,2023-02-27 12:15:00,Doing this can strengthen your retirement plan.,VRTX,0.05339,0.053016,Neutral
Earn Massive 10%+ Yields With These 5 Funds,https://www.forbes.com/sites/brettowens/2023/02/26/earn-massive-10-yields-with-these-5-funds/,2023-02-26 12:30:00,Bull or bear? Who cares when we can collect dividends between 10.1% and 11.8%.,VRTX,0.050359,0.067786,Neutral
3 Stocks to Buy Right Now That Are Cash Cows,https://www.fool.com/investing/2023/02/25/3-stocks-to-buy-right-now-that-are-cash-cows/,2023-02-25 11:25:00,"If cash is king, these three stocks should wear crowns.",VRTX,0.163631,-0.031846,Neutral
"3 Top Stocks to Invest $3,000 in Right Now",https://www.fool.com/investing/2023/02/25/3-top-stocks-to-invest-3000-in-right-now/,2023-02-25 10:50:00,These three stocks have tremendous growth prospects.,VRTX,0.16099,0.218529,Somewhat-Bullish
Nasdaq Bear Market: 5 Superb Growth Stocks You'll Regret Not Buying on the Dip,https://www.fool.com/investing/2023/02/25/nasdaq-bear-market-5-growth-stocks-regret-not-buy/,2023-02-25 10:06:00,A 33% plunge in the Nasdaq Composite is the perfect excuse for opportunistic investors to pounce on innovation-driven businesses.,VRTX,0.081276,0.142667,Neutral
Regenerative Medicine Market is Expected to Reach $40.6 Billion | MarketsandMarkets.,https://www.benzinga.com/pressreleases/23/02/g31045680/regenerative-medicine-market-is-expected-to-reach-40-6-billion-marketsandmarkets,2023-02-24 12:30:00,"Chicago, Feb. 24, 2023 ( GLOBE NEWSWIRE ) -- Regenerative medicine is an emerging field of medicine that is focused on using the body's natural healing processes to repair and regenerate damaged tissue.",VRTX,0.076358,0.116363,Neutral
"Moderna  ( MRNA )  Lags on Q4 Earnings, COVID Jab Sales Down Y/Y",https://www.zacks.com/stock/news/2058315/moderna-mrna-lags-on-q4-earnings-covid-jab-sales-down-yy,2023-02-23 17:08:00,Moderna's (MRNA) fourth-quarter earnings and sales miss expectations. Management reiterates guidance to record a minimum of $5 billion from COVID vaccine sales in 2023.,VRTX,0.135857,0.110412,Neutral
Crispr Therapeutics Stock Gains on Hope for Sickle-Cell Gene Therapy,https://www.barrons.com/articles/crispr-therapeutics-stock-fda-sickle-cell-gene-therapy-bf56a18c,2023-02-22 21:10:00,Crispr Therapeutics: FDA Filing on Sickle Cell Gene Therapy Is Almost Done ...,VRTX,0.690822,-0.127082,Neutral
"CRISPR  ( CRSP )  Q4 Earnings Surpass Estimates, Sales Miss",https://www.zacks.com/stock/news/2057623/crispr-crsp-q4-earnings-surpass-estimates-sales-miss,2023-02-22 17:42:00,"CRISPR Therapeutics' (CRSP) fourth-quarter 2022 loss is narrower than expected, while sales miss estimates.",VRTX,0.206245,-0.039037,Neutral
"The Zacks Analyst Blog Highlights JPMorgan Chase, Elevance Health, Vertex Pharmaceuticals, Sony Group and General Mills",https://www.zacks.com/stock/news/2057534/the-zacks-analyst-blog-highlights-jpmorgan-chase-elevance-health-vertex-pharmaceuticals-sony-group-and-general-mills,2023-02-22 15:31:00,"JPMorgan Chase, Elevance Health, Vertex Pharmaceuticals, Sony Group and General Mills are part of the Zacks top Analyst Blog.",VRTX,0.699089,0.0,Neutral
Better Buy: Beam Therapeutics or Intellia Therapeutics?,https://www.fool.com/investing/2023/02/22/better-buy-beam-therapeutics-or-intellia-therapeut/,2023-02-22 11:00:00,The two clinical-stage gene-editing companies have good long-term prospects.,VRTX,0.051663,0.025006,Neutral
"Top Stock Reports for JPMorgan Chase, Elevance Health & Vertex Pharmaceuticals",https://www.zacks.com/research-daily/2056869/top-stock-reports-for-jpmorgan-chase-elevance-health-vertex-pharmaceuticals,2023-02-21 21:11:00,"Today's Research Daily features new research reports on 16 major stocks, including JPMorgan Chase & Co. (JPM), Elevance Health, Inc. (ELV) and Vertex Pharmaceuticals Incorporated (VRTX).",VRTX,0.235252,0.151036,Somewhat-Bullish
2 Bruised Growth Stocks to Buy While They're Cheap,https://www.fool.com/investing/2023/02/21/2-bruised-growth-stocks-to-buy-while-theyre-cheap/,2023-02-21 14:53:00,"Both are on the verge of fast growth, and they haven't had any major setbacks yet.",VRTX,0.058903,0.026003,Neutral
3 Healthcare Stocks to Buy and Hold for the Next 10 Years,https://www.fool.com/investing/2023/02/21/3-healthcare-stocks-to-buy-and-hold-next-10-years/,2023-02-21 11:45:00,These stocks have something to offer every type of investor.,VRTX,0.145583,0.082868,Neutral
Vertex Pharmaceuticals  ( VRTX )  Gains As Market Dips: What You Should Know,https://www.zacks.com/stock/news/2064395/vertex-pharmaceuticals-vrtx-gains-as-market-dips-what-you-should-know,2023-03-10 21:45:20,"In the latest trading session, Vertex Pharmaceuticals (VRTX) closed at $287.24, marking a +0.13% move from the previous day.",VRTX,0.656549,0.121263,Neutral
5 Best ETFs Tracking CRISPR Gene Editing,https://www.fool.com/investing/stock-market/market-sectors/healthcare/genomics-stocks/crispr-etfs/,2023-03-10 20:45:33,These exchange-traded funds track companies in this biotech space.,VRTX,0.087503,0.094818,Neutral
"Dow Jones Dips, Tech Stocks Pressured; First Republic Plunges 60% As Contagion Fears Hammer Financials",https://www.investors.com/market-trend/stock-market-today/dow-jones-dips-tech-stocks-pressured-contagion-fears-hammer-financial-stocks-first-republic-plunges/,2023-03-10 15:36:00,"Dow Jones Dips, Tech Stocks Pressured. First Republic Plunges 60 ... Investor's Business Daily ...",VRTX,0.136888,-0.07103,Neutral
Vertex  ( VRTX )  to Begin Clinical Study on Type I Diabetes Drug,https://www.zacks.com/stock/news/2064147/vertex-vrtx-to-begin-clinical-study-on-type-i-diabetes-drug,2023-03-10 14:25:00,"Vertex Pharmaceuticals (VRTX) receives FDA clearance to begin clinical development of VX-264, which has the potential to treat type I diabetes.",VRTX,0.163354,0.074784,Neutral
This HealthCare Company Is Gearing Up for Its Next Launch: Here Is Why The Stock Is a Buy,https://www.fool.com/investing/2023/03/10/this-healthcare-company-is-gearing-up-for-its-next/,2023-03-10 13:30:00,The company's future in the stock market could look very much like its past.,VRTX,0.406745,0.160194,Somewhat-Bullish
"If You Invested $10,000 in CRISPR Therapeutics In 2020, This Is How Much You Would Have Today",https://www.fool.com/investing/2023/03/10/if-you-invested-10000-crispr-therapeutics-in-2020/,2023-03-10 13:15:00,The stock has been on a wild ride over the past few years.,VRTX,0.070105,0.049788,Neutral
Vertex  ( VRTX )  Down 2.8% Since Last Earnings Report: Can It Rebound?,https://www.zacks.com/stock/news/2063687/vertex-vrtx-down-28-since-last-earnings-report-can-it-rebound,2023-03-09 16:30:48,Vertex (VRTX) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.,VRTX,0.047749,0.097969,Neutral
2 Top Stocks to Buy in March and Hold Forever,https://www.fool.com/investing/2023/03/09/2-top-stocks-to-buy-in-march-and-hold-forever/,2023-03-09 14:53:00,Don't let a turbulent market keep you on the sidelines this month.,VRTX,0.107255,0.129334,Neutral
2 Explosive Stocks That Could Go Parabolic,https://www.fool.com/investing/2023/03/09/2-explosive-stocks-that-could-go-parabolic/,2023-03-09 14:00:00,Don't let these stocks pass you by when you go shopping for more wonderful businesses.,VRTX,0.120632,0.038041,Neutral
Missed Out on Vertex? My Best Gene-Editing Stock to Buy and Hold,https://www.fool.com/investing/2023/03/09/missed-out-on-vertex-my-best-gene-editing-stock-to/,2023-03-09 13:50:00,Get in on CRISPR Therapeutics before it gets expensive.,VRTX,0.112269,-0.033197,Neutral
4 Growth Stocks to Buy and Hold Forever,https://www.fool.com/investing/2023/03/09/4-growth-stocks-to-buy-and-hold-forever/,2023-03-09 10:52:00,These stocks have what it takes to achieve long-term success.,VRTX,0.162802,-0.126871,Neutral
2 Healthcare Stocks That Could Help Make You a Fortune,https://www.fool.com/investing/2023/03/08/2-healthcare-stocks-that-could-help-make-you-a-for/,2023-03-08 19:00:00,These companies also happen to be a bargain right now.,VRTX,0.053271,0.035812,Neutral
2 No-Brainer Growth Stocks to Buy Right Now,https://www.fool.com/investing/2023/03/08/2-no-brainer-growth-stocks-to-buy-right-now/,2023-03-08 10:57:00,These companies have what it takes to survive and thrive beyond the next bear market.,VRTX,0.277958,0.33308,Somewhat-Bullish
 ( VRTX )  - Analyzing Vertex Pharmaceuticals's Short Interest - Vertex Pharmaceuticals  ( NASDAQ:VRTX ) ,https://www.benzinga.com/short-sellers/23/03/31242705/vrtx-analyzing-vertex-pharmaceuticalss-short-interest,2023-03-07 17:15:44,"Vertex Pharmaceuticals's VRTX short percent of float has fallen 11.38% since its last report. The company recently reported that it has 2.80 million shares sold short, which is 1.09% of all regular shares that are available for trading.",VRTX,0.221819,0.083071,Neutral
Better Growth Stock: Moderna vs. CRISPR Therapeutics,https://www.fool.com/investing/2023/03/05/better-growth-stock-moderna-vs-crispr-therapeutics/,2023-03-05 10:30:00,Both stocks are ripe for a rebound.,VRTX,0.054114,0.132767,Neutral
3 Things About CRISPR Therapeutics That Smart Investors Know,https://www.fool.com/investing/2023/03/04/3-things-about-crispr-therapeutics-that-smart-inve/,2023-03-04 12:25:00,Institutional investors might be on to something.,VRTX,0.09495,0.164042,Somewhat-Bullish
3 Game-Changing Stocks to Buy in March,https://www.fool.com/investing/2023/03/04/3-game-changing-stocks-to-buy-in-march/,2023-03-04 11:14:00,Innovation is in these companies' DNA.,VRTX,0.275867,0.19738,Somewhat-Bullish
Prediction: These 3 S&P 500 Stocks Will at Least Double in 7 Years,https://www.fool.com/investing/2023/03/04/prediction-these-3-sp-500-stocks-will-double/,2023-03-04 10:52:00,These large-cap stocks should grow much larger.,VRTX,0.100518,0.166512,Somewhat-Bullish
GILD: 1 Resilient Growth Stock to Buy Now and Hold Forever,https://stocknews.com/news/gild-vrtx-biib-incy-1-resilient-growth-stock-to-buy-now-and-hold-forever/,2023-03-03 17:05:02,"After a brutal 2022, growth stocks are expected to stage a recovery amid cooling inflation, the Fed's downshift on monetary policy tightening, and recent economic data, including strong retail sales and job growth, hinting at the possibility of the economy getting a soft landing.",VRTX,0.06623,0.091152,Neutral
2 Soaring Stocks to Buy and Hold Through 2023 and Beyond,https://www.fool.com/investing/2023/03/03/2-soaring-stocks-to-buy-and-hold-through-2023-and/,2023-03-03 14:15:00,"Investors are bidding up shares of these companies, and there are good reasons for doing so.",VRTX,0.047371,0.0,Neutral
"2 Growth Stocks to Invest $1,000 in Right Now",https://www.fool.com/investing/2023/03/03/2-growth-stocks-to-invest-1000-in-right-now/,2023-03-03 13:41:00,Both of these biopharmas have major catalysts that are in play or drawing near.,VRTX,0.100518,0.059458,Neutral
3 Nasdaq 100 Stocks to Buy Hand Over Fist in March,https://www.fool.com/investing/2023/03/03/3-nasdaq-100-stocks-to-buy-hand-over-fist-in-march/,2023-03-03 10:21:00,The predominantly growth-oriented Nasdaq 100 is home to three amazing deals hiding in plain sight.,VRTX,0.118209,0.042173,Neutral
3 Incredible Growth Stocks to Buy if the Market Dips,https://www.fool.com/investing/2023/03/02/3-incredible-growth-stocks-to-buy-if-the-market-di/,2023-03-02 15:45:00,These top growth stocks sport premium valuations for a very good reason.,VRTX,0.113866,0.189198,Somewhat-Bullish
Here's Why You Should Add CRISPR Stock to Your Portfolio,https://www.zacks.com/stock/news/2068648/heres-why-you-should-add-crispr-stock-to-your-portfolio,2023-03-21 15:59:00,"CRISPR Therapeutics (CRSP), a top-ranked stock at present, is developing its lead pipeline candidate to treat TDT and SCD.",VRTX,0.112008,0.121311,Neutral
"Exelixis Stock Shows Market Leadership, Earns 81 RS Rating",https://www.investors.com/research/stocks-showing-improving-market-leadership-exelixis-earns-81-rs-rating/,2023-03-21 15:25:00,"Exelixis ( EXEL ) saw a welcome improvement to its Relative Strength ( RS ) Rating on Tuesday, with an increase from 66 to 81. Mostly related to the yesterday's gap up and today's continued move up. According to an article on Motley Fool, the rise is attributed to a stock buy-back.",VRTX,0.234684,0.0,Neutral
Buyer Beware: 3 Risks to Watch for With Biotech Stocks in 2023,https://www.fool.com/investing/2023/03/21/buyer-beware-3-risks-to-watch-for-with-biotech-sto/,2023-03-21 11:25:00,"It's still a decent time to invest, but you'll need to be more careful than usual.",VRTX,0.055109,0.0,Neutral
"The Best Stocks to Invest $20,000 in Right Now",https://www.fool.com/investing/2023/03/21/the-best-stocks-to-invest-20000-in-right-now/,2023-03-21 09:50:00,"These businesses are already strong, but they could grow much larger.",VRTX,0.098054,-0.059065,Neutral
Stocks Showing Improving Market Leadership: Exelixis Earns 81 RS Rating,https://www.investors.com/ibd-data-stories/stocks-showing-improving-market-leadership-exelixis-earns-81-rs-rating/,2023-03-21 08:00:00,Stocks Showing Improving Market Leadership: Exelixis Earns 81 RS ... Investor's Business Daily ...,VRTX,0.348103,0.0,Neutral
GILD: 3 Nasdaq Stocks That Could Carry Your Portfolio for Years,https://stocknews.com/news/gild-vrtx-adsk-3-nasdaq-stocks-that-could-carry-your-portfolio-for-years/,2023-03-20 19:46:36,"Nasdaq components Gilead Sciences, Inc. ( GILD ) , Vertex Pharmaceuticals Incorporated ( VRTX ) , and Autodesk, Inc.'s ( ADSK ) ever-improving performance could translate into impressive returns in the long run. In this piece, I have discussed several reasons I am bullish on these stocks despite ...",VRTX,0.236332,0.205616,Somewhat-Bullish
Brokers Suggest Investing in Vertex  ( VRTX ) : Read This Before Placing a Bet,https://www.zacks.com/stock/news/2067938/brokers-suggest-investing-in-vertex-vrtx-read-this-before-placing-a-bet,2023-03-20 13:30:06,"According to the average brokerage recommendation (ABR), one should invest in Vertex (VRTX). It is debatable whether this highly sought-after metric is effective because Wall Street analysts' recommendations tend to be overly optimistic. Would it be worth investing in the stock?",VRTX,0.053153,0.120663,Neutral
3 Monster Stocks to Buy Without Any Hesitation,https://www.fool.com/investing/2023/03/20/3-monster-stocks-to-buy-without-any-hesitation/,2023-03-20 09:50:00,These stocks are monsters now. They'll probably be much bigger monsters over the next decade and beyond.,VRTX,0.096866,0.040235,Neutral
3 Surefire Stocks That Can Thrive During a Recession,https://www.fool.com/investing/2023/03/20/3-surefire-stocks-that-can-thrive-during-recession/,2023-03-20 09:21:00,These time-tested businesses have the sustainable cash flow and catalysts needed to outperform when the U.S. economy isn't at its best.,VRTX,0.099066,0.113069,Neutral
Worried About the Banking Turmoil? These 3 Stocks Shouldn't Skip a Beat,https://www.fool.com/investing/2023/03/19/worried-about-the-banking-turmoil-these-3-stocks-s/,2023-03-19 09:56:00,Investors can sleep peacefully owning these stocks.,VRTX,0.103331,-0.242013,Somewhat-Bearish
3 Beaten-Down Stocks That Could Soar This Year,https://www.fool.com/investing/2023/03/18/3-beaten-down-stocks-that-could-soar-this-year/,2023-03-18 10:14:00,These stocks could enjoy big rebounds in 2023.,VRTX,0.039353,0.089941,Neutral
Vertex Pharmaceuticals  ( VRTX )  Dips More Than Broader Markets: What You Should Know,https://www.zacks.com/stock/news/2067585/vertex-pharmaceuticals-vrtx-dips-more-than-broader-markets-what-you-should-know,2023-03-17 21:50:25,"Vertex Pharmaceuticals (VRTX) closed the most recent trading day at $295.77, moving -1.62% from the previous trading session.",VRTX,0.668563,0.184708,Somewhat-Bullish
Biogen Inc.  ( BIIB )  Down 2.3% Since Last Earnings Report: Can It Rebound?,https://www.zacks.com/stock/news/2067425/biogen-inc-biib-down-23-since-last-earnings-report-can-it-rebound,2023-03-17 15:30:53,Biogen Inc. (BIIB) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.,VRTX,0.026532,0.054365,Neutral
MaxCyte Reports Fourth Quarter and Full Year 2022 Financial Results,https://www.globenewswire.com/news-release/2023/03/15/2628171/0/en/MaxCyte-Reports-Fourth-Quarter-and-Full-Year-2022-Financial-Results.html,2023-03-15 20:05:00,31% Total Revenue Growth for Full Year 2022 including 26% Core Business Revenue Growth and $4.6 million in Program-related Revenue 31% Total Revenue Growth for Full Year 2022 including 26% Core Business Revenue Growth and $4.6 million in Program-related Revenue ...,VRTX,0.019538,0.0987,Neutral
MaxCyte Reports Fourth Quarter and Full Year 2022 Financial Results,https://www.globenewswire.com/news-release/2023/03/15/2628139/0/en/MaxCyte-Reports-Fourth-Quarter-and-Full-Year-2022-Financial-Results.html,2023-03-15 20:05:00,"31% Total Revenue Growth for Full Year 2022 including 26% Core Business Revenue Growth and $4.6 million in Program-related Revenue ROCKVILLE, MD, March 15, 2023 - MaxCyte, Inc., ( NASDAQ: MXCT.",VRTX,0.019364,0.098589,Neutral
2 Top Biotech Stocks to Buy for the Long Haul,https://www.fool.com/investing/2023/03/15/2-top-biotech-stocks-to-buy-for-the-long-haul/,2023-03-15 09:30:00,These companies have what it takes to grow their revenues -- and their share prices -- over time.,VRTX,0.057079,0.16198,Somewhat-Bullish
CRISPR Therapeutics to Present at the American Association for Cancer Research 2023 Annual Meeting - CRISPR Therapeutics  ( NASDAQ:CRSP ) ,https://www.benzinga.com/pressreleases/23/03/g31351703/crispr-therapeutics-to-present-at-the-american-association-for-cancer-research-2023-annual-meeting,2023-03-14 22:02:48,"ZUG, Switzerland and BOSTON, March 14, 2023 ( GLOBE NEWSWIRE ) -- CRISPR Therapeutics CRSP, a biopharmaceutical company focused on creating transformative gene-based medicines for serious diseases, today announced an oral presentation of preclinical data at the American Association for Cancer ...",VRTX,0.121037,0.143013,Neutral
CRISPR Therapeutics to Present at the American Association for Cancer Research 2023 Annual Meeting,https://www.globenewswire.com/news-release/2023/03/14/2627284/0/en/CRISPR-Therapeutics-to-Present-at-the-American-Association-for-Cancer-Research-2023-Annual-Meeting.html,2023-03-14 22:02:00,"ZUG, Switzerland and BOSTON, March 14, 2023 ( GLOBE NEWSWIRE ) -- CRISPR Therapeutics ( Nasdaq: CRSP ) , a biopharmaceutical company focused on creating transformative gene-based medicines for serious diseases, today announced an oral presentation of preclinical data at the American Association ...",VRTX,0.124809,0.147396,Neutral
PBF Energy Announces Appointment of Georganne Hodges and Damian W. Wilmot as Directors,https://www.prnewswire.com/news-releases/pbf-energy-announces-appointment-of-georganne-hodges-and-damian-w-wilmot-as-directors-301771616.html,2023-03-14 20:30:00,PBF Energy Announces Appointment of Georganne Hodges and ... PR ...,VRTX,0.076115,-0.034096,Neutral
CRISPR Therapeutics Announces Transition of Chief Financial Officer,https://www.globenewswire.com/news-release/2023/03/13/2626202/0/en/CRISPR-Therapeutics-Announces-Transition-of-Chief-Financial-Officer.html,2023-03-13 20:15:00,"ZUG, Switzerland and BOSTON, March 13, 2023 ( GLOBE NEWSWIRE ) -- CRISPR Therapeutics ( Nasdaq: CRSP ) , a biopharmaceutical company focused on creating transformative gene-based medicines for serious diseases, announces the hiring and appointment of Raju Prasad, Ph.D., as Chief Financial ...",VRTX,0.039944,0.123563,Neutral
CRISPR Therapeutics Announces Transition of Chief Financial Officer - CRISPR Therapeutics  ( NASDAQ:CRSP ) ,https://www.benzinga.com/pressreleases/23/03/g31329097/crispr-therapeutics-announces-transition-of-chief-financial-officer,2023-03-13 20:15:00,"ZUG, Switzerland and BOSTON, March 13, 2023 ( GLOBE NEWSWIRE ) -- CRISPR Therapeutics CRSP, a biopharmaceutical company focused on creating transformative gene-based medicines for serious diseases, announces the hiring and appointment of Raju Prasad, Ph.D., as Chief Financial Officer, effective ...",VRTX,0.039353,0.12139,Neutral
Prediction: These 3 Stocks Will Be in the Dow by 2030,https://www.fool.com/investing/2023/03/13/prediction-these-stocks-will-be-in-the-dow-by-2030/,2023-03-13 09:52:00,Being added to the Dow Jones Industrial Average would just be another feather in the cap for these successful stocks.,VRTX,0.103109,0.054529,Neutral
3 Supercharged Stocks With More Potential Than Any Cryptocurrency,https://www.fool.com/investing/2023/03/12/3-superior-growth-stocks-with-more-potential-than/,2023-03-12 11:53:00,These growth stocks are going from strength to strength.,VRTX,0.121445,0.240545,Somewhat-Bullish
ORCL: 3 Stocks That'll Survive Any Recession,https://stocknews.com/news/orcl-vrtx-hum-nvda-crsp-3-stocks-thatll-survive-any-recession/,2023-03-31 16:48:33,"Risks associated with an economic slowdown, high inflation, and credit crunch woes have dampened the growth prospects. Amid this, we look into fundamentally sound stocks, Oracle Corporation ( ORCL ) , Vertex Pharmaceuticals Incorporated ( VRTX ) , and Humana Inc. ( HUM ) , that could help one ...",VRTX,0.186199,0.090403,Neutral
This Top Growth Stock Is Targeting a Multi-Billion-Dollar Market. Here's What It Means for Investors,https://www.fool.com/investing/2023/03/31/this-top-growth-stock-is-targeting-a-multibillion/,2023-03-31 13:00:00,It wouldn't be the first time the company finds success in a lucrative area.,VRTX,0.428632,0.17322,Somewhat-Bullish
"Have $2,000? 2 Exceptional Stocks to Buy In a Bear Market",https://www.fool.com/investing/2023/03/31/2-exceptional-stocks-to-buy-in-a-bear-market/,2023-03-31 11:45:00,"The current market is challenging investors' fortitude, but patience can pay off.",VRTX,0.146916,0.181796,Somewhat-Bullish
5 Bargain-Basement Stocks to Buy Right Now,https://www.fool.com/investing/2023/03/31/5-bargain-basement-stocks-to-buy-right-now/,2023-03-31 09:30:00,Down markets offer us something very positive: deals on quality companies.,VRTX,0.037563,0.009785,Neutral
What Bear Market? These 2 Winning Stocks Are Still Worth Buying.,https://www.fool.com/investing/2023/03/30/what-bear-market-these-2-winning-stocks-are-still/,2023-03-30 14:30:00,These two pharma stocks are rock-solid picks in any kind of market.,VRTX,0.136499,-0.103427,Neutral
"2 Top Stocks to Buy With $1,000 Right Now",https://www.fool.com/investing/2023/03/30/2-top-stocks-to-buy-with-1000-right-now/,2023-03-30 14:00:00,These growth-oriented businesses are marking wins even in a challenging environment.,VRTX,0.094762,-0.105269,Neutral
2 No-Brainer Stocks to Buy Before the Next Bull Market,https://www.fool.com/investing/2023/03/30/2-no-brainer-stocks-to-buy-before-next-bull-market/,2023-03-30 13:53:00,These stocks each have superior businesses that can reward investors over the long haul.,VRTX,0.105372,-0.044189,Neutral
2 No-Brainer Growth Stocks to Buy and Hold for Years,https://www.fool.com/investing/2023/03/30/2-no-brainer-growth-stocks-to-buy-and-hold-for-yea/,2023-03-30 13:40:00,A long-term investment in these highly profitable businesses could pay off in manifold returns over the next 5 to 10 years.,VRTX,0.112008,0.213681,Somewhat-Bullish
2 Reasons to Sell Editas Medicine Stock and 1 Reason to Buy It,https://www.fool.com/investing/2023/03/30/2-reasons-to-sell-editas-stock-and-1-reason-to-buy/,2023-03-30 12:45:00,Editas Medicine is a high-risk stock with the potential of a big reward.,VRTX,0.052112,0.008978,Neutral
Better Growth Stock: Vertex Pharmaceuticals vs. AbbVie,https://www.fool.com/investing/2023/03/29/better-growth-stock-vertex-pharmaceuticals-abbvie/,2023-03-29 18:00:00,These stocks look reasonably priced considering their future prospects.,VRTX,0.099271,0.045094,Neutral
Why Bluebird Bio  ( BLUE )  Shares Are Plunging Today - bluebird bio  ( NASDAQ:BLUE ) ,https://www.benzinga.com/general/biotech/23/03/31550276/why-bluebird-bio-shares-are-plunging-today,2023-03-29 15:39:21,"Bluebird Bio Inc BLUE shares are plummeting after the company signaled a delay in its sickle cell disease drug application to the FDA in its Q4 earnings release. In early March, the company responded to feedback from the FDA on vector and drug product analytical comparability evaluations ...",VRTX,0.235823,-0.121366,Neutral
GILD: 3 of the Best Stocks in 1 of Wall Street's Worst-Rated Industry,https://stocknews.com/news/gild-vrtx-biib-crsp-sage-3-of-the-best-stocks-in-1-of-wall-streets/,2023-03-29 14:59:32,"The biotech industry thrived during the pandemic with rising demand for drugs, therapies, and vaccines. However, various macroeconomic and regulatory challenges have hampered the industry's growth since last year, prompting massive layoffs and shutdowns.",VRTX,0.196411,0.159672,Somewhat-Bullish
Here's How Much $100 Invested In Vertex Pharmaceuticals 5 Years Ago Would Be Worth Today - Vertex Pharmaceuticals  ( NASDAQ:VRTX ) ,https://www.benzinga.com/news/earnings/23/03/31537531/heres-how-much-100-invested-in-vertex-pharmaceuticals-5-years-ago-would-be-worth-today,2023-03-28 19:30:48,"Vertex Pharmaceuticals VRTX has outperformed the market over the past 5 years by 5.94% on an annualized basis producing an average annual return of 14.87%. Currently, Vertex Pharmaceuticals has a market capitalization of $80.38 billion.",VRTX,0.980595,0.386944,Bullish
Vertex  ( VRTX )  Inks Licensing Deal With CRISPR for Diabetes Drug,https://www.zacks.com/stock/news/2071388/vertex-vrtx-inks-licensing-deal-with-crispr-for-diabetes-drug,2023-03-28 14:41:00,Vertex Therapeutics (VRTX) enters into a licensing agreement with CRISPR for the latter's gene-editing technology to accelerate the development of its type I diabetes hypoimmune therapy programs.,VRTX,0.222157,0.154239,Somewhat-Bullish
Vertex Pharmaceuticals  ( VRTX )  Stock Sinks As Market Gains: What You Should Know,https://www.zacks.com/stock/news/2071019/vertex-pharmaceuticals-vrtx-stock-sinks-as-market-gains-what-you-should-know,2023-03-27 21:50:24,"In the latest trading session, Vertex Pharmaceuticals (VRTX) closed at $308.47, marking a -1.88% move from the previous day.",VRTX,0.699089,0.372211,Bullish
Vertex Pharmaceuticals Nearing A Buy Point; Institutions Scooping Up Shares,https://www.investors.com/research/vrtx-stock-nears-a-buy-point-and-52-week-high/,2023-03-27 17:31:00,VRTX stock Near Buy Point And 52-Week High Investor's Business Daily ...,VRTX,0.524949,0.196025,Somewhat-Bullish
Should You Invest in the VanEck Biotech ETF  ( BBH ) ?,https://www.zacks.com/stock/news/2070609/should-you-invest-in-the-vaneck-biotech-etf-bbh,2023-03-27 10:20:08,Sector ETF report for ...,VRTX,0.136113,0.07192,Neutral
Could CRISPR Therapeutics Become the Next Moderna?,https://www.fool.com/investing/2023/03/27/could-crispr-therapeutics-become-the-next-moderna/,2023-03-27 10:00:00,Both companies use cutting-edge technology.,VRTX,0.055621,0.086868,Neutral
Stocks Showing Rising Market Leadership: Deciphera Pharm Earns 83 RS Rating,https://www.investors.com/ibd-data-stories/stocks-showing-rising-market-leadership-deciphera-pharm-earns-83-rs-rating/,2023-03-27 07:00:00,Stocks Showing Rising Market Leadership: Deciphera Pharm Earns ... Investor's Business Daily ...,VRTX,0.353059,0.0,Neutral
Want $1 Million in Retirement? Buy and Hold These 5 Stocks,https://www.fool.com/investing/2023/03/26/want-1-million-in-retirement-buy-hold-5-stocks/,2023-03-26 09:54:00,There's no guarantee that you'll be a millionaire retiree. But these stocks could improve your odds.,VRTX,0.097259,0.063303,Neutral
A Bull Market Is Coming: 1 Excellent Growth Stock to Buy Now,https://www.fool.com/investing/2023/03/25/a-bull-market-is-coming-1-excellent-growth-stock/,2023-03-25 13:45:00,The company has many of the characteristics that lead to long-term success.,VRTX,0.060236,0.137009,Neutral
Could This Stock Become the Tesla of Its Industry?,https://www.fool.com/investing/2023/03/25/could-this-stock-become-the-tesla-of-its-industry/,2023-03-25 13:30:00,It's in a race to a multi-billion dollar market.,VRTX,0.05339,0.20478,Somewhat-Bullish
Nasdaq Bear Market: 2 Growth Stocks to Buy That Keep Bucking the Trend,https://www.fool.com/investing/2023/03/25/nasdaq-bear-market-2-growth-stocks-to-buy-that-kee/,2023-03-25 09:41:00,These red-hot stocks keep climbing despite the bear market.,VRTX,0.184834,-0.156373,Somewhat-Bearish
How Is The Market Feeling About Vertex Pharmaceuticals? - Vertex Pharmaceuticals  ( NASDAQ:VRTX ) ,https://www.benzinga.com/short-sellers/23/03/31481078/how-is-the-market-feeling-about-vertex-pharmaceuticals,2023-03-23 19:00:25,"Vertex Pharmaceuticals's VRTX short percent of float has fallen 4.59% since its last report. The company recently reported that it has 2.68 million shares sold short, which is 1.04% of all regular shares that are available for trading.",VRTX,0.221819,0.083071,Neutral
GILD: 2 Biotech Stocks to Buy Hand Over Fist in March,https://stocknews.com/news/gild-vrtx-2-biotech-stocks-to-buy-hand-over-fist-in-march/,2023-03-23 17:24:52,"Despite macroeconomic challenges, the biotech industry has been performing relatively well. Government initiatives, rapid technology breakthroughs, and inelastic demand for healthcare are fostering the growth of the biotech industry.",VRTX,0.329866,0.258818,Somewhat-Bullish
Halozyme Therapeutics  ( HALO )  Down 34.4% Since Last Earnings Report: Can It Rebound?,https://www.zacks.com/stock/news/2069690/halozyme-therapeutics-halo-down-344-since-last-earnings-report-can-it-rebound,2023-03-23 15:30:41,Halozyme Therapeutics (HALO) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.,VRTX,0.051999,0.059637,Neutral
"This Cathie Wood Stock Could Nearly Double, According to Wall Street",https://www.fool.com/investing/2023/03/23/this-cathie-wood-stock-crispr-could-nearly-double/,2023-03-23 14:07:00,"If the stock market continues to rally, this biotech could benefit.",VRTX,0.057352,0.115963,Neutral
This Is My Highest-Conviction Stock to Own in 2023 and Beyond,https://www.fool.com/investing/2023/03/23/this-is-my-highest-conviction-stock-to-own-in-2023/,2023-03-23 11:45:00,"This company has already delivered market-beating returns, but it's not too late to get in.",VRTX,0.2872,0.158054,Somewhat-Bullish
"Got $3,000? 3 Growth Stocks to Double Up on Right Now",https://www.fool.com/investing/2023/03/23/got-3000-3-growth-stocks-to-double-up-on-right-now/,2023-03-23 09:50:00,The great prospects for these stocks make them worthy of bigger bets.,VRTX,0.104002,-0.035723,Neutral
"Here's one for the battered bulls: the second-largest sector in the S&P 500 is stirring to life, says this strategist.",https://www.marketwatch.com/story/heres-one-for-the-battered-bulls-the-second-largest-sector-in-the-s-p-500-is-stirring-to-life-says-this-strategist-5e179744,2023-03-22 10:52:00,"Everyone is watching the banks, but what about healthcare. It's breaking out, says this strategist.",VRTX,0.077593,0.0,Neutral
Four Elements Of Healthcare Industry Leadership: China Summit,https://www.forbes.com/sites/forbeschina/2023/03/22/four-elements-of-healthcare-industry-leadership-forbes-china-summit/,2023-03-22 04:56:00,"""Healthcare can often be a very conservative industry because it's an industry that deals with very long timetables. However, playing it too safe and too careful can leave you behind competitors,"" Forbes Senior Editor Alex Knapp believes.",VRTX,0.042876,0.0109,Neutral
"Futures: Big Bank Earnings, Key Inflation Data Due Out",https://www.investors.com/market-trend/stock-market-today/dow-jones-futures-key-inflation-data-big-bank-earnings-due-apple-pioneer-tesla-in-focus/,2023-04-10 20:48:00,"Dow Jones futures were little changed ahead of Tuesday's open, with key inflation data due out Wednesday and Thursday. Meanwhile, first-quarter bank earnings kick off later this week. And Apple, Pioneer Natural Resources and Tesla stock were in focus after big swings Monday.",VRTX,0.148548,0.080591,Neutral
My 5 Top Stocks to Buy in April,https://www.fool.com/investing/2023/04/10/my-5-top-stocks-to-buy-in-april/,2023-04-10 09:54:00,These stocks share one primary common denominator -- great growth prospects.,VRTX,0.102449,0.22007,Somewhat-Bullish
Legend Biotech ADR Shows Rising Price Performance With Jump To 84 RS Rating,https://www.investors.com/ibd-data-stories/legend-biotech-adr-shows-rising-price-performance-with-jump-to-84-rs-rating/,2023-04-10 07:00:00,Legend Biotech ADR Shows Rising Price Performance With Jump ... Investor's Business Daily ...,VRTX,0.395012,0.0,Neutral
Stock Upgrades: Xencor Shows Rising Relative Strength,https://www.investors.com/ibd-data-stories/stock-upgrades-xencor-shows-rising-relative-strength-5/,2023-04-10 07:00:00,"In a welcome move, Xencor ( XNCR ) saw its Relative Strength Rating rise from 63 to 72 on Monday. When looking for the best stocks to buy and watch, one factor to watch closely is relative price strength. IBD's proprietary rating measures share price performance with a 1 ( worst ) to 99 ( best ...",VRTX,0.340915,0.0,Neutral
Where Will CRISPR Therapeutics Be in 5 Years?,https://www.fool.com/investing/2023/04/09/where-will-crispr-therapeutics-be-in-5-years/,2023-04-09 11:45:00,Could CRISPR Therapeutics be the next big healthcare stock?,VRTX,0.116631,0.070893,Neutral
"2 Winning Stocks That Could Turn $10,000 into $50,000 by 2030",https://www.fool.com/investing/2023/04/09/2-winning-stocks-that-could-turn-10000-into-50000/,2023-04-09 10:30:00,These stocks have growth stories that could supercharge returns over the long run.,VRTX,0.228717,0.186444,Somewhat-Bullish
3 No-Brainer Stocks to Buy in a New Bull Market,https://www.fool.com/investing/2023/04/08/3-no-brainer-stocks-to-buy-in-a-new-bull-market/,2023-04-08 10:11:00,These stocks have what it takes to soar if and when a new bull market begins.,VRTX,0.16849,0.188699,Somewhat-Bullish
CRISPR Stock: Bull vs. Bear,https://www.fool.com/investing/2023/04/08/crispr-stock-bull-vs-bear/,2023-04-08 09:30:00,CRISPR's first approved product may be right around the corner.,VRTX,0.05833,0.110988,Neutral
Nasdaq Bear Market: 5 Astonishing Growth Stocks You'll Regret Not Buying on the Dip,https://www.fool.com/investing/2023/04/08/nasdaq-bear-market-5-growth-stocks-regret-not-buy/,2023-04-08 09:06:00,A 33% plunge in the Nasdaq Composite is the perfect excuse for opportunistic investors to pounce on discounted growth stocks.,VRTX,0.053569,-0.023141,Neutral
5 S&P 500 Stocks Showing Strength As Recession Fears Rise,https://www.investors.com/news/5-sp-500-stocks-showing-strength-as-recession-fears-rise/,2023-04-07 17:14:00,"S&P 500 medical stocks Cardinal Health ( CAH ) , Vertex Pharmaceuticals ( VRTX ) , Merck ( MRK ) , Intuitive Surgical ( ISRG ) and Insulet ( PODD ) are in focus this week. Medical stocks are coming into favor again - with companies involved in biotech, pharmaceuticals, medical products and ...",VRTX,0.162073,0.109066,Neutral
2 Once-in-a-Decade Buying Opportunities in a Growth Stock Bear Market,https://www.fool.com/investing/2023/04/07/2-once-in-a-decade-buying-opportunities-in-a-bear/,2023-04-07 14:15:00,These stocks have growth stories that investors might find too compelling to overlook.,VRTX,0.098054,0.167844,Somewhat-Bullish
A Bull Market Is Coming: 2 Unstoppable Growth Stocks to Scoop Up Right Now,https://www.fool.com/investing/2023/04/07/a-bull-market-is-coming-2-unstoppable-growth-stock/,2023-04-07 09:41:00,Don't let these superior stocks pass you by.,VRTX,0.211191,0.160225,Somewhat-Bullish
Dow Jones Off Lows As Bullard Says This; Data Weakens Ahead Of Key Jobs Report; AMC Stock Soars,https://www.investors.com/market-trend/stock-market-today/dow-jones-off-lows-as-fed-james-bullard-says-this-data-weakens-of-key-jobs-report-amc-stock-soars-apple-stock-microsoft-stock-costco-stock/,2023-04-06 19:03:00,Dow Jones Off Lows As Bullard Says This. Data Weakens Ahead Of ... Investor's Business Daily ...,VRTX,0.139804,0.204136,Somewhat-Bullish
"Action Plan: Bank Earnings In Focus; Delta, UnitedHealth On Tap",https://www.investors.com/research/investing-action-plan/jpmorgan-big-bank-earnings-get-special-attention-delta-unitedhealth-due/,2023-04-06 16:55:00,JPMorgan and other bank earnings On Tap Investor's Business Daily ...,VRTX,0.090134,-0.020401,Neutral
2 Smartest Growth Stocks to Buy Without Hesitation Right Now,https://www.fool.com/investing/2023/04/06/2-smartest-growth-stocks-to-buy-without-hesitation/,2023-04-06 13:37:00,A turbulent market is still full of opportunity for shrewd investors.,VRTX,0.101367,0.196406,Somewhat-Bullish
Is Vertex  ( VRTX )  a Buy as Wall Street Analysts Look Optimistic?,https://www.zacks.com/stock/news/2075514/is-vertex-vrtx-a-buy-as-wall-street-analysts-look-optimistic,2023-04-06 13:30:06,"The average brokerage recommendation (ABR) for Vertex (VRTX) is equivalent to a Buy. The overly optimistic recommendations of Wall Street analysts make the effectiveness of this highly sought-after metric questionable. So, is it worth buying the stock?",VRTX,0.053749,0.120725,Neutral
"Where to Invest $2,500 Right Now",https://www.fool.com/investing/2023/04/06/where-to-invest-2500-right-now/,2023-04-06 12:15:00,Even another bear market doesn't need to deter investors with the appropriate buy-and-hold horizon.,VRTX,0.140348,0.119016,Neutral
What's the Better Dip to Buy: CRISPR Therapeutics vs. Bluebird Bio,https://www.fool.com/investing/2023/04/06/whats-the-better-dip-to-buy-crispr-vs-bluebird/,2023-04-06 12:00:00,"Both biotechs are aiming for the same markets, but they are not equally risky.",VRTX,0.061473,0.080099,Neutral
"The Zacks Analyst Blog Highlights bluebird, Oncternal Therapeutics, Avidity, Ascendis and Vertex Pharmaceuticals",https://www.zacks.com/stock/news/2075286/the-zacks-analyst-blog-highlights-bluebird-oncternal-therapeutics-avidity-ascendis-and-vertex-pharmaceuticals,2023-04-06 09:37:00,"bluebird, Oncternal Therapeutics, Avidity, Ascendis and Vertex Pharmaceuticals are included in this Analyst Blog.",VRTX,0.10863,0.0,Neutral
2 Top Stocks to Buy Before the Next Nasdaq Bull Market,https://www.fool.com/investing/2023/04/06/top-stocks-buy-before-next-nasdaq-bull-market/,2023-04-06 09:20:00,Tough market conditions will eventually give way to the next bull run on stocks.,VRTX,0.213988,0.080438,Neutral
"Cathie Wood Boosts Biotech Holdings, Coinbase Stake - Beam Therapeutics  ( NASDAQ:BEAM ) , ARK Genomic Revolution ETF  ( BATS:ARKG ) , CRISPR Therapeutics  ( NASDAQ:CRSP ) , Ginkgo Bioworks Holdings  ( NYSE:DNA ) , Vertex Pharmaceuticals  ( NASDAQ:VRTX ) , Verve Therapeutics  ( NASDAQ:VERV ) , Coinbase Glb  ( NASDAQ:COIN ) , ARK Innovation ETF  ( ARCA:ARKK ) , Intellia Therapeutics  ( NASDAQ:NTLA ) ",https://www.benzinga.com/trading-ideas/long-ideas/23/04/31691159/cathie-wood-loads-up-on-biotech-stocks-continues-to-raise-stake-in-coinbase-global,2023-04-06 04:15:46,"Cathie Wood-led ARK Investment Management raised stakes in a number of biotech companies on Wednesday with these stocks recording negative returns over the last one month, potentially making them attractive in terms of valuations.",VRTX,0.258351,0.068169,Neutral
"Biotech Stock Roundup: BLUE Announces Q4 Results, ONCT, ASND & RNA Fall on Updates",https://www.zacks.com/stock/news/2074967/biotech-stock-roundup-blue-announces-q4-results-onct-asnd-rna-fall-on-updates,2023-04-05 14:14:00,Earnings and pipeline updates from bluebird bio (BLUE) and Avidity (RNA) are the key highlights for the biotech sector.,VRTX,0.076971,0.0,Neutral
2 Under-the-Radar Biotech Stocks to Buy in 2023,https://www.fool.com/investing/2023/04/05/2-under-the-radar-biotech-stocks-to-buy-in-2023/,2023-04-05 14:11:00,Both companies have game-changing product portfolios that should result in stock price growth.,VRTX,0.055109,0.059852,Neutral
Vertex Is 1 Step Closer to Bringing a New Blockbuster to Market. Time to Buy?,https://www.fool.com/investing/2023/04/04/vertex-closer-to-bringing-blockbuster-to-market/,2023-04-04 18:00:00,Vertex shares are on the rise.,VRTX,0.11983,0.125509,Neutral
CRISPR  ( CRSP )  & Vertex Complete BLA Submission for Exa-Cel,https://www.zacks.com/stock/news/2074488/crispr-crsp-vertex-complete-bla-submission-for-exa-cel,2023-04-04 17:32:00,CRISPR (CRSP) and Vertex complete BLA submissions to the FDA for exa-cel for treating sickle cell disease and transfusion-dependent beta-thalassemia.,VRTX,0.165031,0.060452,Neutral
Composite Rating For Vertex Pharmaceuticals Jumps To 96,https://www.investors.com/ibd-data-stories/composite-rating-for-vertex-pharmaceuticals-jumps-to-96-2/,2023-04-04 07:00:00,"On Tuesday, Vertex Pharmaceuticals ( VRTX ) got an upgrade for its IBD SmartSelect Composite Rating from 94 to 96. X The revised score means the stock currently tops 96% of all other stocks in terms of key performance metrics and technical strength.",VRTX,0.598621,-0.103262,Neutral
Stocks Showing Rising Market Leadership: BioXcel Therapeutics Earns 85 RS Rating,https://www.investors.com/ibd-data-stories/stocks-showing-rising-market-leadership-bioxcel-therapeutics-earns-85-rs-rating/,2023-04-04 07:00:00,Stocks Showing Rising Market Leadership: BioXcel Therapeutics ... Investor's Business Daily ...,VRTX,0.343279,0.0,Neutral
Vertex Pharmaceuticals  ( VRTX )  Outpaces Stock Market Gains: What You Should Know,https://www.zacks.com/stock/news/2073997/vertex-pharmaceuticals-vrtx-outpaces-stock-market-gains-what-you-should-know,2023-04-03 21:50:19,"In the latest trading session, Vertex Pharmaceuticals (VRTX) closed at $316.33, marking a +0.4% move from the previous day.",VRTX,0.659949,0.326587,Somewhat-Bullish
Here's How Much You Would Have Made Owning Vertex Pharmaceuticals Stock In The Last 5 Years - Vertex Pharmaceuticals  ( NASDAQ:VRTX ) ,https://www.benzinga.com/news/earnings/23/04/31638629/heres-how-much-you-would-have-made-owning-vertex-pharmaceuticals-stock-in-the-last-5-years,2023-04-03 16:30:27,"Vertex Pharmaceuticals VRTX has outperformed the market over the past 5 years by 6.0% on an annualized basis producing an average annual return of 15.55%. Currently, Vertex Pharmaceuticals has a market capitalization of $81.69 billion.",VRTX,0.980595,0.386944,Bullish
1 Small-Cap Stock That Could Soar in 2023,https://www.fool.com/investing/2023/04/02/1-small-cap-stock-that-could-soar-in-2023/,2023-04-02 13:15:00,Investors should think twice before initiating a position.,VRTX,0.063425,0.080459,Neutral
A Nasdaq Bull Market Could Begin in April: 3 Top Stocks to Buy Now,https://www.fool.com/investing/2023/04/02/a-nasdaq-bull-market-could-begin-in-april-3-top-st/,2023-04-02 09:52:00,The momentum for these stocks should accelerate when a Nasdaq bull market begins.,VRTX,0.123209,0.189612,Somewhat-Bullish
5 Top Stocks for April,https://www.fool.com/investing/2023/04/02/5-top-stocks-for-april/,2023-04-02 09:30:00,"From growth stocks to dividend stocks, there are plenty of buying opportunities this spring.",VRTX,0.088309,0.059936,Neutral
Here's a New Million-Dollar Reason to Buy CRISPR Therapeutics,https://www.fool.com/investing/2023/04/01/heres-a-new-million-dollar-reason-to-buy-crispr/,2023-04-01 09:30:00,"Together, the companies could produce a game-changing product.",VRTX,0.123526,0.066322,Neutral
Better Big Biotech Buy: Biogen vs. Vertex,https://www.fool.com/investing/2023/04/20/better-big-biotech-buy-biogen-vs-vertex/,2023-04-20 18:00:00,One is slightly cheaper than the other.,VRTX,0.110209,0.304465,Somewhat-Bullish
"Have $1,000? 2 Explosive Growth Stocks to Buy and Hold No Matter What the Market Does Next",https://www.fool.com/investing/2023/04/20/have-1000-2-great-stocks-to-buy-and-hold-no-matter/,2023-04-20 14:15:00,A volatile market can be an investor's friend.,VRTX,0.142565,0.200403,Somewhat-Bullish
Futures Fall After Jobless Claims; Tesla Dives On Earnings,https://www.investors.com/market-trend/stock-market-today/dow-jones-futures-fall-ahead-of-jobless-claims-tesla-dives-on-earnings/,2023-04-20 12:28:00,Futures Fall Ahead Of Jobless Claims. Tesla Dives On Earnings Investor's Business Daily ...,VRTX,0.053153,0.099667,Neutral
Futures Lower As Netflix Drops On Earnings,https://www.investors.com/market-trend/stock-market-today/dow-jones-futures-fall-as-netflix-drops-on-earnings-tesla-stock-skids-on-price-cuts-before-earnings/,2023-04-19 12:35:00,"Dow Jones Futures Fall: Netflix Drops On Q1 Results, Tesla Skids ... Investor's Business Daily ...",VRTX,0.076439,0.065686,Neutral
Vertex Pharmaceuticals  ( VRTX )  Stock Sinks As Market Gains: What You Should Know,https://www.zacks.com/stock/news/2080736/vertex-pharmaceuticals-vrtx-stock-sinks-as-market-gains-what-you-should-know,2023-04-18 21:50:20,"Vertex Pharmaceuticals (VRTX) closed the most recent trading day at $325.15, moving -0.79% from the previous trading session.",VRTX,0.549988,0.189661,Somewhat-Bullish
$100 Invested In This Stock 5 Years Ago Would Be Worth $200 Today - Vertex Pharmaceuticals  ( NASDAQ:VRTX ) ,https://www.benzinga.com/news/earnings/23/04/31863407/100-invested-in-this-stock-5-years-ago-would-be-worth-200-today,2023-04-18 16:30:35,"Vertex Pharmaceuticals VRTX has outperformed the market over the past 5 years by 6.25% on an annualized basis producing an average annual return of 15.45%. Currently, Vertex Pharmaceuticals has a market capitalization of $83.86 billion.",VRTX,0.980595,0.386944,Bullish
Why Vertex  ( VRTX )  Could Beat Earnings Estimates Again,https://www.zacks.com/stock/news/2080565/why-vertex-vrtx-could-beat-earnings-estimates-again,2023-04-18 16:10:12,Vertex (VRTX) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.,VRTX,0.17715,0.154203,Somewhat-Bullish
"Got $5,000? Buy and Hold These Fast-Growing Stocks for Years",https://www.fool.com/investing/2023/04/18/got-5000-buy-and-hold-these-fast-growing-stocks/,2023-04-18 13:45:00,These companies have doubled their sales within the past five years.,VRTX,0.141726,0.246361,Somewhat-Bullish
Tech Futures Lead As Q1 Earnings Heats Up,https://www.investors.com/market-trend/stock-market-today/dow-jones-futures-rise-as-goldman-sachs-dives-on-earnings-nvidia-jumps-on-buy-rating/,2023-04-18 13:01:00,Dow Jones Futures Rise As Goldman Sachs Dives On Earnings ... Investor's Business Daily ...,VRTX,0.146025,0.056006,Neutral
The Fed Thinks a Recession Is More Likely: Here Are 3 Great Stocks to Buy Now,https://www.fool.com/investing/2023/04/18/fed-recession-more-likely-stocks-buy-now/,2023-04-18 09:52:00,These stocks should hold up quite well regardless of what happens with the U.S. economy.,VRTX,0.106541,0.078639,Neutral
The Top Healthcare Stocks to Buy With $100,https://www.fool.com/investing/2023/04/18/the-top-healthcare-stocks-to-buy-with-100/,2023-04-18 09:30:00,A small investment now may bring big results over time.,VRTX,0.060694,0.057,Neutral
"Dow Jones Futures: Netflix, Tesla Earnings On Deck",https://www.investors.com/market-trend/stock-market-today/dow-jones-futures-netflix-tesla-earnings-on-deck-what-to-do-now-todays-stock-market/,2023-04-17 20:54:00,"Dow Jones futures were little changed ahead of Tuesday's open, with first-quarter earnings season set to heat up this week. Netflix ( NFLX ) earnings are out Tuesday, while Tesla ( TSLA ) earnings are set for Wednesday.",VRTX,0.17484,0.062891,Neutral
Why Shares of Editas Medicine Rose Monday,https://www.fool.com/investing/2023/04/17/why-shares-of-editas-medicine-rose-monday/,2023-04-17 18:50:38,The company is benefiting from positive news affecting other gene-editing stocks.,VRTX,0.229149,0.103127,Neutral
Futures Mixed Ahead Of Economic Data,https://www.investors.com/market-trend/stock-market-today/dow-jones-futures-rise-ahead-of-economic-data-tesla-rival-xpeng-surges-on-new-production-platform/,2023-04-17 12:12:00,Dow Jones Futures Rise Ahead Of Key Data. Tesla Rival Xpeng ... Investor's Business Daily ...,VRTX,0.147818,0.095486,Neutral
HLS Therapeutics Announces CEO Transition,https://www.newswire.ca/news-releases/hls-therapeutics-announces-ceo-transition-846646495.html,2023-04-17 11:00:00," Craig Millian to replace retiring CEO, Gilbert Godin, on May 1, 2023",VRTX,0.037329,0.094634,Neutral
"Which Stocks Pass Warren Buffett's $10,000 Test?",https://www.fool.com/investing/2023/04/17/which-stocks-pass-warren-buffetts-10000-test/,2023-04-17 09:56:00,Buffett's recent CNBC interview raises an interesting question.,VRTX,0.120733,-0.11092,Neutral
Prediction: These Will Be 3 of the Biggest Monster Stocks of the Decade,https://www.fool.com/investing/2023/04/17/prediction-biggest-monster-stocks-decade/,2023-04-17 09:50:00,They're already highly successful. But there's a lot more room to run.,VRTX,0.108958,0.133072,Neutral
Better Growth Stock: Axsome vs. CRISPR Therapeutics,https://www.fool.com/investing/2023/04/16/better-growth-stock-axsome-vs-crispr-therapeutics/,2023-04-16 09:30:00,These companies are both in the early days of their growth stories.,VRTX,0.057215,0.0,Neutral
Is CRISPR Therapeutics Stock a Buy Now?,https://www.fool.com/investing/2023/04/14/is-crispr-therapeutics-stock-a-buy-now/,2023-04-14 14:23:00,The biotech could soon be a commercial-stage company.,VRTX,0.230454,0.133629,Neutral
"$2M Price Tag for Sickle Cell Gene Therapies Could Be Cost-Effective Under Certain Scenarios, Finds ICER Analysis - Vertex Pharmaceuticals  ( NASDAQ:VRTX ) ",https://www.benzinga.com/general/biotech/23/04/31789949/2m-price-tag-for-sickle-cell-gene-therapies-could-be-cost-effective-under-certain-scenarios-finds,2023-04-13 16:17:09,"Prices for incoming sickle cell disease gene therapies from Vertex Pharmaceuticals Inc VRTX/CRISPR Therapeutics AG CRSP, dubbed exagamglogene autotemcel ( exa-cel ) , and Bluebird bio Inc's BLUE lovotibeglogene autotemcel ( lovo-cel ) at $2 million could be cost-effective under some scenarios.",VRTX,0.268294,0.10352,Neutral
Why Shares of CRISPR Therapeutics Jumped Thursday,https://www.fool.com/investing/2023/04/13/why-shares-of-crispr-therapeutics-jumped-thursday/,2023-04-13 15:58:37,An independent drug-pricing group said that a $1.9 million cost for the company's exa-cel therapy would be cost-effective.,VRTX,0.10607,0.139768,Neutral
2 Nasdaq Growth Stocks That Are Screaming Buys in April,https://www.fool.com/investing/2023/04/13/2-nasdaq-growth-stocks-that-are-screaming-buys-in/,2023-04-13 14:15:00,"Massive drivers of fresh earnings are drawing closer, and risks are declining.",VRTX,0.114956,0.236026,Somewhat-Bullish
"Moderna, ConocoPhillips, Vertex Pharmaceuticals And This ETF: CNBC's 'Final Trades' - ConocoPhillips  ( NYSE:COP ) , Moderna  ( NASDAQ:MRNA ) ",https://www.benzinga.com/news/23/04/31782035/moderna-conocophillips-vertex-pharmaceuticals-and-this-etf-cnbcs-final-trades,2023-04-13 12:34:56,"On CNBC's ""Halftime Report Final Trades,"" Anastasia Amoroso of JP Morgan Private Bank named iShares Preferred and Income Securities ETF PFF as her final trade. Jim Lebenthal of Cerity Partners said Vertex Pharmaceuticals Incorporated VRTX is a ""new position"" for him.",VRTX,0.441059,0.280522,Somewhat-Bullish
"Futures Mixed Ahead Of Jobless Claims, Inflation Data",https://www.investors.com/market-trend/stock-market-today/dow-jones-futures-slip-ahead-of-jobless-claims-inflation-data-delta-jumps-on-strong-outlook/,2023-04-13 12:17:00,"Dow Jones Futures Slip Ahead Of Jobless Claims, Inflation Data ... Investor's Business Daily ...",VRTX,0.149285,0.054105,Neutral
These Up-and-Coming Stocks Are Screaming Buys Right Now,https://www.fool.com/investing/2023/04/13/these-up-and-coming-stocks-are-screaming-buys-now/,2023-04-13 09:30:00,Both companies could deliver revenue and share price growth over the long term.,VRTX,0.06211,0.0,Neutral
Proceed With Caution When Considering These 5 Ultra-Popular Stocks,https://www.fool.com/investing/2023/04/13/proceed-caution-consider-ultra-popular-stocks/,2023-04-13 09:25:00,Four of these five stocks are losing money.,VRTX,0.035502,-0.00868,Neutral
Vertex/CRISPR's gene editing therapy cost effective at $1.9 million - pricing review group,https://www.reuters.com/business/healthcare-pharmaceuticals/vertexcrisprs-gene-editing-therapy-cost-effective-19-million-pricing-review-2023-04-12/,2023-04-12 21:54:29,Vertex/CRISPR's gene editing therapy cost effective at $1.9 million ... ...,VRTX,0.190417,0.171335,Somewhat-Bullish
Vertex Pharmaceuticals  ( VRTX )  Gains As Market Dips: What You Should Know,https://www.zacks.com/stock/news/2077869/vertex-pharmaceuticals-vrtx-gains-as-market-dips-what-you-should-know,2023-04-12 21:50:22,"In the latest trading session, Vertex Pharmaceuticals (VRTX) closed at $326.37, marking a +0.47% move from the previous day.",VRTX,0.670305,0.166362,Somewhat-Bullish
Stock Market Has A Bumpy Ride After CPI Numbers,https://www.investors.com/market-trend/stock-market-today/stock-market-has-a-bumpy-ride-after-cpi-numbers/,2023-04-12 17:56:00,"The major stock market indexes were choppy Wednesday after the mild March inflation numbers were released, although indexes were off the lows of the day. The Federal Reserve is set to announce minutes from its most recent meeting at 2 p.m. ET.",VRTX,0.10607,0.0,Neutral
Stock Market Remains Erratic After Inflation Data; Airlines Tumble On This Forecast,https://www.investors.com/market-trend/stock-market-today/stock-market-erratic-after-inflation-data-this-stock-soars-32-on-buyout/,2023-04-12 14:40:00,Stock Market Erratic After Inflation Data. This Stock Soars 32% On ... Investor's Business Daily ...,VRTX,0.109705,-0.174492,Somewhat-Bearish
Futures Mixed Ahead Of Impending CPI Inflation Data,https://www.investors.com/market-trend/stock-market-today/dow-jones-futures-rise-ahead-of-impending-cpi-inflation-data-fed-minutes-later/,2023-04-12 12:11:00,Dow Jones Futures Rise Ahead Of Impending CPI Inflation Data ... Investor's Business Daily ...,VRTX,0.174335,0.125847,Neutral
Could This Move Make Vertex's Next Blockbuster Even Bigger?,https://www.fool.com/investing/2023/04/12/could-this-make-vertexs-next-blockbuster-bigger/,2023-04-12 09:30:00,Vertex is showing it can branch out beyond its cystic fibrosis specialty.,VRTX,0.108222,0.092478,Neutral
"Futures Lower As Bitcoin Tops $30,000",https://www.investors.com/market-trend/stock-market-today/dow-jones-futures-fall-as-bitcoin-jumps-above-30000-top-stocks-to-buy-and-watch/,2023-04-11 12:14:00,"Dow Jones Futures Fall As Bitcoin Jumps Above $30,000. 7 Top ... Investor's Business Daily ...",VRTX,0.155451,0.045465,Neutral
"2 Stocks That Could Turn $200,000 Into $1 Million by the Time You Retire",https://moneymorning.com/investing/2-stocks-that-could-turn-200000-into-1-million-by-the-time-you-retire/,2023-04-30 12:43:00,"The stock market has proven its ability to build wealth time and time again. However, patience is required, and investors seeking to realize optimal returns over the long term will need to contend with the ups and downs that the market inevitably presents.",VRTX,0.238133,0.100616,Neutral
"2 Stocks That Could Turn $200,000 Into $1 Million by the Time You Retire",https://www.fool.com/investing/2023/04/30/2-stocks-that-could-turn-200000-into-1-million-by/,2023-04-30 12:43:00,Planning for the long term starts now.,VRTX,0.217834,0.221433,Somewhat-Bullish
3 Unstoppable Stocks to Buy Right Now,https://www.fool.com/investing/2023/04/29/3-unstoppable-stocks-to-buy-right-now/,2023-04-29 10:14:00,Don't let the temporary headwinds for two of these stocks fool you.,VRTX,0.29234,0.142088,Neutral
3 Unstoppable Stocks to Buy Right Now,https://moneymorning.com/investing/3-unstoppable-stocks-to-buy-right-now/,2023-04-29 10:14:00,"The laws of physics apply in some ways to investing. For example, some stocks have inertia -- they just can't break out of their rut. Others, though, either have momentum or the likelihood of gaining it in the future. Those are the kinds of stocks that are hard to keep down.",VRTX,0.159043,-0.063206,Neutral
"Stock Charts Strategy May 1-5: Fed Policy, April Payrolls, Apple Earnings",https://www.investors.com/all-categories/stock-charts-action-plan-may-1-5-fed-policy-april-payrolls-apple-earnings/,2023-04-28 17:12:00,"Stock Charts Strategy May 1-5: Fed Policy, April Payrolls, Apple ... Investor's Business Daily ...",VRTX,0.047371,0.066605,Neutral
Dennis Huang of Ultragenyx Named to MassBio's Board of Directors - Ultragenyx Pharmaceutical  ( NASDAQ:RARE ) ,https://www.benzinga.com/pressreleases/23/04/g32088448/dennis-huang-of-ultragenyx-named-to-massbios-board-of-directors,2023-04-28 16:27:07,"BEDFORD, Mass., April 28, 2023 ( GLOBE NEWSWIRE ) -- Ultragenyx Pharmaceutical Inc., a biopharmaceutical company focused on the development and commercialization of novel therapies for rare and ultrarare diseases, today announced Dennis Huang, chief technical operations officer and executive ...",VRTX,0.056674,-0.084923,Neutral
Dennis Huang of Ultragenyx Named to MassBio's Board of Directors,https://www.globenewswire.com/news-release/2023/04/28/2657695/20739/en/Dennis-Huang-of-Ultragenyx-Named-to-MassBio-s-Board-of-Directors.html,2023-04-28 16:27:00,Huang brings decades of expertise to MassBio Board to aid in organizational mission Huang brings decades of expertise to MassBio Board to aid in organizational mission ...,VRTX,0.058047,-0.084972,Neutral
Why ImmunoGen  ( IMGN )  Shares Are Surging Today - Immunogen  ( NASDAQ:IMGN ) ,https://www.benzinga.com/general/biotech/23/04/32083714/immunogen-boosts-annual-guidance-on-upbeat-uptake-of-newly-approved-ovarian-cancer-drug,2023-04-28 14:12:20,"ImmunoGen Inc IMGN shares are surging Friday morning following its impressive first-quarter performance. IMGN reported Q1 revenues of $49.9 million, easily surpassing the consensus of $20.47 million and higher than $38.1 million a year ago.",VRTX,0.263942,0.287589,Somewhat-Bullish
Moderna  ( MRNA )  to Report Q1 Earnings: Will It Beat Estimates?,https://www.zacks.com/stock/news/2086825/moderna-mrna-to-report-q1-earnings-will-it-beat-estimates,2023-04-28 12:25:00,"Investors focus will likely be on Moderna's (MRNA) pipeline, especially its late-stage pipeline candidates, when it reports first-quarter earnings.",VRTX,0.042876,-0.032334,Neutral
Strength Seen in Vertex  ( VRTX ) : Can Its 5.0% Jump Turn into More Strength?,https://www.zacks.com/stock/news/2086632/strength-seen-in-vertex-vrtx-can-its-50-jump-turn-into-more-strength,2023-04-28 07:28:00,Vertex (VRTX) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock doesn't suggest further strength down the road.,VRTX,0.342487,0.231897,Somewhat-Bullish
2 Growth Stocks That Could Double in 5 Years,https://moneymorning.com/investing/2-growth-stocks-that-could-double-in-5-years/,2023-04-27 14:23:00,"As a group, growth stocks had a year to forget in 2022. And even with the market recovery we are experiencing this year, many remain in the red over the past 12 months. But there are always outliers. Some growth stocks have performed just fine recently compared to the broader market.",VRTX,0.385286,0.301318,Somewhat-Bullish
2 Growth Stocks That Could Double in 5 Years,https://www.fool.com/investing/2023/04/27/2-growth-stocks-that-could-double-in-5-years/,2023-04-27 14:23:00,Both of these companies did more than that in the past five years.,VRTX,0.261678,0.224657,Somewhat-Bullish
Is It Too Late to Buy CRISPR Stock?,https://moneymorning.com/investing/is-it-too-late-to-buy-crispr-stock/,2023-04-27 12:15:00,"CRISPR Therapeutics ( NASDAQ: CRSP ) has been a volatile stock over the past couple of years. Lately, the gene-editing company's shares have been trading for under $51 a share, but I believe they could go much higher, considering the company's long-term potential.",VRTX,0.074926,0.152027,Somewhat-Bullish
Is It Too Late to Buy CRISPR Stock?,https://www.fool.com/investing/2023/04/27/is-it-too-late-to-buy-crispr-stock/,2023-04-27 12:15:00,Five reasons to buy the promising biotech stock now.,VRTX,0.05234,0.148997,Neutral
"Cytek Biosciences, Inc.  ( CTKB )  Soars 13.4%: Is Further Upside Left in the Stock?",https://www.zacks.com/stock/news/2085589/cytek-biosciences-inc-ctkb-soars-134-is-further-upside-left-in-the-stock,2023-04-27 07:30:00,"Cytek Biosciences, Inc. (CTKB) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock doesn't suggest further strength down the road.",VRTX,0.355588,-0.126949,Neutral
Stock Market Parses Through Earnings Reports; Chipotle Rises Above The Rest,https://www.investors.com/market-trend/stock-market-today/stock-market-parses-through-earnings-reports-chipotle-rises-above-the-rest/,2023-04-26 17:55:00,Stock Market Parses Through Earnings Reports. Chipotle Rises ... Investor's Business Daily ...,VRTX,0.13873,0.051996,Neutral
Why CRISPR Therapeutics Just Became an Even Better Buy,https://www.fool.com/investing/2023/04/26/why-crispr-therapeutics-just-became-an-even-better/,2023-04-26 14:07:00,Is this a no-brainer investment to add to your portfolio?,VRTX,0.077094,0.129698,Neutral
Vertex Pharmaceuticals  ( VRTX )  Stock Moves -0.27%: What You Should Know,https://www.zacks.com/stock/news/2084562/vertex-pharmaceuticals-vrtx-stock-moves--027-what-you-should-know,2023-04-25 21:45:18,"In the latest trading session, Vertex Pharmaceuticals (VRTX) closed at $331.93, marking a -0.27% move from the previous day.",VRTX,0.617188,0.089501,Neutral
Vertex Pharmaceuticals Is In The Buy Zone; Earnings On Deck Monday,https://www.investors.com/research/vertex-stock-in-buy-zone-as-drugmaker-gets-on-a-roll-before-earnings/,2023-04-25 19:15:00,Vertex Stock In Buy Zone As Drugmaker On A Roll Before Earnings ... Investor's Business Daily ...,VRTX,0.157483,0.191153,Somewhat-Bullish
"Will Rhythm Pharmaceuticals, Inc.  ( RYTM )  Report Negative Earnings Next Week? What You Should Know",https://www.zacks.com/stock/news/2084213/will-rhythm-pharmaceuticals-inc-rytm-report-negative-earnings-next-week-what-you-should-know,2023-04-25 14:01:26,"Rhythm Pharmaceuticals, Inc. (RYTM) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.",VRTX,0.086556,0.037971,Neutral
This Supercharged Dividend King Stock Might Soon Run Out of Steam,https://www.fool.com/investing/2023/04/25/this-supercharged-dividend-king-stock-may-soon-run/,2023-04-25 13:45:00,"Emerging competitive threats in immunology, oncology, and medical aesthetics, along with a highly leveraged balance sheet, might dampen the drugmaker's growth trajectory post-2025.",VRTX,0.038223,0.001966,Neutral
Vertex Pharmaceuticals  ( VRTX )  Outpaces Stock Market Gains: What You Should Know,https://www.zacks.com/stock/news/2083717/vertex-pharmaceuticals-vrtx-outpaces-stock-market-gains-what-you-should-know,2023-04-24 21:50:20,"Vertex Pharmaceuticals (VRTX) closed the most recent trading day at $332.84, moving +0.53% from the previous trading session.",VRTX,0.673811,0.352442,Bullish
3 Healthcare Stocks That Could Help Make You a Fortune,https://www.fool.com/investing/2023/04/24/3-health-stocks-that-could-help-make-you-a-fortune/,2023-04-24 18:00:00,These companies are top players in their fields.,VRTX,0.123844,0.232926,Somewhat-Bullish
"With FDA Submission For Sickle Cell Gene Therapy, Bluebird Bio Can Potentially Have 3 Approved Products By 2023 - bluebird bio  ( NASDAQ:BLUE ) ",https://www.benzinga.com/analyst-ratings/analyst-color/23/04/31961584/with-fda-submission-for-sickle-cell-gene-therapy-bluebird-bio-can-potentially-have-,2023-04-24 17:49:54,Bluebird Bio Inc BLUE has submitted its Biologics License Application ( BLA ) to the FDA seeking approval for lovotibeglogene autotemcel ( lovo-cel ) gene therapy in patients with sickle cell disease ( SCD ) ages 12 and older who have a history of vaso-occlusive events ( VOEs ) .,VRTX,0.256989,0.0,Neutral
Earnings Preview: Vertex Pharmaceuticals  ( VRTX )  Q1 Earnings Expected to Decline,https://www.zacks.com/stock/news/2083428/earnings-preview-vertex-pharmaceuticals-vrtx-q1-earnings-expected-to-decline,2023-04-24 14:00:46,Vertex (VRTX) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.,VRTX,0.088309,0.026125,Neutral
"The Zacks Analyst Blog Highlights Linde, Vertex Pharmaceuticals, Edwards Lifesciences, General Motors and MSCI",https://www.zacks.com/stock/news/2083212/the-zacks-analyst-blog-highlights-linde-vertex-pharmaceuticals-edwards-lifesciences-general-motors-and-msci,2023-04-24 11:10:00,"Linde, Vertex Pharmaceuticals, Edwards Lifesciences, General Motors and MSCI are included in this Analyst Blog.",VRTX,0.348919,0.131792,Neutral
"The Best Stocks to Invest $20,000 in Right Now",https://www.fool.com/investing/2023/04/23/the-best-stocks-to-invest-20000-in-right-now/,2023-04-23 18:00:00,You'll want to hold on to these top stocks for the long term.,VRTX,0.052685,0.164637,Somewhat-Bullish
Buy the Dip: 2 Top Stocks to Snatch Up Now,https://www.fool.com/investing/2023/04/23/buy-the-dip-2-top-stocks-to-snatch-up-now/,2023-04-23 13:53:00,You don't need to be too gutsy to buy these two stocks while they're down.,VRTX,0.059049,0.100996,Neutral
3 Stocks With Huge Catalysts on the Way,https://www.fool.com/investing/2023/04/22/3-stocks-with-huge-catalysts-on-the-way/,2023-04-22 10:18:00,Big news could mean big boosts for these stocks.,VRTX,0.089797,0.172169,Somewhat-Bullish
"Top Stock Reports for Linde, Vertex Pharmaceuticals & Edwards Lifesciences",https://www.zacks.com/research-daily/2082680/top-stock-reports-for-linde-vertex-pharmaceuticals-edwards-lifesciences,2023-04-21 20:20:00,"Today's Research Daily features new research reports on 16 major stocks, including Linde plc (LIN), Vertex Pharmaceuticals Incorporated (VRTX) and Edwards Lifesciences Corporation (EW).",VRTX,0.252332,0.228969,Somewhat-Bullish
Vertex  ( VRTX )  to Report Q1 Earnings: What's in the Cards?,https://www.zacks.com/stock/news/2082829/vertex-vrtx-to-report-q1-earnings-whats-in-the-cards,2023-04-21 13:49:00,"On Vertex's (VRTX) Q1 earnings call, investors will likely focus on the sales performance of its cystic fibrosis medicines and development updates of its non-CF pipeline.",VRTX,0.247838,0.202652,Somewhat-Bullish
"B - Berkshire Hathaway Inc. Common Stock  ( NYSE:BRK/A ) , Berkshire Hathaway Inc. New Common Stock  ( NYSE:BRK/B ) ",https://www.benzinga.com/trading-ideas/long-ideas/23/04/31929561/berkshire-hathaway-gilead-sciences-vertex-pharmaceuticals-and-a-break-out-casino-stock-f,2023-04-21 11:59:32,"On CNBC's ""Halftime Report Final Trades,"" Bryn Talkington of Requisite Capital Management named Gilead Sciences, Inc. GILD, which has 7% free cash flow yield and a 3.6% dividend yield. ""I think it will continue to be a good name to own this year,"" she added.",VRTX,0.443626,0.593413,Bullish
2 Growth Stocks That Could Keep Growing for Decades,https://www.fool.com/investing/2023/04/21/2-growth-stocks-that-could-keep-growing-for-decade/,2023-04-21 11:30:00,These businesses will likely only get larger in the future.,VRTX,0.059636,-0.0232,Neutral
Biotech ETFs Pop on M&A Resurgence,https://www.zacks.com/stock/news/2093665/biotech-etfs-pop-on-ma-resurgence,2023-05-10 16:33:00,2023 could be a year of heightened biotech dealmaking activity ...,VRTX,0.199859,0.13748,Neutral
2 Cathie Wood Stocks That Can Get You Through Any Recession,https://www.fool.com/investing/2023/05/10/cathie-wood-stocks-that-can-get-through-recession/,2023-05-10 13:53:00,Shares of both companies moved higher even as the stock market fell last year.,VRTX,0.136888,-0.038037,Neutral
Why CRISPR Therapeutics Stock Is on Fire Today,https://www.fool.com/investing/2023/05/09/why-crispr-therapeutics-stock-is-on-fire-today/,2023-05-09 18:25:44,"Thanks to the gene-editing pioneer having a pipeline chock-full of deep value and a possible regulatory approval on tap, investors are bidding up shares today.",VRTX,0.288893,0.242782,Somewhat-Bullish
CRISPR Therapeutics  ( CRSP )  Q1 Earnings and Revenues Beat,https://www.zacks.com/stock/news/2092314/crispr-therapeutics-crsp-q1-earnings-and-revenues-beat,2023-05-09 12:31:00,CRISPR Therapeutics (CRSP) provides updates for its gene therapy candidates.,VRTX,0.263373,0.140364,Neutral
BioMarin Pharmaceutical Getting Closer To Key Technical Measure,https://www.investors.com/ibd-data-stories/biomarin-pharmaceutical-getting-closer-to-key-technical-measure/,2023-05-09 07:00:00,"On Tuesday, BioMarin Pharmaceutical ( BMRN ) got a positive adjustment to its Relative Strength ( RS ) Rating, from 70 to 76. X When looking for the best stocks to buy and watch, one factor to watch closely is relative price strength.",VRTX,0.310843,0.0,Neutral
Alkermes Earns Relative Strength Rating Upgrade,https://www.investors.com/ibd-data-stories/alkermes-earns-relative-strength-rating-upgrade/,2023-05-09 07:00:00,"When looking for the best stocks to buy and watch, focus on those with rising relative price strength. One stock that fits that bill is Alkermes ( ALKS ) , which saw a positive improvement to its Relative Strength ( RS ) Rating on Tuesday, with an increase from 88 to 91.",VRTX,0.295867,0.122585,Neutral
BANK OF AMERICA: Buy these 16 healthcare stocks to capture their collective 50% upside ahead of a sector rally,https://www.businessinsider.com/best-stock-picks-to-buy-healthcare-investing-market-rally-bofa-2023-5,2023-05-07 10:00:00,16 Best Healthcare Stock Picks to Buy: BofA's Savita Subramanian - Business Insider ...,VRTX,0.07157,0.138919,Neutral
This Incredible Growth Stock Has All the Hallmarks of a Prototypical Warren Buffett Stock,https://www.fool.com/investing/2023/05/06/this-incredible-growth-stock-has-all-the-hallmarks/,2023-05-06 17:00:00,"Vertex Pharmaceuticals faces limited competition in its core area of expertise, has a top-shelf CEO, and is building out a profoundly valuable pipeline of next-generation assets.",VRTX,0.089965,0.171585,Somewhat-Bullish
$100 Invested In This Stock 10 Years Ago Would Be Worth $500 Today - Vertex Pharmaceuticals  ( NASDAQ:VRTX ) ,https://www.benzinga.com/news/earnings/23/05/32246052/100-invested-in-this-stock-10-years-ago-would-be-worth-500-today,2023-05-05 18:30:21,"Vertex Pharmaceuticals VRTX has outperformed the market over the past 10 years by 6.64% on an annualized basis producing an average annual return of 16.36%. Currently, Vertex Pharmaceuticals has a market capitalization of $90.00 billion.",VRTX,0.980595,0.386944,Bullish
Market Rally Finishes Strong As Banks Slash Losses: Weekly Review,https://www.investors.com/news/market-rally-finishes-strong-regional-banks-fed-rate-hike-jobs-report-apple-in-focus/,2023-05-05 17:16:00,"Market Rally Finishes Strong. Regional Banks, Fed Rate Hike, Jobs ... Investor's Business Daily ...",VRTX,0.024686,-0.169883,Somewhat-Bearish
Top Funds Back Up The Truck To Bet Billions On These 10 Stocks,https://www.investors.com/etfs-and-funds/mutual-funds/best-mutual-funds-bet-bet-billions-on-these-10-stocks-including-microsoft-salesforce-broadcom/,2023-05-05 10:45:00,"The Best Mutual Funds Bet Billions On 10 Stocks, Including ... Investor's Business Daily ...",VRTX,0.153797,0.192363,Somewhat-Bullish
Revolution Medicines Scores Relative Strength Rating Upgrade; Hits Key Threshold,https://www.investors.com/ibd-data-stories/revolution-medicines-scores-relative-strength-rating-upgrade-hits-key-threshold/,2023-05-05 07:00:00,Revolution Medicines Scores Relative Strength Rating Upgrade ... Investor's Business Daily ...,VRTX,0.295867,0.0,Neutral
"Top Stock Reports for McDonald's, Deere & Marsh & McLennan",https://www.zacks.com/research-daily/2090158/top-stock-reports-for-mcdonalds-deere-marsh-mclennan,2023-05-04 18:52:00,"Today's Research Daily features new research reports on 16 major stocks, including McDonald's Corporation (MCD), Deere & Company (DE) and Marsh & McLennan Companies, Inc. (MMC).",VRTX,0.126119,0.187002,Somewhat-Bullish
Immunogen Stock Shows Market Leadership With Jump To 99 RS Rating,https://www.investors.com/research/immunogen-shows-market-leadership-with-jump-to-99-rs-rating/,2023-05-04 18:30:00,Immunogen Stock Shows Market Leadership With Jump To 99 RS ... Investor's Business Daily ...,VRTX,0.236972,0.105952,Neutral
"Moderna  ( MRNA )  Q1 Earnings & Sales Top Estimates, Stock Up 2%",https://www.zacks.com/stock/news/2090342/moderna-mrna-q1-earnings-sales-top-estimates-stock-up-2,2023-05-04 18:01:00,Moderna (MRNA) beats expectations for both earnings and sales. The company posts higher-than-expected product sales from its COVID vaccine ...,VRTX,0.0378,0.111927,Neutral
1 Incredibly Undervalued Growth Stock to Buy Hand Over Fist in May,https://www.fool.com/investing/2023/05/04/1-incredibly-undervalued-growth-stock-to-buy-hand/,2023-05-04 14:38:25,This market-beating biotech stock still has more room to run.,VRTX,0.122894,0.0593,Neutral
2 Potentially Explosive Stocks to Buy in May,https://www.fool.com/investing/2023/05/04/2-potentially-explosive-stocks-to-buy-in-may/,2023-05-04 09:32:00,These companies should outpace the overall market for years.,VRTX,0.147216,0.189888,Somewhat-Bullish
3 Top Healthcare Stocks to Buy in May,https://www.fool.com/investing/2023/05/04/3-top-healthcare-stocks-to-buy-in-may/,2023-05-04 09:30:00,You'll want to hold onto these innovative companies for the long term.,VRTX,0.056143,0.067899,Neutral
Inhibrx Shows Market Leadership With Jump To 92 RS Rating,https://www.investors.com/ibd-data-stories/inhibrx-shows-market-leadership-with-jump-to-92-rs-rating/,2023-05-04 07:00:00,"On Thursday, Inhibrx ( INBX ) hit a noteworthy performance benchmark, seeing its Relative Strength ( RS ) Rating jump into the 90-plus percentile with an improvement to 92, up from 86 the day before. X When looking for the best stocks to buy and watch, keep a close on eye on relative price ...",VRTX,0.301315,0.128659,Neutral
Here's 1 Magnificent Reason to Buy Vertex Pharmaceuticals Stock,https://www.fool.com/investing/2023/05/03/heres-1-magnificent-reason-to-buy-vertex-pharmaceu/,2023-05-03 14:15:00,The bull case for the cystic fibrosis treatment maker is as strong as ever.,VRTX,0.2842,0.430235,Bullish
"Vertex Pharmaceuticals, Transocean, And 'One Of The Best Companies' In Staples: CNBC's 'Final Trades' - Transocean  ( NYSE:RIG ) , Procter & Gamble  ( NYSE:PG ) ",https://www.benzinga.com/trading-ideas/long-ideas/23/05/32180098/procter-gamble-transocean-and-one-of-the-best-companies-in-staples-cnbcs-final-trades,2023-05-03 12:11:43,"On CNBC's ""Halftime Report Final Trades,"" Jim Lebenthal of Cerity Partners chose Transocean Ltd RIG, after the company reported its first-quarter results. EBITDA was ""a lot better than expected,"" he said. ""Rig day rates are going up. This is going to be a home run,"" Lebenthal added.",VRTX,0.459624,0.368138,Bullish
Cerevel Therapeutics Appoints Ron Renaud as President and Chief Executive Officer and Reports First Quarter 2023 Financial Results,https://www.globenewswire.com/news-release/2023/05/03/2660120/0/en/Cerevel-Therapeutics-Appoints-Ron-Renaud-as-President-and-Chief-Executive-Officer-and-Reports-First-Quarter-2023-Financial-Results.html,2023-05-03 10:30:00,"Ron Renaud to succeed Tony Coles, M.D. as CEO, effective June 12, 2023. Dr. Coles will continue as chairperson of the board ...",VRTX,0.014541,-0.024664,Neutral
Should You Invest in the Invesco Dynamic Biotechnology & Genome ETF  ( PBE ) ?,https://www.zacks.com/stock/news/2088704/should-you-invest-in-the-invesco-dynamic-biotechnology-genome-etf-pbe,2023-05-03 10:20:07,Sector ETF report for ...,VRTX,0.130571,0.07042,Neutral
7 Reasons to Buy Vertex Pharmaceuticals Stock Now,https://www.fool.com/investing/2023/05/03/7-reasons-to-buy-vertex-pharmaceuticals-stock-now/,2023-05-03 09:50:00,It's not too late to invest in this top biotech stock.,VRTX,0.128822,0.257153,Somewhat-Bullish
Vertex Pharmaceuticals Just Lost a Potential Rival. Is the Stock a Buy?,https://www.fool.com/investing/2023/05/02/vertex-lost-potential-rival-is-stock-a-buy/,2023-05-02 18:00:00,Vertex dominates the cystic fibrosis market today.,VRTX,0.110973,-0.288541,Somewhat-Bearish
CRISPR  ( CRSP )  to Report Q1 Earnings: What's in the Cards?,https://www.zacks.com/stock/news/2088392/crispr-crsp-to-report-q1-earnings-whats-in-the-cards,2023-05-02 16:49:00,"On CRISPR's (CRSP) first-quarter earnings call, investors will likely focus on its pipeline, especially its lead candidate exa-cel, due to the absence of marketed drugs.",VRTX,0.252463,0.105954,Neutral
"Vertex  ( VRTX )  Q1 Earnings Top Estimates, Revenues Up Y/Y",https://www.zacks.com/stock/news/2088409/vertex-vrtx-q1-earnings-top-estimates-revenues-up-yy,2023-05-02 16:06:00,Vertex Pharmaceuticals' (VRTX) first-quarter 2023 earnings and sales beat estimates. Management reiterates financial guidance for 2023.,VRTX,0.164188,0.081911,Neutral
2 Market-Beating Growth Stocks That Are Just Getting Started,https://www.fool.com/investing/2023/05/02/2-market-beating-stocks-are-just-getting-started/,2023-05-02 14:07:00,It's not too late to get in on these companies.,VRTX,0.047371,0.097829,Neutral
2 Supercharged Stocks to Buy for 2023 and Hold for at Least 10 Years,https://www.fool.com/investing/2023/05/02/2-supercharged-stocks-to-buy-for-2023-and-hold-for/,2023-05-02 14:00:00,"These businesses are leaders in their respective industries, but aren't close to done growing.",VRTX,0.102888,0.074,Neutral
"2 Incredible Growth Stocks That Could Turn $20,000 Into $100,000 by 2030",https://www.fool.com/investing/2023/05/02/2-incredible-growth-stocks-that-could-turn-20000-i/,2023-05-02 13:09:00,These growth stocks each have a competitive edge in their respective industries.,VRTX,0.142847,0.156853,Somewhat-Bullish
"Futures Fall Ahead Of Key Data, Fed Meeting",https://www.investors.com/market-trend/stock-market-today/dow-jones-futures-dip-ahead-of-key-economic-data-fed-meeting-tesla-hikes-prices/,2023-05-02 12:39:00,"Dow Jones futures slipped Tuesday morning ahead of key economic data, led by factory orders and the JOLTS jobs report. Meanwhile, the Federal Reserve's two-day policy meeting kicks off Tuesday. EV giant Tesla ( TSLA ) raised prices on its cars in Canada, China, Japan and the U.S.",VRTX,0.048572,0.0,Neutral
3 Growth Stocks Cathie Wood Just Bought That Could Be Absolute Game-Changers,https://www.fool.com/investing/2023/05/02/3-growth-stocks-cathie-wood-just-bought-that-could/,2023-05-02 09:53:00,Cathie Wood is loading up on these biotech stocks.,VRTX,0.054983,0.182892,Somewhat-Bullish
Vertex Pharmaceuticals Stock Is an Even Better Buy Now Thanks to AbbVie,https://www.fool.com/investing/2023/05/02/vertex-pharmaceuticals-stock-is-an-even-better-buy/,2023-05-02 09:50:00,One big drugmaker's pain translates into another big drugmaker's gain.,VRTX,0.123526,0.104295,Neutral
Vertex Pharmaceuticals  ( VRTX )  Q1 2023 Earnings Call Transcript,https://www.fool.com/earnings/call-transcripts/2023/05/01/vertex-pharmaceuticals-vrtx-q1-2023-earnings-call/,2023-05-02 01:30:19,"VRTX earnings call for the period ending March 31, 2023.",VRTX,0.004929,0.152121,Somewhat-Bullish
"Futures Loom Ahead Of Fed Decision, Apple Earnings, Jobs Report",https://www.investors.com/market-trend/stock-market-today/dow-jones-futures-in-focus-ahead-of-fed-rate-hike-apple-earnings-jobs-report/,2023-05-01 21:52:00,"Dow Jones stock futures were little changed ahead of Tuesday's open, with the Federal Reserve's two-day policy meeting set to kick off in the wake of JPMorgan Chase's ( JPM ) purchase of failed First Republic Bank ( FRC ) . Meanwhile, Apple ( AAPL ) earnings are Thursday, with the April jobs ...",VRTX,0.05749,0.0,Neutral
Vertex Pharmaceuticals  ( VRTX )  Q1 Earnings and Revenues Surpass Estimates,https://www.zacks.com/stock/news/2087663/vertex-pharmaceuticals-vrtx-q1-earnings-and-revenues-surpass-estimates,2023-05-01 21:25:10,"Vertex (VRTX) delivered earnings and revenue surprises of 3.39% and 3.02%, respectively, for the quarter ended March 2023. Do the numbers hold clues to what lies ahead for the stock?",VRTX,0.14131,0.096884,Neutral
"Vertex Keeps Its Outlook Despite Beating Views, And Dives",https://www.investors.com/news/technology/vrtx-stock-vertex-earnings-q1-2023/,2023-05-01 20:15:00,VRTX Stock Falls On Maintained Outlook Despite Quarterly Beat Investor's Business Daily ...,VRTX,0.872847,0.335394,Somewhat-Bullish
"ImmunoGen  ( IMGN )  Q1 Earnings Beat, Elahere Uptake Encouraging",https://www.zacks.com/stock/news/2087582/immunogen-imgn-q1-earnings-beat-elahere-uptake-encouraging,2023-05-01 15:00:00,"ImmunoGen (IMGN) reports impressive Q1 earnings results on strong adoption of sole-marketed drug Elahere. The company raises financial guidance for 2023. Post the news, shares moved up 25%.",VRTX,0.146692,0.120221,Neutral
"The Best Stocks to Invest $5,000 in Right Now",https://moneymorning.com/investing/the-best-stocks-to-invest-5000-in-right-now/,2023-05-01 09:50:00,"A recession is coming. At least, that's what the Federal Reserve and many economists think. If they're right, many investors might be inclined to hunker down rather than buy stocks. I don't blame anyone for being apprehensive about the stock market.",VRTX,0.147818,0.107898,Neutral
"The Best Stocks to Invest $5,000 in Right Now",https://www.fool.com/investing/2023/05/01/the-best-stocks-to-invest-5000-in-right-now/,2023-05-01 09:50:00,These appear to be the ideal stocks in times like these.,VRTX,0.130217,0.101687,Neutral
2 Stocks Near 52-Week Highs That Still Look Like Bargains,https://www.fool.com/investing/2023/05/20/2-stocks-near-52-week-highs-that-still-look-like-b/,2023-05-20 09:13:00,These stocks are way up but forward-looking expectations still aren't very high.,VRTX,0.123209,0.127226,Neutral
2 Healthcare Stocks You Can Buy and Hold for the Next Decade,https://www.fool.com/investing/2023/05/19/2-healthcare-stocks-you-can-hold-for-next-decade/,2023-05-19 14:23:00,These two solid companies should be buoyed by recent tailwinds.,VRTX,0.089965,0.220609,Somewhat-Bullish
2 Stocks You'll Be Glad You Bought at These Prices,https://www.fool.com/investing/2023/05/17/2-stocks-youll-be-glad-you-bought-at-these-prices/,2023-05-17 12:41:00,Bear markets create opportunities to buy high-growth stocks at discounted valuations.,VRTX,0.054359,0.18885,Somewhat-Bullish
Looking Into Vertex Pharmaceuticals's Recent Short Interest - Vertex Pharmaceuticals  ( NASDAQ:VRTX ) ,https://www.benzinga.com/short-sellers/23/05/32423247/looking-into-vertex-pharmaceuticalss-recent-short-interest,2023-05-16 14:00:36,"Vertex Pharmaceuticals's VRTX short percent of float has risen 25.96% since its last report. The company recently reported that it has 3.38 million shares sold short, which is 1.31% of all regular shares that are available for trading.",VRTX,0.221819,0.155473,Somewhat-Bullish
2 Soaring Growth Stocks That Could Rocket Even Higher,https://www.fool.com/investing/2023/05/16/2-soaring-growth-stocks-that-could-rocket-even-hig/,2023-05-16 09:41:00,"One of these stocks is up 57% this year, and the other one has more than tripled already.",VRTX,0.057079,0.007,Neutral
Is CRISPR Therapeutics Stock a Buy Now?,https://www.fool.com/investing/2023/05/13/is-crispr-therapeutics-stock-a-buy-now/,2023-05-13 12:45:00,The clinical-stage biotech company has been on the rise.,VRTX,0.096091,0.003238,Neutral
3 Growth Stocks to Buy and Hold,https://www.fool.com/investing/2023/05/13/3-growth-stocks-to-buy-and-hold/,2023-05-13 12:00:00,These three stocks defied the bear market last year.,VRTX,0.153226,0.034958,Neutral
"Where to Invest $10,000 in a Bear Market",https://www.fool.com/investing/2023/05/13/where-to-invest-10000-in-a-bear-market/,2023-05-13 09:30:00,Cautious and aggressive investors both might find opportunities in a bear market.,VRTX,0.111747,0.20793,Somewhat-Bullish
"AI-Run ETF Dumps Apple In Favor Of This Chip Stock And Hints At New Opportunity Brewing In Market - Meta Platforms  ( NASDAQ:META ) , NVIDIA  ( NASDAQ:NVDA ) , Apple  ( NASDAQ:AAPL ) , TJX Companies  ( NYSE:TJX ) , Monster Beverage  ( NASDAQ:MNST ) , Vertex Pharmaceuticals  ( NASDAQ:VRTX ) , QRAFT AI-Enhanced U.S. Large Cap Momentum ETF  ( ARCA:AMOM ) , Starbucks  ( NASDAQ:SBUX ) , Lowe's Companies  ( NYSE:LOW ) , O'Reilly Automotive  ( NASDAQ:ORLY ) , AutoZone  ( NYSE:AZO ) , Eli Lilly  ( NYSE:LLY ) , Home Depot  ( NYSE:HD ) , Regeneron Pharmaceuticals  ( NASDAQ:REGN ) , Walmart  ( NYSE:WMT ) ",https://www.benzinga.com/analyst-ratings/analyst-color/23/05/32366764/ai-run-etf-dumps-apple-in-favor-of-this-chip-stock-and-hints-at-new-opportunity-bre,2023-05-12 15:11:24,"Apple, Inc. AAPL is often touted as an all-weather stock but one exchange-traded fund, powered by artificial intelligence, has deemed it fit to dump its entire Apple holdings and switched its allegiance to a chipmaker. What Happened: QRAFT AI-Enhanced U.S.",VRTX,0.249106,0.194412,Somewhat-Bullish
Why These 3 Nasdaq Stocks Were Glowing Green This Week,https://www.fool.com/investing/2023/05/11/why-these-3-nasdaq-stocks-were-glowing-green-this/,2023-05-11 19:13:59,These three biopharmaceutical stocks rocketed higher this week.,VRTX,0.077343,0.083711,Neutral
3 Healthcare Stocks to Buy and Hold for the Next 10 Years,https://www.fool.com/investing/2023/05/11/3-stocks-to-buy-and-hold-for-the-next-10-years/,2023-05-11 18:00:00,These stocks may help your portfolio thrive over time.,VRTX,0.104002,0.107509,Neutral
This FDA Nod Is a Game Changer for Patients: Could It Equal Billions for Vertex Pharmaceuticals?,https://www.fool.com/investing/2023/05/11/could-latest-fda-nod-equal-billions-for-vertex/,2023-05-11 13:05:00,Vertex already has generated billions of dollars in earnings from its cystic fibrosis portfolio.,VRTX,0.104455,0.120651,Neutral
Moderna's Revolutionary Cancer Vaccine Sets Investors Abuzz,https://www.forbes.com/sites/jonmarkman/2023/05/10/modernas-revolutionary-cancer-vaccine-sets-investors-abuzz/,2023-05-11 01:54:54,Investors should buy Moderna shares into any future weakness.,VRTX,0.122894,0.049003,Neutral
3 Disruptors I Love Right Now,https://www.fool.com/investing/2023/05/30/3-disruptors-i-love-right-now/,2023-05-30 10:49:00,These stocks could deliver huge returns as the companies transform the economy.,VRTX,0.044718,0.089354,Neutral
VRTX: 3 Momentum Stocks to Buy Now,https://stocknews.com/news/vrtx-usfd-vnt-3-momentum-stocks-to-buy-now/,2023-05-29 16:21:57,"Amid persistent market turbulence and indecisiveness regarding monetary policy, investors could look to capitalize on stocks with solid momentum.",VRTX,0.186122,0.157474,Somewhat-Bullish
Prediction: These 2 Stocks Could Double In the Next Year,https://www.fool.com/investing/2023/05/28/prediction-these-2-stocks-could-double-in-the-next/,2023-05-28 14:15:00,It would be a continuation of solid recent performances.,VRTX,0.056674,0.229063,Somewhat-Bullish
Wall Street Thinks This Stock Will Only Rise 12%: Here's Why It Could Jump a Lot More,https://www.fool.com/investing/2023/05/28/wall-street-thinks-this-stock-will-only-rise-12-he/,2023-05-28 09:53:00,Analysts could be too reserved about this biotech stock's prospects.,VRTX,0.124486,0.236941,Somewhat-Bullish
Want to Get Richer? 3 Top Stocks to Buy Now and Hold Forever,https://www.fool.com/investing/2023/05/28/want-to-get-richer-3-top-stocks-to-buy-now-and-hol/,2023-05-28 09:50:00,These stocks have what it takes to help you build long-term wealth.,VRTX,0.129866,0.26436,Somewhat-Bullish
3 No-Brainer Stocks to Buy for Under $100 Right Now,https://www.fool.com/investing/2023/05/27/3-no-brainer-stocks-to-buy-for-under-100-right-now/,2023-05-27 10:14:00,These stocks might not remain under $100 for too much longer.,VRTX,0.050894,0.121367,Neutral
"The Best Stocks to Invest $20,000 in Right Now",https://www.fool.com/investing/2023/05/27/the-best-stocks-to-invest-20000-in-right-now/,2023-05-27 09:50:00,These stocks should be winners in good times and bad times.,VRTX,0.129516,-0.26016,Somewhat-Bearish
2 Supercharged Stocks to Buy With $100,https://www.fool.com/investing/2023/05/27/2-supercharged-stocks-to-buy-with-100/,2023-05-27 09:30:00,These stocks are climbing in the double digits.,VRTX,0.064973,-0.034021,Neutral
Harvard Business School Celebrates 113th Commencement,https://www.prnewswire.com/news-releases/harvard-business-school-celebrates-113th-commencement-301836000.html,2023-05-26 20:09:00,"BOSTON, May 26, 2023 /PRNewswire/ -- Harvard Business School ( HBS ) held its 113th Commencement exercises yesterday with a diploma ceremony on its campus in Boston.",VRTX,0.089462,0.133724,Neutral
2 Biotech Stocks That Could Help Set You Up for Life,https://www.fool.com/investing/2023/05/26/2-biotech-stocks-could-help-set-you-up-for-life/,2023-05-26 13:37:00,These two promising companies have the potential to beat the market over time.,VRTX,0.147216,0.154094,Somewhat-Bullish
"2 Top Trends to Invest $5,000 in Right Now",https://www.fool.com/investing/2023/05/25/2-top-trends-to-invest-5000-in-right-now/,2023-05-25 13:40:00,Renewable energy and gene-editing medical therapies are poised to grow exponentially.,VRTX,0.082677,0.251479,Somewhat-Bullish
Better Growth Stock: CRISPR Therapeutics vs. Teladoc Health,https://www.fool.com/investing/2023/05/25/better-growth-stock-crispr-therapeutics-vs-teladoc/,2023-05-25 09:30:00,Both stocks are recovering after big losses last year.,VRTX,0.05339,0.304939,Somewhat-Bullish
Stocks To Watch: SpringWorks Therapeutics Sees Relative Strength Rating Jump To 87,https://www.investors.com/ibd-data-stories/stocks-to-watch-springworks-therapeutics-sees-relative-strength-rating-jump-to-87/,2023-05-23 07:00:00,Stocks To Watch: SpringWorks Therapeutics Sees Relative Strength ... Investor's Business Daily ...,VRTX,0.350564,0.0,Neutral
"Sickle Cell Disease Market to Observe Impressive Growth, Predicts DelveInsight | Key Companies Active in the Domain - Sanofi, Novartis, Vertex, CRISPR, Vifor, Pfizer, GlaxoSmithKline, Alexion, Global Blood",https://www.prnewswire.com/news-releases/sickle-cell-disease-market-to-observe-impressive-growth-predicts-delveinsight--key-companies-active-in-the-domain---sanofi-novartis-vertex-crispr-vifor-pfizer-glaxosmithkline-alexion-global-blood-301830486.html,2023-05-22 15:00:00,"Sickle Cell Disease Market to Observe Impressive Growth, Predicts ... PR ...",VRTX,0.029043,0.068706,Neutral
2 Hot Stocks to Buy and Hold Until You Retire,https://www.fool.com/investing/2023/05/22/2-hot-stocks-to-buy-and-hold-until-you-retire/,2023-05-22 11:15:00,A perk of investing in growth stocks is that they have a lot of room to run.,VRTX,0.15347,0.335377,Somewhat-Bullish
"Kymera Appoints Jeremy Chadwick, Ph.D., as Chief Operating Officer",https://www.globenewswire.com/news-release/2023/05/22/2673217/0/en/Kymera-Appoints-Jeremy-Chadwick-Ph-D-as-Chief-Operating-Officer.html,2023-05-22 11:00:00,"WATERTOWN, Mass., May 22, 2023 ( GLOBE NEWSWIRE ) -- Kymera Therapeutics, Inc. ( NASDAQ: KYMR ) , a clinical-stage biopharmaceutical company advancing targeted protein degradation ( TPD ) to deliver novel small molecule protein degrader medicines, today announced the appointment of Jeremy ...",VRTX,0.034233,0.051093,Neutral
"Kymera Appoints Jeremy Chadwick, Ph.D., as Chief Operating Officer - Kymera Therapeutics  ( NASDAQ:KYMR ) ",https://www.benzinga.com/pressreleases/23/05/g32504498/kymera-appoints-jeremy-chadwick-ph-d-as-chief-operating-officer,2023-05-22 11:00:00,"WATERTOWN, Mass., May 22, 2023 ( GLOBE NEWSWIRE ) -- Kymera Therapeutics, Inc. KYMR, a clinical-stage biopharmaceutical company advancing targeted protein degradation ( TPD ) to deliver novel small molecule protein degrader medicines, today announced the appointment of Jeremy Chadwick, Ph.D., as ...",VRTX,0.033846,0.051021,Neutral
Cathie Wood Just Sold CRISPR Therapeutics Stock. Here's Why You Should Consider Buying It,https://www.fool.com/investing/2023/05/21/cathie-wood-just-sold-crispr-consider-buying/,2023-05-21 13:30:00,Her investing thesis for holding it is probably the same as ever.,VRTX,0.053749,0.151746,Somewhat-Bullish
Vertex Pharmaceuticals  ( VRTX )  Outpaces Stock Market Gains: What You Should Know,https://www.zacks.com/stock/news/2106663/vertex-pharmaceuticals-vrtx-outpaces-stock-market-gains-what-you-should-know,2023-06-09 21:50:19,"Vertex Pharmaceuticals (VRTX) closed the most recent trading day at $334.11, moving +0.46% from the previous trading session.",VRTX,0.613743,0.330638,Somewhat-Bullish
Breakthrough in CRISPR-Based Therapy: FDA Accepts Vertex and CRISPR Therapeutics' Exa-cel Application,https://markets.businessinsider.com/news/stocks/breakthrough-in-crispr-based-therapy-fda-accepts-vertex-and-crispr-therapeutics-exa-cel-application-1032381458,2023-06-09 18:08:34,The FDA has accepted the application for Vertex Pharmaceuticals Incorporated and CRISPR Therapeutics AG ( NASDAQ:CRSP ) exa-cel for sickle cell disease and transfusion-dependent beta-thalassemia ( TDT ) .,VRTX,0.151539,0.132824,Neutral
"Breakthrough in CRISPR-Based Therapy: FDA Accepts Vertex and CRISPR Therapeutics' Exa-cel Application - CRISPR Therapeutics  ( NASDAQ:CRSP ) , Vertex Pharmaceuticals  ( NASDAQ:VRTX ) ",https://www.benzinga.com/analyst-ratings/analyst-color/23/06/32800629/breakthrough-in-crispr-based-therapy-fda-accepts-vertex-and-crispr-therapeutics-exa,2023-06-09 18:08:34,The FDA has accepted the application for Vertex Pharmaceuticals Incorporated and CRISPR Therapeutics AG CRSP exa-cel for sickle cell disease and transfusion-dependent beta-thalassemia ( TDT ) .,VRTX,0.143415,0.112463,Neutral
"FDA Accepts Vertex  ( VRTX ) , CRISPR's BLA Filings for Exa-Cel",https://www.zacks.com/stock/news/2106602/fda-accepts-vertex-vrtx-crisprs-bla-filings-for-exa-cel,2023-06-09 17:37:00,"The FDA grants priority review to Vertex (VRTX)/CRISPR's (CRSP) filings for exa-cel in SCD, with a final decision expected in December.",VRTX,0.276491,0.153294,Somewhat-Bullish
"Vertex/CRISPR Partnered Cell Therapy Shows Encouraging Response In Sickle Cell Disease, Thalassemia Patients - CRISPR Therapeutics  ( NASDAQ:CRSP ) , Vertex Pharmaceuticals  ( NASDAQ:VRTX ) ",https://www.benzinga.com/general/biotech/23/06/32796250/vertexcrispr-partnered-cell-therapy-shows-encouraging-in-sickle-cell-disease-thalassemia-patients,2023-06-09 15:23:43,Vertex Pharmaceuticals Incorporated VRTX and CRISPR Therapeutics AG CRSP announced that pivotal trials for exagamglogene autotemcel ( exa-cel ) for transfusion-dependent beta-thalassemia ( TDT ) or severe sickle cell disease ( SCD ) met primary and key secondary endpoints at pre-specified ...,VRTX,0.38489,0.074241,Neutral
The FDA Could Approve The First CRISPR Drug Is Just 6 Months,https://www.investors.com/news/technology/crsp-stock-pops-as-fda-sets-december-date-to-potentially-ok-gene-editing-drug/,2023-06-09 14:19:00,CRSP Stock Pops As FDA Sets December Data To Potentially OK ... Investor's Business Daily ...,VRTX,0.128135,0.197731,Somewhat-Bullish
2 Top Biotech Stocks to Buy in June,https://www.fool.com/investing/2023/06/09/2-top-biotech-stocks-to-buy-in-june/,2023-06-09 14:15:00,Both companies have solid therapy franchises and continue to expand their horizons.,VRTX,0.145437,0.113764,Neutral
Wall Street Loves These 3 Growth Stocks -- Should You?,https://www.fool.com/investing/2023/06/09/wall-street-loves-these-3-growth-stocks-should-you/,2023-06-09 09:50:00,Analysts think all three of these stocks could soar.,VRTX,0.066784,0.178564,Somewhat-Bullish
Can This Gene-Editing Stock Deliver 10X Returns?,https://www.fool.com/investing/2023/06/08/can-this-gene-editing-stock-deliver-10x-returns/,2023-06-08 15:30:00,Buying shares of Intellia Therapeutics might be a smart move.,VRTX,0.05749,0.041119,Neutral
5 Top Stocks to Buy in June,https://www.fool.com/investing/2023/06/08/5-top-stocks-to-buy-in-june/,2023-06-08 13:21:00,There are always buying opportunities in the stock market.,VRTX,0.094669,0.012032,Neutral
Could CRISPR Therapeutics Become the Next Vertex Pharmaceuticals?,https://www.fool.com/investing/2023/06/08/could-crispr-therapeutics-become-the-next-vertex/,2023-06-08 10:00:00,"Today, CRISPR has reached an important turning point.",VRTX,0.214937,0.266498,Somewhat-Bullish
Vertex  ( VRTX )  Stock Poised Well for Growth in 2023: Here's Why,https://www.zacks.com/stock/news/2104944/vertex-vrtx-stock-poised-well-for-growth-in-2023-heres-why,2023-06-07 12:55:00,"Vertex Pharmaceuticals (VRTX) stock is likely to be driven by several catalysts this year. Multiple clinical milestones are likely to be achieved in 2023 and 2024, both in its CF and non-CF portfolio.",VRTX,0.110209,0.100765,Neutral
Is Invesco Dynamic Biotechnology & Genome ETF  ( PBE )  a Strong ETF Right Now?,https://www.zacks.com/stock/news/2104843/is-invesco-dynamic-biotechnology-genome-etf-pbe-a-strong-etf-right-now,2023-06-07 10:20:06,Smart Beta ETF report for ...,VRTX,0.11894,0.061867,Neutral
A New S&P 500 Bull Market Is Nearly Here: 3 No-Brainer Stocks to Buy Sooner Rather Than Later,https://www.fool.com/investing/2023/06/07/new-sp-500-bull-market-no-brainer-stocks-buy/,2023-06-07 09:52:00,These stocks are already performing well but could kick into higher gear in a new S&P 500 bull market.,VRTX,0.138066,0.053894,Neutral
"24TH ANNUAL BEST BUDDIES CHALLENGE: HYANNIS PORT PRESENTED BY SHAW'S AND STAR MARKET FOUNDATION AND THE TJX COMPANIES, INC. RAISES NEARLY $4 MILLION FOR PEOPLE WITH INTELLECTUAL AND DEVELOPMENTAL DISABILITIES",https://www.benzinga.com/pressreleases/23/06/n32740682/24th-annual-best-buddies-challenge-hyannis-port-presented-by-shaws-and-star-market-foundation-and-,2023-06-06 15:15:00,"Curtis ""50 Cent"" Jackson, Celebrity Chef Buddy Valastro, and 9-Time Olympic Gold Medalist Carl Lewis were in attendance to help promote the organization's mission of inclusion",VRTX,0.042953,0.122203,Neutral
3 Top Healthcare Stocks to Buy for June,https://www.fool.com/investing/2023/06/06/3-top-healthcare-stocks-to-buy-for-june/,2023-06-06 09:30:00,These stocks have what it takes to deliver long-term growth.,VRTX,0.047654,0.108827,Neutral
"Alkeus Announces $150 Million Series B Financing, Supporting Rapid Registration Path for gildeuretinol  ( ALK-001 )  in the Treatment of Stargardt Disease",https://www.benzinga.com/pressreleases/23/06/g32710749/alkeus-announces-150-million-series-b-financing-supporting-rapid-registration-path-for-gildeuretin,2023-06-05 10:00:00,"CAMBRIDGE, Mass., June 05, 2023 ( GLOBE NEWSWIRE ) -- Alkeus Pharmaceuticals announced today that it has raised a $150 million Series B financing to support the registration and launch of gildeuretinol ( ALK-001 ) , a potential disease-modifying, precision medicine for the treatment of Stargardt ...",VRTX,0.045054,0.037478,Neutral
"Wall Street Says This Growth Stock Is a Buy, but Is It Overvalued?",https://www.fool.com/investing/2023/06/03/wall-street-says-this-growth-stock-is-a-buy-but-is/,2023-06-03 13:30:00,This company might be worth a premium.,VRTX,0.297301,0.181473,Somewhat-Bullish
"Want $1 Million in Retirement? Invest $250,000 in These 3 Stocks and Wait a Decade",https://www.fool.com/investing/2023/06/03/want-1-million-in-retirement-invest-250000-in-thes/,2023-06-03 11:45:00,All three trounced the market over the past 10 years.,VRTX,0.316168,0.230526,Somewhat-Bullish
"Got $1,000? 2 Amazing Growth Stocks That Could Help You Retire Richer",https://www.fool.com/investing/2023/05/31/got-1000-2-amazing-growth-stocks-that-could-help-y/,2023-05-31 14:05:00,These businesses have considerable growth runways ahead.,VRTX,0.145145,0.106002,Neutral
CRISPR Therapeutics: A Galaxy's Worth of Deep Value,https://www.fool.com/investing/2023/05/31/crispr-therapeutics-a-galaxys-worth-of-deep-value/,2023-05-31 11:45:00,"Wall Street is at max pessimism with this biotech, which might be a big mistake.",VRTX,0.108222,0.108894,Neutral
Should You Invest in the VanEck Biotech ETF  ( BBH ) ?,https://www.zacks.com/stock/news/2101737/should-you-invest-in-the-vaneck-biotech-etf-bbh,2023-05-31 10:20:06,Sector ETF report for ...,VRTX,0.134968,0.071604,Neutral
2 Market-Beating Stocks With Major Catalysts on the Way,https://www.fool.com/investing/2023/06/17/2-market-beating-stocks-with-major-catalysts-on/,2023-06-17 14:07:00,Can these companies keep climbing?,VRTX,0.190793,0.229458,Somewhat-Bullish
3 Cathie Wood Investments That Could Deliver Superior Returns,https://www.fool.com/investing/2023/06/17/3-cathie-wood-investments-that-could-deliver-super/,2023-06-17 13:15:00,These three stocks fit Wood's profile for big-time growth.,VRTX,0.07887,0.112709,Neutral
Vertex Pharmaceuticals  ( VRTX )  Stock Moves -0.34%: What You Should Know,https://www.zacks.com/stock/news/2109677/vertex-pharmaceuticals-vrtx-stock-moves--034-what-you-should-know,2023-06-16 21:50:20,"Vertex Pharmaceuticals (VRTX) closed the most recent trading day at $347.89, moving -0.34% from the previous trading session.",VRTX,0.677342,0.263889,Somewhat-Bullish
Anti-Ageing Drugs Market to Amass Notable Gains by 2029 Says Brandessence Market Research,https://www.prnewswire.com/news-releases/anti-ageing-drugs-market-to-amass-notable-gains-by-2029-says-brandessence-market-research-301851923.html,2023-06-15 14:01:00,"LONDON, June 15, 2023 /PRNewswire/ -- The body undergoes numerous changes as people age. They eventually start showing signs of ageing and become susceptible to numerous diseases.",VRTX,0.023933,0.100746,Neutral
2 Short-Squeeze Candidates That Could Go Parabolic,https://www.fool.com/investing/2023/06/15/2-short-squeeze-candidates-that-could-go-parabolic/,2023-06-15 14:00:00,Editas Medicine and Bluebird Bio have been favorite targets for short-sellers lately.,VRTX,0.050148,0.212308,Somewhat-Bullish
Biomarkers Market to Grow Significantly by 2029- Brandessence Market Research,https://www.prnewswire.com/news-releases/biomarkers-market-to-grow-significantly-by-2029--brandessence-market-research-301851886.html,2023-06-15 10:40:00,"LONDON, June 15, 2023 /PRNewswire/ -- Biomarkers are referred to as a type of measurable biological indicators or characteristics found in body tissues or fluids like blood.",VRTX,0.023861,0.109009,Neutral
3 Revolutionary Stocks I'd Buy Right Now Without Hesitation,https://www.fool.com/investing/2023/06/15/3-revolutionary-stocks-id-buy-right-now-without-he/,2023-06-15 09:54:00,All three of these stocks should be huge winners over the long run.,VRTX,0.138863,0.242485,Somewhat-Bullish
2 Magnificent Growth Stocks to Buy Before the Next Bull Market,https://www.fool.com/investing/2023/06/15/2-magnificent-growth-stocks-to-buy-before-the-next/,2023-06-15 09:12:00,A bull market could be the tip of the iceberg for these businesses.,VRTX,0.134841,0.107397,Neutral
Where Will CRISPR Therapeutics Be in 10 Years?,https://www.fool.com/investing/2023/06/14/where-will-crispr-therapeutics-be-in-10-years/,2023-06-14 13:45:00,The biotech is part of a revolution in gene-editing therapies.,VRTX,0.049629,0.109186,Neutral
Spero Therapeutics Appoints Sath Shukla as President & Chief Executive Officer,https://www.globenewswire.com/news-release/2023/06/14/2688043/0/en/Spero-Therapeutics-Appoints-Sath-Shukla-as-President-Chief-Executive-Officer.html,2023-06-14 12:05:00,"Sath Shukla, current Spero Chief Financial Officer, will bring more than 20 years of strategic and financial leadership to the role of CEO, to be effective August ...",VRTX,0.02674,0.069052,Neutral
"Spero Therapeutics Appoints Sath Shukla as President & Chief Executive Officer - GSK  ( NYSE:GSK ) , Pfizer  ( NYSE:PFE ) ",https://www.benzinga.com/pressreleases/23/06/g32852871/spero-therapeutics-appoints-sath-shukla-as-president-chief-executive-officer,2023-06-14 12:05:00,"Sath Shukla, current Spero Chief Financial Officer, will bring more than 20 years of strategic and financial leadership to the role of CEO, to be effective August 1, 2023 Current President and Chief Executive Officer, Ankit Mahadevia, M.D to become Chairman of the Board of Directors",VRTX,0.025929,0.066862,Neutral
"Fed On Tap As Nasdaq, Leaders Look Extended",https://www.investors.com/market-trend/stock-market-today/dow-jones-futures-nasdaq-looking-extended-as-fed-decision-looms-what-investors-need-now/,2023-06-13 21:02:00,Dow Jones Futures: Breadth expands. Fed Next Investor's Business Daily ...,VRTX,0.075004,0.099955,Neutral
"Fed On Tap As Nasdaq, Leaders Look Extended",https://www.investors.com/market-trend/stock-market-today/dow-jones-futures-nasdaq-looking-extended-as-fed-decision-looms-what-investors-need-now/,2023-06-13 21:02:00,Dow Jones Futures: Breadth expands. Fed Next Investor's Business Daily ...,VRTX,0.074926,0.099945,Neutral
Alkermes Issues Letter to Shareholders Highlighting Skills and Experience of Refreshed Board of Directors - Alkermes  ( NASDAQ:ALKS ) ,https://www.benzinga.com/pressreleases/23/06/n32831446/alkermes-issues-letter-to-shareholders-highlighting-skills-and-experience-of-refreshed-board-of-di,2023-06-13 11:00:00,"Sarissa's Proposed Candidates Would Not Bring New Skills to the Board Recommends Shareholders Vote ""FOR"" Alkermes' Director Nominees on Company's WHITE Proxy Card",VRTX,0.009551,-0.048746,Neutral
This Move Is a First for the FDA. Could It Signal a Big Turning Point for CRISPR Therapeutics?,https://www.fool.com/investing/2023/06/13/this-fda-first-could-signal-crispr-turning-point/,2023-06-13 09:30:00,All eyes are on CRISPR Therapeutics' gene editing technology.,VRTX,0.056011,0.0,Neutral
2 Biotech Stocks That Could Help Make You a Fortune,https://www.fool.com/investing/2023/06/12/2-biotech-stocks-that-could-help-make-a-fortune/,2023-06-12 11:30:00,Biotech stocks with cutting-edge therapies have the potential to generate substantial returns over time.,VRTX,0.055751,0.137998,Neutral
3 No-Brainer Stocks to Buy in June,https://www.fool.com/investing/2023/06/10/3-no-brainer-stocks-to-buy-in-june/,2023-06-10 10:14:00,These biopharma stocks could be big winners.,VRTX,0.176825,-0.157262,Somewhat-Bearish
Vertex Pharmaceuticals  ( VRTX )  Stock Sinks As Market Gains: What You Should Know,https://www.zacks.com/stock/news/2115035/vertex-pharmaceuticals-vrtx-stock-sinks-as-market-gains-what-you-should-know,2023-06-29 21:50:21,"Vertex Pharmaceuticals (VRTX) closed the most recent trading day at $348.18, moving -0.74% from the previous trading session.",VRTX,0.605266,0.290835,Somewhat-Bullish
2 Unstoppable Growth Stocks to Buy in 2023 and Beyond,https://www.fool.com/investing/2023/06/29/2-unstoppable-growth-stocks-to-buy-in-2023-and/,2023-06-29 12:00:00,Both companies have therapies that should help grow revenue and earnings for years.,VRTX,0.091509,0.204696,Somewhat-Bullish
Is Bluebird Bio Stock a Buy Now?,https://www.fool.com/investing/2023/06/29/is-bluebird-bio-stock-a-buy-now/,2023-06-29 11:45:00,"If the company can pull off a comeback, investors who get in now will see incredible returns. But how likely is a comeback?",VRTX,0.054114,0.032998,Neutral
Verve Therapeutics Sees IBD RS Rating Climb To 71,https://www.investors.com/ibd-data-stories/verve-therapeutics-sees-ibd-rs-rating-climb-to-71/,2023-06-29 07:00:00,"In a welcome move, Verve Therapeutics ( VERV ) saw its Relative Strength Rating rise from 66 to 71 on Thursday. X When looking for the best stocks to buy and watch, one factor to watch closely is relative price strength. IBD's proprietary rating tracks market leadership with a 1 ( worst ) to ...",VRTX,0.331765,0.0,Neutral
"Agios Pharmaceuticals Clears Key Benchmark, Hitting 80-Plus RS Rating",https://www.investors.com/ibd-data-stories/agios-pharmaceuticals-clears-key-benchmark-hitting-80-plus-rs-rating-5/,2023-06-29 07:00:00,"Agios Pharmaceuticals Clears Key Benchmark, Hitting 80-Plus RS ... Investor's Business Daily ...",VRTX,0.329551,0.0,Neutral
Is Editas Medicine Stock a Buy Now?,https://www.fool.com/investing/2023/06/28/is-editas-medicine-stock-a-buy-now/,2023-06-28 14:15:00,The fortunes of this once-promising biotech company have changed in the past year.,VRTX,0.059935,0.181028,Somewhat-Bullish
2 Under-the-Radar Biotech Stocks to Buy in 2023,https://www.fool.com/investing/2023/06/28/2-under-the-radar-biotech-stocks-to-buy-in-2023/,2023-06-28 11:45:00,These companies are coming into their own.,VRTX,0.058472,0.03203,Neutral
"The Best Stocks to Invest $20,000 in Right Now",https://www.fool.com/investing/2023/06/28/the-best-stocks-to-invest-20000-in-right-now/,2023-06-28 09:30:00,"You can invest in these companies with $20,000 -- or even a lot less.",VRTX,0.0378,0.168065,Somewhat-Bullish
Vertex Pharmaceuticals  ( NASDAQ:VRTX )  Downgraded to Buy at StockNews.com,https://www.defenseworld.net/2023/06/28/vertex-pharmaceuticals-nasdaqvrtx-downgraded-to-buy-at-stocknews-com.html,2023-06-28 07:50:47,Vertex Pharmaceuticals ( NASDAQ:VRTX ) Downgraded to Buy at ... Defense World ...,VRTX,0.822,0.470866,Bullish
"Xenon Pharmaceuticals Clears Technical Benchmark, Hitting 80-Plus RS Rating",https://www.investors.com/ibd-data-stories/xenon-pharmaceuticals-clears-technical-benchmark-hitting-80-plus-rs-rating-2/,2023-06-28 07:00:00,"Xenon Pharmaceuticals Clears Technical Benchmark, Hitting 80 ... Investor's Business Daily ...",VRTX,0.350564,0.0,Neutral
Wall Street Estimates That CRISPR Therapeutics Stock Could Jump 49%. Here's Why That's Right.,https://www.fool.com/investing/2023/06/27/wall-street-estimates-that-crispr-therapeutics/,2023-06-27 14:15:00,"With two huge catalysts drawing near, its stock could go even higher.",VRTX,0.056943,0.117006,Neutral
Weight-loss drugs in development aim to replace injections with pills,https://www.marketwatch.com/story/weight-loss-drugs-in-development-aim-to-replace-injections-with-pills-b830168d,2023-06-26 19:21:00,"Promising results for weight-loss treatments that could compete with Ozempic and Wegovy, along with new screening recommendations for fatty-liver disease, emerge from diabetes conference.",VRTX,0.114682,0.111197,Neutral
These Fund Yields Up To 13% And Leave ETFs In The Dust,https://www.forbes.com/sites/brettowens/2023/06/25/these-fund-yields-up-to-13-and-leave-etfs-in-the-dust/,2023-06-25 13:14:00,AI bubble? Bear market rally? I don't care because I see five dividends between 10.1% and 13.5%.,VRTX,0.050096,0.087325,Neutral
3 Monster Stocks in the Making to Buy Right Now,https://www.fool.com/investing/2023/06/25/3-monster-stocks-in-the-making-to-buy-right-now/,2023-06-25 10:07:00,They're not monsters now -- but just give them some time.,VRTX,0.047559,0.057185,Neutral
Op-ed: Here's a midyear stock-picking guide for both bears and bulls amid recession debate,https://www.cnbc.com/2023/06/23/midyear-stock-picking-guide-for-bears-and-bulls-amid-recession-debate.html,2023-06-23 13:00:01,"Amid debate about a possible recession, there are reasonable stock picks for both optimists and pessimists - as well as evergreen, all-weather choices.",VRTX,0.032425,0.281022,Somewhat-Bullish
Vertex Pharmaceuticals  ( VRTX )  Outpaces Stock Market Gains: What You Should Know,https://www.zacks.com/stock/news/2112054/vertex-pharmaceuticals-vrtx-outpaces-stock-market-gains-what-you-should-know,2023-06-22 21:50:21,"Vertex Pharmaceuticals (VRTX) closed the most recent trading day at $348.16, moving +1.42% from the previous trading session.",VRTX,0.661658,0.366891,Bullish
VRTX: 3 Biotech Stocks With 'A' POWR Ratings,https://stocknews.com/news/vrtx-regn-uthr-crsp-3-biotech-stocks-with-a-powr-ratings/,2023-06-22 17:09:33,"The biotech industry shows solid growth, mainly driven by the influx of emerging and innovative technology and government-backed investments.",VRTX,0.33127,0.275125,Somewhat-Bullish
The co-leader of an AI-driven quant fund beating the market this year shares 2 stocks his model is betting most on right now - and a simple way individual investors can use AI technology to pick stocks,https://www.businessinsider.com/how-to-use-ai-to-invest-artificial-intelligence-stock-picks-2023-6,2023-06-22 14:59:00,How to Use AI to Invest in the Stock Market: Quant Fund CEO - Business Insider ...,VRTX,0.116631,-0.002266,Neutral
Alleged Industrial Espionage Makes an Interesting Story,https://www.fool.com/investing/2023/06/21/alleged-industrial-espionage-makes-an-interesting/,2023-06-22 01:09:00,We also chat about Vertex Pharmaceuticals and its role at the center of cystic fibrosis treatment.,VRTX,0.049629,0.067792,Neutral
Buying This Growth Stock Hand-Over-Fist Right Now Could Make You a Lot Wealthier by 2030,https://www.fool.com/investing/2023/06/21/buying-this-growth-stock-hand-over-fist-right-now/,2023-06-21 11:15:00,"This company has several catalysts for growth coming up, with more on the way.",VRTX,0.05654,0.118,Neutral
Is CRISPR Therapeutics Stock a Buy Now?,https://www.fool.com/investing/2023/06/21/is-crispr-therapeutics-stock-a-buy-now/,2023-06-21 09:30:00,CRISPR stock has climbed more than 40% so far this year.,VRTX,0.059935,0.115001,Neutral
Verve  ( VERV )  Up 9.9% in a Week on Collaboration With Eli Lilly,https://www.zacks.com/stock/news/2110592/verve-verv-up-99-in-a-week-on-collaboration-with-eli-lilly,2023-06-20 12:54:00,Verve's (VERV) shares rise on collaboration with Eli Lilly to develop gene editing treatment for cardiovascular disease.,VRTX,0.273807,0.174364,Somewhat-Bullish
"2 Unstoppable Growth Stocks That Could Turn $20,000 into $100,000 by 2030",https://www.fool.com/investing/2023/06/20/2-unstoppable-growth-stocks-that-could-turn-20000/,2023-06-20 09:39:00,These one-of-a-kind businesses have an edge over the competition that could steadily push their stock prices in the right direction through the end of the decade and beyond.,VRTX,0.121959,0.056934,Neutral
"Want to Get Richer? 2 Unstoppable Stocks to Invest $1,000 In This Week",https://www.fool.com/investing/2023/07/09/want-to-get-richer-2-unstoppable-stocks-to-invest/,2023-07-09 10:13:00,A tech giant and a biotech standout are both proving their mettle in 2023.,VRTX,0.22616,0.240754,Somewhat-Bullish
"3 Growth Stocks With 55% to 71% Upside, According to Wall Street",https://www.fool.com/investing/2023/07/09/3-growth-stocks-with-55-to-71-upside-according-to/,2023-07-09 09:21:00,Find out why investment bank analysts are so bullish on these stocks.,VRTX,0.047371,-0.076976,Neutral
3 No-Brainer Stocks You Can Buy Right Now,https://www.fool.com/investing/2023/07/08/3-no-brainer-stocks-you-can-buy-right-now/,2023-07-08 10:14:00,Going with these stocks is an easy decision.,VRTX,0.158519,0.089712,Neutral
"Delta Air Lines, Vertex Pharmaceuticals, And A Major US Bank Nearing A Breakout Level: CNBC's 'Final Trades' - Cooper Companies  ( NYSE:COO ) , Delta Air Lines  ( NYSE:DAL ) ",https://www.benzinga.com/trading-ideas/long-ideas/23/07/33144384/delta-air-lines-vertex-pharmaceuticals-and-a-major-us-bank-nearing-a-breakout-level-cnbc,2023-07-07 13:25:42,"On CNBC's ""Halftime Report Final Trades,"" Amy Raskin of Chevy Chase Trust said Vertex Pharmaceuticals Incorporated VRTX, has ""done relatively well this year."" Morgan Stanley recently reiterated Vertex Pharmaceuticals with an Equal-Weight and raised the price target from $305 to $340.",VRTX,0.595343,0.0,Neutral
Xenon Pharmaceuticals Sees IBD RS Rating Improve To 72,https://www.investors.com/ibd-data-stories/xenon-pharmaceuticals-sees-ibd-rs-rating-improve-to-72/,2023-07-07 07:00:00,"Xenon Pharmaceuticals ( XENE ) had its Relative Strength ( RS ) Rating upgraded from 67 to 72 Friday -- a welcome improvement, but still shy of the 80 or better score you look for. X When looking for the best stocks to buy and watch, one factor to watch closely is relative price strength.",VRTX,0.299478,0.0,Neutral
Vertex Pharmaceuticals  ( VRTX )  Stock Moves -0.73%: What You Should Know,https://www.zacks.com/stock/news/2117784/vertex-pharmaceuticals-vrtx-stock-moves--073-what-you-should-know,2023-07-06 21:50:22,"Vertex Pharmaceuticals (VRTX) closed the most recent trading day at $345.76, moving -0.73% from the previous trading session.",VRTX,0.598621,0.170487,Somewhat-Bullish
Vertex  ( VRTX )  Gets Nod in EU for Orkambi Expanded Indication,https://www.zacks.com/stock/news/2117584/vertex-vrtx-gets-nod-in-eu-for-orkambi-expanded-indication,2023-07-06 14:45:00,Vertex's (VRTX) Orkambi gets approval from the European Commission in the EU for the treatment of cystic fibrosis in patients (aged 1 to <2 years) who have two copies of the F508del mutation.,VRTX,0.302429,-0.067755,Neutral
Sarepta  ( SRPT )  Sells Priority Review Voucher for $102M,https://www.zacks.com/stock/news/2117602/sarepta-srpt-sells-priority-review-voucher-for-102m,2023-07-06 14:29:00,Sarepta (SRPT) sells its priority review voucher that was awarded following the FDA's approval to Elevidys gene therapy for treating DMD. The company will invest these proceeds into R&D.,VRTX,0.134214,0.057065,Neutral
2 Growth Stocks That Might Be Too Cheap to Ignore,https://www.fool.com/investing/2023/07/06/2-growth-stocks-that-might-be-too-cheap-to-ignore/,2023-07-06 13:17:00,The sky is the limit for these healthcare companies.,VRTX,0.214937,0.318495,Somewhat-Bullish
2 Supercharged Growth Stocks to Invest In Before the Next Bull Market,https://www.fool.com/investing/2023/07/06/2-supercharged-growth-stocks-to-invest-in-before-t/,2023-07-06 10:33:00,"Whatever the market does in the next few months, these stocks have plenty of room left to run.",VRTX,0.204503,0.173886,Somewhat-Bullish
"Vertex Pharmaceuticals  ( NASDAQ:VRTX )  Upgraded to ""Strong-Buy"" by StockNews.com",https://www.defenseworld.net/2023/07/06/vertex-pharmaceuticals-nasdaqvrtx-upgraded-to-strong-buy-by-stocknews-com.html,2023-07-06 07:26:42,StockNews.com upgraded shares of Vertex Pharmaceuticals ( NASDAQ:VRTX - Free Report ) from a buy rating to a strong-buy rating in a report published on Wednesday morning. Other research analysts have also issued reports about the company.,VRTX,0.72663,0.475983,Bullish
Celldex Therapeutics Getting Closer To Key Technical Measure,https://www.investors.com/ibd-data-stories/celldex-therapeutics-getting-closer-to-key-technical-measure/,2023-07-06 07:00:00,"Celldex Therapeutics ( CLDX ) had its Relative Strength ( RS ) Rating upgraded from 70 to 75 Thursday -- a welcome improvement, but still short of the 80 or higher score you look for. When you're researching the best stocks to buy and watch, be sure to pay attention to relative price strength.",VRTX,0.331765,0.0,Neutral
"Axsome Therapeutics Clears Technical Benchmark, Hitting 90-Plus RS Rating",https://www.investors.com/ibd-data-stories/axsome-therapeutics-clears-technical-benchmark-hitting-90-plus-rs-rating/,2023-07-06 07:00:00,"When looking for the best stocks to buy and watch, focus on those with rising relative price strength. One stock that fits that bill is Axsome Therapeutics ( AXSM ) , which saw a welcome improvement to its Relative Strength ( RS ) Rating on Thursday, with an increase from 88 to 92.",VRTX,0.31482,0.12658,Neutral
Replimune Group Shows Market Leadership With Jump To 82 RS Rating,https://www.investors.com/ibd-data-stories/replimune-group-shows-market-leadership-with-jump-to-82-rs-rating/,2023-07-06 07:00:00,"When looking for the best stocks to buy and watch, focus on those with rising relative price strength. One stock that fits that bill is Replimune Group ( REPL ) , which had its Relative Strength ( RS ) Rating upgraded from 79 to 82 Thursday.",VRTX,0.306963,0.0,Neutral
CRISPR  ( CRSP )  Shares Rise 24% in the Last Quarter: Here's Why,https://www.zacks.com/stock/news/2116809/crispr-crsp-shares-rise-24-in-the-last-quarter-heres-why,2023-07-05 11:36:00,"Shares of CRISPR (CRSP) surge 24% in the last quarter after the company, along with Vertex, provides positive regulatory updates on exa-cel BLAs in SCD and TDT treatment.",VRTX,0.21258,0.128027,Neutral
Stocks Showing Market Leadership: Ventyx Biosciences Earns 96 RS Rating,https://www.investors.com/ibd-data-stories/stocks-showing-market-leadership-ventyx-biosciences-earns-96-rs-rating/,2023-07-05 07:00:00,"On Wednesday, Ventyx Biosciences ( VTYX ) received an upgrade to its Relative Strength ( RS ) Rating, from 89 to 96. As you try to find the best stocks to buy and watch, be sure to pay attention to relative price strength.",VRTX,0.343279,0.135398,Neutral
AstraZeneca  ( AZN )  Down 9% on Mixed Lung Cancer Study Results,https://www.zacks.com/stock/news/2116564/astrazeneca-azn-down-9-on-mixed-lung-cancer-study-results,2023-07-04 14:41:00,"While AstraZeneca's (AZN) late-stage study evaluating an experimental lung cancer treatment showed improvement in progression free survival, it did not meet the threshold for statistical significance in overall survival.",VRTX,0.12013,0.050791,Neutral
Peering Into Vertex Pharmaceuticals's Recent Short Interest - Vertex Pharmaceuticals  ( NASDAQ:VRTX ) ,https://www.benzinga.com/short-sellers/23/07/33098267/peering-into-vertex-pharmaceuticalss-recent-short-interest,2023-07-03 15:30:57,"Vertex Pharmaceuticals's VRTX short percent of float has fallen 10.92% since its last report. The company recently reported that it has 2.73 million shares sold short, which is 1.06% of all regular shares that are available for trading.",VRTX,0.221819,0.083071,Neutral
Should You Invest in the Invesco Dynamic Biotechnology & Genome ETF  ( PBE ) ?,https://www.zacks.com/stock/news/2115804/should-you-invest-in-the-invesco-dynamic-biotechnology-genome-etf-pbe,2023-07-03 10:20:09,Sector ETF report for ...,VRTX,0.128478,0.069872,Neutral
Vertex Pharmaceuticals Stock: Bear vs. Bull,https://www.fool.com/investing/2023/07/03/vertex-pharmaceuticals-stock-bear-vs-bull/,2023-07-03 09:30:00,Vertex has reached a key moment in its story.,VRTX,0.114682,0.047439,Neutral
Intra-Cellular Therapies Meets 80-Plus Relative Strength Rating Benchmark,https://www.investors.com/ibd-data-stories/intra-cellular-therapies-meets-80-plus-relative-strength-rating-benchmark/,2023-07-03 07:00:00,Intra-Cellular Therapies Meets 80-Plus Relative Strength Rating ... Investor's Business Daily ...,VRTX,0.33628,0.0,Neutral
Buying These 3 Stocks Could Be the Smartest Investing Move You'll Ever Make,https://www.fool.com/investing/2023/06/30/buying-these-3-stocks-could-be-the-smartest-invest/,2023-06-30 09:50:00,Buying these stocks now could pay off handsomely over the long run.,VRTX,0.125134,0.015159,Neutral
Vertex Pharmaceuticals  ( VRTX )  Stock Sinks As Market Gains: What You Should Know,https://www.zacks.com/stock/news/2124100/vertex-pharmaceuticals-vrtx-stock-sinks-as-market-gains-what-you-should-know,2023-07-19 21:50:21,"Vertex Pharmaceuticals (VRTX) closed the most recent trading day at $358.57, moving -0.11% from the previous trading session.",VRTX,0.600271,0.359101,Bullish
"Coinbase Global, Moderna And 2 Other Stocks Insiders Are Selling - Moderna  ( NASDAQ:MRNA ) , Coinbase Glb  ( NASDAQ:COIN ) ",https://www.benzinga.com/news/23/07/33283526/coinbase-global-moderna-and-2-other-stocks-insiders-are-selling,2023-07-19 12:26:44,"The Nasdaq 100 closed higher on Tuesday. Investors, meanwhile, focused on some notable insider trades. When insiders sell shares, it could be a preplanned sale, or could indicate their concern in the company's prospects or that they view the stock as being overpriced.",VRTX,0.466325,0.054598,Neutral
3 Healthcare Stocks to Buy and Hold for the Next 10 Years,https://www.fool.com/investing/2023/07/19/3-healthcare-stocks-to-buy-and-hold-for-the-next/,2023-07-19 12:15:00,It helps to offer products everyone needs.,VRTX,0.259451,0.263973,Somewhat-Bullish
3 No-Brainer Stocks to Buy With $400 Right Now,https://www.fool.com/investing/2023/07/19/3-no-brainer-stocks-to-buy-with-400-right-now/,2023-07-19 09:21:00,A modest amount of money can go a long way when it's invested in industry-leading businesses.,VRTX,0.099066,0.130987,Neutral
Replimune Group Getting Closer To Key Technical Benchmark,https://www.investors.com/ibd-data-stories/replimune-group-getting-closer-to-key-technical-benchmark-2/,2023-07-19 07:00:00,"The Relative Strength ( RS ) Rating for Replimune Group ( REPL ) headed into a higher percentile Wednesday, as it got a lift from 69 to 75. X When looking for the best stocks to buy and watch, one factor to watch closely is relative price strength.",VRTX,0.308891,0.0,Neutral
argenx ADR Joins Elite Club Of Stocks With RS Ratings Over 90,https://www.investors.com/ibd-data-stories/argenx-adr-joins-elite-club-of-stocks-with-rs-ratings-over-90/,2023-07-19 07:00:00,"argenx ADR ( ARGX ) saw a positive improvement to its Relative Strength ( RS ) Rating on Wednesday, rising from 88 to 91. When looking for the best stocks to buy and watch, one factor to watch closely is relative price strength.",VRTX,0.297661,0.116829,Neutral
Aurinia Pharmaceuticals Stock Returns To A Rising Relative Strength,https://www.investors.com/research/stock-upgrades-aurinia-pharmaceuticals-shows-rising-relative-strength-3/,2023-07-18 14:55:00,"The Relative Strength ( RS ) Rating for Aurinia Pharmaceuticals ( AUPH ) climbed into a new percentile Tuesday, with a rise from 79 to 82. Last week it actually hit 83, then fell on a couple of down days before reversing higher.",VRTX,0.249106,0.0,Neutral
Halozyme Therapeutics  ( HALO )  Soars 5.4%: Is Further Upside Left in the Stock?,https://www.zacks.com/stock/news/2122549/halozyme-therapeutics-halo-soars-54-is-further-upside-left-in-the-stock,2023-07-18 09:39:00,Halozyme Therapeutics (HALO) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock doesn't suggest further strength down the road.,VRTX,0.293506,0.0,Neutral
Stock Upgrades: Aurinia Pharmaceuticals Shows Rising Relative Strength,https://www.investors.com/ibd-data-stories/stock-upgrades-aurinia-pharmaceuticals-shows-rising-relative-strength-3/,2023-07-18 07:00:00,"The Relative Strength ( RS ) Rating for Aurinia Pharmaceuticals ( AUPH ) climbed into a new percentile Tuesday, with a rise from 79 to 82. X When looking for the best stocks to buy and watch, one factor to watch closely is relative price strength.",VRTX,0.33628,0.0,Neutral
Stocks With Rising Relative Strength: SpringWorks Therapeutics,https://www.investors.com/ibd-data-stories/stocks-with-rising-relative-strength-springworks-therapeutics/,2023-07-18 07:00:00,"On Tuesday, SpringWorks Therapeutics ( SWTX ) earned a positive adjustment to its Relative Strength ( RS ) Rating, from 68 to 73. X When looking for the best stocks to buy and watch, one factor to watch closely is relative price strength.",VRTX,0.323078,0.0,Neutral
Stocks To Watch: Mirum Pharmaceuticals Sees Relative Strength Rating Jump To 82,https://www.investors.com/ibd-data-stories/stocks-to-watch-mirum-pharmaceuticals-sees-relative-strength-rating-jump-to-82/,2023-07-18 07:00:00,"When looking for the best stocks to buy and watch, focus on those with rising relative price strength. One stock that fits that bill is Mirum Pharmaceuticals ( MIRM ) , which had its Relative Strength ( RS ) Rating upgraded from 78 to 82 Tuesday.",VRTX,0.310843,0.0,Neutral
Vertex Pharmaceuticals Unusual Options Activity For July 17 - Vertex Pharmaceuticals  ( NASDAQ:VRTX ) ,https://www.benzinga.com/markets/options/23/07/33253241/vertex-pharmaceuticals-unusual-options-activity-for-july-17,2023-07-17 16:31:16,"Someone with a lot of money to spend has taken a bullish stance on Vertex Pharmaceuticals VRTX. We noticed this today when the big position showed up on publicly available options history that we track here at Benzinga. Whether this is an institution or just a wealthy individual, we don't know.",VRTX,0.690822,0.359856,Bullish
2 Monster Stocks to Buy Without Any Hesitation,https://www.fool.com/investing/2023/07/17/2-monster-stocks-to-buy-without-any-hesitation/,2023-07-17 09:30:00,These players each bring in billions of dollars in earnings every year.,VRTX,0.130217,0.141193,Neutral
"More Investing Advice From 's ""Rule Breaker Investing""",https://www.fool.com/retirement/2023/07/15/investing-advice-from-motley-fools-rule-breaker-in/,2023-07-15 12:30:00,"We talk about Royal Caribbean stock, advice for new investors, dividend reinvestment, and more.",VRTX,0.007697,0.096375,Neutral
Vertex Pharmaceuticals: Buy at the High?,https://www.fool.com/investing/2023/07/14/vertex-pharmaceuticals-buy-at-the-high/,2023-07-14 09:30:00,Vertex's next blockbuster may be right around the corner.,VRTX,0.105836,-0.080201,Neutral
Vertex Pharmaceuticals  ( NASDAQ:VRTX )  Lifted to Strong-Buy at StockNews.com,https://www.defenseworld.net/2023/07/14/vertex-pharmaceuticals-nasdaqvrtx-lifted-to-strong-buy-at-stocknews-com.html,2023-07-14 05:34:48,"Vertex Pharmaceuticals ( NASDAQ:VRTX - Get Free Report ) was upgraded by stock analysts at StockNews.com from a ""buy"" rating to a ""strong-buy"" rating in a report released on Friday.",VRTX,0.702807,0.420627,Bullish
Vertex Pharmaceuticals  ( VRTX )  Outpaces Stock Market Gains: What You Should Know,https://www.zacks.com/stock/news/2120936/vertex-pharmaceuticals-vrtx-outpaces-stock-market-gains-what-you-should-know,2023-07-13 21:50:20,"In the latest trading session, Vertex Pharmaceuticals (VRTX) closed at $349.02, marking a +0.86% move from the previous day.",VRTX,0.670305,0.410341,Bullish
2 No-Brainer Healthcare Stocks to Buy With $100 Right Now,https://www.fool.com/investing/2023/07/13/2-no-brainer-healthcare-stocks-to-buy-with-100-now/,2023-07-13 13:30:00,These stocks may not stay this low for long.,VRTX,0.068502,0.124448,Neutral
2 Magnificient Growth Stocks to Buy in July,https://www.fool.com/investing/2023/07/13/2-magnificient-growth-stocks-to-buy-in-july/,2023-07-13 13:30:00,These two growth stocks might be incredibly undervalued right now.,VRTX,0.066784,0.118275,Neutral
3 Top Biotech Stocks Defying the Bear Market,https://www.fool.com/investing/2023/07/13/3-top-biotech-stocks-defying-the-bear-market/,2023-07-13 11:45:00,Each has the potential to dramatically outperform the market.,VRTX,0.09186,0.124205,Neutral
Got $500? 3 Growth Stocks to Buy That Could Double Your Money,https://www.fool.com/investing/2023/07/13/got-500-3-growth-stocks-to-buy-that-could-double-y/,2023-07-13 09:50:00,"There's no guarantee these stocks will deliver 2x returns over the next few years, but their prospects look good.",VRTX,0.110717,0.060194,Neutral
IBD Rating Upgrades: Agios Pharmaceuticals Flashes Improved Price Strength,https://www.investors.com/ibd-data-stories/ibd-rating-upgrades-agios-pharmaceuticals-flashes-improved-price-strength/,2023-07-13 07:00:00,"The Relative Strength ( RS ) Rating for Agios Pharmaceuticals ( AGIO ) entered a new percentile Thursday, as it got a lift from 67 to 79. X As you try to find the best stocks to buy and watch, keep a close on eye on relative price strength.",VRTX,0.325208,0.0,Neutral
Stocks Showing Improved Relative Strength: Arcus Biosciences,https://www.investors.com/ibd-data-stories/stocks-showing-improved-relative-strength-arcus-biosciences/,2023-07-13 07:00:00,"On Thursday, Arcus Biosciences ( RCUS ) received an upgrade to its Relative Strength ( RS ) Rating, from 67 to 75. X When looking for the best stocks to buy and watch, one factor to watch closely is relative price strength. IBD's unique rating tracks price action with a 1 ( worst ) to 99 ( ...",VRTX,0.310843,0.0,Neutral
Cryoport Announces Certain Preliminary Results for Second Quarter & Updates 2023 Revenue Expectations,https://www.prnewswire.com/news-releases/cryoport-announces-certain-preliminary-results-for-second-quarter--updates-2023-revenue-expectations-301875999.html,2023-07-12 20:05:00, Second quarter results were impacted by weaker than expected global demand for capital equipment. clinical trial start delays.,VRTX,0.031696,0.096272,Neutral
Is Now the Right Time to Embrace Biotech ETFs?,https://www.zacks.com/stock/news/2120021/is-now-the-right-time-to-embrace-biotech-etfs,2023-07-12 15:09:00,Look if it's the right time to invest in biotech ETFs to help diversify your portfolio.,VRTX,0.124164,0.04872,Neutral
3 Things About Vertex Pharmaceuticals That Smart Investors Know,https://www.fool.com/investing/2023/07/12/3-things-about-vertex-pharmaceuticals-that-smart-i/,2023-07-12 10:00:00,Vertex shares have advanced about 20% so far this year.,VRTX,0.105604,0.18866,Somewhat-Bullish
2 Top Healthcare Stocks Defying the Bear Market,https://www.fool.com/investing/2023/07/11/2-top-healthcare-stocks-defying-the-bear-market/,2023-07-11 10:00:00,These stocks are rising in the double digits -- and outperforming the S&P 500.,VRTX,0.067919,0.053115,Neutral
Sitting on Cash? These 2 Stocks Are Great Buys,https://www.fool.com/investing/2023/07/11/sitting-on-cash-these-2-stocks-are-great-buys/,2023-07-11 09:30:00,Coca-Cola and Vertex Pharmaceuticals are excellent choices to add to your portfolio for the long term.,VRTX,0.112269,0.116972,Neutral
Stocks Flashing Renewed Technical Strength: Immunocore Holdings ADR,https://www.investors.com/ibd-data-stories/stocks-flashing-renewed-technical-strength-immunocore-holdings-adr/,2023-07-11 07:00:00,"Immunocore Holdings ADR ( IMCR ) saw a positive improvement to its Relative Strength ( RS ) Rating on Tuesday, with an increase from 88 to 92. X As you try to find the best stocks to buy and watch, be sure to pay attention to relative price strength.",VRTX,0.340915,0.129984,Neutral
Rocket Pharmaceuticals Hits 80-Plus Relative Strength Rating Benchmark,https://www.investors.com/ibd-data-stories/rocket-pharmaceuticals-hits-80-plus-relative-strength-rating-benchmark/,2023-07-11 07:00:00,"When putting together your watch list, look for stocks with an 80 or higher RS Rating. Rocket Pharmaceuticals ( RCKT ) now meets that criteria, with a jump from 71 to 81 Tuesday. X When looking for the best stocks to buy and watch, one factor to watch closely is relative price strength.",VRTX,0.331765,0.0,Neutral
Stocks To Watch: Viridian Therapeutics Sees Relative Strength Rating Jump To 84,https://www.investors.com/ibd-data-stories/stocks-to-watch-viridian-therapeutics-sees-relative-strength-rating-jump-to-84/,2023-07-11 07:00:00,"When putting together your watch list, focus on stocks with an 80 or higher RS Rating. Viridian Therapeutics ( VRDN ) just met that criteria with a new score of 84. X When looking for the best stocks to buy and watch, one factor to watch closely is relative price strength.",VRTX,0.331765,0.0,Neutral
Stock Upgrades: Sage Therapeutics Shows Rising Relative Strength,https://www.investors.com/ibd-data-stories/stock-upgrades-sage-therapeutics-shows-rising-relative-strength-7/,2023-07-11 07:00:00,"When looking for the best stocks to buy and watch, focus on those with rising relative price strength. One stock that fits that bill is Sage Therapeutics ( SAGE ) , which had its Relative Strength ( RS ) Rating upgraded from 80 to 84 Tuesday.",VRTX,0.323078,0.0,Neutral
"Dynavax Technologies Clears Technical Benchmark, Hitting 80-Plus RS Rating",https://www.investors.com/ibd-data-stories/dynavax-technologies-clears-technical-benchmark-hitting-80-plus-rs-rating/,2023-07-11 07:00:00,"On Tuesday, Dynavax Technologies ( DVAX ) received an upgrade to its Relative Strength ( RS ) Rating, from 78 to 84. When looking for the best stocks to buy and watch, one factor to watch closely is relative price strength.",VRTX,0.316846,0.0,Neutral
Celldex Therapeutics Shows Rising Price Performance With Jump To 83 RS Rating,https://www.investors.com/ibd-data-stories/celldex-therapeutics-shows-rising-price-performance-with-jump-to-83-rs-rating/,2023-07-11 07:00:00,"When putting together your watch list, focus on stocks with an 80 or higher RS Rating. Celldex Therapeutics ( CLDX ) is one stock that just reached the mark, now earning a score of 83. X When looking for the best stocks to buy and watch, one factor to watch closely is relative price strength.",VRTX,0.316846,0.0,Neutral
Stock Upgrades: Agios Pharmaceuticals Shows Rising Relative Strength,https://www.investors.com/ibd-data-stories/stock-upgrades-agios-pharmaceuticals-shows-rising-relative-strength-4/,2023-07-11 07:00:00,"The Relative Strength ( RS ) Rating for Agios Pharmaceuticals ( AGIO ) headed into a new percentile Tuesday, as it got a lift from 66 to 73. X When you're researching the best stocks to buy and watch, keep a close on eye on relative price strength.",VRTX,0.306963,0.0,Neutral
Stocks Generating Improved Relative Strength: Arrowhead Pharm,https://www.investors.com/ibd-data-stories/stocks-generating-improved-relative-strength-arrowhead-pharm/,2023-07-11 07:00:00,"Arrowhead Pharm ( ARWR ) had its Relative Strength ( RS ) Rating upgraded from 64 to 79 Tuesday -- a welcome improvement, but still short of the 80 or better score you look for. X When looking for the best stocks to buy and watch, one factor to watch closely is relative price strength.",VRTX,0.306963,0.0,Neutral
Amicus Therapeutics Sees Relative Strength Rating Climb To 73,https://www.investors.com/ibd-data-stories/amicus-therapeutics-sees-relative-strength-rating-climb-to-73/,2023-07-11 07:00:00,"On Tuesday, Amicus Therapeutics ( FOLD ) got an upgrade to its Relative Strength ( RS ) Rating, from 61 to 73. X When looking for the best stocks to buy and watch, one factor to watch closely is relative price strength.",VRTX,0.306963,0.0,Neutral
Aurinia Pharmaceuticals Stock Shows Rising Relative Strength,https://www.investors.com/research/stock-upgrades-aurinia-pharmaceuticals-shows-rising-relative-strength-2/,2023-07-11 07:00:00,Stock Upgrades: Aurinia Pharmaceuticals Shows Rising Relative Strength Investor's Business Daily ...,VRTX,0.240489,0.0,Neutral
Here's How Much $1000 Invested In Vertex Pharmaceuticals 20 Years Ago Would Be Worth Today - Vertex Pharmaceuticals  ( NASDAQ:VRTX ) ,https://www.benzinga.com/news/earnings/23/07/33175319/heres-how-much-1000-invested-in-vertex-pharmaceuticals-20-years-ago-would-be-worth-today,2023-07-10 21:31:49,"Vertex Pharmaceuticals VRTX has outperformed the market over the past 20 years by 9.24% on an annualized basis producing an average annual return of 17.01%. Currently, Vertex Pharmaceuticals has a market capitalization of $88.72 billion.",VRTX,0.980595,0.386944,Bullish
Vertex  ( VRTX )  to Report Q2 Earnings: What's in the Cards?,https://www.zacks.com/stock/news/2128982/vertex-vrtx-to-report-q2-earnings-whats-in-the-cards,2023-07-27 16:38:00,"On Vertex's (VRTX) Q2 earnings call, investors focus will likely be on the sales performance of its cystic fibrosis medicines and development updates of its non-CF pipeline.",VRTX,0.213048,0.175148,Somewhat-Bullish
Could Vertex Pharmaceuticals Stock Help You Retire a Millionaire?,https://www.fool.com/investing/2023/07/27/could-vertex-pharmaceuticals-stock-help-you-retire/,2023-07-27 14:15:00,"The biotech is currently firing on all cylinders, but can it last?",VRTX,0.258351,0.129023,Neutral
2 No-Brainer Cathie Wood Stocks to Buy Right Now,https://www.fool.com/investing/2023/07/26/2-no-brainer-cathie-wood-stocks-to-buy-right-now/,2023-07-26 15:15:00,Vertex Pharmaceuticals and Pfizer should be stellar long-term buys.,VRTX,0.191675,0.043791,Neutral
Earnings Preview: Repligen  ( RGEN )  Q2 Earnings Expected to Decline,https://www.zacks.com/stock/news/2127919/earnings-preview-repligen-rgen-q2-earnings-expected-to-decline,2023-07-26 14:02:16,Repligen (RGEN) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.,VRTX,0.088472,0.039149,Neutral
Vertex Pharmaceuticals  ( VRTX )  Stock Moves 0.28%: What You Should Know,https://www.zacks.com/stock/news/2127326/vertex-pharmaceuticals-vrtx-stock-moves-028-what-you-should-know,2023-07-25 21:50:20,"In the latest trading session, Vertex Pharmaceuticals (VRTX) closed at $358.06, marking a +0.28% move from the previous day.",VRTX,0.553265,0.291722,Somewhat-Bullish
A Look Into Vertex Pharmaceuticals Inc's Price Over Earnings - Vertex Pharmaceuticals  ( NASDAQ:VRTX ) ,https://www.benzinga.com/news/23/07/33370813/a-look-into-vertex-pharmaceuticals-incs-price-over-earnings,2023-07-25 14:30:20,"In the current market session, Vertex Pharmaceuticals Inc. VRTX stock price is at $355.94, after a 0.31% drop. However, over the past month, the company's stock spiked by 2.54%, and in the past year, by 24.03%.",VRTX,0.428632,-0.048765,Neutral
Vertex Pharmaceuticals  ( VRTX )  Reports Next Week: Wall Street Expects Earnings Growth,https://www.zacks.com/stock/news/2126998/vertex-pharmaceuticals-vrtx-reports-next-week-wall-street-expects-earnings-growth,2023-07-25 14:01:24,Vertex (VRTX) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.,VRTX,0.102449,0.129645,Neutral
3 Top ETFs to Buy Right Now,https://www.fool.com/investing/2023/07/24/3-top-etfs-to-buy-right-now/,2023-07-24 21:45:00,These three exchange-traded funds could be winning plays for patient investors.,VRTX,0.07423,0.039438,Neutral
"$100 Invested In This Stock 20 Years Ago Would Be Worth $2,500 Today - Vertex Pharmaceuticals  ( NASDAQ:VRTX ) ",https://www.benzinga.com/news/earnings/23/07/33348153/100-invested-in-this-stock-20-years-ago-would-be-worth-2-500-today,2023-07-24 15:00:26,"Vertex Pharmaceuticals VRTX has outperformed the market over the past 20 years by 9.51% on an annualized basis producing an average annual return of 17.4%. Currently, Vertex Pharmaceuticals has a market capitalization of $92.58 billion.",VRTX,0.980595,0.386944,Bullish
Better Big Biotech Buy: Vertex vs. Biogen,https://www.fool.com/investing/2023/07/24/better-big-biotech-buy-vertex-vs-biogen/,2023-07-24 14:09:27,These companies have a track record of billion-dollar earnings.,VRTX,0.109705,0.255323,Somewhat-Bullish
Biotech wins fail to move stock indicators ahead of earnings,https://www.financialexpress.com/healthcare/news-healthcare/biotech-wins-fail-to-move-stock-indicators-ahead-of-earnings/3184760/,2023-07-24 10:35:25,Biotech has had a pretty good year between a flurry of deals and approvals of new drugs for vexing diseases such as Alzheimer's. Yet that isn't showing up in stock performance. Two closely watched indicators lag far behind the overall market.,VRTX,0.057215,0.0,Neutral
Stocks Showing Improving Market Leadership: Twist Bioscience Earns 84 RS Rating,https://www.investors.com/ibd-data-stories/stocks-showing-improving-market-leadership-twist-bioscience-earns-84-rs-rating/,2023-07-24 07:00:00,"Twist Bioscience ( TWST ) saw a positive improvement to its Relative Strength ( RS ) Rating on Monday, rising from 74 to 84. X When looking for the best stocks to buy and watch, keep a close on eye on relative price strength.",VRTX,0.348103,0.0,Neutral
Stocks Showing Improving Market Leadership: Immunocore Holdings ADR Earns 82 RS Rating,https://www.investors.com/ibd-data-stories/stocks-showing-improving-market-leadership-immunocore-holdings-adr-earns-82-rs-rating/,2023-07-24 07:00:00,"When looking for the best stocks to buy and watch, focus on those with rising relative price strength. One stock that fits that bill is Immunocore Holdings ADR ( IMCR ) , which had its Relative Strength ( RS ) Rating upgraded from 79 to 82 Monday.",VRTX,0.303175,0.0,Neutral
"Barron's Weekend Stock Picks: Barbie Bonanza, Vertex's Promising Drug And Tesla Doubts - Mattel  ( NASDAQ:MAT ) , AMC Enter Hldgs  ( NYSE:AMC ) ",https://www.benzinga.com/news/23/07/33333490/barrons-weekend-stock-picks-barbie-bonanza-vertexs-promising-drug-and-tesla-doubts,2023-07-22 15:13:57,"Benzinga reviews this weekend's top stories covered by Barron's. Here are the articles investors need to read. In ""It's the Summer of Barbie.",VRTX,0.228073,0.179426,Somewhat-Bullish
3 Small-Cap Stocks That Could Be Big-Time Winners,https://www.fool.com/investing/2023/07/22/3-small-cap-stocks-that-could-be-big-time-winners/,2023-07-22 10:14:00,These stocks come with significant risks. But they could generate huge returns over time.,VRTX,0.03853,0.043021,Neutral
"The Best Stocks to Invest $5,000 in Right Now",https://www.fool.com/investing/2023/07/22/the-best-stocks-to-invest-5000-in-right-now/,2023-07-22 09:50:00,Investors won't have to worry about overpaying for any of these stocks.,VRTX,0.12645,0.203536,Somewhat-Bullish
2 Soaring Stocks With More Upside Potential,https://www.fool.com/investing/2023/07/21/2-soaring-stocks-with-more-upside-potential/,2023-07-21 12:15:00,Are these mid-cap stocks giants in the making?,VRTX,0.083541,0.151674,Somewhat-Bullish
Is Now a Good Time to Buy CRISPR Therapeutics?,https://www.fool.com/investing/2023/07/21/is-now-a-good-time-to-buy-crispr-therapeutics/,2023-07-21 09:30:00,CRISPR shares have climbed more than 40% this year.,VRTX,0.065866,-0.034032,Neutral
Stocks Flashing Renewed Technical Strength: Blueprint Medicines,https://www.investors.com/ibd-data-stories/stocks-flashing-renewed-technical-strength-blueprint-medicines/,2023-07-21 07:00:00,"Blueprint Medicines ( BPMC ) saw a positive improvement to its Relative Strength ( RS ) Rating on Friday, with an upgrade from 79 to 82. X When looking for the best stocks to buy and watch, one factor to watch closely is relative price strength.",VRTX,0.343279,0.0,Neutral
Stocks To Watch: Legend Biotech ADR Sees Relative Strength Rating Rise To 93,https://www.investors.com/ibd-data-stories/stocks-to-watch-legend-biotech-adr-sees-relative-strength-rating-rise-to-93/,2023-07-21 07:00:00,"Legend Biotech ADR ( LEGN ) saw a welcome improvement to its Relative Strength ( RS ) Rating on Friday, rising from 90 to 93. When you're researching the best stocks to buy and watch, be sure to pay attention to relative price strength.",VRTX,0.305058,0.119142,Neutral
Stocks With Rising Relative Strength: SpringWorks Therapeutics,https://www.investors.com/ibd-data-stories/stocks-with-rising-relative-strength-springworks-therapeutics-2/,2023-07-21 07:00:00,"On Friday, SpringWorks Therapeutics ( SWTX ) received an upgrade to its Relative Strength ( RS ) Rating, from 70 to 79. X When looking for the best stocks to buy and watch, one factor to watch closely is relative price strength.",VRTX,0.303175,0.0,Neutral
Agios Pharmaceuticals Getting Closer To Key Technical Benchmark,https://www.investors.com/ibd-data-stories/agios-pharmaceuticals-getting-closer-to-key-technical-benchmark-3/,2023-07-21 07:00:00,"Agios Pharmaceuticals ( AGIO ) saw a welcome improvement to its Relative Strength ( RS ) Rating on Friday, with an increase from 64 to 73. X When looking for the best stocks to buy and watch, one factor to watch closely is relative price strength.",VRTX,0.297661,0.0,Neutral
Diabetic Peripheral Neuropathy Market Growing at a CAGR of ~6% by 2032 | DelveInsight,https://www.prnewswire.com/news-releases/diabetic-peripheral-neuropathy-market-growing-at-a-cagr-of-6-by-2032--delveinsight-301881945.html,2023-07-20 21:01:00,The dynamics of the diabetic peripheral neuropathy market are anticipated to change as companies across the globe are thoroughly working toward the development of new drug therapy options to treat this disease,VRTX,0.047797,0.089954,Neutral
IBD Stock Of The Day: Weight-Loss Kingpin Retakes 50-Day Line,https://www.investors.com/research/ibd-stock-of-the-day/novo-nordisk-stock-bounds-above-50-day-line-weight-loss-drugs-drive-enthusiasm/,2023-07-20 17:10:00,Novo Nordisk Stock Stock Bounds Above 50-Day Line. Weight-Loss Drugs Drive Enthusiasm Investor's Business Daily ...,VRTX,0.121037,0.154758,Somewhat-Bullish
Vir Biotech slumps to over 3-year low as flu prevention therapy fails trial,https://www.reuters.com/business/healthcare-pharmaceuticals/vir-biotech-slumps-over-3-year-low-flu-prevention-therapy-fails-trial-2023-07-20/,2023-07-20 16:37:48,July 20 ( Reuters ) - Vir Biotechnology's ( VIR.O ) shares plunged 45% to a more than three-year low on Thursday after the company's experimental antibody therapy to prevent a type of flu failed to meet its goals in a mid-stage trial.,VRTX,0.144275,0.076742,Neutral
Who is Reshma Kewalramani: Know more about her journey from a trained doctor to first female CEO of large US biotech company | The Financial Express,https://www.financialexpress.com/lifestyle/who-is-reshma-kewalramani-know-more-about-her-journey-from-a-trained-doctor-to-first-female-ceo-of-large-us-biotech-company/3177748/,2023-07-20 03:00:00,Who is Reshma Kewalramani: Know about her journey from a trained doctor to first female CEO of a US-based biotech company The Financial Express ...,VRTX,0.144275,0.0,Neutral
Why CRISPR Therapeutics Stock Is Jumping Today,https://www.fool.com/investing/2023/08/08/why-crispr-therapeutics-stock-is-jumping-today/,2023-08-08 16:14:52,Analysts continue to like this gene-editing stock.,VRTX,0.305058,-0.318771,Somewhat-Bearish
Claire's Place Foundation Launches First East Coast Glow Ride for Cystic Fibrosis,https://www.benzinga.com/pressreleases/23/08/g33635377/claires-place-foundation-launches-first-east-coast-glow-ride-for-cystic-fibrosis,2023-08-08 15:50:17,"Los Angeles, CA, Aug. 08, 2023 ( GLOBE NEWSWIRE ) -- Claire's Place Foundation, a non-profit organization providing support to children and families affected by cystic fibrosis ( CF ) , is excited to expand its reach and bring the unique Glow Ride for CF experience to the East Coast for the ...",VRTX,0.051221,0.098964,Neutral
CRISPR Therapeutics  ( CRSP )  Q2 Loss Narrower Than Expected,https://www.zacks.com/stock/news/2133785/crispr-therapeutics-crsp-q2-loss-narrower-than-expected,2023-08-08 15:09:00,CRISPR Therapeutics' (CRSP) second-quarter results beat the mark for both earnings and sales.,VRTX,0.217834,0.05771,Neutral
IBD Rating Upgrades: Vertex Pharmaceuticals Flashes Improved Relative Price Strength,https://www.investors.com/ibd-data-stories/ibd-rating-upgrades-vertex-pharmaceuticals-flashes-improved-relative-price-strength/,2023-08-08 07:00:00,"Vertex Pharmaceuticals ( VRTX ) had its Relative Strength ( RS ) Rating upgraded from 67 to 72 Tuesday -- a welcome improvement, but still below the 80 or higher score you look for. X When looking for the best stocks to buy and watch, one factor to watch closely is relative price strength.",VRTX,0.549581,0.509917,Bullish
CRISPR  ( CRSP )  to Post Q2 Earnings: What's in the Offing?,https://www.zacks.com/stock/news/2133170/crispr-crsp-to-post-q2-earnings-whats-in-the-offing,2023-08-07 15:01:00,"CRISPR (CRSP) currently does not have any marketed product in its portfolio. The company is expected to provide regulatory updates on exa-cel applications, along with other pipeline updates.",VRTX,0.158519,0.072024,Neutral
2 Top Biotech Stocks to Buy in August,https://www.fool.com/investing/2023/08/06/2-top-biotech-stocks-to-buy-in-august/,2023-08-06 13:15:00,Both companies are performing exceedingly well.,VRTX,0.206157,0.254022,Somewhat-Bullish
"1 Beaten-Down Stock That Could Soar by 89%, According to Wall Street",https://www.fool.com/investing/2023/08/05/1-beaten-down-stock-that-could-soar-by-89-accordin/,2023-08-05 13:40:00,Are you feeling brave?,VRTX,0.053629,-0.033994,Neutral
3 Top Healthcare Stocks to Buy for August,https://www.fool.com/investing/2023/08/05/3-top-healthcare-stocks-to-buy-for-august/,2023-08-05 13:15:00,"Shares of Humana, Vertex Pharmaceuticals, and Idexx Laboratories have all increased by at least 20% so far this year.",VRTX,0.133841,0.261916,Somewhat-Bullish
3 Fantastic Growth Stocks to Buy in August,https://www.fool.com/investing/2023/08/05/3-fantastic-growth-stocks-to-buy-in-august/,2023-08-05 10:55:00,These stocks could be poised to soar.,VRTX,0.262052,0.324917,Somewhat-Bullish
VRTX: 3 Biotech Stocks With Strong Value in August,https://stocknews.com/news/vrtx-jazz-alks-lzagy-crsp-zyme-3-biotech-stocks-with-strong-value-in-august/,2023-08-04 17:32:27,"Amid heightened product demand and intensified investor attention, the biotechnology sector remarkably performed during the global upheaval triggered by the COVID-19 pandemic, successfully drawing in a substantial influx of fresh capital.",VRTX,0.29234,0.135408,Neutral
Market Rally Under Pressure As Yields Soar: Weekly Review,https://www.investors.com/news/market-rally-under-pressure-as-yields-soar-amazon-elf-caterpillar-are-earnings-winners/,2023-08-04 14:51:00,"The stock market rally came under pressure amid surging Treasury yields, fueled by a U.S. credit-rating downgrade as well, swelling Treasury issuance and improving U.S. economic growth. But yields pared gains following a mixed jobs report. Apple ( AAPL ) and Amazon ( AMZN ) capped a huge week of ...",VRTX,0.04872,-0.016999,Neutral
2 Nasdaq 100 Stocks That Are Surefire Buys in August and 1 to Avoid,https://www.fool.com/investing/2023/08/04/2-nasdaq-100-stocks-buy-in-august-and-1-to-avoid/,2023-08-04 09:21:00,"Two Nasdaq 100 components are plain-as-day bargains, while another Nasdaq 100 stock could struggle to live up to lofty expectations.",VRTX,0.081645,0.120388,Neutral
"Moderna  ( MRNA )  Beats on Q2 Earnings & Sales, Raises '23 View",https://www.zacks.com/stock/news/2132136/moderna-mrna-beats-on-q2-earnings-sales-raises-23-view,2023-08-03 15:15:00,Moderna (MRNA) beats expectations for earnings and sales. Management raises its product revenue guidance based on potential U.S. demand for COVID vaccines during the upcoming fall season.,VRTX,0.045139,0.114229,Neutral
"Company News for Aug 3, 2023",https://www.zacks.com/stock/news/2131877/company-news-for-aug-3-2023,2023-08-03 13:23:00,"Companies in The News Are: VRTX, DVN, AFL, HUM ...",VRTX,0.608634,0.370666,Bullish
This Is Arguably the Single Best Stock to Buy Right Now,https://www.fool.com/investing/2023/08/03/single-best-stock-to-buy-right-now/,2023-08-03 09:51:00,This stock appears to be in a league of its own.,VRTX,0.102449,0.205731,Somewhat-Bullish
Vertex Pharmaceuticals Shows Improved Relative Strength; Still Shy Of Benchmark,https://www.investors.com/ibd-data-stories/vertex-pharmaceuticals-shows-improved-relative-strength-still-shy-of-benchmark-2/,2023-08-03 07:00:00,Vertex Pharmaceuticals Shows Improved Relative Strength. Still Shy Of Benchmark Investor's Business Daily ...,VRTX,0.481177,0.113825,Neutral
Here's Why Investors Should Buy These 2 Medical Stocks After Earnings,https://www.zacks.com/stock/news/2131624/heres-why-investors-should-buy-these-2-medical-stocks-after-earnings,2023-08-03 05:31:00,Following their favorable Q2 reports now looks like a good time to buy Encompass Health (EHC) and Vertex Pharmaceuticals (VRTX) stock.,VRTX,0.281422,0.286481,Somewhat-Bullish
"Analysts' Top Healthcare Picks: Tenet Healthcare  ( THC ) , Vertex Pharmaceuticals  ( VRTX ) ",https://markets.businessinsider.com/news/stocks/analysts-top-healthcare-picks-tenet-healthcare-thc-vertex-pharmaceuticals-vrtx-1032509298,2023-08-03 02:30:40,"Analysts' Top Healthcare Picks: Tenet Healthcare (THC), Vertex Pharmaceuticals (VRTX) - Markets Insider ...",VRTX,0.294682,0.280823,Somewhat-Bullish
1 No-Brainer Cathie Wood Stock to Buy Hand Over Fist in August,https://www.fool.com/investing/2023/08/02/1-no-brainer-cathie-wood-stock-to-buy-hand-over-fi/,2023-08-02 20:15:00,Crispr Therapeutics could be incredibly undervalued right now.,VRTX,0.110973,0.035423,Neutral
"Vertex Pharma Raises Annual Forecast On Strong Uptake For Cystic Fibrosis Drug, Analysts Says Investors' Focus On Non-CF Pipeline - Vertex Pharmaceuticals  ( NASDAQ:VRTX ) ",https://www.benzinga.com/analyst-ratings/analyst-color/23/08/33525374/vertex-pharma-raises-annual-forecast-on-strong-uptake-for-cystic-fibrosis-drug-anal,2023-08-02 18:10:49,"Vertex Pharmaceuticals Inc's VRTX Q2 sales increased 14% to $2.49 billion, beating the consensus of $2.41 billion. The increase was driven by the strong uptake of Trikafta/Kaftrio, including the launch in children with cystic fibrosis ( CF ) 2 to 5 years of age.",VRTX,0.421485,-0.065343,Neutral
"Vertex  ( VRTX )  Beats on Q2 Earnings & Sales, Raises '23 View",https://www.zacks.com/stock/news/2131278/vertex-vrtx-beats-on-q2-earnings-sales-raises-23-view,2023-08-02 16:06:00,"Vertex Pharmaceuticals' (VRTX) second-quarter 2023 earnings and sales beat estimates. Based on strong Trikafta uptake, management raises its financial guidance for 2023.",VRTX,0.17813,0.109711,Neutral
Vertex Pharmaceuticals  ( VRTX )  Q2 2023 Earnings Call Transcript,https://www.fool.com/earnings/call-transcripts/2023/08/01/vertex-pharmaceuticals-vrtx-q2-2023-earnings-call/,2023-08-02 01:00:25,"VRTX earnings call for the period ending June 30, 2023.",VRTX,0.005084,0.128311,Neutral
Vertex Pharmaceuticals  ( VRTX )  Q2 Earnings and Revenues Top Estimates,https://www.zacks.com/stock/news/2130667/vertex-pharmaceuticals-vrtx-q2-earnings-and-revenues-top-estimates,2023-08-01 21:15:06,"Vertex (VRTX) delivered earnings and revenue surprises of 1.04% and 3.47%, respectively, for the quarter ended June 2023. Do the numbers hold clues to what lies ahead for the stock?",VRTX,0.14131,0.096884,Neutral
Vertex Pharma raises full-year revenue forecast on cystic fibrosis treatment strength,https://www.reuters.com/business/healthcare-pharmaceuticals/vertex-pharma-raises-full-year-revenue-forecast-cystic-fibrosis-treatment-2023-08-01/,2023-08-01 20:47:22,"Aug 1 ( Reuters ) - Vertex Pharmaceuticals ( VRTX.O ) raised its full-year sales forecast on Tuesday, banking on strong demand for its cystic fibrosis ( CF ) treatment. The company now sees full-year sales from its CF treatments to be between $9.7 billion and $9.8 billion, from a prior ...",VRTX,0.139265,0.092115,Neutral
This Tech Giant And Cash Machine Just Beat Expectations,https://www.investors.com/news/technology/vrtx-stock-vertex-earnings-q2-2023/,2023-08-01 20:15:00,"VRTX Stock: Tech Leader Beats And Raises, But Shares Dip Investor's Business Daily ...",VRTX,0.800175,-0.144347,Neutral
Peering Into Vertex Pharmaceuticals's Recent Short Interest - Vertex Pharmaceuticals  ( NASDAQ:VRTX ) ,https://www.benzinga.com/short-sellers/23/08/33499790/peering-into-vertex-pharmaceuticalss-recent-short-interest,2023-08-01 16:30:23,"Vertex Pharmaceuticals's VRTX short percent of float has fallen 7.55% since its last report. The company recently reported that it has 2.51 million shares sold short, which is 0.98% of all regular shares that are available for trading.",VRTX,0.221819,0.083071,Neutral
ImmunoGen  ( IMGN )  Stock Down Despite Q2 Earnings & Sales Beat,https://www.zacks.com/stock/news/2130525/immunogen-imgn-stock-down-despite-q2-earnings-sales-beat,2023-08-01 14:09:00,"ImmunoGen's (IMGN) Q2 earnings show an encouraging adoption of the sole-marketed drug Elahere. The company, however, did not issue any product sales guidance for Elahere for 2023.",VRTX,0.109289,0.142275,Neutral
Auron Establishes Premier Scientific Advisory Board to Support the Advancement of its AI-Powered Platform and Pipeline Targeting Cellular Plasticity in Cancer,https://www.benzinga.com/pressreleases/23/08/g33489909/auron-establishes-premier-scientific-advisory-board-to-support-the-advancement-of-its-ai-powered-p,2023-08-01 11:30:00,"NEWTON, Mass., Aug. 01, 2023 ( GLOBE NEWSWIRE ) -- Auron Therapeutics, a platform-based, product-driven biotechnology company focused on developing novel cancer therapies that target cellular plasticity, today announced the members of its scientific advisory board ( SAB ) , comprised of ...",VRTX,0.0226,-0.025756,Neutral
"Rising Stars, Falling Trends: July's Industry ETF Winners and Losers - Invesco Solar ETF  ( ARCA:TAN ) , Deere  ( NYSE:DE ) , SLB  ( NYSE:SLB ) , Archer-Daniels Midland  ( NYSE:ADM ) , Mueller Industries  ( NYSE:MLI ) , Amgen  ( NASDAQ:AMGN ) , Ferguson  ( NYSE:FERG ) , Vanguard Real Estate ETF  ( ARCA:VNQ ) , VanEck Gold Miners ETF  ( ARCA:GDX ) , SPDR S&P 500  ( ARCA:SPY ) , American Tower  ( NYSE:AMT ) , SMA Solar Tech  ( OTC:SMTGF ) , VanEck Oil Services ETF  ( ARCA:OIH ) , VanEck Semiconductor ETF  ( NASDAQ:SMH ) , Taiwan Semiconductor  ( NYSE:TSM ) , Invesco QQQ Trust, Series 1  ( NASDAQ:QQQ ) , Antero Resources  ( NYSE:AR ) , First Solar  ( NASDAQ:FSLR ) , SPDR S&P Oil & Gas Explor & Product  ( ARCA:XOP ) , Biogen  ( NASDAQ:BIIB ) , SPDR S&P Regional Banking ETF  ( ARCA:KRE ) , Enphase Energy  ( NASDAQ:ENPH ) , Broadcom  ( NASDAQ:AVGO ) , Western Alliance  ( NYSE:WAL ) , CoStar Gr  ( NASDAQ:CSGP ) , iShares Biotechnology ETF  ( NASDAQ:IBB ) , Prologis  ( NYSE:PLD ) , Waters  ( NYSE:WAT ) , Ovintiv  ( NYSE:OVV ) , Danaher  ( NYSE:DHR ) , Invesco Water Resources ETF  ( NASDAQ:PHO ) , U.S. Global Jets ETF  ( ARCA:JETS ) , Lam Research  ( NASDAQ:LRCX ) , Zoetis  ( NYSE:ZTS ) , SM Energy  ( NYSE:SM ) , SPDR Dow Jones Industrial Average ETF  ( ARCA:DIA ) , iShares Russell 2000 ETF  ( ARCA:IWM ) , NVIDIA  ( NASDAQ:NVDA ) , Zions Bancorp  ( NASDAQ:ZION ) , Apellis Pharmaceuticals  ( NASDAQ:APLS ) , Crown Castle  ( NYSE:CCI ) , Vertex Pharmaceuticals  ( NASDAQ:VRTX ) , Southwest Airlines  ( NYSE:LUV ) , VanEck Agribusiness ETF  ( ARCA:MOO ) , Pinnacle Finl Partners  ( NASDAQ:PNFP ) , Delta Air Lines  ( NYSE:DAL ) , Ecolab  ( NYSE:ECL ) , APA  ( NASDAQ:APA ) , Halliburton  ( NYSE:HAL ) , SolarEdge Technologies  ( NASDAQ:SEDG ) , Valmont Industries  ( NYSE:VMI ) , Intel  ( NASDAQ:INTC ) ",https://www.benzinga.com/markets/equities/23/07/33471902/rising-stars-falling-trends-julys-industry-etf-winners-and-losers,2023-07-31 14:59:22,"As July comes to an end, it's time to take a look at the best- and worst-performing industry ETFs for the month. Among the largest ETFs that represent major U.S. stock indices, the SPDR S&P 500 ETF Trust SPY returned 3.1% in July, marking its fifth consecutive month of gains.",VRTX,0.110209,0.049137,Neutral
"Drug, Biotech Stocks' Q2 Earnings Due on Aug 1: PFE, MRK & More",https://www.zacks.com/stock/news/2129900/drug-biotech-stocks-q2-earnings-due-on-aug-1-pfe-mrk-more,2023-07-31 13:58:00,"Let's look at five big biotech, pharma companies, PFE, MRK, VRTX, EXEL and INCY, slated to release quarterly results on Aug 1.",VRTX,0.215702,0.0,Neutral
These 2 Stocks Are Heading for a Big Moment. Time to Buy?,https://www.fool.com/investing/2023/07/31/2-stocks-heading-for-big-moment-time-to-buy/,2023-07-31 09:30:00,Both stocks have climbed in the double digits this year.,VRTX,0.09989,0.119081,Neutral
Peering Into Vertex Pharmaceuticals's Recent Short Interest - Vertex Pharmaceuticals  ( NASDAQ:VRTX ) ,https://www.benzinga.com/short-sellers/23/08/33922199/peering-into-vertex-pharmaceuticalss-recent-short-interest,2023-08-18 18:45:20,"Vertex Pharmaceuticals's VRTX short percent of float has risen 13.27% since its last report. The company recently reported that it has 2.86 million shares sold short, which is 1.11% of all regular shares that are available for trading.",VRTX,0.221819,0.155473,Somewhat-Bullish
3 Monster Stocks to Buy Without Any Hesitation,https://www.fool.com/investing/2023/08/18/3-monster-stocks-to-buy-without-any-hesitation/,2023-08-18 09:50:00,You can rest easy investing in these great stocks.,VRTX,0.130217,0.037364,Neutral
bluebird's  ( BLUE )  Lovo-cel to Not Face Advisory Committee,https://www.zacks.com/stock/news/2137766/bluebirds-blue-lovo-cel-to-not-face-advisory-committee,2023-08-17 17:06:00,"bluebird (BLUE) announces that its gene therapy, lovotibeglogene autotemcel, developed for sickle cell disease, will not be scheduled for advisory committee meeting, thereby accelerating the path for approval.",VRTX,0.208166,0.13733,Neutral
2 Excellent Stocks to Buy and Hold Forever,https://www.fool.com/investing/2023/08/17/2-excellent-stocks-to-buy-and-hold-forever/,2023-08-17 13:20:00,These companies have solid long-term potential.,VRTX,0.472338,0.338499,Somewhat-Bullish
Is Invesco Dynamic Biotechnology & Genome ETF  ( PBE )  a Strong ETF Right Now?,https://www.zacks.com/stock/news/2137310/is-invesco-dynamic-biotechnology-genome-etf-pbe-a-strong-etf-right-now,2023-08-17 10:20:07,Smart Beta ETF report for ...,VRTX,0.118064,0.06168,Neutral
"Vertex Pharmaceuticals Stock Shows Rising Relative Strength, Hits 80+",https://www.investors.com/news/stock-upgrades-vertex-pharmaceuticals-shows-rising-relative-strength-4/,2023-08-16 20:01:00,"Vertex Pharmaceuticals Stock Shows Rising Relative Strength, Hits ... Investor's Business Daily ...",VRTX,0.262522,0.55491,Bullish
Stock Upgrades: Vertex Pharmaceuticals Shows Rising Relative Strength,https://www.investors.com/ibd-data-stories/stock-upgrades-vertex-pharmaceuticals-shows-rising-relative-strength-4/,2023-08-16 07:00:00,"On Wednesday, Vertex Pharmaceuticals ( VRTX ) earned a positive adjustment to its Relative Strength ( RS ) Rating, from 78 to 81. X When looking for the best stocks to buy and watch, one factor to watch closely is relative price strength.",VRTX,0.382925,0.68233,Bullish
Here's How Much You Would Have Made Owning Vertex Pharmaceuticals Stock In The Last 10 Years - Vertex Pharmaceuticals  ( NASDAQ:VRTX ) ,https://www.benzinga.com/news/earnings/23/08/33841959/heres-how-much-you-would-have-made-owning-vertex-pharmaceuticals-stock-in-the-last-10-years,2023-08-14 19:00:22,"Vertex Pharmaceuticals VRTX has outperformed the market over the past 10 years by 5.97% on an annualized basis producing an average annual return of 16.4%. Currently, Vertex Pharmaceuticals has a market capitalization of $90.22 billion.",VRTX,0.980595,0.386944,Bullish
Missed Out on CRISPR Therapeutics? My Best Biotech Stock to Buy and Hold,https://www.fool.com/investing/2023/08/14/missed-out-on-crispr-therapeutics-my-best-biotech/,2023-08-14 10:15:00,CRISPR Therapeutics is an intriguing biotech stock to consider now.,VRTX,0.055492,0.113867,Neutral
Want to Get Richer? Buy and Hold These 5 Unstoppable Stocks,https://www.fool.com/investing/2023/08/13/get-richer-buy-and-hold-5-unstoppable-stocks/,2023-08-13 09:52:00,Buying these stocks and waiting should help you boost your personal wealth.,VRTX,0.130926,0.190233,Somewhat-Bullish
"Analysts Have Conflicting Sentiments on These Healthcare Companies: Ambrx Biopharma  ( AMAM ) , QuidelOrtho  ( QDEL )  and Aveanna Healthcare Holdings  ( AVAH ) ",https://markets.businessinsider.com/news/stocks/analysts-have-conflicting-sentiments-on-these-healthcare-companies-ambrx-biopharma-amam-quidelortho-qdel-and-aveanna-healthcare-holdings-avah-1032548424,2023-08-13 00:00:37,"Analysts Have Conflicting Sentiments on These Healthcare Companies: Ambrx Biopharma (AMAM), QuidelOrtho (QDEL) and Aveanna Healthcare Holdings ...",VRTX,0.092927,0.108556,Neutral
Ready to Buy the Dip? CRISPR Therapeutics Stock Is a Smart Buy,https://www.fool.com/investing/2023/08/11/ready-to-buy-the-dip-crispr-therapeutics-stock-is/,2023-08-11 13:45:00,"Its shares tumbled due to factors outside its control, but the biotech still has substantial long-term potential.",VRTX,0.062597,0.145089,Neutral
Should You Invest in the VanEck Biotech ETF  ( BBH ) ?,https://www.zacks.com/stock/news/2135485/should-you-invest-in-the-vaneck-biotech-etf-bbh,2023-08-11 10:20:08,Sector ETF report for ...,VRTX,0.13459,0.071501,Neutral
Could Vertex Pharmaceuticals Stock Help You Become a Millionaire?,https://www.fool.com/investing/2023/08/10/vertex-pharmaceuticals-stock-help-millionaire/,2023-08-10 10:40:00,Vertex stock has been a growth beast in recent years -- can that trend continue?,VRTX,0.151858,0.203642,Somewhat-Bullish
Verve Therapeutics Highlights Recent Company Progress and Reports Second Quarter 2023 Financial Results,https://www.globenewswire.com/news-release/2023/08/10/2722440/0/en/Verve-Therapeutics-Highlights-Recent-Company-Progress-and-Reports-Second-Quarter-2023-Financial-Results.html,2023-08-10 10:30:00,heart-1 Initial Clinical Data Expected in the Fourth Quarter of ...,VRTX,0.020317,0.011651,Neutral
3 Explosive Stocks to Buy Right Now,https://www.fool.com/investing/2023/08/10/3-explosive-stocks-to-buy-right-now/,2023-08-10 09:50:00,These stocks are poised to pop in the not-too-distant future.,VRTX,0.132733,0.022265,Neutral
3 Top Biotech Stocks Defying the Bear Market,https://www.fool.com/investing/2023/08/10/3-top-biotech-stocks-defying-the-bear-market/,2023-08-10 09:21:00,"Biotech is still booming, if you pick the right biotech stocks.",VRTX,0.125025,0.159439,Somewhat-Bullish
Stocks To Watch: Arcturus Therapeutics Sees Relative Strength Rating Jump To 91,https://www.investors.com/ibd-data-stories/stocks-to-watch-arcturus-therapeutics-sees-relative-strength-rating-jump-to-91/,2023-08-10 07:00:00,"On Thursday, Arcturus Therapeutics ( ARCT ) earned an upgrade to its Relative Strength ( RS ) Rating, from 77 to 91. X When looking for the best stocks to buy and watch, one factor to watch closely is relative price strength.",VRTX,0.374312,0.144504,Neutral
Regeneron Pharmaceuticals Trying To Close In On Key Technical Benchmark,https://www.investors.com/ibd-data-stories/regeneron-pharmaceuticals-trying-to-close-in-on-key-technical-benchmark/,2023-08-10 07:00:00,"On Thursday, Regeneron Pharmaceuticals ( REGN ) received a positive adjustment to its Relative Strength ( RS ) Rating, from 68 to 74. X As you try to find the best stocks to buy and watch, keep a close on eye on relative price strength.",VRTX,0.350564,0.0,Neutral
"Vericel Clears Technical Benchmark, Hitting 80-Plus RS Rating",https://www.investors.com/ibd-data-stories/vericel-clears-technical-benchmark-hitting-80-plus-rs-rating/,2023-08-10 07:00:00,"On Thursday, Vericel ( VCEL ) reached an important technical milestone, seeing its Relative Strength ( RS ) Rating jump into the 80-plus percentile with an improvement to 87, up from 80 the day before. X When you're researching the best stocks to buy and watch, be sure to pay attention to ...",VRTX,0.325208,0.0,Neutral
Stock Upgrades: Zentalis Pharmaceuticals Shows Rising Relative Strength,https://www.investors.com/ibd-data-stories/stock-upgrades-zentalis-pharmaceuticals-shows-rising-relative-strength-2/,2023-08-10 07:00:00,"Zentalis Pharmaceuticals ( ZNTL ) saw a positive improvement to its Relative Strength ( RS ) Rating on Thursday, with an upgrade from 68 to 78. X When looking for the best stocks to buy and watch, keep a close on eye on relative price strength.",VRTX,0.323078,0.0,Neutral
Stocks Flashing Renewed Technical Strength: IDEAYA Biosciences,https://www.investors.com/ibd-data-stories/stocks-flashing-renewed-technical-strength-ideaya-biosciences/,2023-08-10 07:00:00,"On Thursday, IDEAYA Biosciences ( IDYA ) received an upgrade to its Relative Strength ( RS ) Rating, from 84 to 93. When looking for the best stocks to buy and watch, one factor to watch closely is relative price strength.",VRTX,0.31282,0.125945,Neutral
2 Supercharged Growth Stocks That Could Make You Richer,https://www.fool.com/investing/2023/08/09/2-supercharged-growth-stocks-that-could-make-you-r/,2023-08-09 18:30:00,These two biotechs are poised for a sustained period of growth.,VRTX,0.188193,0.130682,Neutral
2 Great Stocks Under $100 to Buy and Hold for 10 Years,https://www.fool.com/investing/2023/08/09/2-great-stocks-under-100-to-buy-and-hold-for-10/,2023-08-09 13:30:00,"Neither has performed well over the past year, but investors would do well to focus on the longer term.",VRTX,0.095327,0.214506,Somewhat-Bullish
Is Vertex Pharmaceuticals Stock a Buy Now?,https://www.fool.com/investing/2023/08/09/is-vertex-pharmaceuticals-stock-a-buy-now/,2023-08-09 09:35:00,"It's got upcoming catalysts, strong earnings, and a solid base of sales, too.",VRTX,0.181137,0.465547,Bullish
Stocks With Rising Relative Price Strength: Biomea Fusion,https://www.investors.com/ibd-data-stories/stocks-with-rising-relative-price-strength-biomea-fusion/,2023-08-09 07:00:00,"On Wednesday, Biomea Fusion ( BMEA ) reached an important technical milestone, with its Relative Strength ( RS ) Rating entering into the 90-plus percentile with an improvement to 93, an increase from 90 the day before.",VRTX,0.331765,0.127279,Neutral
Stock Upgrades: Immunocore Holdings ADR Shows Rising Relative Strength,https://www.investors.com/ibd-data-stories/stock-upgrades-immunocore-holdings-adr-shows-rising-relative-strength/,2023-08-09 07:00:00,"On Wednesday, Immunocore Holdings ADR ( IMCR ) got an upgrade to its Relative Strength ( RS ) Rating, from 67 to 73. When looking for the best stocks to buy and watch, one factor to watch closely is relative price strength. IBD's proprietary rating measures market leadership with a 1 ( worst ...",VRTX,0.308891,0.0,Neutral
3 Top Growth Stocks I'd Buy Right Now Without Hesitation,https://www.fool.com/investing/2023/08/28/3-top-growth-stocks-id-buy-right-now-without/,2023-08-28 12:30:00,These drugmakers are all leaders in their respective niches.,VRTX,0.18602,0.127057,Neutral
"Ross Stores, Vertex Pharmaceuticals And 2 Other Stocks Insiders Are Selling - Moderna  ( NASDAQ:MRNA ) , DXC Technology  ( NYSE:DXC ) ",https://www.benzinga.com/news/23/08/34066417/ross-stores-vertex-pharmaceuticals-and-2-other-stocks-insiders-are-selling,2023-08-28 12:17:11,"The Nasdaq 100 closed higher on Friday. Investors, meanwhile, focused on some notable insider trades. When insiders sell shares, it could be a preplanned sale, or could indicate their concern in the company's prospects or that they view the stock as being overpriced.",VRTX,0.425746,0.017448,Neutral
3 Surprisingly Underrated Stocks to Buy Right Now,https://www.fool.com/investing/2023/08/26/3-surprisingly-underrated-stocks-to-buy-right-now/,2023-08-26 10:55:00,These stocks deserve more respect than they're getting.,VRTX,0.036587,0.189238,Somewhat-Bullish
Here's How Much You Would Have Made Owning Vertex Pharmaceuticals Stock In The Last 10 Years - Vertex Pharmaceuticals  ( NASDAQ:VRTX ) ,https://www.benzinga.com/news/earnings/23/08/34043286/heres-how-much-you-would-have-made-owning-vertex-pharmaceuticals-stock-in-the-last-10-years,2023-08-25 14:30:23,"Vertex Pharmaceuticals VRTX has outperformed the market over the past 10 years by 5.87% on an annualized basis producing an average annual return of 16.23%. Currently, Vertex Pharmaceuticals has a market capitalization of $89.73 billion.",VRTX,0.980595,0.386944,Bullish
PM360 Announces 2023 Trailblazer Award Finalists,https://www.prnewswire.com/news-releases/pm360-announces-2023-trailblazer-award-finalists-301907769.html,2023-08-24 13:00:00,"Top Companies, Marketers, CEOs, Products, and Initiatives to be Honored During Gala on October 3rd NEW YORK, Aug. 24, 2023 /PRNewswire/ -- PM360 has announced the finalists for its 15th annual Trailblazer Awards.",VRTX,0.027747,-0.073367,Neutral
2 No-Brainer Biotech Stocks to Buy Right Now,https://www.fool.com/investing/2023/08/24/2-no-brainer-biotech-stocks-to-buy-right-now/,2023-08-24 11:30:00,These two companies make a compelling case for a high price.,VRTX,0.102231,0.066391,Neutral
Should Invesco S&P 500 Pure Growth ETF  ( RPG )  Be on Your Investing Radar?,https://www.zacks.com/stock/news/2140009/should-invesco-sp-500-pure-growth-etf-rpg-be-on-your-investing-radar,2023-08-24 10:20:05,Style Box ETF report for ...,VRTX,0.122269,0.068311,Neutral
3 Clever Tricks to Find Winning Biotech Stocks,https://www.fool.com/investing/2023/08/24/3-clever-tricks-to-find-winning-biotech-stocks/,2023-08-24 09:58:00,"You'll need to dig into company details, but the effort is worthwhile.",VRTX,0.075043,0.062541,Neutral
"These 2 Stocks Could Skyrocket by 54% and 119%, According to Wall Street",https://www.fool.com/investing/2023/08/23/these-2-stocks-could-skyrocket-by-54-and-119-accor/,2023-08-23 12:25:00,Is the Street's optimism justified here?,VRTX,0.051221,0.057817,Neutral
3 Revolutionary Stocks I'd Buy Right Now Without Hesitation,https://www.fool.com/investing/2023/08/22/3-revolutionary-stocks-id-buy-right-now-without/,2023-08-22 14:00:00,Helping save and improve patients' lives in novel ways can be a lucrative activity.,VRTX,0.093289,0.136447,Neutral
How to Boost Your Portfolio with Top Medical Stocks Set to Beat Earnings,https://www.zacks.com/stock/news/2138556/how-to-boost-your-portfolio-with-top-medical-stocks-set-to-beat-earnings,2023-08-21 12:50:04,Investors looking for ways to find stocks that are set to beat quarterly earnings estimates should check out the Zacks Earnings ESP.,VRTX,0.322233,0.248688,Somewhat-Bullish
4 Superlative Growth Stocks You'll Regret Not Buying in the Wake of the Nasdaq Bear Market Dip,https://www.fool.com/investing/2023/08/19/nasdaq-bear-market-4-growth-stocks-regret-not-buy/,2023-08-19 09:06:00,"With the Nasdaq Composite still 15% below its record-closing high, amazing deals are hiding in plain sight.",VRTX,0.050359,0.082966,Neutral
Vertex Pharmaceuticals  ( VRTX )  Stock Moves -0.1%: What You Should Know,https://www.zacks.com/stock/news/2146294/vertex-pharmaceuticals-vrtx-stock-moves--01-what-you-should-know,2023-09-07 21:50:17,"In the latest trading session, Vertex Pharmaceuticals (VRTX) closed at $343.96, marking a -0.1% move from the previous day.",VRTX,0.659949,0.287819,Somewhat-Bullish
Should You Invest in the Invesco Biotechnology & Genome  ( PBE ) ?,https://www.zacks.com/stock/news/2145173/should-you-invest-in-the-invesco-biotechnology-genome-pbe,2023-09-06 10:20:04,Sector ETF report for ...,VRTX,0.130926,0.070514,Neutral
"2 Brilliant Growth Stocks With Upsides of About 70%, According to Wall Street",https://www.fool.com/investing/2023/09/06/2-brilliant-growth-stocks-with-upsides-of-about-70/,2023-09-06 10:17:00,Wall Street analysts foresee these pre-commercial-stage drugmakers rocketing higher over the next 12 months.,VRTX,0.053992,0.100055,Neutral
"With a Prediction for a 70% Gain, Is Wall Street Too Optimistic About This Biotech Stock?",https://www.fool.com/investing/2023/09/05/is-wall-street-crispr-prediction-too-optimistic/,2023-09-05 10:00:00,Big news could come in December and in March.,VRTX,0.058615,0.0,Neutral
5 Surefire Stocks That Can Build Generational Wealth in 20 Years,https://www.fool.com/investing/2023/09/04/5-stocks-can-build-generational-wealth-in-20-years/,2023-09-04 09:06:00,Time is a trusted ally when you're invested in innovative businesses with sustained competitive advantages.,VRTX,0.060925,0.247193,Somewhat-Bullish
2 Spectacular Growth Stocks You Can Buy in September With No Hesitation,https://www.fool.com/investing/2023/09/03/2-spectacular-growth-stocks-you-can-buy-in-septemb/,2023-09-03 09:50:00,There's no need for any anxiety with investing in these great stocks.,VRTX,0.114956,0.133713,Neutral
Vertex Pharmaceuticals  ( VRTX )  Outpaces Stock Market Gains: What You Should Know,https://www.zacks.com/stock/news/2143955/vertex-pharmaceuticals-vrtx-outpaces-stock-market-gains-what-you-should-know,2023-09-01 21:45:15,"In the latest trading session, Vertex Pharmaceuticals (VRTX) closed at $351.13, marking a +0.8% move from the previous day.",VRTX,0.618922,0.304273,Somewhat-Bullish
Sarepta Therapeutics  ( SRPT )  Up 12.7% Since Last Earnings Report: Can It Continue?,https://www.zacks.com/stock/news/2143804/sarepta-therapeutics-srpt-up-127-since-last-earnings-report-can-it-continue,2023-09-01 15:31:38,Sarepta Therapeutics (SRPT) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.,VRTX,0.058903,0.059985,Neutral
"As Medicare drug-price negotiations inch forward, some states are flexing new powers to cut costs for a broader swath of drugs",https://www.marketwatch.com/story/as-medicare-drug-price-negotiations-inch-forward-some-states-are-flexing-new-powers-to-cut-costs-for-a-broader-swath-of-drugs-a4ca7f3e,2023-09-01 15:30:00,States like Colorado are looking to set upper payment limits on certain drugs as soon as next year.,VRTX,0.063678,-0.049016,Neutral
Vertex  ( VRTX )  Down 2.1% Since Last Earnings Report: Can It Rebound?,https://www.zacks.com/stock/news/2143104/vertex-vrtx-down-21-since-last-earnings-report-can-it-rebound,2023-08-31 15:31:29,Vertex (VRTX) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.,VRTX,0.04406,-0.003978,Neutral
Twist Bioscience Sees Relative Strength Rating Climb To 72,https://www.investors.com/ibd-data-stories/twist-bioscience-sees-relative-strength-rating-climb-to-72/,2023-08-31 07:00:00,"Twist Bioscience ( TWST ) saw a welcome improvement to its Relative Strength ( RS ) Rating on Thursday, rising from 67 to 72. X As you try to find the best stocks to buy and watch, be sure to pay attention to relative price strength.",VRTX,0.368773,0.0,Neutral
Neurocrine Biosciences Sees RS Rating Climb To 72,https://www.investors.com/ibd-data-stories/neurocrine-biosciences-sees-rs-rating-climb-to-72/,2023-08-31 07:00:00,"In a welcome move, Neurocrine Biosciences ( NBIX ) saw its Relative Strength Rating improve from 67 to 72 on Thursday. X When looking for the best stocks to buy and watch, be sure to pay attention to relative price strength.",VRTX,0.345674,0.0,Neutral
Zentalis Pharmaceuticals Scores Relative Strength Rating Upgrade; Hits Key Benchmark,https://www.investors.com/ibd-data-stories/zentalis-pharmaceuticals-scores-relative-strength-rating-upgrade-hits-key-benchmark/,2023-08-31 07:00:00,Zentalis Pharmaceuticals Scores Relative Strength Rating Upgrade ... Investor's Business Daily ...,VRTX,0.325208,0.0,Neutral
Vertex  ( VRTX )  Outperforms Industry Year to Date: Here's Why,https://www.zacks.com/stock/news/2142369/vertex-vrtx-outperforms-industry-year-to-date-heres-why,2023-08-30 13:27:00,"Vertex Pharmaceuticals (VRTX) is expected to benefit from several catalysts this year. The company is likely to achieve multiple clinical milestones in 2023 and 2024, both in its CF and non-CF portfolio.",VRTX,0.21258,0.127966,Neutral
"The Zacks Analyst Blog Highlights Exxon Mobil, The Home Depot, Intel, NextEra Energy and Vertex Pharmaceuticals",https://www.zacks.com/stock/news/2142303/the-zacks-analyst-blog-highlights-exxon-mobil-the-home-depot-intel-nextera-energy-and-vertex-pharmaceuticals,2023-08-30 11:41:00,"Exxon Mobil, The Home Depot, Intel, NextEra Energy and Vertex Pharmaceuticals are part of the Zacks top Analyst Blog.",VRTX,0.138863,0.037466,Neutral
Vertex Pharmaceuticals  ( NASDAQ:VRTX )  Stock Rating Lowered by StockNews.com,https://www.defenseworld.net/2023/08/30/vertex-pharmaceuticals-nasdaqvrtx-stock-rating-lowered-by-stocknews-com.html,2023-08-30 06:30:42,Vertex Pharmaceuticals ( NASDAQ:VRTX ) Stock Rating Lowered by ... Defense World ...,VRTX,0.796171,0.532488,Bullish
AMGN: 3 Best Biotech Stocks for Health and Wealth,https://stocknews.com/news/amgn-vrtx-incy-repl-sndx-3-best-biotech-stocks-for-health-and-wealth/,2023-08-29 17:56:51,"Innovative biotech companies are making remarkable progress in creating novel medications and therapies for a diverse array of conditions, such as cancer, heart disease, and rare ailments. Encouraging trial outcomes and enhanced patient well-being are spurring the demand for continuous medical ...",VRTX,0.141034,0.136199,Neutral
"Here's the 1 Cathie Wood Stock Most Likely to Turn $100,000 Into $1 Million Over the Next 20 Years",https://www.fool.com/investing/2023/09/17/heres-the-1-cathie-wood-stock-most-likely-to-turn/,2023-09-17 09:50:00,There's no guarantee that any stock will be a millionaire-maker. But the chances for this one look pretty good.,VRTX,0.100729,0.36073,Bullish
Looking for Growth? These Companies' Revenue May Skyrocket,https://www.fool.com/investing/2023/09/17/these-companies-revenue-may-skyrocket/,2023-09-17 09:30:00,Catalysts on the horizon could drive gains in these top stocks.,VRTX,0.107255,0.066468,Neutral
"If You Invested $30,000 in CRISPR Therapeutics in 2016, This Is How Much You Would Have Today",https://www.fool.com/investing/2023/09/16/if-you-invested-30000-crispr-therapeutics-in-2016-/,2023-09-16 13:21:00,"The returns are impressive, but will they continue to be so?",VRTX,0.064276,0.108101,Neutral
Is Moderna Stock a Top Buy?,https://www.fool.com/investing/2023/09/15/is-moderna-stock-a-top-buy/,2023-09-15 14:30:00,Wall Street is bullish on the biotech's novel pipeline.,VRTX,0.05339,-0.024004,Neutral
Better Growth Stock: Recursion Pharmaceuticals vs. CRISPR Therapeutics,https://www.fool.com/investing/2023/09/15/better-growth-stock-recursion-vs-crispr/,2023-09-15 14:07:00,"They're both liable to grow by a lot, but one of them is a safer bet in the near term.",VRTX,0.054857,0.238949,Somewhat-Bullish
2 No-Brainer Stocks That Could Make You Richer,https://www.fool.com/investing/2023/09/15/2-no-brainer-stocks-that-could-make-you-richer/,2023-09-15 12:30:00,Both companies have trounced the market over the past five years.,VRTX,0.050359,0.148268,Neutral
Biotech Stocks Near An Inflection Point In Gene Therapy,https://www.investors.com/news/technology/biotech-stocks-near-a-significant-inflection-point-in-gene-therapy-but-watch-your-wallet/,2023-09-15 12:00:00,"Get ready for a world of million-dollar drugs. Pricey gene therapies that could cure devastating genetic disorders in one fell swoop are gaining momentum, brightening the horizon for biotech stocks like Sarepta Therapeutics ( SRPT ) and BioMarin Pharmaceutical ( BMRN ) .",VRTX,0.02695,0.0,Neutral
3 Top Healthcare Stocks Defying the Bear Market,https://www.fool.com/investing/2023/09/15/3-top-healthcare-stocks-defying-the-bear-market/,2023-09-15 09:49:00,"Revenue at all three companies improved last quarter, and their share prices have followed suit.",VRTX,0.04076,0.073671,Neutral
Better Bull Market Buy: CRISPR vs. Medtronic Stock,https://www.fool.com/investing/2023/09/14/better-bull-market-buy-crispr-vs-medtronic-stock/,2023-09-14 10:15:00,Investors may look for growth stocks ahead of the next bull market.,VRTX,0.048919,0.098104,Neutral
Vertex Pharmaceuticals  ( VRTX )  Gains But Lags Market: What You Should Know,https://www.zacks.com/stock/news/2148611/vertex-pharmaceuticals-vrtx-gains-but-lags-market-what-you-should-know,2023-09-13 21:50:18,"In the latest trading session, Vertex Pharmaceuticals (VRTX) closed at $346.84, marking a +0.08% move from the previous day.",VRTX,0.606946,0.24523,Somewhat-Bullish
Score an 11% Yield at a Discount on This Superb Income Play,https://moneymorning.com/investing/score-an-11-yield-at-a-discount-on-this-superb-income-play/,2023-09-13 18:24:58,"August inflation numbers came in today, with the Consumer Price Index rising 0.6% over last month and 3.7% over the prior year. This number was slightly higher than economists' forecasts of a 3.6% increase.",VRTX,0.097655,0.109862,Neutral
More Likely to 5x First: Bluebird Bio vs. CRISPR Therapeutics,https://www.fool.com/investing/2023/09/12/more-likely-to-5x-first-bluebird-bio-vs-crispr/,2023-09-12 11:00:00,"These companies are innovators, something that can prove highly lucrative.",VRTX,0.04823,0.050332,Neutral
2 No-Brainer Biotech Stocks to Buy Right Now,https://www.fool.com/investing/2023/09/12/2-no-brainer-biotech-stocks-to-buy-right-now/,2023-09-12 10:00:00,You can get in early on these potential winners.,VRTX,0.062271,0.069119,Neutral
"Vertex Pharmaceuticals  ( NASDAQ:VRTX )  Upgraded to ""Strong-Buy"" at StockNews.com",https://www.defenseworld.net/2023/09/12/vertex-pharmaceuticals-nasdaqvrtx-upgraded-to-strong-buy-at-stocknews-com.html,2023-09-12 07:40:43,"Vertex Pharmaceuticals ( NASDAQ:VRTX ) Upgraded to ""Strong-Buy ... Defense World ...",VRTX,0.756917,0.388806,Bullish
A Bull Market Is  ( Still )  Coming: Here Are 3 Spectacular Stocks to Buy Sooner Rather Than Later,https://www.fool.com/investing/2023/09/10/a-bull-market-is-still-coming-here-are-3-spectacul/,2023-09-10 09:52:00,These stocks should be even bigger winners than they already are when a new bull market takes hold.,VRTX,0.119235,0.0,Neutral
3 Unstoppable Growth Stocks to Buy Right Now,https://www.fool.com/investing/2023/09/09/3-unstoppable-growth-stocks-to-buy-right-now/,2023-09-09 10:55:00,These healthcare stocks show no signs of slowing down.,VRTX,0.165598,0.085992,Neutral
1 Top Pharma Growth Stock to Buy Today and Hold Forever,https://www.fool.com/investing/2023/09/08/1-top-pharma-growth-stock-to-buy-today-and-hold/,2023-09-08 14:15:00,Vertex's encouraging mix of recurring revenue and growth make it a leader.,VRTX,0.135729,0.082838,Neutral
2 Top Biotech Stocks to Buy in September,https://www.fool.com/investing/2023/09/08/2-top-biotech-stocks-to-buy-in-september/,2023-09-08 13:53:00,There is rarely a bad time to buy stocks with massive upside potential.,VRTX,0.109956,0.216707,Somewhat-Bullish
Could These Be Vertex Pharmaceuticals' Most Promising Candidates?,https://www.fool.com/investing/2023/09/08/could-these-be-vertex-most-promising-candidates/,2023-09-08 12:45:00,The biotech has no shortage of promising pipeline programs.,VRTX,0.335519,0.276435,Somewhat-Bullish
3 Must-Know Tricks for Investing in Big Pharma Stocks,https://www.fool.com/investing/2023/09/08/must-know-tricks-investing-in-big-pharma-stocks/,2023-09-08 09:46:00,Using these tricks will help you appreciate where and when to invest.,VRTX,0.090474,-0.041389,Neutral
CRISPR Therapeutics to Present at the Society for Immunotherapy of Cancer  ( SITC )  38th Annual Meeting,https://www.globenewswire.com/news-release/2023/09/27/2750466/0/en/CRISPR-Therapeutics-to-Present-at-the-Society-for-Immunotherapy-of-Cancer-SITC-38th-Annual-Meeting.html,2023-09-27 13:01:00,"ZUG, Switzerland and BOSTON, Sept. 27, 2023 ( GLOBE NEWSWIRE ) -- CRISPR Therapeutics ( Nasdaq: CRSP ) , a biopharmaceutical company focused on creating transformative gene-based medicines for serious diseases, today announced poster presentations of preclinical data at the Society for ...",VRTX,0.122894,0.14635,Neutral
Looking Into Vertex Pharmaceuticals's Recent Short Interest - Vertex Pharmaceuticals  ( NASDAQ:VRTX ) ,https://www.benzinga.com/short-sellers/23/09/34923954/looking-into-vertex-pharmaceuticalss-recent-short-interest,2023-09-26 19:15:15,"Vertex Pharmaceuticals's VRTX short percent of float has risen 6.6% since its last report. The company recently reported that it has 2.92 million shares sold short, which is 1.13% of all regular shares that are available for trading.",VRTX,0.221819,0.155473,Somewhat-Bullish
Vertex Pharmaceuticals  ( VRTX )  Gains But Lags Market: What You Should Know,https://www.zacks.com/stock/news/2155113/vertex-pharmaceuticals-vrtx-gains-but-lags-market-what-you-should-know,2023-09-25 21:50:18,"Vertex Pharmaceuticals (VRTX) closed at $350.67 in the latest trading session, marking a +0.33% move from the prior day.",VRTX,0.709186,0.366927,Bullish
This Is What Whales Are Betting On Vertex Pharmaceuticals - Vertex Pharmaceuticals  ( NASDAQ:VRTX ) ,https://www.benzinga.com/markets/options/23/09/34879667/this-is-what-whales-are-betting-on-vertex-pharmaceuticals,2023-09-25 20:01:49,"Someone with a lot of money to spend has taken a bearish stance on Vertex Pharmaceuticals VRTX. We noticed this today when the big position showed up on publicly available options history that we track here at Benzinga. Whether this is an institution or just a wealthy individual, we don't know.",VRTX,0.68039,0.162363,Somewhat-Bullish
Buying These 2 Remarkable Growth Stocks in Any Market Could Be a Genius Move,https://www.fool.com/investing/2023/09/25/buying-2-remarkable-growth-stocks-in-market/,2023-09-25 16:22:41,Great companies haven't gone anywhere.,VRTX,0.227007,0.15098,Somewhat-Bullish
3 Magnificent Growth Stocks to Buy Right Now,https://www.fool.com/investing/2023/09/24/3-magnificent-growth-stocks-to-buy-right-now/,2023-09-24 10:50:00,"If you're looking for growth, these stocks could be just the ticket.",VRTX,0.12546,0.201716,Somewhat-Bullish
Look Don't Touch: Meta Leads 5 Stocks For Watchlists,https://www.investors.com/news/meta-stock-leads-5-names-showing-resilience-in-market-downturn/,2023-09-23 12:00:00,Meta Leads 5 Stocks Showing Resilience In Market Downturn Investor's Business Daily ...,VRTX,0.154257,0.044798,Neutral
An Ambitious Antiracism Center Scales Back Amid a Funding Slowdown,https://www.nytimes.com/2023/09/23/us/politics/ibram-x-kendi-antiracism-boston-university.html,2023-09-23 11:49:52,"In the wake of George Floyd's murder in May 2020, protests, looting, and anger were boiling up in the streets of Boston, a city that has played host to both abolitionists and vicious race riots. At Boston University, Black students demanded action to address campus racism.",VRTX,0.025679,0.009975,Neutral
"Diving Back Into A Correction: Watchlists, Nike Earnings, Coal Stocks, Housing Data",https://www.investors.com/research/investing-action-plan/diving-back-into-a-correction-watchlists-nike-earnings-coal-stocks-housing-data/,2023-09-22 21:21:00,"Diving Back Into A Correction: Watchlists, Nike Earnings, Coal ... Investor's Business Daily ...",VRTX,0.146916,0.118412,Neutral
How To Handle The Correction; Is Tesla The Next To Break?,https://www.investors.com/market-trend/stock-market-today/dow-jones-futures-what-to-do-with-market-in-correction-is-tesla-next-leader-to-crack/,2023-09-22 21:03:00,Dow Jones Futures: What To Do With Market In Correction. Is Tesla ... Investor's Business Daily ...,VRTX,0.103442,0.056466,Neutral
Price Over Earnings Overview: Vertex Pharmaceuticals - Vertex Pharmaceuticals  ( NASDAQ:VRTX ) ,https://www.benzinga.com/news/23/09/34827560/price-over-earnings-overview-vertex-pharmaceuticals,2023-09-22 16:15:22,"In the current market session, Vertex Pharmaceuticals Inc. VRTX stock price is at $353.85, after a 0.12% decrease. However, over the past month, the company's stock increased by 0.95%, and in the past year, by 27.68%.",VRTX,0.360752,0.060733,Neutral
2 Healthcare Stocks That Could Make You Richer,https://www.fool.com/investing/2023/09/22/2-healthcare-stocks-that-could-make-you-richer/,2023-09-22 14:07:00,They've beaten the market before.,VRTX,0.341699,-0.00737,Neutral
Futures: Stocks Keep Falling As Yields Soar; Tesla's New Buy Point,https://www.investors.com/market-trend/stock-market-today/dow-jones-futures-sp-500-marks-new-low-as-yields-spike-tesla-forges-new-buy-point/,2023-09-21 20:44:00,Dow Jones Futures: S&P 500 Marks New Low As Yields Spike ... Investor's Business Daily ...,VRTX,0.101154,0.04423,Neutral
3 Unstoppable Stocks to Buy and Hold for the Next 20 Years,https://www.fool.com/investing/2023/09/21/3-unstoppable-stocks-to-buy-and-hold-for-the-next/,2023-09-21 09:50:00,These stocks are great long-term picks.,VRTX,0.107255,0.0,Neutral
Better Growth Stock: CRISPR Therapeutics vs. Bluebird Bio,https://www.fool.com/investing/2023/09/20/better-growth-stock-crispr-therapeutics-vs-bluebir/,2023-09-20 11:21:00,"These two biotechs have a lot in common, but one is much better capitalized.",VRTX,0.046633,0.132912,Neutral
Should You Invest in the iShares Biotechnology ETF  ( IBB ) ?,https://www.zacks.com/stock/news/2152870/should-you-invest-in-the-ishares-biotechnology-etf-ibb,2023-09-20 10:20:05,Sector ETF report for ...,VRTX,0.138066,0.072464,Neutral
6 Healthcare Stocks Analysts Still Like,https://www.barrons.com/articles/healthcare-stocks-analysts-like-8b0f4dd2,2023-09-20 07:00:00,"This has been an epically bad year for the healthcare sector, but there are still a few stocks out there that Wall Street analysts like. Some of them are even more beaten down than the rest of the industry. The S&P 500 Health Care sector index is down 3% this year, vastly behind the S&P 500, ...",VRTX,0.16171,0.059347,Neutral
Vertex Pharmaceuticals  ( VRTX )  Gains As Market Dips: What You Should Know,https://www.zacks.com/stock/news/2152768/vertex-pharmaceuticals-vrtx-gains-as-market-dips-what-you-should-know,2023-09-19 21:50:19,"In the latest trading session, Vertex Pharmaceuticals (VRTX) closed at $358.26, marking a +1.78% move from the previous day.",VRTX,0.665097,0.222611,Somewhat-Bullish
Where Will CRISPR Therapeutics Be in 5 Years?,https://www.fool.com/investing/2023/09/19/where-will-crispr-therapeutics-be-in-5-years/,2023-09-19 13:53:00,"The company hasn't performed well in the past five years, but things could change.",VRTX,0.151858,0.180788,Somewhat-Bullish
Vertex  ( VRTX )  Gets Positive CHMP Opinion for Kaftrio Expanded Use,https://www.zacks.com/stock/news/2151774/vertex-vrtx-gets-positive-chmp-opinion-for-kaftrio-expanded-use,2023-09-18 12:01:00,Vertex's (VRTX) Kaftrio gets a positive opinion from the European Medicines Agency's Committee for Medicinal Products for Human Use for extended use to treat younger age groups of two to five years old with cystic fibrosis.,VRTX,0.345674,0.138744,Neutral
2 Top Trends to Invest $500 In Right Now,https://www.fool.com/investing/2023/09/18/2-top-trends-to-invest-500-in-right-now/,2023-09-18 09:00:00,Early investors in these trends may reap the rewards over time.,VRTX,0.047185,0.018814,Neutral
3 No-Brainer Growth Stocks to Buy in October,https://www.fool.com/investing/2023/10/07/3-no-brainer-growth-stocks-to-buy-in-october/,2023-10-07 10:53:00,The time is right to invest in these great stocks.,VRTX,0.156207,0.168497,Somewhat-Bullish
Vertex Pharmaceuticals  ( NASDAQ:VRTX )  Rating Lowered to Buy at StockNews.com,https://www.defenseworld.net/2023/10/07/vertex-pharmaceuticals-nasdaqvrtx-rating-lowered-to-buy-at-stocknews-com.html,2023-10-07 06:56:46,Vertex Pharmaceuticals ( NASDAQ:VRTX ) Rating Lowered to Buy at ... Defense World ...,VRTX,0.731711,0.440448,Bullish
"Jim Cramer: This Company Is 'Arranging Deck Chairs On The Titanic... Not A Believer' - BlackBerry  ( NYSE:BB ) , Kyndryl Hldgs  ( NYSE:KD ) ",https://www.benzinga.com/trading-ideas/long-ideas/23/10/35122422/jim-cramer-this-company-is-arranging-deck-chairs-on-the-titanic-not-a-believer,2023-10-06 13:08:02,"On CNBC's ""Mad Money Lightning Round,"" Jim Cramer said Topgolf Callaway Brands Corp. MODG is making money. ""I think it's a great experiential situation, but I have been wrong,"" he added. When asked about Under Armour, Inc. UA, he said, ""We got to see something, we got to see a good quarter.",VRTX,0.261117,0.442191,Bullish
"HP, Zoom Video And 2 Other Stocks Insiders Are Selling - HP  ( NYSE:HPQ ) , FirstCash Hldgs  ( NASDAQ:FCFS ) ",https://www.benzinga.com/news/23/10/35124492/hp-zoom-video-and-2-other-stocks-insiders-are-selling,2023-10-06 12:01:33,"The Nasdaq 100 closed lower by over 50 points on Thursday. Investors, meanwhile, focused on some notable insider trades. When insiders sell shares, it could be a preplanned sale, or could indicate their concern in the company's prospects or that they view the stock as being overpriced.",VRTX,0.345674,0.059394,Neutral
"Zacks Investment Ideas feature highlights: Applied Industrial, Applied Materials and Vertex Pharmaceuticals",https://www.zacks.com/stock/news/2161280/zacks-investment-ideas-feature-highlights-applied-industrial-applied-materials-and-vertex-pharmaceuticals,2023-10-06 08:33:00,"Applied Industrial, Applied Materials and Vertex Pharmaceuticals have been highlighted in this Investment Ideas article.",VRTX,0.290952,0.070744,Neutral
Futures: Jobs Report Looms; 7 Stocks Boasting This Bullish Trait,https://www.investors.com/market-trend/stock-market-today/dow-jones-futures-stocks-slash-sharp-losses-with-jobs-report-due-nvidia-meta-at-key-levels/,2023-10-05 22:02:00,Dow Jones Futures: Stocks Slash Losses With Jobs Report Due ... Investor's Business Daily ...,VRTX,0.081092,0.047788,Neutral
3 Top Ranked Stocks with Superior Free Cash Flow Yield,https://www.zacks.com/commentary/2161054/3-top-ranked-stocks-with-superior-free-cash-flow-yield,2023-10-05 18:31:00,"In this article, we'll introduce you to three standout stocks with impressive FCF yields, remarkable historical returns, and top Zacks Ranks ...",VRTX,0.244109,0.072995,Neutral
"2 Growth Stocks That Can Rocket 98% to 108% Higher, According to Wall Street",https://www.fool.com/investing/2023/10/05/2-growth-stocks-that-can-rocket-98-to-108-higher-a/,2023-10-05 09:39:00,The analysts who follow these stocks have some big expectations for the year ahead.,VRTX,0.063594,0.087047,Neutral
"3 No-Brainer Stocks to Buy With $1,000 Right Now",https://www.fool.com/investing/2023/10/04/3-no-brainer-stocks-to-buy-with-1000-right-now/,2023-10-04 09:21:00,A modest amount of money can go a long way when it's invested in highly profitable industry leaders with sustained competitive advantages.,VRTX,0.118064,0.040623,Neutral
Cathie Wood Is Buying This Growth Stock Hand Over Fist Lately. Should You Follow Her Lead?,https://www.fool.com/investing/2023/10/03/cathie-wood-is-buying-this-stock-hand-over-fist-la/,2023-10-03 10:27:00,The Internet's most famous innovation-focused investor is excited about this company's innovative approach to editing the human genome.,VRTX,0.056275,0.006,Neutral
2 Top Biotech Stocks to Buy in October,https://www.fool.com/investing/2023/10/03/2-top-biotech-stocks-to-buy-in-october/,2023-10-03 09:30:00,Growth catalysts lie ahead for both of these players.,VRTX,0.173333,0.17143,Somewhat-Bullish
Vertex Pharmaceuticals  ( VRTX )  Outpaces Stock Market Gains: What You Should Know,https://www.zacks.com/stock/news/2158860/vertex-pharmaceuticals-vrtx-outpaces-stock-market-gains-what-you-should-know,2023-10-02 21:50:19,"In the latest trading session, Vertex Pharmaceuticals (VRTX) closed at $347.83, marking a +0.03% move from the previous day.",VRTX,0.663374,0.374305,Bullish
Revvity's  ( RVTY )  New Launch to Widen Access to Editing Technology,https://www.zacks.com/stock/news/2158739/revvitys-rvty-new-launch-to-widen-access-to-editing-technology,2023-10-02 14:10:00,Revvity's (RVTY) latest offering is likely to improve access to new-generation editing technology and bridge both preclinical and clinical discoveries with the same technology platform.,VRTX,0.177475,0.191238,Somewhat-Bullish
"Got $1,000? 2 No-Brainer Stocks to Buy",https://www.fool.com/investing/2023/10/02/got-1000-2-no-brainer-stocks-to-buy/,2023-10-02 14:07:00,You can bet the farm on these companies.,VRTX,0.285526,0.296181,Somewhat-Bullish
Better Gene Editing Stock: Editas Medicine vs. CRISPR Therapeutics,https://www.fool.com/investing/2023/10/02/better-gene-editing-stock-editas-medicine-vs-crisp/,2023-10-02 14:00:00,The better of the pair should be able to beat Bluebird Bio.,VRTX,0.05749,0.088957,Neutral
3 Magnificent Stocks That Are Screaming Buys in October,https://www.fool.com/investing/2023/10/02/3-magnificent-stocks-that-are-screaming-buys-in-oc/,2023-10-02 09:53:00,These stocks give investors something to yell about -- in a good way.,VRTX,0.114409,0.103512,Neutral
3 Revolutionary Stocks I'd Buy Right Now Without Hesitation,https://www.fool.com/investing/2023/10/01/3-revolutionary-stocks-id-buy-right-now-without-he/,2023-10-02 02:07:00,These companies are helping change medicine. they could make boatloads of money along the way.,VRTX,0.09239,0.086438,Neutral
"2 Brilliant Growth Stocks to Invest $2,000 in Right Now",https://www.fool.com/investing/2023/10/01/2-brilliant-growth-stocks-to-invest-2000-in-right/,2023-10-01 14:00:00,These growth companies are capitalizing on underserved target markets.,VRTX,0.121037,0.148453,Neutral
5 Top Stocks for October,https://www.fool.com/investing/2023/10/01/5-top-stocks-for-october/,2023-10-01 13:09:00,"Venture into October's investment landscape with our five experts, unveiling opportunities in an uneven market environment.",VRTX,0.063313,-0.027064,Neutral
3 No-Brainer Growth Stocks to Buy in October,https://www.fool.com/investing/2023/10/01/3-no-brainer-growth-stocks-to-buy-in-october/,2023-10-01 12:30:00,These three top mid-cap stocks could be poised for a long-tailed growth spurt.,VRTX,0.045655,0.04609,Neutral
"The Best Stocks to Invest $5,000 in Right Now",https://www.fool.com/investing/2023/09/30/the-best-stocks-to-invest-5000-in-right-now/,2023-09-30 09:52:00,"Now is a great time to buy Amazon, Enterprise Products Partners, and Vertex Pharmaceuticals.",VRTX,0.112269,0.04369,Neutral
$100 Invested In Vertex Pharmaceuticals 15 Years Ago Would Be Worth This Much Today - Vertex Pharmaceuticals  ( NASDAQ:VRTX ) ,https://www.benzinga.com/news/earnings/23/09/35011961/100-invested-in-vertex-pharmaceuticals-15-years-ago-would-be-worth-this-much-today,2023-09-29 20:30:19,"Vertex Pharmaceuticals VRTX has outperformed the market over the past 15 years by 8.49% on an annualized basis producing an average annual return of 18.32%. Currently, Vertex Pharmaceuticals has a market capitalization of $89.75 billion.",VRTX,0.980595,0.386944,Bullish
Why Editas Medicine Stock Is Soaring Today,https://www.fool.com/investing/2023/09/29/why-editas-medicine-stock-is-soaring-today/,2023-09-29 15:21:29,Investors are cheering a big analyst upgrade for the gene-editing stock.,VRTX,0.141726,0.173513,Somewhat-Bullish
Is It Worth Investing in Vertex  ( VRTX )  Based on Wall Street's Bullish Views?,https://www.zacks.com/stock/news/2157747/is-it-worth-investing-in-vertex-vrtx-based-on-wall-streets-bullish-views,2023-09-29 13:30:05,"Based on the average brokerage recommendation (ABR), Vertex (VRTX) should be added to one's portfolio. Wall Street analysts' overly optimistic recommendations cast doubt on the effectiveness of this highly sought-after metric. So, is the stock worth buying?",VRTX,0.053992,0.120749,Neutral
Is iShares Biotechnology ETF  ( IBB )  a Strong ETF Right Now?,https://www.zacks.com/stock/news/2157520/is-ishares-biotechnology-etf-ibb-a-strong-etf-right-now,2023-09-29 10:20:05,Smart Beta ETF report for ...,VRTX,0.122894,0.068464,Neutral
Crispr Gene-Editing Faces Its Make-Or-Break Moment,https://www.investors.com/news/technology/crsp-stock-and-crispr-gene-editing-face-their-make-or-break-moment/,2023-09-28 12:00:00,"CRSP Stock, And CRISPR Gene-Editing, Face Their Make-Or-Break ... Investor's Business Daily ...",VRTX,0.064104,0.101623,Neutral
2 Bargain Growth Stocks to Buy Hand Over Fist,https://www.fool.com/investing/2023/09/28/2-bargain-growth-stocks-to-buy-hand-over-fist/,2023-09-28 09:30:00,Both stocks have declined in recent times.,VRTX,0.053509,0.043796,Neutral
Health Canada Grants Market Authorization for TRIKAFTA  ( elexacaftor/tezacaftor/ivacaftor and ivacaftor )  in Children With Cystic Fibrosis Ages 2 To 5 Years With At Least One F508del Mutation,https://www.newswire.ca/news-releases/health-canada-grants-market-authorization-for-trikafta-r-elexacaftor-tezacaftor-ivacaftor-and-ivacaftor-in-children-with-cystic-fibrosis-ages-2-to-5-years-with-at-least-one-f508del-mutation-858010273.html,2023-10-17 18:44:00,Health Canada Grants Market Authorization for TRIKAFTA ( elexacaftor/tezacaftor/ivacaftor and ivacaftor ) in Children ... Canada ...,VRTX,0.131105,0.13335,Neutral
Cautious Optimism For Bluebird Bio's Sickle Cell Therapy: Analyst Sees Financial Challenges - bluebird bio  ( NASDAQ:BLUE ) ,https://www.benzinga.com/analyst-ratings/analyst-color/23/10/35294513/cautious-optimism-for-bluebird-bios-sickle-cell-therapy-analyst-sees-financial-chal,2023-10-17 18:40:07,"Cantor Fitzgerald initiated coverage on Bluebird Bio Inc BLUE, saying sickle cell disorder ( SCD ) has been a hotbed of development for genetic medicines as the company's lovo-cel marches towards the U.S. market.",VRTX,0.143415,0.0,Neutral
Editas Medicine Has To Navigate Sickle Cell Therapy Competition: Analyst - Editas Medicine  ( NASDAQ:EDIT ) ,https://www.benzinga.com/general/biotech/23/10/35295251/editas-medicine-has-to-navigate-sickle-cell-therapy-competition-analyst,2023-10-17 18:35:55,Cantor Fitzgerald has downgraded Editas Medicine Inc EDIT to Neutral from Overweight. The analyst says that Editas' sickle cell therapy EDIT-301 is running approximately two years behind Vertex Pharmaceuticals/CRISPR Therapeutics AG's CRSP exa-cel and Bluebird Bio Inc's BLUE lovo-cel.,VRTX,0.136113,0.0,Neutral
"Mixed Signals For CRISPR Therapeutics, Analyst Weighs Barriers, Potential Sales For Sickle Cell Therapy - CRISPR Therapeutics  ( NASDAQ:CRSP ) ",https://www.benzinga.com/general/biotech/23/10/35295139/mixed-signals-for-crispr-therapeutics-analyst-weighs-barriers-potential-sales-for-sickle-cell-the,2023-10-17 18:33:07,"Cantor Fitzgerald has downgraded CRISPR Therapeutics AG CRSP to Neutral from Overweight, noting that its sickle cell therapy, exa-cel, in partnership with Vertex Pharmaceuticals Inc VRTX, is expected to be approved on or around its PDUFA date ( 8 December ) .",VRTX,0.295867,0.015371,Neutral
Why Vertex  ( VRTX )  is Poised to Beat Earnings Estimates Again,https://www.zacks.com/stock/news/2167418/why-vertex-vrtx-is-poised-to-beat-earnings-estimates-again,2023-10-17 16:10:09,Vertex (VRTX) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.,VRTX,0.170275,0.207948,Somewhat-Bullish
Vericel Scores Relative Strength Rating Upgrade; Hits Key Threshold,https://www.investors.com/ibd-data-stories/vericel-scores-relative-strength-rating-upgrade-hits-key-threshold/,2023-10-17 07:00:00,Vericel Scores Relative Strength Rating Upgrade. Hits Key Threshold Investor's Business Daily ...,VRTX,0.345674,0.0,Neutral
3 Nasdaq Biotechs With New 52-Week Highs,https://www.forbes.com/sites/johnnavin/2023/10/16/3-nasdaq-biotechs-with-new-52-week-highs/,2023-10-17 01:04:31,"Biotech stocks are having a bad year with the XBI trending downward for months now, but at least 3 Nasdaq-traded biotechnology companies are now hitting 52-week highs:...",VRTX,0.16171,-0.086808,Neutral
Vertex Pharmaceuticals  ( VRTX )  Increases Yet Falls Behind Market: What Investors Need to Know,https://www.zacks.com/stock/news/2166753/vertex-pharmaceuticals-vrtx-increases-yet-falls-behind-market-what-investors-need-to-know,2023-10-16 21:50:19,"In the closing of the recent trading day, Vertex Pharmaceuticals (VRTX) stood at $374, denoting a +0.81% change from the preceding trading day.",VRTX,0.459624,0.248314,Somewhat-Bullish
GILD: 4 Promising Biotech Stocks for Smart Investment Strategies,https://stocknews.com/news/gild-vrtx-uthr-jazz-4-promising-biotech-stocks-for-smart-investment-strategies/,2023-10-16 19:25:31,"The biotechnology sector has thrived exceptionally over the past few years, catalyzed by continued innovations that fortify its status as a vanguard in crucial sectors like healthcare, agriculture, and the environment.",VRTX,0.082464,0.099953,Neutral
Why This Top 1% Biotech Just Surged Within Striking Distance Of A Breakout,https://www.investors.com/news/technology/mltx-stock-top-rated-biotech-surges-within-striking-distance-of-a-breakout/,2023-10-16 14:41:00,Why This Top 1% Biotech Just Surged Within Striking Distance Of A ... Investor's Business Daily ...,VRTX,0.086245,0.318982,Somewhat-Bullish
"Moderna, BioNTech Leads Covid Sell-Off After Pfizer Slashes Outlook",https://www.investors.com/news/technology/moderna-stock-biontech-stock-lead-covid-sell-off-after-pfizer-slashes-guidance/,2023-10-16 14:18:00,Moderna ( MRNA ) stock and BioNTech ( BNTX ) led a sell-off Monday among Covid vaccine makers after Pfizer ( PFE ) slashed about $9 billion from its full-year guidance. Pfizer said it wrote off about $5.5 billion in inventory during the third quarter due to lower-than-expected demand for ...,VRTX,0.067919,0.309934,Somewhat-Bullish
2 Healthcare Stocks Near 52-Week Highs Still Worth Buying,https://www.fool.com/investing/2023/10/16/2-healthcare-stocks-near-52-week-highs-still-worth/,2023-10-16 13:26:00,These two large-cap biopharma companies could have more room to run.,VRTX,0.349575,0.21068,Somewhat-Bullish
"This Cathie Wood Stock Is Set to Soar 100%, Says Wall Street",https://www.fool.com/investing/2023/10/16/cathie-wood-stock-may-soar-says-wall-street/,2023-10-16 09:30:00,This Wood favorite is heading for a big moment.,VRTX,0.158173,0.104372,Neutral
Revolution Medicines Joins Elite Club Of Stocks With RS Ratings Over 90,https://www.investors.com/ibd-data-stories/revolution-medicines-joins-elite-club-of-stocks-with-rs-ratings-over-90-2/,2023-10-16 07:00:00,Revolution Medicines Joins Elite Club Of Stocks With RS Ratings ... Investor's Business Daily ...,VRTX,0.308891,0.11597,Neutral
"Ionis Pharmaceuticals Clears Key Benchmark, Hitting 90-Plus RS Rating",https://www.investors.com/ibd-data-stories/ionis-pharmaceuticals-clears-key-benchmark-hitting-90-plus-rs-rating-2/,2023-10-16 07:00:00,"Ionis Pharmaceuticals Clears Key Benchmark, Hitting 90-Plus RS ... Investor's Business Daily ...",VRTX,0.306963,0.115394,Neutral
"2 Growth Stocks That Could Double Your Money, According to Wall Street",https://www.fool.com/investing/2023/10/15/2-growth-stocks-that-could-double-your-money-accor/,2023-10-15 10:47:00,Find out why investment bank analysts are pounding the table on these stocks.,VRTX,0.057628,0.113972,Neutral
Is Vertex Pharmaceuticals Stock a Buy Now?,https://www.fool.com/investing/2023/10/15/is-vertex-pharmaceuticals-stock-a-buy-now/,2023-10-15 10:18:00,Jim Cramer recently hyped up one of the company's promising drugs.,VRTX,0.11894,0.370904,Bullish
StockNews.com Downgrades Vertex Pharmaceuticals  ( NASDAQ:VRTX )  to Buy,https://www.defenseworld.net/2023/10/15/stocknews-com-downgrades-vertex-pharmaceuticals-nasdaqvrtx-to-buy.html,2023-10-15 06:42:54,StockNews.com Downgrades Vertex Pharmaceuticals ( NASDAQ ... Defense World ...,VRTX,0.826469,0.450451,Bullish
2 Growth Stocks That Could Deliver Parabolic Returns in Under 5 Years,https://www.fool.com/investing/2023/10/14/2-growth-stocks-that-could-deliver-parabolic-retur/,2023-10-14 16:20:22,These two gene-editing stocks could be diamonds in the rough.,VRTX,0.055109,0.127992,Neutral
"If You Invested $100 In This Stock 10 Years Ago, You Would Have $500 Today - Vertex Pharmaceuticals  ( NASDAQ:VRTX ) ",https://www.benzinga.com/news/earnings/23/10/35248116/if-you-invested-100-in-this-stock-10-years-ago-you-would-have-500-today,2023-10-13 20:00:25,"Vertex Pharmaceuticals VRTX has outperformed the market over the past 10 years by 7.47% on an annualized basis producing an average annual return of 17.0%. Currently, Vertex Pharmaceuticals has a market capitalization of $95.13 billion.",VRTX,0.980595,0.386944,Bullish
Here's Why You May Invest in CRISPR Therapeutics  ( CRSP )  Stock,https://www.zacks.com/stock/news/2165644/heres-why-you-may-invest-in-crispr-therapeutics-crsp-stock,2023-10-13 14:22:00,Here we discuss some reasons why investing in CRISPR Therapeutics (CRSP) stock now may turn out to be a more prudent move than ever.,VRTX,0.188683,0.088687,Neutral
The Surprising Opportunity Driving Vertex Stock To A Record High,https://www.investors.com/research/the-new-america/vrtx-stock-breaks-out-to-a-record-high-the-surprising-opportunity/,2023-10-12 19:17:00,"Almost three-quarters of prescribed pain meds are opioids, and Vertex Pharmaceuticals ( VRTX ) could change that, an analyst said before VRTX stock broke out to a record high Thursday. Leerink Partners analyst David Risinger drew parallels between the drug development arc for obesity drugs and ...",VRTX,0.50287,0.052359,Neutral
Dow Jones Falls As Nasdaq Holds Key Level; Bank Earnings Loom,https://www.investors.com/market-trend/stock-market-today/dow-jones-falls-after-economic-data-as-nasdaq-holds-key-level-bank-earnings-loom/,2023-10-12 15:07:00,Dow Jones Falls As Nasdaq Holds Key Level. Bank Earnings Loom Investor's Business Daily ...,VRTX,0.104228,-0.152018,Somewhat-Bearish
2 Top Biotech Stocks to Buy Right Now,https://www.fool.com/investing/2023/10/12/2-top-biotech-stocks-to-buy-right-now/,2023-10-12 13:37:00,Both companies are known innovators.,VRTX,0.215415,0.362586,Bullish
3 Top Healthcare Stocks to Buy for October,https://www.fool.com/investing/2023/10/12/3-top-healthcare-stocks-to-buy-for-october/,2023-10-12 13:36:48,These stocks have oodles of room left to run.,VRTX,0.089797,0.185757,Somewhat-Bullish
Stocks Showing Improved Relative Strength: Alkermes,https://www.investors.com/ibd-data-stories/stocks-showing-improved-relative-strength-alkermes/,2023-10-12 07:00:00,"Alkermes ( ALKS ) had its Relative Strength ( RS ) Rating upgraded from 70 to 74 Thursday -- a welcome improvement, but still shy of the 80 or higher score you prefer to see. X When you're researching the best stocks to buy and watch, be sure to pay attention to relative price strength.",VRTX,0.329551,0.0,Neutral
Stocks Flashing Renewed Technical Strength: Sarepta Therapeutics,https://www.investors.com/ibd-data-stories/stocks-flashing-renewed-technical-strength-sarepta-therapeutics/,2023-10-12 07:00:00,"When looking for the best stocks to buy and watch, focus on those with rising relative price strength. One stock that fits that bill is Sarepta Therapeutics ( SRPT ) , which had its Relative Strength ( RS ) Rating upgraded from 78 to 81 Thursday.",VRTX,0.294093,0.0,Neutral
Should You Invest in the VanEck Biotech ETF  ( BBH ) ?,https://www.zacks.com/stock/news/2164069/should-you-invest-in-the-vaneck-biotech-etf-bbh,2023-10-11 10:20:06,Sector ETF report for ...,VRTX,0.134968,0.071604,Neutral
BEAM Focuses on Developing Gene Drug for Growth,https://www.zacks.com/stock/news/2163582/beam-focuses-on-developing-gene-drug-for-growth,2023-10-10 14:06:00,"While BEAM's pipeline candidates are in early-stage clinical studies, their development is progressing well. Collaborations are a primary source of revenues in the absence of a marketed product.",VRTX,0.237358,0.060948,Neutral
Cathie Wood Is Buying CRISPR Therapeutics Ahead of This Big Event. Should You?,https://www.fool.com/investing/2023/10/10/cathie-wood-buys-crispr-therapeutics-should-you/,2023-10-10 09:30:00,Wood has outperformed the market so far this year.,VRTX,0.103109,0.069557,Neutral
Vertex Pharmaceuticals  ( VRTX )  Stock Falls Amid Market Uptick: What Investors Need to Know,https://www.zacks.com/stock/news/2162978/vertex-pharmaceuticals-vrtx-stock-falls-amid-market-uptick-what-investors-need-to-know,2023-10-09 21:50:18,"In the most recent trading session, Vertex Pharmaceuticals (VRTX) closed at $355.20, indicating a -1.5% shift from the previous trading day.",VRTX,0.598621,0.250964,Somewhat-Bullish
"The Evolving Market Dynamics of Factor-based Bleeding Disorders: Hemophilia A, Hemophilia B, and Von Willebrand Disease | Key Analysis by DelveInsight",https://www.prnewswire.com/news-releases/the-evolving-market-dynamics-of-factor-based-bleeding-disorders-hemophilia-a-hemophilia-b-and-von-willebrand-disease--key-analysis-by-delveinsight-301950491.html,2023-10-09 21:01:00,"The Evolving Market Dynamics of Factor-based Bleeding Disorders: Hemophilia A, Hemophilia B, and Von Willebrand ... PR ...",VRTX,0.036338,0.036038,Neutral
Jim Cramer's Take on Vertex: Tackling Opioid Addiction with New Drug in Pipeline - Vertex Pharmaceuticals  ( NASDAQ:VRTX ) ,https://www.benzinga.com/general/biotech/23/10/35149268/jim-cramers-take-on-vertex-tackling-opioid-addiction-with-new-drug-in-pipeline,2023-10-09 18:28:24,"CNBC's Jim Cramer has drawn investors' attention to Vertex Pharmaceuticals VRTX, a biotechnology company currently in the late stages of developing a non-opioid drug to treat acute pain. The company's potential candidate, known as VX-548, is being positioned to address the critical issue of ...",VRTX,0.507107,0.089971,Neutral
Vertex Pharmaceuticals  ( VRTX )  Declines More Than Market: Some Information for Investors,https://www.zacks.com/stock/news/2174050/vertex-pharmaceuticals-vrtx-declines-more-than-market-some-information-for-investors,2023-10-27 21:45:16,"In the closing of the recent trading day, Vertex Pharmaceuticals (VRTX) stood at $355.28, denoting a -1.66% change from the preceding trading day.",VRTX,0.654859,0.128276,Neutral
Rocket Pharmaceuticals Stock Sees RS Rating Pops Higher,https://www.investors.com/news/technology/rocket-pharmaceuticals-stock-sees-rs-rating-pops-higher/,2023-10-27 18:49:00,"Rocket Pharmaceuticals ( RCKT ) stock saw a positive improvement to its Relative Strength ( RS ) Rating on Friday, with an increase from 69 to 74. As you try to find the best stocks to buy and watch, be sure to pay attention to relative price strength.",VRTX,0.261117,0.0,Neutral
"Questions Surround Vertex/CRISPR's Sickle Cell Gene Therapy As FDA AdComm Meeting Approaches - CRISPR Therapeutics  ( NASDAQ:CRSP ) , Vertex Pharmaceuticals  ( NASDAQ:VRTX ) ",https://www.benzinga.com/general/biotech/23/10/35468228/questions-surround-vertexcrisprs-sickle-cell-gene-therapy-as-fda-adcomm-meeting-approaches,2023-10-27 16:57:00,"The FDA's Cellular, Tissue, and Gene Therapies Advisory Committee will meet next week, Tuesday, 31 October, to discuss whether Vertex Pharmaceuticals Inc VRTX and CRISPR Therapeutics AG's CRSP sickle cell disease ( SCD ) gene therapy candidate.",VRTX,0.3007,0.094266,Neutral
US FDA advisers to determine need for more studies of Vertex/CRISPR gene therapy,https://www.reuters.com/business/healthcare-pharmaceuticals/us-fda-advisers-consider-need-more-studies-vertexcrispr-gene-therapy-2023-10-27/,2023-10-27 15:57:00,"[1/2] Signage is seen outside of the Food and Drug Administration ( FDA ) headquarters in White Oak, Maryland, U.S., August 29, 2020. REUTERS/Andrew Kelly/File Photo Acquire Licensing Rights Oct 27 ( Reuters ) - The U.S.",VRTX,0.110462,0.0,Neutral
A new cure for sickle cell disease may be coming. Health advisers will review it next week,https://apnews.com/article/sickle-cell-gene-therapy-crispr-8ded5e3a35b30bd257ac756f8a223c51,2023-10-27 15:47:00,"The only cure for painful sickle cell disease today is a bone marrow transplant. But soon there may be a new cure that attacks the disorder at its genetic source. On Tuesday, advisers to the Food and Drug Administration will review a gene therapy for the inherited blood disorder, which in the ...",VRTX,0.043421,-0.073293,Neutral
Incyte  ( INCY )  to Report Q3 Earnings: What's in the Cards?,https://www.zacks.com/stock/news/2173871/incyte-incy-to-report-q3-earnings-whats-in-the-cards,2023-10-27 15:36:00,Higher sales of lead drug Jakafi and incremental sales of newly approved drugs are likely to have boosted Incyte's (INCY) top line during the third quarter of 2023.,VRTX,0.161349,0.048938,Neutral
"Got $1,000? 3 Growth Stocks to Buy That Could Double Your Money",https://www.fool.com/investing/2023/10/27/got-1000-3-growth-stocks-to-buy-that-could-double/,2023-10-27 14:15:00,"These companies come from very different industries, but each has businesses that investors may find compelling.",VRTX,0.116161,0.135385,Neutral
2 Healthcare Stocks That Could Make You Richer,https://www.fool.com/investing/2023/10/27/2-healthcare-stocks-that-could-make-you-richer/,2023-10-27 09:20:00,"The need for healthcare is consistent and ongoing, a reality that makes this industry resilient to economic downturns.",VRTX,0.129052,0.25619,Somewhat-Bullish
"Azenta Clears Technical Benchmark, Hitting 80-Plus RS Rating",https://www.investors.com/ibd-data-stories/azenta-clears-technical-benchmark-hitting-80-plus-rs-rating/,2023-10-27 07:00:00,"One important metric to look for in a stock is an 80 or higher Relative Strength Rating. Azenta ( AZTA ) now clears that threshold, with a jump from 78 to 83 Friday. X When looking for the best stocks to buy and watch, one factor to watch closely is relative price strength.",VRTX,0.338582,0.0,Neutral
Stocks To Watch: Rhythm Pharmaceuticals Sees RS Rating Jump To 91,https://www.investors.com/ibd-data-stories/stocks-to-watch-rhythm-pharmaceuticals-sees-rs-rating-jump-to-91/,2023-10-27 07:00:00,Stocks To Watch: Rhythm Pharmaceuticals Sees RS Rating Jump ... Investor's Business Daily ...,VRTX,0.331765,0.120368,Neutral
Rocket Pharmaceuticals Trying To Close In On Key Technical Measure,https://www.investors.com/ibd-data-stories/rocket-pharmaceuticals-trying-to-close-in-on-key-technical-measure/,2023-10-27 07:00:00,Rocket Pharmaceuticals Trying To Close In On Key Technical ... Investor's Business Daily ...,VRTX,0.327366,0.0,Neutral
This Market-Beating Growth Stock Is Set to Outperform Yet Again in 2024,https://www.fool.com/investing/2023/10/26/this-market-beating-growth-stock-is-set-to-outperf/,2023-10-26 14:00:00,This rare disease company is on a roll.,VRTX,0.110462,0.174915,Somewhat-Bullish
2 Top Healthcare Stocks Defying the Bear Market,https://www.fool.com/investing/2023/10/26/2-top-healthcare-stocks-defying-the-bear-market/,2023-10-26 14:00:00,"These companies are building out their revenue and profit streams, and the proof is in the pudding.",VRTX,0.107255,0.248954,Somewhat-Bullish
2 Best Healthcare Stocks to Buy Right Now,https://www.fool.com/investing/2023/10/26/2-best-healthcare-stocks-to-buy-right-now/,2023-10-26 13:15:00,"The healthcare industry is an explosive space full of promising, profitable companies.",VRTX,0.113329,0.194721,Somewhat-Bullish
CRISPR  ( CRSP )  to Report Q3 Earnings: What's in the Cards?,https://www.zacks.com/stock/news/2172563/crispr-crsp-to-report-q3-earnings-whats-in-the-cards,2023-10-26 12:22:00,"Devoid of marketed drugs, investors will focus on CRISPR Therapeutics' (CRSP) pipeline, specifically regulatory updates on lead candidate exa-cel.",VRTX,0.184834,0.115115,Neutral
Eli Lilly  ( LLY )  to Report Q3 Earnings: What's in the Cards?,https://www.zacks.com/stock/news/2172391/eli-lilly-lly-to-report-q3-earnings-whats-in-the-cards,2023-10-26 11:40:00,"On Eli Lilly's (LLY) third-quarter conference call, investor focus is likely to be on the sales of its new diabetes drug, Mounjaro.",VRTX,0.173958,0.050098,Neutral
Vertex Pharmaceuticals: Buy at the High?,https://www.fool.com/investing/2023/10/26/vertex-pharmaceuticals-buy-at-the-high/,2023-10-26 10:15:00,Vertex shares have been flying high in recent times.,VRTX,0.115509,0.033291,Neutral
3 Healthcare Stocks to Buy and Hold for the Next 10 Years,https://www.fool.com/investing/2023/10/26/healthcare-stocks-buy-and-hold-for-decade/,2023-10-26 09:20:00,Great healthcare businesses are out there and their stocks are ripe for the picking.,VRTX,0.088472,0.113,Neutral
2 No-Brainer Growth Stocks to Buy Right Now,https://www.fool.com/investing/2023/10/26/2-no-brainer-growth-stocks-to-buy-right-now/,2023-10-26 09:05:00,These businesses are thriving and raking in profits.,VRTX,0.112532,0.087797,Neutral
2 Fantastic Growth Stocks to Buy Hand Over Fist,https://www.fool.com/investing/2023/10/26/2-fantastic-growth-stocks-to-buy-hand-over-fist/,2023-10-26 09:00:00,These stocks make great bargains today.,VRTX,0.063763,0.0,Neutral
Bioventus  ( BVS )  to Report Q3 Earnings: What's in the Cards?,https://www.zacks.com/stock/news/2171824/bioventus-bvs-to-report-q3-earnings-whats-in-the-cards,2023-10-25 14:48:00,"On Bioventus' (BVS) third-quarter 2023 earnings call, investors' focus is likely to be on the sales numbers of its three business units - pain treatments, restorative therapies and surgical solutions.",VRTX,0.181137,0.103363,Neutral
3 Red-Hot Growth Stocks That Are Still Cheap Buys,https://www.fool.com/investing/2023/10/25/3-red-hot-growth-stocks-that-are-still-cheap-buys/,2023-10-25 13:45:00,It's not too late to invest in these great businesses.,VRTX,0.148731,0.131831,Neutral
2 Biotech Stocks You Can Buy and Hold for the Next Decade,https://www.fool.com/investing/2023/10/25/2-biotech-stocks-you-can-buy-and-hold-for-the-next/,2023-10-25 12:45:00,Neither has performed well on the stock market this year.,VRTX,0.055751,0.132896,Neutral
Amgen  ( AMGN )  to Report Q3 Earnings: Will It Beat Estimates?,https://www.zacks.com/stock/news/2171289/amgen-amgn-to-report-q3-earnings-will-it-beat-estimates,2023-10-25 11:26:00,"Volume growth from Amgen's (AMGN) key drugs like Prolia, Repatha and Evenity, among others, is expected to have been partially offset by biosimilar/generic competition for mature drugs.",VRTX,0.219312,0.114532,Neutral
Axsome Therapeutics Hits 80-Plus Relative Strength Rating Benchmark,https://www.investors.com/ibd-data-stories/axsome-therapeutics-hits-80-plus-relative-strength-rating-benchmark/,2023-10-25 07:00:00,Axsome Therapeutics Hits 80-Plus Relative Strength Rating ... Investor's Business Daily ...,VRTX,0.343279,0.0,Neutral
"Arcellx Clears Technical Benchmark, Hitting 90-Plus RS Rating",https://www.investors.com/ibd-data-stories/arcellx-clears-technical-benchmark-hitting-90-plus-rs-rating/,2023-10-25 07:00:00,"On Wednesday, Arcellx ( ACLX ) got a positive adjustment to its Relative Strength ( RS ) Rating, from 87 to 91. X When looking for the best stocks to buy and watch, keep a close on eye on relative price strength.",VRTX,0.325208,0.118507,Neutral
Sarepta Therapeutics Earns Relative Strength Rating Upgrade,https://www.investors.com/ibd-data-stories/sarepta-therapeutics-earns-relative-strength-rating-upgrade-2/,2023-10-25 07:00:00,"On Wednesday, Sarepta Therapeutics ( SRPT ) received a positive adjustment to its Relative Strength ( RS ) Rating, from 68 to 73. X As you try to find the best stocks to buy and watch, be sure to pay attention to relative price strength.",VRTX,0.325208,0.0,Neutral
Gilead Sciences Getting Closer To Key Technical Benchmark,https://www.investors.com/ibd-data-stories/gilead-sciences-getting-closer-to-key-technical-benchmark/,2023-10-25 07:00:00,"Gilead Sciences ( GILD ) saw a welcome improvement to its Relative Strength ( RS ) Rating on Wednesday, rising from 70 to 73. When looking for the best stocks to buy and watch, one factor to watch closely is relative price strength.",VRTX,0.31282,0.0,Neutral
Stock Upgrades: Apellis Pharmaceuticals Shows Rising Relative Strength,https://www.investors.com/ibd-data-stories/stock-upgrades-apellis-pharmaceuticals-shows-rising-relative-strength-4/,2023-10-25 07:00:00,Stock Upgrades: Apellis Pharmaceuticals Shows Rising Relative ... Investor's Business Daily ...,VRTX,0.301315,0.113697,Neutral
Stocks Showing Market Leadership: Vericel Earns 92 RS Rating,https://www.investors.com/ibd-data-stories/stocks-showing-market-leadership-vericel-earns-92-rs-rating-2/,2023-10-25 07:00:00,"When looking for the best stocks to buy and watch, focus on those with rising relative price strength. One stock that fits that bill is Vericel ( VCEL ) , which saw a welcome improvement to its Relative Strength ( RS ) Rating on Wednesday, rising from 88 to 92.",VRTX,0.297661,0.112591,Neutral
Dynavax  ( DVAX )  to Report Q3 Earnings: Will It Beat Estimates?,https://www.zacks.com/stock/news/2170685/dynavax-dvax-to-report-q3-earnings-will-it-beat-estimates,2023-10-24 11:45:00,"On Dynavax's (DVAX) third-quarter earnings call, investors' focus is likely to be on the sales performance of the company's hepatitis B vaccine, HEPLISAV-B.",VRTX,0.183895,0.103042,Neutral
Pfizer  ( PFE )  to Report Q3 Earnings: Here's What to Expect,https://www.zacks.com/stock/news/2170681/pfizer-pfe-to-report-q3-earnings-heres-what-to-expect,2023-10-24 11:39:00,"Pfizer (PFE) expects better non-COVID operational revenue growth sequentially in the third quarter, driven by its key products, new launches as well as newly acquired products.",VRTX,0.188928,0.102132,Neutral
"The Best Stocks to Invest $5,000 In Right Now",https://www.fool.com/investing/2023/10/24/the-best-stocks-to-invest-5000-in-right-now/,2023-10-24 09:30:00,"Today, the following three healthcare players look like fantastic bargains.",VRTX,0.102668,0.214111,Somewhat-Bullish
ACADIA Pharmaceuticals Shows Market Leadership With Jump To 84 RS Rating,https://www.investors.com/ibd-data-stories/acadia-pharmaceuticals-shows-market-leadership-with-jump-to-84-rs-rating/,2023-10-24 07:00:00,ACADIA Pharmaceuticals Shows Market Leadership With Jump To ... Investor's Business Daily ...,VRTX,0.323078,0.0,Neutral
Stocks With Rising Relative Price Strength: Viking Therapeutics,https://www.investors.com/ibd-data-stories/stocks-with-rising-relative-price-strength-viking-therapeutics/,2023-10-24 07:00:00,"Viking Therapeutics ( VKTX ) saw a welcome improvement to its Relative Strength ( RS ) Rating on Tuesday, with an increase from 87 to 92. X When looking for the best stocks to buy and watch, one factor to watch closely is relative price strength.",VRTX,0.31282,0.117139,Neutral
Apellis Pharmaceuticals Stock Shows Rising Relative Strength,https://www.investors.com/news/stock-upgrades-apellis-pharmaceuticals-shows-rising-relative-strength-3/,2023-10-24 07:00:00,Stock Upgrades: Apellis Pharmaceuticals Shows Rising Relative ... Investor's Business Daily ...,VRTX,0.244109,0.0,Neutral
Vertex Pharmaceuticals  ( VRTX )  Increases Despite Market Slip: Here's What You Need to Know,https://www.zacks.com/stock/news/2170469/vertex-pharmaceuticals-vrtx-increases-despite-market-slip-heres-what-you-need-to-know,2023-10-23 21:50:18,"In the closing of the recent trading day, Vertex Pharmaceuticals (VRTX) stood at $367.66, denoting a +1.6% change from the preceding trading day.",VRTX,0.50605,0.191827,Somewhat-Bullish
Intellia  ( NTLA )  Focuses on Developing Gene-Editing Therapies,https://www.zacks.com/stock/news/2170217/intellia-ntla-focuses-on-developing-gene-editing-therapies,2023-10-23 13:40:00,Intellia's (NTLA) in-vivo CRISPR-based gene-edited therapy candidate NTLA-2001 holds potential. Other pipeline candidates are in early-stage development and progressing well.,VRTX,0.159569,0.053858,Neutral
Merck  ( MRK )  to Report Q3 Earnings: What's in the Cards?,https://www.zacks.com/stock/news/2170134/merck-mrk-to-report-q3-earnings-whats-in-the-cards,2023-10-23 11:25:00,"Investor focus is likely to be on the sales of Merck's (MRK) blockbuster oncology medicine, Keytruda, when the company reports Q3 earnings.",VRTX,0.206245,-0.024239,Neutral
3 Unstoppable Stocks to Buy Sooner Rather Than Later,https://www.fool.com/investing/2023/10/22/3-unstoppable-stocks-to-buy-sooner-rather-than-lat/,2023-10-22 10:55:00,Now is the time to invest in these great stocks.,VRTX,0.166743,0.014889,Neutral
CRISPR Therapeutics Stock: Bull vs. Bear,https://www.fool.com/investing/2023/10/21/crispr-therapeutics-stock-bull-vs-bear/,2023-10-21 22:45:00,Here's the scoop on one of the most widely followed gene-editing stocks on the market.,VRTX,0.060085,-0.031007,Neutral
Vertex Pharmaceuticals  ( NASDAQ:VRTX )  Upgraded at StockNews.com,https://www.defenseworld.net/2023/10/21/vertex-pharmaceuticals-nasdaqvrtx-upgraded-at-stocknews-com.html,2023-10-21 07:26:44,Vertex Pharmaceuticals ( NASDAQ:VRTX ) Upgraded at StockNews ... Defense World ...,VRTX,0.744539,0.471326,Bullish
A Look Into Vertex Pharmaceuticals Inc's Price Over Earnings - Vertex Pharmaceuticals  ( NASDAQ:VRTX ) ,https://www.benzinga.com/news/23/10/35358746/a-look-into-vertex-pharmaceuticals-incs-price-over-earnings,2023-10-20 20:45:38,"In the current market session, Vertex Pharmaceuticals Inc. VRTX stock price is at $361.86, after a 0.81% decrease. However, over the past month, the company's stock went up by 3.53%, and in the past year, by 16.54%.",VRTX,0.419153,-0.064286,Neutral
3 Monster Stocks to Buy Without Any Hesitation,https://www.fool.com/investing/2023/10/20/3-monster-stocks-to-buy-without-any-hesitation/,2023-10-20 09:50:00,These big stocks could become a lot bigger.,VRTX,0.104911,0.216626,Somewhat-Bullish
Intellia's  ( NTLA )  IND for Gene-Editing Therapy Gets FDA Clearance,https://www.zacks.com/stock/news/2169049/intellias-ntla-ind-for-gene-editing-therapy-gets-fda-clearance,2023-10-19 15:46:00,"Intellia (NTLA) gets FDA nod to begin a phase III study on its gene editing candidate, NTLA-2001 to treat transthyretin amyloidosis with cardiomyopathy. The study is set to begin by 2023-end.",VRTX,0.182506,0.059067,Neutral
GILD or VRTX: Which Is the Better Value Stock Right Now?,https://www.zacks.com/stock/news/2169033/gild-or-vrtx-which-is-the-better-value-stock-right-now,2023-10-19 15:40:12,GILD vs. VRTX: Which Stock Is the Better Value Option?,VRTX,0.606706,0.49223,Bullish
"4 Ways to Grow $100,000 Into $1 Million for Retirement",https://www.fool.com/investing/2023/10/19/4-ways-to-grow-100000-into-1-million-for-retiremen/,2023-10-19 13:13:00,Investing for big-time growth doesn't have to be risky.,VRTX,0.077343,0.050792,Neutral
Why Investors Need to Take Advantage of These 2 Medical Stocks Now,https://www.zacks.com/stock/news/2168656/why-investors-need-to-take-advantage-of-these-2-medical-stocks-now,2023-10-19 12:50:05,Why investors should use the Zacks Earnings ESP tool to help find stocks that are poised to top quarterly earnings estimates.,VRTX,0.33446,0.306402,Somewhat-Bullish
3 Under-the-Radar Biotech Stocks to Buy in 2023,https://www.fool.com/investing/2023/10/19/3-under-the-radar-biotech-stocks-to-buy-in-2023/,2023-10-19 12:15:00,These three lesser-known biotech companies are profitable and growing revenue.,VRTX,0.051221,0.070937,Neutral
"Vertex Pharmaceuticals, Gilead Sciences And 2 Other Stocks Insiders Are Selling - Gilead Sciences  ( NASDAQ:GILD ) , HubSpot  ( NYSE:HUBS ) ",https://www.benzinga.com/news/23/10/35326531/vertex-pharmaceuticals-gilead-sciences-and-2-other-stocks-insiders-are-selling,2023-10-19 11:42:01,"The Nasdaq 100 closed lower by over 200 points on Wednesday. Investors, meanwhile, focused on some notable insider trades. When insiders sell shares, it could be a preplanned sale, or could indicate their concern in the company's prospects or that they view the stock as being overpriced.",VRTX,0.421485,-0.042918,Neutral
5 Biotech Stocks Set to Outpace Q3 Earnings Estimates,https://www.zacks.com/stock/news/2168288/5-biotech-stocks-set-to-outpace-q3-earnings-estimates,2023-10-18 15:20:00,"Let us look at some biotech stocks, AMGN, BIIB, GSK, PRTA and VRTX, which are poised to beat on third-quarter earnings.",VRTX,0.30569,0.052098,Neutral
Biotech Stumbles As It Aims For A First-Ever In CRISPR Gene Editing,https://www.investors.com/news/technology/ntla-stock-stumbles-as-intellia-aims-for-a-first-ever-in-crispr-gene-editing/,2023-10-18 14:38:00,"The Food and Drug Administration gave Intellia Therapeutics ( NTLA ) the go-ahead to begin a pivotal study of its gene-editing treatment for a deadly heart disease, but NTLA stock reversed lower at the open.",VRTX,0.192694,0.0,Neutral
Hyloris Pharma wins US FDA approval for pain treatment,https://www.reuters.com/business/healthcare-pharmaceuticals/hyloris-pharma-wins-us-fda-approval-pain-treatment-2023-10-18/,2023-10-18 00:10:35,"Signage is seen outside of the Food and Drug Administration ( FDA ) headquarters in White Oak, Maryland, U.S., August 29, 2020. REUTERS/Andrew Kelly/File Photo Acquire Licensing Rights",VRTX,0.13459,0.135121,Neutral
Vertex Pharma misses sales estimates on weak demand for older CF treatments,https://www.reuters.com/business/healthcare-pharmaceuticals/vertex-pharma-misses-sales-estimates-weak-demand-older-cf-treatments-2023-11-06/,2023-11-06 23:02:00,"A sign hangs in front of the world headquarters of Vertex Pharmaceuticals in Boston, Massachusetts, U.S., October 23, 2019. REUTERS/Brian Snyder/File Photo Acquire Licensing Rights",VRTX,0.297661,-0.280958,Somewhat-Bearish
Vertex Pharmaceuticals  ( VRTX )  Tops Q3 Earnings Estimates,https://www.zacks.com/stock/news/2179574/vertex-pharmaceuticals-vrtx-tops-q3-earnings-estimates,2023-11-06 22:25:05,"Vertex (VRTX) delivered earnings and revenue surprises of 4.08% and 0.06%, respectively, for the quarter ended September 2023. Do the numbers hold clues to what lies ahead for the stock?",VRTX,0.14131,0.096884,Neutral
"Tech Leader Slips Despite Beating Views, Raising Outlook",https://www.investors.com/news/technology/vrtx-stock-vertex-earnings-q3-2023/,2023-11-06 21:21:00,"VRTX Stock Slips, But IBD Tech Leader Boosts Outlook On Strong ... Investor's Business Daily ...",VRTX,0.769861,0.291868,Somewhat-Bullish
CRISPR Therapeutics Provides Business Update and Reports Third Quarter 2023 Financial Results,https://www.globenewswire.com/news-release/2023/11/06/2774541/0/en/CRISPR-Therapeutics-Provides-Business-Update-and-Reports-Third-Quarter-2023-Financial-Results.html,2023-11-06 21:15:00,"-Advisory Committee meeting for exagamglogene autotemcel ( exa-cel ) for the treatment of severe sickle cell disease ( SCD ) completed October 31, 2023. exa-cel assigned Prescription Drug User Fee Act ( PDUFA ) target action date of December 8, 2023 for ...",VRTX,0.036001,0.067565,Neutral
England's young cystic fibrosis patients face new treatment worry,https://www.reuters.com/business/healthcare-pharmaceuticals/englands-young-cystic-fibrosis-patients-face-new-treatment-worry-2023-11-06/,2023-11-06 16:14:00,"A sign hangs in front of the world headquarters of Vertex Pharmaceuticals in Boston, Massachusetts, U.S., October 23, 2019. REUTERS/Brian Snyder/File Photo Acquire Licensing Rights",VRTX,0.13459,0.195361,Somewhat-Bullish
Is It Worth Investing in Vertex  ( VRTX )  Based on Wall Street's Bullish Views?,https://www.zacks.com/stock/news/2179160/is-it-worth-investing-in-vertex-vrtx-based-on-wall-streets-bullish-views,2023-11-06 14:30:06,"Based on the average brokerage recommendation (ABR), Vertex (VRTX) should be added to one's portfolio. Wall Street analysts' overly optimistic recommendations cast doubt on the effectiveness of this highly sought-after metric. So, is the stock worth buying?",VRTX,0.05387,0.14275,Neutral
Cathie Wood's ARKK Had Its Best Week Due To 11 Huge Winners,https://www.investors.com/news/cathie-wood-ark-innovation-just-had-its-best-week-ever-thanks-to-11-huge-winners/,2023-11-06 12:45:00,"Cathie Wood's Ark Innovation ETF ( ARKK ) typically outpaces the overall market to the upside and downside. Last week, the S&P 500, Dow Jones and Nasdaq had their best gains of 2023. But the Ark Innovation ETF had its best week ever, up 18.6%. Credit massive moves among key components.",VRTX,0.062352,0.27244,Somewhat-Bullish
"US Stocks Set To Extend 5-Day Winning Streak Today? Traders Anxiously Watch Fed Speech, Climbing Bond Yields - Matterport  ( NASDAQ:MTTR ) , TripAdvisor  ( NASDAQ:TRIP ) , Adtran  ( NASDAQ:ADTN ) , NXP Semiconductors  ( NASDAQ:NXPI ) ",https://www.benzinga.com/markets/equities/23/11/35615654/us-stocks-set-to-extend-5-day-winning-streak-today-traders-anxiously-watch-fed-speech-climbing-b,2023-11-06 11:47:18,"The market looks set to extend last week's gains, with the stock futures holding up early Monday ahead of a slew of earnings reports mostly from the small and mid-cap space. Some mega-cap techs gained ground in the premarket, which bodes well for the broader market.",VRTX,0.088309,0.0,Neutral
"Futures indicate stocks will look on Monday to extend their latest rally, though additional gains will be meager",https://www.marketwatch.com/story/s-p-500-futures-show-stocks-extending-latest-rally-4a0996e2,2023-11-06 10:10:00,"U.S. stock futures nudged higher early Monday, as hopes the Federal Reserve has finished raising borrowing costs continued to underpin sentiment.",VRTX,0.188928,-0.195476,Somewhat-Bearish
CRISPR Therapeutics Announces Preclinical Data at the American Heart Association  ( AHA )  Scientific Sessions 2023,https://www.globenewswire.com/news-release/2023/11/06/2773808/0/en/CRISPR-Therapeutics-Announces-Preclinical-Data-at-the-American-Heart-Association-AHA-Scientific-Sessions-2023.html,2023-11-06 10:01:00,-CTX310 led to durable reductions of angiopoietin-like 3 protein ( ANGPTL3 ) and triglyceride levels in non-human primates ( NHPs ) after a single ...,VRTX,0.033421,0.121171,Neutral
CRISPR Therapeutics Announces Preclinical Data at the American Heart Association  ( AHA )  Scientific Sessions 2023 - CRISPR Therapeutics  ( NASDAQ:CRSP ) ,https://www.benzinga.com/pressreleases/23/11/g35614028/crispr-therapeutics-announces-preclinical-data-at-the-american-heart-association-aha-scientific-se,2023-11-06 10:01:00,-CTX310 led to durable reductions of angiopoietin-like 3 protein ( ANGPTL3 ) and triglyceride levels in non-human primates ( NHPs ) after a single dose- -CTX320 led to durable reductions of lipoprotein ( a ) ( Lp ( a ) ) levels in NHPs after a single dose-,VRTX,0.032781,0.120893,Neutral
Vaxcyte Earns Relative Strength Rating Upgrade; Hits Key Benchmark,https://www.investors.com/ibd-data-stories/vaxcyte-earns-relative-strength-rating-upgrade-hits-key-benchmark/,2023-11-06 08:00:00,Vaxcyte Earns Relative Strength Rating Upgrade. Hits Key Benchmark Investor's Business Daily ...,VRTX,0.368773,0.0,Neutral
Rhythm Pharmaceuticals Shows Market Leadership With Jump To 92 RS Rating,https://www.investors.com/ibd-data-stories/rhythm-pharmaceuticals-shows-market-leadership-with-jump-to-92-rs-rating/,2023-11-06 08:00:00,Rhythm Pharmaceuticals Shows Market Leadership With Jump To ... Investor's Business Daily ...,VRTX,0.338582,0.133973,Neutral
Stocks Showing Market Leadership: Rocket Pharmaceuticals Earns 90 RS Rating,https://www.investors.com/ibd-data-stories/stocks-showing-market-leadership-rocket-pharmaceuticals-earns-90-rs-rating/,2023-11-06 08:00:00,Stocks Showing Market Leadership: Rocket Pharmaceuticals Earns ... Investor's Business Daily ...,VRTX,0.318897,0.12787,Neutral
Azenta Shows Rising Relative Price Performance; Still Shy Of Key Benchmark,https://www.investors.com/ibd-data-stories/azenta-shows-rising-relative-price-performance-still-shy-of-key-benchmark/,2023-11-06 08:00:00,Azenta Shows Rising Relative Price Performance. Still Shy Of Key ... Investor's Business Daily ...,VRTX,0.306963,0.0,Neutral
Ionis Pharmaceuticals Shows Market Leadership With Jump To 93 RS Rating,https://www.investors.com/ibd-data-stories/ionis-pharmaceuticals-shows-market-leadership-with-jump-to-93-rs-rating/,2023-11-06 08:00:00,Ionis Pharmaceuticals Shows Market Leadership With Jump To 93 ... Investor's Business Daily ...,VRTX,0.290607,0.1146,Neutral
"Biotechs Bounce. New Highs For Ideaya, Olema And Vertex.",https://www.forbes.com/sites/johnnavin/2023/11/04/biotechs-bounce-new-highs-for-ideaya-olema-and-vertex/,2023-11-04 14:22:11,"Biotechs rallied this week, a strong indication that ""risk on"" is back on after Fed Chair Jerome Powell said interest rates won't be raised again right now. This sector is the non-value stock sector - investors going for growth like to place money here when they feel that a bottom may be in place.",VRTX,0.087824,0.10524,Neutral
Is Bluebird Bio Stock a Buy?,https://www.fool.com/investing/2023/11/04/is-bluebird-bio-stock-a-buy/,2023-11-04 12:45:00,"This biotech looks cheap, but is it a value trap?",VRTX,0.055236,0.164891,Somewhat-Bullish
"Fed Holds Rates Steady, Powell's Cautious Stance Soothes Investors, Labor Market Softens: The Week In The Markets - Apple  ( NASDAQ:AAPL ) , Advanced Micro Devices  ( NASDAQ:AMD ) ",https://www.benzinga.com/markets/equities/23/11/35601229/fed-holds-rates-steady-powells-cautious-stance-soothes-investors-labor-market-softens-the-week-i,2023-11-03 20:03:39,"Markets bounced back decisively this week, shrugging off prior volatile months marked by heightened geopolitical tensions. The resurgence of risk sentiment ignited a relief rally in both equities and bonds, with investors embracing the Federal Reserve's decision to hold steady on interest rates.",VRTX,0.129168,-0.093536,Neutral
It's Time To Find Breakouts As Growth Stocks Get A Lift; Microsoft Is One,https://www.investors.com/stock-lists/ibd-50/growth-stocks-in-ibd-to-are-near-buy-points/,2023-11-03 18:13:54,Growth stocks In IBD 50 Are Near Buy Points Investor's Business Daily ...,VRTX,0.150592,0.223047,Somewhat-Bullish
Market Rally Back In Force As Yields Plunge: Weekly Review,https://www.investors.com/news/stock-market-rally-back-in-force-as-treasury-yields-plunge-arista-palantir-are-winners/,2023-11-03 16:55:59,"The stock market rally took off this past week as Treasury yields plunged on generally weak economic data and soothing words from Fed Chief Jerome Powell Nasdaq staged a follow-through day to confirm the market rally on Wednesday, with the S&P 500 and Dow Jones following through on Thursday.",VRTX,0.035476,0.15563,Somewhat-Bullish
Why CRISPR Therapeutics Stock Charged Northward This Week,https://www.fool.com/investing/2023/11/03/why-crispr-therapeutics-stock-charged-northward-th/,2023-11-03 13:56:47,Gene correction technology took a big step forward this week.,VRTX,0.115787,0.040005,Neutral
Here's What Investors Need to Know About Vertex Pharmaceuticals and CRISPR Therapeutics' Big Day at the FDA,https://www.fool.com/investing/2023/11/03/heres-what-investors-need-to-know-about-vertex-pha/,2023-11-03 12:05:00,The meeting went almost as well as could be expected.,VRTX,0.1437,0.031677,Neutral
Arcellx Earns Relative Strength Rating Upgrade,https://www.investors.com/ibd-data-stories/arcellx-earns-relative-strength-rating-upgrade/,2023-11-03 08:00:00,"Arcellx ( ACLX ) saw a welcome improvement to its Relative Strength ( RS ) Rating on Friday, rising from 88 to 95. X When looking for the best stocks to buy and watch, one factor to watch closely is relative price strength.",VRTX,0.334008,0.120999,Neutral
Vertex Pharmaceuticals  ( VRTX )  Rises Higher Than Market: Key Facts,https://www.zacks.com/stock/news/2177676/vertex-pharmaceuticals-vrtx-rises-higher-than-market-key-facts,2023-11-02 21:45:06,"The latest trading day saw Vertex Pharmaceuticals (VRTX) settling at $376.55, representing a +1.95% change from its previous close.",VRTX,0.570165,0.281396,Somewhat-Bullish
"Moderna  ( MRNA )  Beats on Q3 Earnings & Sales, Expects Lower COVID Demand",https://www.zacks.com/stock/news/2177609/moderna-mrna-beats-on-q3-earnings-sales-expects-lower-covid-demand,2023-11-02 16:19:00,"Moderna (MRNA) beats expectations for earnings and sales. However, the company projects lower-than-expected 2024 guidance, which likely led to a decline in share price after the earnings announcement.",VRTX,0.038223,0.112084,Neutral
"One Month Ahead of its Most Crucial Moment Ever, Should You Buy CRISPR Therapeutics?",https://www.fool.com/investing/2023/11/02/is-crispr-therapeutics-a-buy-before-big-moment/,2023-11-02 09:30:00,"This stock could be a long-term winner, thanks to its game-changing technology.",VRTX,0.058188,0.103034,Neutral
This Pain Pill Could Replace Opioids. It's an Opportunity.,https://www.barrons.com/articles/vertex-pain-pill-non-opioid-573cae68,2023-11-02 06:00:00,"Americans filled roughly one opioid pain prescription for every two U.S. adults in 2020-despite a raging opioid epidemic, where 80,000 people a year fatally overdose. Everyone knows the drugs are dangerous, but patients need pain relief, and the alternatives are limited.",VRTX,0.368773,0.259141,Somewhat-Bullish
"Stocks Muted After Fed Leaves Rates Unchanged, As Expected",https://www.investors.com/market-trend/stock-market-today/stock-market-climbs-ahead-of-fed-announcement-this-leader-plummets-nearly-40/,2023-11-01 18:23:42,"The stock market had an unusually moderate reaction to the Fed's decision to leave interest rates unchanged Wednesday afternoon. Investors now wait for Chair Jerome Powell's press conference, which often moves stocks more than the Fed announcement itself.",VRTX,0.07913,0.109697,Neutral
Crispr Therapeutics' stock soars as FDA-panel meeting raises hopes sickle-cell-disease drug will be approved,https://www.marketwatch.com/story/crispr-therapeutics-stock-soars-premarket-after-positive-meeting-of-fda-panel-on-sickle-cell-disease-therapy-887fc893,2023-11-01 16:07:00,Crispr Therapeutics' stock rallied 12% Wednesday amid hopes a treatment for sickle-cell disease will win regulatory approval.,VRTX,0.751437,0.437407,Bullish
Crispr Rallies As The First-Ever Gene-Editing Drug Faces The FDA,https://www.investors.com/news/technology/crsp-stock-surges-as-fda-considers-the-first-ever-crispr-based-gene-editing-drug/,2023-11-01 14:31:00,"The Food and Drug Administration appears likely to approve Crispr Therapeutics' ( CRSP ) gene-editing approach to sickle cell disease, analysts said Wednesday as CRSP stock gapped higher. The bullish sentiment follows a ""relatively benign"" FDA advisory committee on Tuesday, Mizuho Securities ...",VRTX,0.119532,-0.110289,Neutral
"Futures Fall As AMD Slides; All Eyes On Fed, Powell",https://www.investors.com/market-trend/stock-market-today/dow-jones-futures-amd-slides-all-eyes-on-fed-decision-powell/,2023-11-01 11:26:00,"Futures Fall As AMD Slides. All Eyes On Fed, Powell Investor's Business Daily ...",VRTX,0.09186,0.064944,Neutral
"10 things you need to know today: November 1, 2023",https://theweek.com/digest/round-up/10-things-you-need-to-know-today-november-1-2023,2023-11-01 11:18:17,1. Israel bombs refugee camp to kill a Hamas leader 2. Cornell student charged with threats against Jewish students 3. Senate confirms Jack Lew as ambassador to Israel 4. FBI director tells senators US faces growing terrorism threats 5. Biden to meet with Xi for 'constructive' talks,VRTX,0.020668,0.037113,Neutral
FDA considers first CRISPR gene editing treatment that may cure sickle cell,https://www.cnn.com/2023/10/31/health/fda-considers-crispr-treatment-cure-sickle-cell/index.html,2023-10-31 23:28:04,"At age 45, Dr. Lakiea Bailey said, for the longest time, that she was the oldest person with sickle cell anemia that she knew. The executive director of the nonprofit patient advocacy group the Sickle Cell Consortium was diagnosed with sickle cell disease at age three.",VRTX,0.061949,0.065649,Neutral
FDA panel says Vertex/CRISPR to assess safety risks of gene therapy in follow-up study,https://www.reuters.com/business/healthcare-pharmaceuticals/fda-panel-says-vertexcrispr-assess-safety-risks-gene-therapy-follow-up-study-2023-10-31/,2023-10-31 22:30:00,"Signage is seen outside of the Food and Drug Administration ( FDA ) headquarters in White Oak, Maryland, U.S., August 29, 2020. REUTERS/Andrew Kelly/File Photo Acquire Licensing Rights",VRTX,0.114137,0.108329,Neutral
CRISPR Therapeutics Announces Completion of FDA Advisory Committee Meeting for Exagamglogene Autotemcel  ( exa-cel )  for Severe Sickle Cell Disease,https://www.globenewswire.com/news-release/2023/10/31/2770707/0/en/CRISPR-Therapeutics-Announces-Completion-of-FDA-Advisory-Committee-Meeting-for-Exagamglogene-Autotemcel-exa-cel-for-Severe-Sickle-Cell-Disease.html,2023-10-31 21:53:00,"-Exa-cel PDUFA target action date is December 8, 2023 for severe sickle cell disease ...",VRTX,0.089797,0.086372,Neutral
CRISPR Therapeutics Trading Halted Today; FDA Advisory Committee to Review Biologics License Application  ( BLA )  for Exagamglogene Autotemcel  ( exa-cel )  in Sickle Cell Disease  ( SCD ) ,https://www.globenewswire.com/news-release/2023/10/31/2770020/0/en/CRISPR-Therapeutics-Trading-Halted-Today-FDA-Advisory-Committee-to-Review-Biologics-License-Application-BLA-for-Exagamglogene-Autotemcel-exa-cel-in-Sickle-Cell-Disease-SCD.html,2023-10-31 11:05:00,"ZUG, Switzerland and BOSTON, Oct. 31, 2023 ( GLOBE NEWSWIRE ) -- CRISPR Therapeutics ( Nasdaq: CRSP ) , a biopharmaceutical company focused on creating transformative gene-based medicines for serious diseases, today announced that NASDAQ has halted trading of the Company's common stock.",VRTX,0.123526,0.146693,Neutral
Is Invesco Biotechnology & Genome ETF  ( PBE )  a Strong ETF Right Now?,https://www.zacks.com/stock/news/2175072/is-invesco-biotechnology-genome-etf-pbe-a-strong-etf-right-now,2023-10-31 10:20:05,Smart Beta ETF report for ...,VRTX,0.117486,0.060435,Neutral
Vericel Shows Market Leadership With Jump To 91 RS Rating,https://www.investors.com/ibd-data-stories/vericel-shows-market-leadership-with-jump-to-91-rs-rating/,2023-10-31 08:00:00,"On Tuesday, Vericel ( VCEL ) received an upgrade to its Relative Strength ( RS ) Rating, from 86 to 91. X When looking for the best stocks to buy and watch, keep a close on eye on relative price strength. IBD's proprietary rating measures market leadership with a 1 ( worst ) to 99 ( best ) ...",VRTX,0.348103,0.124912,Neutral
Gilead Sciences Sees RS Rating Improve To 71,https://www.investors.com/ibd-data-stories/gilead-sciences-sees-rs-rating-improve-to-71/,2023-10-31 08:00:00,"The Relative Strength ( RS ) Rating for Gilead Sciences ( GILD ) jumped into a higher percentile Tuesday, as it got a lift from 67 to 71. X When looking for the best stocks to buy and watch, one factor to watch closely is relative price strength.",VRTX,0.279015,0.0,Neutral
Apellis Pharmaceuticals Stock Improves With An RS Ratings Over 90,https://www.investors.com/news/apellis-pharmaceuticals-joins-rank-of-stocks-with-rs-ratings-over-90/,2023-10-31 08:00:00,Apellis Pharmaceuticals Joins Rank Of Stocks With RS Ratings Over ... Investor's Business Daily ...,VRTX,0.254307,0.099105,Neutral
Vertex Pharmaceuticals  ( VRTX )  Expected to Beat Earnings Estimates: Should You Buy?,https://www.zacks.com/stock/news/2174558/vertex-pharmaceuticals-vrtx-expected-to-beat-earnings-estimates-should-you-buy,2023-10-30 14:00:42,Vertex (VRTX) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.,VRTX,0.087824,0.033384,Neutral
"Here are 16 stocks Jim Cramer is watching, including Microsoft, Chevron, Southwest",https://www.cnbc.com/2023/10/30/here-are-16-stocks-jim-cramer-is-watching-including-microsoft-chevron-southwest.html,2023-10-30 13:38:20,"Here are some of the tickers on Jim's radar for Monday, Oct. 30, taken directly from his reporter's notebook: ...",VRTX,0.140076,-0.241673,Somewhat-Bearish
5 Reasons Beam Therapeutics Remains a Risky Stock,https://www.fool.com/investing/2023/10/30/reasons-why-beam-therapeutics-remains-risky-stock/,2023-10-30 13:18:15,Shares of the gene-editing biotech might not have hit rock bottom yet.,VRTX,0.047559,0.089913,Neutral
Vertex  ( VRTX )  to Report Q3 Earnings: What's in the Cards?,https://www.zacks.com/stock/news/2174363/vertex-vrtx-to-report-q3-earnings-whats-in-the-cards,2023-10-30 13:00:00,"Vertex (VRTX) is likely to outperform third-quarter 2023 estimates, driven by the increased international sales of its lead drug, Trikafta/Kaftrio.",VRTX,0.361626,0.020466,Neutral
"With 1 Roadblock Down, Is Verve Therapeutics a Buy Now?",https://www.fool.com/investing/2023/10/30/with-1-roadblock-down-is-verve-therapeutics-a-buy/,2023-10-30 12:30:00,It takes more than starting a clinical trial to make for a good investment.,VRTX,0.049526,0.145115,Neutral
"Gene Therapy Could Be On the Cusp of a Major Breakthrough, but Investors May Have to Remain Patient",https://www.fool.com/investing/2023/10/30/gene-therapy-could-be-on-the-cusp-of-major-breakth/,2023-10-30 12:30:00,This gene-editing pioneer could make history this week. But shareholders should remain focused on the long term.,VRTX,0.155118,0.002808,Neutral
FDA staff raises concerns over lack of safety data for Sickle-Cell treatment,https://www.financialexpress.com/healthcare/news-healthcare/fda-staff-raises-concerns-over-lack-of-safety-data-for-sickle-cell-treatment/3290517/,2023-10-30 03:30:00,"The Food and Drug Administration's staff raised concerns about safety data on a potential gene-editing treatment for sickle cell disease, ahead of a closely watched meeting where scientific experts will weigh the first therapy using Crispr technology.",VRTX,0.065685,-0.167382,Somewhat-Bearish
"Want $1 Million in Retirement? Invest $250,000 in These 3 Stocks and Wait a Decade",https://www.fool.com/investing/2023/10/28/want-1-million-in-retirement-invest-250000-in-thes/,2023-10-28 09:50:00,4x returns in just a decade is quite an attainable result for these companies.,VRTX,0.09186,0.051923,Neutral
The world's first gene therapy for sickle cell disease has been approved in Britain,https://apnews.com/article/sickle-cell-gene-therapy-treatment-uk-first-9bcf7c7d8b8909fb06e137fee17c767c,2023-11-16 17:00:00,"LONDON ( AP ) - Britain's medicines regulator has authorized the world's first gene therapy treatment for sickle cell disease, in a move that could offer relief to thousands of people with the crippling disease in the U.K.",VRTX,0.089965,0.028603,Neutral
"CRISPR  ( CRSP ) , Vertex Get UK Nod for First Gene Therapy Casgevy",https://www.zacks.com/stock/news/2185508/crispr-crsp-vertex-get-uk-nod-for-first-gene-therapy-casgevy,2023-11-16 16:47:00,"CRISPR (CRSP) and Vertex's Casgevy, the first-ever gene-edited therapy, to treat sickle cell disease and transfusion-dependent beta thalassemia gets MHRA nod. Stock rises in pre-market trading.",VRTX,0.204647,0.032132,Neutral
"Biotech Stock Roundup: BMY's Drug Approval, VRTX & CRSP Gene Therapy Get MHRA Nod",https://www.zacks.com/stock/news/2185428/biotech-stock-roundup-bmys-drug-approval-vrtx-crsp-gene-therapy-get-mhra-nod,2023-11-16 15:30:00,Bristol Myers (BMY) and Vertex (VRTX) drug approvals are in focus in the biotech sector.,VRTX,0.159922,0.039427,Neutral
Crispr Surges After Winning The First CRISPR Gene-Editing Approval,https://www.investors.com/news/technology/crsp-stock-surges-after-winning-the-first-ever-crispr-gene-editing-approval/,2023-11-16 14:27:00,"In a world first, regulators in the UK approved Crispr Therapeutics' ( CRSP ) gene-editing treatment for two blood diseases on Thursday. CRSP stock surged on the news. The drug formerly known as exa-cel will sell under the brand name Casgevy following the approval.",VRTX,0.209365,0.139264,Neutral
What's Going On With Crispr Therapeutics Stock Thursday? - CRISPR Therapeutics  ( NASDAQ:CRSP ) ,https://www.benzinga.com/news/23/11/35827548/whats-going-on-with-crispr-therapeutics-stock-thursday,2023-11-16 14:24:18,CRISPR Therapeutics AG CRSP shares are trading higher Thursday after the company announced regulatory authorization of the first CRISPR/Cas9 gene-edited therapy.,VRTX,0.380012,0.29009,Somewhat-Bullish
"Crispr Therapeutics, Vertex get world's first regulatory green light for CRISPR-based medicine",https://www.marketwatch.com/story/crispr-therapeutics-vertex-get-worlds-first-regulatory-green-light-for-crispr-based-medicine-c051bb14,2023-11-16 13:49:00,"Shares of Crispr Therapeutics, Vertex gain ground after first regulatory clearance for medicine based on transformative gene-editing technology ...",VRTX,0.195814,0.209719,Somewhat-Bullish
AMGN: 3 Biotech Stocks Beating BioMarin Pharmaceutical  ( BMRN ) ,https://stocknews.com/news/amgn-vrtx-jazz-bmrn-3-biotech-stocks-beating-biomarin-pharmaceutical-bmrn/,2023-11-16 13:47:24,AMGN: 3 Biotech Stocks Beating BioMarin Pharmaceutical ...,VRTX,0.1372,0.173495,Somewhat-Bullish
"UK Approves First Crispr Gene Edited Therapy For Sickle Cell Disease, Beta Thalassemia - CRISPR Therapeutics  ( NASDAQ:CRSP ) , Vertex Pharmaceuticals  ( NASDAQ:VRTX ) ",https://www.benzinga.com/general/biotech/23/11/35824646/uk-approves-first-crispr-gene-edited-therapy-for-sickle-cell-disease-beta-thalassemia,2023-11-16 13:17:07,"The U.K. Medicines and Healthcare products Regulatory Agency ( MHRA ) has granted conditional marketing authorization for Casgevy ( exagamglogene autotemcel [exa-cel] ) , a CRISPR/Cas9 gene-edited therapy for sickle cell disease ( SCD ) and transfusion-dependent beta-thalassemia ( TDT ) .",VRTX,0.399204,0.300057,Somewhat-Bullish
"Why Palo Alto Networks Shares Are Trading Lower By Around 5%; Here Are 20 Stocks Moving Premarket - Acutus Medical  ( NASDAQ:AFIB ) , Alpine 4 Holdings  ( NASDAQ:ALPP ) ",https://www.benzinga.com/news/23/11/35825417/why-palo-alto-networks-shares-are-trading-lower-by-around-5-here-are-20-stocks-moving-premarket,2023-11-16 13:08:28,"Shares of Palo Alto Networks, Inc. PANW fell in pre-market trading after reporting first-quarter results. Palo Alto Networks reported quarterly earnings of $1.38 per share, above the analyst consensus estimate of $1.16. Revenue of $1.88 billion beat the analyst consensus estimate of $1.84 billion.",VRTX,0.069495,0.087328,Neutral
Is Vertex Pharmaceuticals Stock a Buy Now?,https://www.fool.com/investing/2023/11/16/is-vertex-pharmaceuticals-stock-a-buy-now/,2023-11-16 12:45:00,The company is close to another breakthrough.,VRTX,0.357293,0.27714,Somewhat-Bullish
UK authorises gene therapy for blood disorders in world first,https://www.reuters.com/business/healthcare-pharmaceuticals/uk-authorises-gene-therapy-blood-disorders-world-first-2023-11-16/,2023-11-16 10:58:00,"A sign hangs in front of the world headquarters of Vertex Pharmaceuticals in Boston, Massachusetts, U.S., October 23, 2019. REUTERS/Brian Snyder Acquire Licensing Rights",VRTX,0.250386,0.249432,Somewhat-Bullish
U.K. Greenlights World's First Crispr Gene Editing Therapy,https://www.forbes.com/sites/roberthart/2023/11/16/uk-greenlights-worlds-first-crispr-gene-editing-therapy/,2023-11-16 10:40:50,"U.K. regulators on Thursday approved a therapy based for two blood disorders based on Crispr gene editing, the country's medicine's regulator said on Thursday, a world first for the lauded tool that has revolutionized the life sciences and is poised to transform medicine.",VRTX,0.066784,0.04657,Neutral
"After Its Stock Crashed 42% in 1 Day, Is Verve Therapeutics a Buy?",https://www.fool.com/investing/2023/11/16/after-stock-crash-1-day-verve-therapeutics-buy/,2023-11-16 10:20:00,"It reported some very bad news, but the market might be overreacting.",VRTX,0.040553,0.008862,Neutral
"Type 1 Diabetes Market to Accelerate Substantially During the Study Period  ( 2019-2032 ) , Predicts DelveInsight | Leading Companies Developing Therapies - Eli Lilly, Vertex, Bayer, Novo Nordisk, Rise, Tolerion, BioKier, Domp Farmaceutici",https://www.prnewswire.com/news-releases/type-1-diabetes-market-to-accelerate-substantially-during-the-study-period-20192032-predicts-delveinsight--leading-companies-developing-therapies---eli-lilly-vertex-bayer-novo-nordisk-rise-tolerion-biokier-dompe-farmac-301989755.html,2023-11-15 22:01:00,"Type 1 Diabetes Market to Accelerate Substantially During the Study Period ( 2019-2032 ) , Predicts DelveInsight ... PR ...",VRTX,0.052056,0.078585,Neutral
Stocks With Rising Relative Price Strength: Neurocrine Biosciences,https://www.investors.com/ibd-data-stories/stocks-with-rising-relative-price-strength-neurocrine-biosciences-3/,2023-11-15 08:00:00,"Neurocrine Biosciences ( NBIX ) had its Relative Strength ( RS ) Rating upgraded from 80 to 83 Wednesday. X As you try to find the best stocks to buy and watch, be sure to pay attention to relative price strength. IBD's unique rating measures market leadership with a 1 ( worst ) to 99 ( best ...",VRTX,0.38588,0.0,Neutral
Intra-Cellular Therapies Trying To Close In On Key Technical Benchmark,https://www.investors.com/ibd-data-stories/intra-cellular-therapies-trying-to-close-in-on-key-technical-benchmark-2/,2023-11-15 08:00:00,Intra-Cellular Therapies Trying To Close In On Key Technical ... Investor's Business Daily ...,VRTX,0.329551,0.0,Neutral
Rocket Pharmaceuticals Shows Market Leadership With Jump To 92 RS Rating,https://www.investors.com/ibd-data-stories/rocket-pharmaceuticals-shows-market-leadership-with-jump-to-92-rs-rating/,2023-11-15 08:00:00,Rocket Pharmaceuticals Shows Market Leadership With Jump To 92 ... Investor's Business Daily ...,VRTX,0.323078,0.129183,Neutral
How Is The Market Feeling About Vertex Pharmaceuticals? - Vertex Pharmaceuticals  ( NASDAQ:VRTX ) ,https://www.benzinga.com/short-sellers/23/11/35782728/how-is-the-market-feeling-about-vertex-pharmaceuticals,2023-11-14 17:00:19,"Vertex Pharmaceuticals's VRTX short percent of float has fallen 9.01% since its last report. The company recently reported that it has 2.60 million shares sold short, which is 1.01% of all regular shares that are available for trading.",VRTX,0.221819,0.083071,Neutral
Right Now Could Be a Once-in-a-Generation Opportunity to Buy These Cathie Wood Stocks,https://www.fool.com/investing/2023/11/14/opportunity-buy-cathie-wood-stocks/,2023-11-14 10:50:00,You might not get a better chance to invest in these disruptive companies.,VRTX,0.113062,0.280415,Somewhat-Bullish
2 Stocks to Buy Hand Over Fist as the S&P 500 Rockets Higher,https://www.fool.com/investing/2023/11/14/2-stocks-to-buy-hand-over-fist-as-market-rallies/,2023-11-14 10:00:00,These stocks look reasonably priced today considering their long-term prospects.,VRTX,0.057079,0.092943,Neutral
Vaxcyte Shows Market Leadership With Jump To 84 RS Rating,https://www.investors.com/ibd-data-stories/vaxcyte-shows-market-leadership-with-jump-to-84-rs-rating/,2023-11-14 08:00:00,"Vaxcyte ( PCVX ) saw a positive improvement to its Relative Strength ( RS ) Rating on Tuesday, with an upgrade from 80 to 84. X When looking for the best stocks to buy and watch, one factor to watch closely is relative price strength.",VRTX,0.358152,0.0,Neutral
Krystal Biotech Shows Rising Price Performance With Jump To 85 RS Rating,https://www.investors.com/ibd-data-stories/krystal-biotech-shows-rising-price-performance-with-jump-to-85-rs-rating/,2023-11-13 08:00:00,Krystal Biotech Shows Rising Price Performance With Jump To 85 ... Investor's Business Daily ...,VRTX,0.345674,0.0,Neutral
3 Revolutionary Stocks I'd Buy Right Now Without Hesitation,https://www.fool.com/investing/2023/11/12/3-revolutionary-stocks-id-buy-right-now-without-he/,2023-11-12 10:50:00,Most stocks aren't truly revolutionary. These really are.,VRTX,0.106541,0.206734,Somewhat-Bullish
1 No-Brainer Stock to Buy and Hold for 10 Years,https://www.fool.com/investing/2023/11/11/1-no-brainer-stock-to-buy-and-hold-for-10-years/,2023-11-11 13:30:00,This company has been in the news for much of the year.,VRTX,0.176287,-0.004422,Neutral
3 Growth Stocks to Buy Right Now Without Any Hesitation,https://www.fool.com/investing/2023/11/11/3-growth-stocks-you-can-buy-right-now-without-any/,2023-11-11 11:50:00,Investors shouldn't have to deliberate for too long about these great stocks.,VRTX,0.159305,0.197144,Somewhat-Bullish
4 First-in-Their-Class Growth Stocks You'll Regret Not Buying in the Wake of the Nasdaq Bear Market Dip,https://www.fool.com/investing/2023/11/11/nasdaq-bear-market-4-growth-stocks-regret-not-buy/,2023-11-11 10:06:00,A 15% decline in the Nasdaq Composite is a red-carpet opportunity for investors to snag high-quality growth stocks at a discount.,VRTX,0.055173,0.053434,Neutral
Amphastar Pharmaceuticals Stock Earns Composite Rating Upgrade,https://www.investors.com/news/technology/amphastar-pharmaceuticals-stock-earns-composite-rating-upgrade/,2023-11-10 20:43:00,"Amphastar Pharmaceuticals ( AMPH ) stock saw its IBD SmartSelect Composite Rating rise to 98 Friday, up from 93 the day before. The new rating shows the stock is outpacing 98% of all stocks when it comes to the most important stock-picking criteria.",VRTX,0.259727,0.0,Neutral
VRTX: Vertex Pharmaceuticals  ( VRTX )  Post-Earnings Analysis: Is It Time to Buy the Stock?,https://stocknews.com/news/vrtx-gild-otsky-cort-vertex-pharmaceuticals-vrtx-post-earnings-analysis-is-it-time-to-buy/,2023-11-10 19:29:32,VRTX: Vertex Pharmaceuticals ( VRTX ) Post-Earnings Analysis: Is It ... ...,VRTX,0.568767,0.3166,Somewhat-Bullish
Market Rally Pauses As Yields Rebound: Weekly Review,https://www.investors.com/news/stock-market-rally-pauses-as-yields-rebound-datadog-affirm-among-earnings-winners-weekly-review/,2023-11-10 12:00:00,"The stock market rally saw the Dow Jones, S&P 500 and Nasdaq snap long win streaks, slashing or erasing weekly gains. The Russell 2000 tumbled amid weak breadth. Earnings generally remained positive.",VRTX,0.070036,0.006148,Neutral
Amphastar Pharm Earns Composite Rating Upgrade,https://www.investors.com/ibd-data-stories/amphastar-pharm-earns-composite-rating-upgrade/,2023-11-10 08:00:00,"Amphastar Pharm ( AMPH ) saw its IBD SmartSelect Composite Rating rise to 98 Friday, up from 93 the day before. X The new rating shows the stock is outpacing 98% of all stocks when it comes to the most important stock-picking criteria.",VRTX,0.318897,0.0,Neutral
This Program for a Common Problem May Be Vertex Pharmaceuticals' Ticket to a New Wave of Billion-Dollar Revenues,https://www.fool.com/investing/2023/11/09/this-program-for-a-common-problem-may-be-vertex-ph/,2023-11-09 10:30:00,Vertex shares look cheap today considering all the company has to offer.,VRTX,0.112008,0.063334,Neutral
Myers Industries  ( NYSE:MYE )  Downgraded by StockNews.com to Hold,https://www.defenseworld.net/2023/11/09/myers-industries-nysemye-downgraded-by-stocknews-com-to-hold.html,2023-11-09 10:23:01,Myers Industries ( NYSE:MYE ) Downgraded by StockNews.com to ... Defense World ...,VRTX,0.081552,0.055691,Neutral
Sunstone Hotel Investors  ( NYSE:SHO )  Upgraded by StockNews.com to Hold,https://www.defenseworld.net/2023/11/09/sunstone-hotel-investors-nysesho-upgraded-by-stocknews-com-to-hold.html,2023-11-09 10:23:01,Sunstone Hotel Investors ( NYSE:SHO ) Upgraded by StockNews ... Defense World ...,VRTX,0.064449,0.161245,Somewhat-Bullish
RH  ( NYSE:RH )  Downgraded by StockNews.com to Sell,https://www.defenseworld.net/2023/11/09/rh-nyserh-downgraded-by-stocknews-com-to-sell.html,2023-11-09 10:23:00,StockNews.com cut shares of RH ( NYSE:RH - Free Report ) from a hold rating to a sell rating in a report published on Wednesday. RH has been the subject of a number of other reports.,VRTX,0.059049,0.139,Neutral
"Primerica  ( NYSE:PRI )  Upgraded to ""Buy"" by StockNews.com",https://www.defenseworld.net/2023/11/09/primerica-nysepri-upgraded-to-buy-by-stocknews-com.html,2023-11-09 10:23:00,StockNews.com upgraded shares of Primerica ( NYSE:PRI - Free Report ) from a hold rating to a buy rating in a research report report published on Wednesday.,VRTX,0.046006,0.103511,Neutral
"H&E Equipment Services  ( NASDAQ:HEES )  Downgraded by StockNews.com to ""Hold""",https://www.defenseworld.net/2023/11/09/he-equipment-services-nasdaqhees-downgraded-by-stocknews-com-to-hold.html,2023-11-09 10:20:47,H&E Equipment Services ( NASDAQ:HEES ) Downgraded by ... Defense World ...,VRTX,0.076847,0.10527,Neutral
"Sanmina  ( NASDAQ:SANM )  Downgraded by StockNews.com to ""Hold""",https://www.defenseworld.net/2023/11/09/sanmina-nasdaqsanm-downgraded-by-stocknews-com-to-hold.html,2023-11-09 10:20:47,"StockNews.com lowered shares of Sanmina ( NASDAQ:SANM - Free Report ) from a buy rating to a hold rating in a report released on Wednesday morning. Shares of NASDAQ:SANM opened at $47.13 on Wednesday. The company has a market capitalization of $2.74 billion, a P/E ratio of 9.19 and a beta of ...",VRTX,0.049629,0.169139,Somewhat-Bullish
Keysight Technologies  ( NYSE:KEYS )  Upgraded to Buy by StockNews.com,https://www.defenseworld.net/2023/11/09/keysight-technologies-nysekeys-upgraded-to-buy-by-stocknews-com.html,2023-11-09 09:51:06,Keysight Technologies ( NYSE:KEYS ) Upgraded to Buy by ... Defense World ...,VRTX,0.052112,0.102876,Neutral
"Ladder Capital  ( NYSE:LADR )  Upgraded by StockNews.com to ""Buy""",https://www.defenseworld.net/2023/11/09/ladder-capital-nyseladr-upgraded-by-stocknews-com-to-buy.html,2023-11-09 09:51:05,StockNews.com upgraded shares of Ladder Capital ( NYSE:LADR - Free Report ) from a hold rating to a buy rating in a research report sent to investors on Wednesday morning. LADR has been the subject of several other reports.,VRTX,0.078354,0.197328,Somewhat-Bullish
"Old Republic International  ( NYSE:ORI )  Upgraded by StockNews.com to ""Buy""",https://www.defenseworld.net/2023/11/09/old-republic-international-nyseori-upgraded-by-stocknews-com-to-buy.html,2023-11-09 09:51:05,Old Republic International ( NYSE:ORI ) Upgraded by StockNews ... Defense World ...,VRTX,0.069094,0.139604,Neutral
Moelis & Company  ( NYSE:MC )  Lowered to Sell at StockNews.com,https://www.defenseworld.net/2023/11/09/moelis-company-nysemc-lowered-to-sell-at-stocknews-com.html,2023-11-09 09:51:05,StockNews.com downgraded shares of Moelis & Company ( NYSE:MC - Free Report ) from a hold rating to a sell rating in a research note published on Wednesday morning.,VRTX,0.065327,0.144259,Neutral
National Health Investors  ( NYSE:NHI )  Downgraded to Hold at StockNews.com,https://www.defenseworld.net/2023/11/09/national-health-investors-nysenhi-downgraded-to-hold-at-stocknews-com.html,2023-11-09 09:51:05,National Health Investors ( NYSE:NHI ) Downgraded to Hold at ... Defense World ...,VRTX,0.059194,0.188014,Somewhat-Bullish
"Weis Markets  ( NYSE:WMK )  Upgraded to ""Strong-Buy"" by StockNews.com",https://www.defenseworld.net/2023/11/09/weis-markets-nysewmk-upgraded-to-strong-buy-by-stocknews-com.html,2023-11-09 09:51:04,"Weis Markets ( NYSE:WMK ) Upgraded to ""Strong-Buy"" by ... Defense World ...",VRTX,0.081276,0.157947,Somewhat-Bullish
Transportadora de Gas del Sur  ( NYSE:TGS )  Upgraded to Strong-Buy at StockNews.com,https://www.defenseworld.net/2023/11/09/transportadora-de-gas-del-sur-nysetgs-upgraded-to-strong-buy-at-stocknews-com.html,2023-11-09 09:51:04,Transportadora de Gas del Sur ( NYSE:TGS ) Upgraded to Strong ... Defense World ...,VRTX,0.07887,0.148046,Neutral
"Tredegar  ( NYSE:TG )  Lowered to ""Sell"" at StockNews.com",https://www.defenseworld.net/2023/11/09/tredegar-nysetg-lowered-to-sell-at-stocknews-com.html,2023-11-09 09:51:04,"StockNews.com lowered shares of Tredegar ( NYSE:TG - Free Report ) from a hold rating to a sell rating in a research note published on Wednesday. Separately, TheStreet cut Tredegar from a c rating to a d rating in a research report on Thursday, August 10th.",VRTX,0.075635,0.089305,Neutral
Occidental Petroleum  ( NYSE:OXY )  Upgraded to Hold by StockNews.com,https://www.defenseworld.net/2023/11/09/occidental-petroleum-nyseoxy-upgraded-to-hold-by-stocknews-com.html,2023-11-09 09:51:04,Occidental Petroleum ( NYSE:OXY ) Upgraded to Hold by StockNews ... Defense World ...,VRTX,0.040969,0.150618,Somewhat-Bullish
"Ocwen Financial  ( NYSE:OCN )  Downgraded to ""Sell"" at StockNews.com",https://www.defenseworld.net/2023/11/09/ocwen-financial-nyseocn-downgraded-to-sell-at-stocknews-com.html,2023-11-09 09:51:04,"Ocwen Financial ( NYSE:OCN ) Downgraded to ""Sell"" at StockNews ... Defense World ...",VRTX,0.100729,0.135449,Neutral
Clarus  ( NASDAQ:CLAR )  Lowered to Sell at StockNews.com,https://www.defenseworld.net/2023/11/09/clarus-nasdaqclar-lowered-to-sell-at-stocknews-com.html,2023-11-09 09:51:03,StockNews.com downgraded shares of Clarus ( NASDAQ:CLAR - Free Report ) from a hold rating to a sell rating in a research report sent to investors on Wednesday.,VRTX,0.055364,0.074946,Neutral
AxoGen  ( NASDAQ:AXGN )  Downgraded by StockNews.com to Hold,https://www.defenseworld.net/2023/11/09/axogen-nasdaqaxgn-downgraded-by-stocknews-com-to-hold.html,2023-11-09 09:51:03,StockNews.com lowered shares of AxoGen ( NASDAQ:AXGN - Free Report ) from a buy rating to a hold rating in a research note issued to investors on Wednesday. Other equities analysts have also recently issued reports about the stock.,VRTX,0.052685,0.001001,Neutral
"CymaBay Therapeutics  ( NASDAQ:CBAY )  Downgraded to ""Sell"" at StockNews.com",https://www.defenseworld.net/2023/11/09/cymabay-therapeutics-nasdaqcbay-downgraded-to-sell-at-stocknews-com.html,2023-11-09 09:51:03,"CymaBay Therapeutics ( NASDAQ:CBAY ) Downgraded to ""Sell"" at ... Defense World ...",VRTX,0.046273,0.139916,Neutral
Consumer Portfolio Services  ( NASDAQ:CPSS )  Upgraded to Buy at StockNews.com,https://www.defenseworld.net/2023/11/09/consumer-portfolio-services-nasdaqcpss-upgraded-to-buy-at-stocknews-com.html,2023-11-09 09:51:01,Consumer Portfolio Services ( NASDAQ:CPSS ) Upgraded to Buy at ... Defense World ...,VRTX,0.088147,0.093371,Neutral
"DLH  ( NASDAQ:DLHC )  Lowered to ""Hold"" at StockNews.com",https://www.defenseworld.net/2023/11/09/dlh-nasdaqdlhc-lowered-to-hold-at-stocknews-com.html,2023-11-09 09:50:59,StockNews.com downgraded shares of DLH ( NASDAQ:DLHC - Free Report ) from a buy rating to a hold rating in a report released on Wednesday. Shares of NASDAQ DLHC opened at $14.37 on Wednesday. DLH has a 12 month low of $9.01 and a 12 month high of $15.42.,VRTX,0.086556,0.20555,Somewhat-Bullish
"Huron Consulting Group  ( NASDAQ:HURN )  Upgraded by StockNews.com to ""Buy""",https://www.defenseworld.net/2023/11/09/huron-consulting-group-nasdaqhurn-upgraded-by-stocknews-com-to-buy.html,2023-11-09 09:50:58,Huron Consulting Group ( NASDAQ:HURN ) Upgraded by ... Defense World ...,VRTX,0.057352,0.113,Neutral
JD.com  ( NASDAQ:JD )  Upgraded to Buy by StockNews.com,https://www.defenseworld.net/2023/11/09/jd-com-nasdaqjd-upgraded-to-buy-by-stocknews-com.html,2023-11-09 09:50:56,StockNews.com upgraded shares of JD.com ( NASDAQ:JD - Free Report ) from a hold rating to a buy rating in a research report sent to investors on Wednesday.,VRTX,0.061631,0.124151,Neutral
Masimo  ( NASDAQ:MASI )  Upgraded to Hold by StockNews.com,https://www.defenseworld.net/2023/11/09/masimo-nasdaqmasi-upgraded-to-hold-by-stocknews-com.html,2023-11-09 09:50:54,StockNews.com upgraded shares of Masimo ( NASDAQ:MASI - Free Report ) from a sell rating to a hold rating in a report issued on Wednesday morning. MASI has been the subject of a number of other research reports.,VRTX,0.051999,0.081841,Neutral
"MacroGenics  ( NASDAQ:MGNX )  Upgraded to ""Buy"" at StockNews.com",https://www.defenseworld.net/2023/11/09/macrogenics-nasdaqmgnx-upgraded-to-buy-at-stocknews-com.html,2023-11-09 09:50:53,StockNews.com upgraded shares of MacroGenics ( NASDAQ:MGNX - Free Report ) from a hold rating to a buy rating in a report released on Wednesday. Several other analysts have also issued reports on the stock.,VRTX,0.056943,0.035085,Neutral
Ocular Therapeutix  ( NASDAQ:OCUL )  Downgraded by StockNews.com to Sell,https://www.defenseworld.net/2023/11/09/ocular-therapeutix-nasdaqocul-downgraded-by-stocknews-com-to-sell.html,2023-11-09 09:50:52,Ocular Therapeutix ( NASDAQ:OCUL ) Downgraded by StockNews ... Defense World ...,VRTX,0.07157,0.028685,Neutral
"Astronics  ( NASDAQ:ATRO )  Downgraded by StockNews.com to ""Hold""",https://www.defenseworld.net/2023/11/09/astronics-nasdaqatro-downgraded-by-stocknews-com-to-hold.html,2023-11-09 09:30:46,"StockNews.com cut shares of Astronics ( NASDAQ:ATRO - Free Report ) from a buy rating to a hold rating in a research note published on Wednesday. Separately, Truist Financial lifted their price objective on shares of Astronics from $15.00 to $17.00 and gave the company a hold rating in a ...",VRTX,0.093289,0.12546,Neutral
"Ascendis Pharma A/S  ( NASDAQ:ASND )  Lowered to ""Sell"" at StockNews.com",https://www.defenseworld.net/2023/11/09/ascendis-pharma-a-s-nasdaqasnd-lowered-to-sell-at-stocknews-com.html,2023-11-09 09:30:44,"Ascendis Pharma A/S ( NASDAQ:ASND ) Lowered to ""Sell"" at ... Defense World ...",VRTX,0.058047,0.080049,Neutral
"Federal Signal  ( NYSE:FSS )  Lifted to ""Buy"" at StockNews.com",https://www.defenseworld.net/2023/11/09/federal-signal-nysefss-lifted-to-buy-at-stocknews-com-2.html,2023-11-09 09:20:50,"Federal Signal ( NYSE:FSS - Get Free Report ) was upgraded by analysts at StockNews.com from a ""hold"" rating to a ""buy"" rating in a research report issued to clients and investors on Thursday. Other equities analysts have also recently issued research reports about the stock.",VRTX,0.08687,0.126279,Neutral
BeiGene  ( NASDAQ:BGNE )  Stock Rating Upgraded by StockNews.com,https://www.defenseworld.net/2023/11/09/beigene-nasdaqbgne-stock-rating-upgraded-by-stocknews-com.html,2023-11-09 08:29:07,"BeiGene ( NASDAQ:BGNE - Get Free Report ) was upgraded by stock analysts at StockNews.com from a ""sell"" rating to a ""hold"" rating in a research report issued to clients and investors on Thursday.",VRTX,0.064797,0.071335,Neutral
RBC Bearings  ( NASDAQ:ROLL )  Receives New Coverage from Analysts at StockNews.com,https://www.defenseworld.net/2023/11/09/rbc-bearings-nasdaqroll-receives-new-coverage-from-analysts-at-stocknews-com-2.html,2023-11-09 08:29:06,RBC Bearings ( NASDAQ:ROLL ) Receives New Coverage from ... Defense World ...,VRTX,0.085629,0.00208,Neutral
Fluent  ( NASDAQ:FLNT )  Earns Hold Rating from Analysts at StockNews.com,https://www.defenseworld.net/2023/11/09/fluent-nasdaqflnt-earns-hold-rating-from-analysts-at-stocknews-com.html,2023-11-09 08:29:06,Fluent ( NASDAQ:FLNT ) Earns Hold Rating from Analysts at ... Defense World ...,VRTX,0.080458,0.087627,Neutral
Xperi  ( NASDAQ:XPER )  Lifted to Hold at StockNews.com,https://www.defenseworld.net/2023/11/09/xperi-nasdaqxper-lifted-to-hold-at-stocknews-com.html,2023-11-09 08:29:06,"Xperi ( NASDAQ:XPER - Get Free Report ) was upgraded by research analysts at StockNews.com from a ""sell"" rating to a ""hold"" rating in a research note issued on Thursday. Separately, Rosenblatt Securities restated a ""buy"" rating and set a $15.00 price target on shares of Xperi in a report on ...",VRTX,0.068112,0.189829,Somewhat-Bullish
StockNews.com Begins Coverage on Biocept  ( NASDAQ:BIOC ) ,https://www.defenseworld.net/2023/11/09/stocknews-com-begins-coverage-on-biocept-nasdaqbioc.html,2023-11-09 08:29:06,"Analysts at StockNews.com began coverage on shares of Biocept ( NASDAQ:BIOC - Get Free Report ) in a research note issued to investors on Thursday. The firm set a ""hold"" rating on the medical research company's stock. Biocept has a 52-week low of $0.32 and a 52-week high of $27.00.",VRTX,0.136113,-0.062271,Neutral
Nabriva Therapeutics  ( NASDAQ:NBRV )  Research Coverage Started at StockNews.com,https://www.defenseworld.net/2023/11/09/nabriva-therapeutics-nasdaqnbrv-research-coverage-started-at-stocknews-com.html,2023-11-09 08:29:06,Nabriva Therapeutics ( NASDAQ:NBRV ) Research Coverage Started ... Defense World ...,VRTX,0.117486,0.068268,Neutral
Old Point Financial  ( NASDAQ:OPOF )  Receives New Coverage from Analysts at StockNews.com,https://www.defenseworld.net/2023/11/09/old-point-financial-nasdaqopof-receives-new-coverage-from-analysts-at-stocknews-com.html,2023-11-09 08:29:05,Old Point Financial ( NASDAQ:OPOF ) Receives New Coverage from ... Defense World ...,VRTX,0.077845,0.036694,Neutral
Host Hotels & Resorts  ( NASDAQ:HST )  Rating Increased to Hold at StockNews.com,https://www.defenseworld.net/2023/11/09/host-hotels-resorts-nasdaqhst-rating-increased-to-hold-at-stocknews-com.html,2023-11-09 08:29:05,Host Hotels & Resorts ( NASDAQ:HST ) Rating Increased to Hold at ... Defense World ...,VRTX,0.063258,0.130474,Neutral
AtriCure  ( NASDAQ:ATRC )  Upgraded at StockNews.com,https://www.defenseworld.net/2023/11/09/atricure-nasdaqatrc-upgraded-at-stocknews-com.html,2023-11-09 08:29:05,"AtriCure ( NASDAQ:ATRC - Get Free Report ) was upgraded by StockNews.com from a ""sell"" rating to a ""hold"" rating in a note issued to investors on Thursday. ATRC has been the subject of a number of other research reports.",VRTX,0.056808,0.05899,Neutral
Qualtrics International  ( BATS:XM )  Research Coverage Started at StockNews.com,https://www.defenseworld.net/2023/11/09/qualtrics-international-batsxm-research-coverage-started-at-stocknews-com-2.html,2023-11-09 08:29:05,Qualtrics International ( BATS:XM ) Research Coverage Started at ... Defense World ...,VRTX,0.197413,0.302543,Somewhat-Bullish
SemiLEDs  ( NASDAQ:LEDS )  Now Covered by StockNews.com,https://www.defenseworld.net/2023/11/09/semileds-nasdaqleds-now-covered-by-stocknews-com.html,2023-11-09 08:29:05,"Research analysts at StockNews.com assumed coverage on shares of SemiLEDs ( NASDAQ:LEDS - Get Free Report ) in a research report issued on Thursday. The brokerage set a ""sell"" rating on the semiconductor company's stock. Shares of LEDS stock opened at $1.20 on Thursday.",VRTX,0.108958,0.253587,Somewhat-Bullish
TRX Gold  ( NYSE:TRX )  Coverage Initiated at StockNews.com,https://www.defenseworld.net/2023/11/09/trx-gold-nysetrx-coverage-initiated-at-stocknews-com.html,2023-11-09 08:29:05,"Equities research analysts at StockNews.com began coverage on shares of TRX Gold ( NYSE:TRX - Get Free Report ) in a research report issued on Thursday. The firm set a ""hold"" rating on the stock. Separately, HC Wainwright lifted their price target on TRX Gold from $1.10 to $1.30 in a research ...",VRTX,0.104228,0.294644,Somewhat-Bullish
Origin Agritech  ( NASDAQ:SEED )  Now Covered by Analysts at StockNews.com,https://www.defenseworld.net/2023/11/09/origin-agritech-nasdaqseed-now-covered-by-analysts-at-stocknews-com-2.html,2023-11-09 08:29:04,Origin Agritech ( NASDAQ:SEED ) Now Covered by Analysts at ... Defense World ...,VRTX,0.09989,0.085154,Neutral
Great Lakes Dredge & Dock  ( NASDAQ:GLDD )  Upgraded to Hold at StockNews.com,https://www.defenseworld.net/2023/11/09/great-lakes-dredge-dock-nasdaqgldd-upgraded-to-hold-at-stocknews-com.html,2023-11-09 08:29:04,Great Lakes Dredge & Dock ( NASDAQ:GLDD ) Upgraded to Hold at ... Defense World ...,VRTX,0.086245,0.128671,Neutral
Orion Energy Systems  ( NASDAQ:OESX )  Coverage Initiated at StockNews.com,https://www.defenseworld.net/2023/11/09/orion-energy-systems-nasdaqoesx-coverage-initiated-at-stocknews-com.html,2023-11-09 08:29:04,Orion Energy Systems ( NASDAQ:OESX ) Coverage Initiated at ... Defense World ...,VRTX,0.076358,0.158029,Somewhat-Bullish
MEI Pharma  ( NASDAQ:MEIP )  Research Coverage Started at StockNews.com,https://www.defenseworld.net/2023/11/09/mei-pharma-nasdaqmeip-research-coverage-started-at-stocknews-com.html,2023-11-09 08:29:04,MEI Pharma ( NASDAQ:MEIP ) Research Coverage Started at ... Defense World ...,VRTX,0.065866,0.010065,Neutral
Digital Ally  ( NASDAQ:DGLY )  Earns Sell Rating from Analysts at StockNews.com,https://www.defenseworld.net/2023/11/09/digital-ally-nasdaqdgly-earns-sell-rating-from-analysts-at-stocknews-com.html,2023-11-09 08:29:04,Digital Ally ( NASDAQ:DGLY ) Earns Sell Rating from Analysts at ... Defense World ...,VRTX,0.105141,0.109513,Neutral
StockNews.com Lowers LSB Industries  ( NYSE:LXU )  to Hold,https://www.defenseworld.net/2023/11/09/stocknews-com-lowers-lsb-industries-nyselxu-to-hold.html,2023-11-09 08:20:43,"LSB Industries ( NYSE:LXU - Get Free Report ) was downgraded by research analysts at StockNews.com from a ""buy"" rating to a ""hold"" rating in a report issued on Thursday. Separately, TheStreet lowered shares of LSB Industries from a ""b-"" rating to a ""c"" rating in a research report on Thursday, ...",VRTX,0.08687,0.074046,Neutral
Regis  ( NYSE:RGS )  Upgraded by StockNews.com to Hold,https://www.defenseworld.net/2023/11/09/regis-nysergs-upgraded-by-stocknews-com-to-hold.html,2023-11-09 08:20:43,"Regis ( NYSE:RGS - Get Free Report ) was upgraded by StockNews.com from a ""sell"" rating to a ""hold"" rating in a research note issued on Thursday. NYSE RGS opened at $0.47 on Thursday. Regis has a fifty-two week low of $0.47 and a fifty-two week high of $1.85.",VRTX,0.077593,0.188515,Somewhat-Bullish
New York Times  ( NYSE:NYT )  Rating Lowered to Hold at StockNews.com,https://www.defenseworld.net/2023/11/09/new-york-times-nysenyt-rating-lowered-to-hold-at-stocknews-com-2.html,2023-11-09 08:20:43,New York Times ( NYSE:NYT ) Rating Lowered to Hold at StockNews ... Defense World ...,VRTX,0.052112,0.103809,Neutral
Navios Maritime  ( NYSE:NM )  Earns Hold Rating from Analysts at StockNews.com,https://www.defenseworld.net/2023/11/09/navios-maritime-nysenm-earns-hold-rating-from-analysts-at-stocknews-com.html,2023-11-09 08:20:42,Navios Maritime ( NYSE:NM ) Earns Hold Rating from Analysts at ... Defense World ...,VRTX,0.085629,0.054331,Neutral
StockNews.com Initiates Coverage on Textainer Group  ( NYSE:TGH ) ,https://www.defenseworld.net/2023/11/09/stocknews-com-initiates-coverage-on-textainer-group-nysetgh.html,2023-11-09 08:20:42,"Analysts at StockNews.com initiated coverage on shares of Textainer Group ( NYSE:TGH - Get Free Report ) in a research report issued to clients and investors on Thursday. The firm set a ""hold"" rating on the transportation company's stock. Other research analysts also recently issued reports ...",VRTX,0.085324,0.049033,Neutral
StockNews.com Initiates Coverage on Navios Maritime  ( NYSE:NM ) ,https://www.defenseworld.net/2023/11/09/stocknews-com-initiates-coverage-on-navios-maritime-nysenm-2.html,2023-11-09 08:20:42,"Research analysts at StockNews.com initiated coverage on shares of Navios Maritime ( NYSE:NM - Get Free Report ) in a report released on Thursday. The firm set a ""hold"" rating on the shipping company's stock. Shares of NYSE:NM opened at $2.22 on Thursday.",VRTX,0.085022,0.067615,Neutral
Comstock  ( NYSE:LODE )  Receives New Coverage from Analysts at StockNews.com,https://www.defenseworld.net/2023/11/09/comstock-nyselode-receives-new-coverage-from-analysts-at-stocknews-com-2.html,2023-11-09 08:20:42,Comstock ( NYSE:LODE ) Receives New Coverage from Analysts at ... Defense World ...,VRTX,0.084127,0.132257,Neutral
PEDEVCO  ( NYSE:PED )  Now Covered by Analysts at StockNews.com,https://www.defenseworld.net/2023/11/09/pedevco-nyseped-now-covered-by-analysts-at-stocknews-com.html,2023-11-09 08:20:42,"StockNews.com began coverage on shares of PEDEVCO ( NYSE:PED - Get Free Report ) in a report issued on Thursday. The firm set a ""sell"" rating on the stock. PEDEVCO stock opened at $0.86 on Thursday. The stock has a market capitalization of $75.25 million, a price-to-earnings ratio of 28.83 and ...",VRTX,0.150592,0.231966,Somewhat-Bullish
Textainer Group  ( NYSE:TGH )  Coverage Initiated at StockNews.com,https://www.defenseworld.net/2023/11/09/textainer-group-nysetgh-coverage-initiated-at-stocknews-com.html,2023-11-09 08:20:41,"Equities research analysts at StockNews.com began coverage on shares of Textainer Group ( NYSE:TGH - Get Free Report ) in a report released on Thursday. The brokerage set a ""hold"" rating on the transportation company's stock. TGH has been the subject of several other research reports. B.",VRTX,0.084127,0.083633,Neutral
Regis  ( NYSE:RGS )  Raised to Hold at StockNews.com,https://www.defenseworld.net/2023/11/09/regis-nysergs-raised-to-hold-at-stocknews-com.html,2023-11-09 08:20:41,"Regis ( NYSE:RGS - Get Free Report ) was upgraded by investment analysts at StockNews.com from a ""sell"" rating to a ""hold"" rating in a research report issued to clients and investors on Thursday. Shares of NYSE:RGS opened at $0.47 on Thursday.",VRTX,0.082111,0.21406,Somewhat-Bullish
Teck Resources  ( NYSE:TECK )  Earns Hold Rating from Analysts at StockNews.com,https://www.defenseworld.net/2023/11/09/teck-resources-nyseteck-earns-hold-rating-from-analysts-at-stocknews-com.html,2023-11-09 08:20:41,Teck Resources ( NYSE:TECK ) Earns Hold Rating from Analysts at ... Defense World ...,VRTX,0.064797,0.119357,Neutral
Teck Resources  ( NYSE:TECK )  Coverage Initiated by Analysts at StockNews.com,https://www.defenseworld.net/2023/11/09/teck-resources-nyseteck-coverage-initiated-by-analysts-at-stocknews-com.html,2023-11-09 08:20:41,Teck Resources ( NYSE:TECK ) Coverage Initiated by Analysts at ... Defense World ...,VRTX,0.064623,0.085361,Neutral
"Banco Santander-Chile  ( NYSE:BSAC )  Downgraded by StockNews.com to ""Sell""",https://www.defenseworld.net/2023/11/09/banco-santander-chile-nysebsac-downgraded-by-stocknews-com-to-sell.html,2023-11-09 08:18:45,Banco Santander-Chile ( NYSE:BSAC ) Downgraded by StockNews ... Defense World ...,VRTX,0.066414,0.160425,Somewhat-Bullish
CACI International  ( NYSE:CACI )  Stock Rating Upgraded by StockNews.com,https://www.defenseworld.net/2023/11/09/caci-international-nysecaci-stock-rating-upgraded-by-stocknews-com-2.html,2023-11-09 08:18:45,CACI International ( NYSE:CACI ) Stock Rating Upgraded by ... Defense World ...,VRTX,0.053749,0.180782,Somewhat-Bullish
Hess  ( NYSE:HES )  Receives New Coverage from Analysts at StockNews.com,https://www.defenseworld.net/2023/11/09/hess-nysehes-receives-new-coverage-from-analysts-at-stocknews-com-3.html,2023-11-09 08:18:45,Hess ( NYSE:HES ) Receives New Coverage from Analysts at ... Defense World ...,VRTX,0.052112,0.146921,Neutral
HP  ( NYSE:HPQ )  Downgraded to Buy at StockNews.com,https://www.defenseworld.net/2023/11/09/hp-nysehpq-downgraded-to-buy-at-stocknews-com.html,2023-11-09 08:18:45,"HP ( NYSE:HPQ - Get Free Report ) was downgraded by StockNews.com from a ""strong-buy"" rating to a ""buy"" rating in a research report issued to clients and investors on Thursday. Other equities research analysts have also recently issued research reports about the company.",VRTX,0.046999,0.061299,Neutral
"CEMEX  ( NYSE:CX )  Raised to ""Strong-Buy"" at StockNews.com",https://www.defenseworld.net/2023/11/09/cemex-nysecx-raised-to-strong-buy-at-stocknews-com.html,2023-11-09 08:18:44,"CEMEX ( NYSE:CX - Get Free Report ) was upgraded by equities research analysts at StockNews.com from a ""buy"" rating to a ""strong-buy"" rating in a research report issued on Thursday.",VRTX,0.087503,0.035778,Neutral
StockNews.com Initiates Coverage on Mastech Digital  ( NYSEAMERICAN:MHH ) ,https://www.defenseworld.net/2023/11/09/stocknews-com-initiates-coverage-on-mastech-digital-nyseamericanmhh.html,2023-11-09 08:18:44,StockNews.com Initiates Coverage on Mastech Digital ... Defense World ...,VRTX,0.084127,0.079814,Neutral
StockNews.com Begins Coverage on iPower  ( NYSE:IPW ) ,https://www.defenseworld.net/2023/11/09/stocknews-com-begins-coverage-on-ipower-nyseipw-2.html,2023-11-09 08:18:44,"Stock analysts at StockNews.com assumed coverage on shares of iPower ( NYSE:IPW - Get Free Report ) in a report issued on Thursday. The brokerage set a ""hold"" rating on the stock. NYSE IPW opened at $0.60 on Thursday. iPower has a 52 week low of $0.35 and a 52 week high of $1.45.",VRTX,0.082963,0.095619,Neutral
"Haverty Furniture Companies  ( NYSE:HVT )  Lifted to ""Buy"" at StockNews.com",https://www.defenseworld.net/2023/11/09/haverty-furniture-companies-nysehvt-lifted-to-buy-at-stocknews-com.html,2023-11-09 08:18:44,"Haverty Furniture Companies ( NYSE:HVT ) Lifted to ""Buy"" at ... Defense World ...",VRTX,0.078099,0.130907,Neutral
"Greenhill & Co., Inc.  ( NYSE:GHL )  Now Covered by StockNews.com",https://www.defenseworld.net/2023/11/09/greenhill-co-inc-nyseghl-now-covered-by-stocknews-com.html,2023-11-09 08:18:44,"Analysts at StockNews.com assumed coverage on shares of Greenhill & Co., Inc. ( NYSE:GHL - Get Free Report ) in a note issued to investors on Thursday. The brokerage set a ""hold"" rating on the financial services provider's stock.",VRTX,0.077845,0.038617,Neutral
Jefferies Financial Group  ( NYSE:JEF )  Stock Rating Lowered by StockNews.com,https://www.defenseworld.net/2023/11/09/jefferies-financial-group-nysejef-stock-rating-lowered-by-stocknews-com.html,2023-11-09 08:18:44,Jefferies Financial Group ( NYSE:JEF ) Stock Rating Lowered by ... Defense World ...,VRTX,0.053992,0.092928,Neutral
StockNews.com Lowers Jefferies Financial Group  ( NYSE:JEF )  to Sell,https://www.defenseworld.net/2023/11/09/stocknews-com-lowers-jefferies-financial-group-nysejef-to-sell.html,2023-11-09 08:18:44,"Jefferies Financial Group ( NYSE:JEF - Get Free Report ) was downgraded by StockNews.com from a ""hold"" rating to a ""sell"" rating in a note issued to investors on Thursday.",VRTX,0.05339,0.093899,Neutral
Holly Energy Partners  ( NYSE:HEP )  Now Covered by Analysts at StockNews.com,https://www.defenseworld.net/2023/11/09/holly-energy-partners-nysehep-now-covered-by-analysts-at-stocknews-com-2.html,2023-11-09 08:18:43,Holly Energy Partners ( NYSE:HEP ) Now Covered by Analysts at ... Defense World ...,VRTX,0.079921,0.009302,Neutral
American Realty Investors  ( NYSE:ARL )  Coverage Initiated at StockNews.com,https://www.defenseworld.net/2023/11/09/american-realty-investors-nysearl-coverage-initiated-at-stocknews-com.html,2023-11-09 08:18:43,American Realty Investors ( NYSE:ARL ) Coverage Initiated at ... Defense World ...,VRTX,0.075635,0.099021,Neutral
Equinor ASA  ( NYSE:EQNR )  Upgraded to Buy by StockNews.com,https://www.defenseworld.net/2023/11/09/equinor-asa-nyseeqnr-upgraded-to-buy-by-stocknews-com.html,2023-11-09 08:18:43,"Equinor ASA ( NYSE:EQNR - Get Free Report ) was upgraded by research analysts at StockNews.com from a ""hold"" rating to a ""buy"" rating in a report issued on Thursday. A number of other equities analysts have also weighed in on the stock.",VRTX,0.070517,0.226659,Somewhat-Bullish
CEMEX  ( NYSE:CX )  Stock Rating Upgraded by StockNews.com,https://www.defenseworld.net/2023/11/09/cemex-nysecx-stock-rating-upgraded-by-stocknews-com.html,2023-11-09 08:18:43,"CEMEX ( NYSE:CX - Get Free Report ) was upgraded by stock analysts at StockNews.com from a ""buy"" rating to a ""strong-buy"" rating in a report issued on Thursday. A number of other research firms have also weighed in on CX. Barclays raised their price target on shares of CEMEX from $8.00 to $9.00 ...",VRTX,0.068306,0.013152,Neutral
Equinor ASA  ( NYSE:EQNR )  Upgraded at StockNews.com,https://www.defenseworld.net/2023/11/09/equinor-asa-nyseeqnr-upgraded-at-stocknews-com.html,2023-11-09 08:18:43,"Equinor ASA ( NYSE:EQNR - Get Free Report ) was upgraded by analysts at StockNews.com from a ""hold"" rating to a ""buy"" rating in a note issued to investors on Thursday. EQNR has been the subject of a number of other reports.",VRTX,0.062926,0.210269,Somewhat-Bullish
HP  ( NYSE:HPQ )  Downgraded by StockNews.com,https://www.defenseworld.net/2023/11/09/hp-nysehpq-downgraded-by-stocknews-com.html,2023-11-09 08:18:43,"HP ( NYSE:HPQ - Get Free Report ) was downgraded by equities research analysts at StockNews.com from a ""strong-buy"" rating to a ""buy"" rating in a research note issued to investors on Thursday.",VRTX,0.045224,0.102342,Neutral
"Global Payments  ( NYSE:GPN )  Lifted to ""Buy"" at StockNews.com",https://www.defenseworld.net/2023/11/09/global-payments-nysegpn-lifted-to-buy-at-stocknews-com.html,2023-11-09 08:18:43,"Global Payments ( NYSE:GPN - Get Free Report ) was upgraded by equities research analysts at StockNews.com from a ""hold"" rating to a ""buy"" rating in a research report issued to clients and investors on Thursday.",VRTX,0.044386,0.120912,Neutral
TG Therapeutics Shows Rising Price Performance With Jump To 81 RS Rating,https://www.investors.com/ibd-data-stories/tg-therapeutics-shows-rising-price-performance-with-jump-to-81-rs-rating/,2023-11-09 08:00:00,TG Therapeutics Shows Rising Price Performance With Jump To 81 ... Investor's Business Daily ...,VRTX,0.353059,0.0,Neutral
1 Gene Therapy Stock to Buy and Hold for the Long Haul,https://www.fool.com/investing/2023/11/08/1-gene-therapy-stock-to-buy-and-hold-for-the-long/,2023-11-08 15:15:00,The biotech has what it takes to overcome recent obstacles.,VRTX,0.060694,0.269104,Somewhat-Bullish
Why CRISPR Therapeutics Stock Could Be About to Take Off,https://www.fool.com/investing/2023/11/08/why-crispr-therapeutics-could-be-about-to-take-off/,2023-11-08 15:07:00,CRISPR's financial prospects could soon get an upgrade.,VRTX,0.071784,0.079647,Neutral
Should You Invest in the Invesco Biotechnology & Genome ETF  ( PBE ) ?,https://www.zacks.com/stock/news/2180608/should-you-invest-in-the-invesco-biotechnology-genome-etf-pbe,2023-11-08 11:20:04,Sector ETF report for ...,VRTX,0.129168,0.070052,Neutral
4 Reasons to Worry About Vertex Pharmaceuticals -- Debunked,https://www.fool.com/investing/2023/11/08/4-reasons-to-worry-about-vertex-pharmaceuticals-de/,2023-11-08 10:50:00,No biotech stock is worry-free. But investors shouldn't fret about these four issues for Vertex.,VRTX,0.09402,-0.061609,Neutral
These Analysts Revise Their Forecasts On Vertex Pharmaceuticals After Q3 Results - Vertex Pharmaceuticals  ( NASDAQ:VRTX ) ,https://www.benzinga.com/news/earnings/23/11/35654688/these-analysts-revise-their-forecasts-on-vertex-pharmaceuticals-after-q3-results,2023-11-07 18:36:49,"Vertex Pharmaceuticals Incorporated VRTX reported upbeat earnings for its third quarter, while sales missed estimates. Vertex Pharmaceuticals posted adjusted earnings of $4.08 per share, beating market estimates of $3.98 per share.",VRTX,0.944494,0.06817,Neutral
Dow Jones Climbs Despite Renewed Fed Rate Fears; Netflix Raises Prices As Disney Looms,https://www.investors.com/market-trend/stock-market-today/dow-jones-paused-as-fed-rate-fears-return-netflix-raises-prices-for-holidays-as-disney-looms/,2023-11-07 16:21:00,Dow Jones Climbs Despite Renewed Fed Rate Fears. Netflix Raises ... Investor's Business Daily ...,VRTX,0.105604,0.071812,Neutral
CRISPR Therapeutics  ( CRSP )  Q3 Loss Narrower Than Expected,https://www.zacks.com/stock/news/2180153/crispr-therapeutics-crsp-q3-loss-narrower-than-expected,2023-11-07 15:11:00,CRISPR Therapeutics (CRSP) beats the mark for earnings and misses the same for sales in the third quarter.,VRTX,0.164656,-0.067048,Neutral
"Vertex  ( VRTX )  Q3 Earnings Beat, Sales Miss, Raises '23 View",https://www.zacks.com/stock/news/2179872/vertex-vrtx-q3-earnings-beat-sales-miss-raises-23-view,2023-11-07 12:50:00,Vertex's (VRTX) third-quarter results reflect a year-over-year increase in revenues. The company raises its net product sales guidance for 2023.,VRTX,0.219147,0.023976,Neutral
"S&P 500, Nasdaq Set To Break 6-Day Rally Today? Traders Await Fed Cues, Analyst Says Seasonal Rally Has Started With Gusto - Celsius Holdings  ( NASDAQ:CELH ) , Matterport  ( NASDAQ:MTTR ) , Choice Hotels Intl  ( NYSE:CHH ) , TripAdvisor  ( NASDAQ:TRIP ) ",https://www.benzinga.com/news/earnings/23/11/35640681/s-p-500-nasdaq-set-to-break-6-day-rally-today-traders-await-fed-cues-analyst-says-seasonal-rally-ha,2023-11-07 12:15:27,"Sentiment appears to have dipped after a six-session winning streak. Stock futures indicate a modestly lower opening on Tuesday as small and mid-cap earnings reports gain momentum. Reaction to earnings has been mixed, adding to the prevailing uncertainty.",VRTX,0.075635,0.051467,Neutral
Verve Therapeutics Highlights Recent Company Progress and Reports Third Quarter 2023 Financial Results,https://www.globenewswire.com/news-release/2023/11/07/2774849/0/en/Verve-Therapeutics-Highlights-Recent-Company-Progress-and-Reports-Third-Quarter-2023-Financial-Results.html,2023-11-07 11:30:00,U.S. Food and Drug Administration ( FDA ) Clears Investigational New Drug Application for VERVE-101 in Patients with Heterozygous Familial Hypercholesterolemia ...,VRTX,0.02018,0.032129,Neutral
Vertex Pharmaceuticals  ( VRTX )  Q3 2023 Earnings Call Transcript,https://www.fool.com/earnings/call-transcripts/2023/11/07/vertex-pharmaceuticals-vrtx-q3-2023-earnings-call/,2023-11-07 06:15:36,"VRTX earnings call for the period ending September 30, 2023.",VRTX,0.004908,0.20039,Somewhat-Bullish
2 Biotech Stocks That Could Soar in December,https://www.fool.com/investing/2023/11/26/2-biotech-stocks-that-could-soar-in-december/,2023-11-26 21:44:00,These two biotechs have important catalysts coming up in December.,VRTX,0.077845,0.136968,Neutral
2 Healthcare Stocks That Could Help Set You Up for Life,https://www.fool.com/investing/2023/11/25/2-healthcare-stocks-that-could-help-set-you-up-for/,2023-11-25 12:00:00,Both companies are leaders in their fields.,VRTX,0.180685,0.192267,Somewhat-Bullish
Investing in These 3 Stocks Now Could Make You a Millionaire Retiree,https://www.fool.com/investing/2023/11/25/investing-in-these-3-stocks-now-could-make-you-a-m/,2023-11-25 10:50:00,These innovators should have tremendous long-term growth prospects.,VRTX,0.051663,0.137476,Neutral
4 First-Class Growth Stocks You'll Regret Not Buying in the Wake of the Nasdaq Bear Market Dip,https://www.fool.com/investing/2023/11/25/nasdaq-bear-market-4-growth-stocks-regret-not-buy/,2023-11-25 10:06:00,"The innovation-fueled Nasdaq Composite is still 11% below its all-time high, which means bargains abound for opportunistic investors.",VRTX,0.053509,-0.001007,Neutral
CRISPR  ( CRSP )  Rises More Than 40% in Past 3 Months: Here's Why,https://www.zacks.com/stock/news/2189212/crispr-crsp-rises-more-than-40-in-past-3-months-heres-why,2023-11-24 16:50:00,"CRISPR (CRSP) expects a potential approval for its gene-edited therapy, Casgevy (exa-cel) in the United States for treating two debilitating blood disorders. The drug has been recently approved in the United Kingdom.",VRTX,0.123844,-0.07445,Neutral
Vertex  ( VRTX )  Gets EU Nod for Kaftrio Use in 2-5 Year Kids,https://www.zacks.com/stock/news/2189211/vertex-vrtx-gets-eu-nod-for-kaftrio-use-in-2-5-year-kids,2023-11-24 16:48:00,The European Commission approves Vertex's (VRTX) Kaftrio for expanded use to treat children aged two to five years with cystic fibrosis.,VRTX,0.20698,0.151862,Somewhat-Bullish
"Zacks Industry Outlook Highlights Gilead Sciences, CRISPR Therapeutics, ACADIA Pharmaceuticals, Dynavax and Ligand Pharmaceuticals",https://www.zacks.com/stock/news/2188966/zacks-industry-outlook-highlights-gilead-sciences-crispr-therapeutics-acadia-pharmaceuticals-dynavax-and-ligand-pharmaceuticals,2023-11-24 14:10:00,"Gilead Sciences, CRISPR Therapeutics, ACADIA Pharmaceuticals, Dynavax and Ligand Pharmaceuticals are part of the Zacks Industry Outlook article.",VRTX,0.021388,0.171316,Somewhat-Bullish
VRTX: 3 Safe Biotech Stocks to Buy This Week,https://stocknews.com/news/vrtx-inva-acor-crsp-3-safe-biotech-stocks-to-buy-this-week/,2023-11-24 12:56:32,"With the rising prevalence of chronic diseases worldwide, increased healthcare spending, favorable government policies and funding, and growing adoption of advanced technologies, demand for innovative drugs and treatments has been rising considerably, boosting the biotech industry's outlook.",VRTX,0.230673,0.167775,Somewhat-Bullish
Gene Editing Will Change Medicine-and Maybe Health Investing Too,https://www.wsj.com/tech/biotech/gene-editing-changing-medicine-9cc02c7e,2023-11-24 12:00:00,"The first treatment based on the Nobel Prize-winning Crispr technology is poised to win FDA approval next month, offering hope to patients and opportunities to investors.",VRTX,0.282234,0.266533,Somewhat-Bullish
Prediction: 3 Stocks That Could Trounce the Market,https://www.fool.com/investing/2023/11/23/prediction-3-stocks-that-could-trounce-the-market/,2023-11-23 10:50:00,These stocks have what it takes to be huge winners over the next several years.,VRTX,0.107736,0.160235,Somewhat-Bullish
5 Biotech Stocks Likely to Thrive as Industry Prospects Look Bright,https://www.zacks.com/commentary/2187656/5-biotech-stocks-likely-to-thrive-as-industry-prospects-look-bright,2023-11-22 13:07:00,"New drug approvals and pipeline progress are likely to help maintain momentum for the Zacks Biomedical and Genetics industry. A strong portfolio and solid pipeline progress position GILD, CRSP, ACAD, DVAX and LGND well amid volatility.",VRTX,0.022326,0.172148,Somewhat-Bullish
New ETF invested in Ozempic maker and exposed to other obesity drugs falls in first day of trade,https://www.marketwatch.com/story/new-etf-invested-in-ozempic-maker-and-exposed-to-other-obesity-drugs-falls-in-first-day-of-trade-a489a9b0,2023-11-22 13:01:00,The new Tema Cardiovascular and Metabolic ETF fell in its first day of trade. It is exposed to weight-loss drugs including Ozempic.,VRTX,0.690822,0.056772,Neutral
Is CRISPR Therapeutics the Best Gene-Editing Stock?,https://www.fool.com/investing/2023/11/22/is-crispr-therapeutics-the-best-gene-editing-stock/,2023-11-22 12:30:00,The biotech's first-mover advantage bodes well for its long-term prospects.,VRTX,0.075043,-0.004045,Neutral
3 Biotech Stocks That Could Be Millionaire Makers,https://www.fool.com/investing/2023/11/22/3-biotech-stocks-that-could-be-millionaire-makers/,2023-11-22 10:30:00,Many biotech stocks offer exciting long-term growth prospects.,VRTX,0.054983,0.060844,Neutral
ROIV: Is Roivant Sciences  ( ROIV )  the Right Biotech Stock for Your Portfolio?,https://stocknews.com/news/roiv-incy-otsky-vrtx-is-roivant-sciences-roiv-the-right-biotech-stock-for-your/,2023-11-21 18:33:24,ROIV: Is Roivant Sciences ( ROIV ) the Right Biotech Stock for Your ... ...,VRTX,0.057698,0.172997,Somewhat-Bullish
Here's How Much $100 Invested In Vertex Pharmaceuticals 20 Years Ago Would Be Worth Today - Vertex Pharmaceuticals  ( NASDAQ:VRTX ) ,https://www.benzinga.com/news/23/11/35902459/heres-how-much-100-invested-in-vertex-pharmaceuticals-20-years-ago-would-be-worth-today,2023-11-21 18:00:29,"Vertex Pharmaceuticals VRTX has outperformed the market over the past 20 years by 12.8% on an annualized basis producing an average annual return of 20.31%. Currently, Vertex Pharmaceuticals has a market capitalization of $92.18 billion.",VRTX,0.980595,0.386944,Bullish
"The Zacks Analyst Blog Highlights Procter & Gamble, Novartis, Mondelez International, Elevance Health and Vertex Pharmaceuticals",https://www.zacks.com/stock/news/2187287/the-zacks-analyst-blog-highlights-procter-gamble-novartis-mondelez-international-elevance-health-and-vertex-pharmaceuticals,2023-11-21 14:48:00,"Procter & Gamble, Novartis, Mondelez International, Elevance Health and Vertex Pharmaceuticals are part of the Zacks top Analyst Blog.",VRTX,0.166169,0.041787,Neutral
These Stocks Are Exploding In November Rally,https://www.investors.com/research/these-stocks-explode-in-november-stock-market-rally/,2023-11-21 13:00:00,The November stock market rally is picking up steam and expanding into more than just the Magnificent Seven stocks. We created an IBD MarketSmith screen that identified stocks that rocked the most in the past month. Each has gained over 50% for the month.,VRTX,0.143843,0.233455,Somewhat-Bullish
Vertex  ( VRTX )  Non-Cystic Fibrosis Pipeline Boosts Stock This Year,https://www.zacks.com/stock/news/2187003/vertex-vrtx-non-cystic-fibrosis-pipeline-boosts-stock-this-year,2023-11-21 11:00:00,"Vertex Pharmaceuticals (VRTX) is likely to achieve multiple clinical milestones in late/2023 and 2024, both in its CF and non-CF portfolio.",VRTX,0.206685,0.160053,Somewhat-Bullish
Should You Invest in the iShares Biotechnology ETF  ( IBB ) ?,https://www.zacks.com/stock/news/2186419/should-you-invest-in-the-ishares-biotechnology-etf-ibb,2023-11-20 11:20:07,Sector ETF report for ...,VRTX,0.135729,0.071814,Neutral
"2 Beaten-Down Growth Stocks That Could Rocket 42% to 67% Higher, According to Wall Street",https://www.fool.com/investing/2023/11/20/2-beaten-down-growth-stocks-that-could-rocket-42-t/,2023-11-20 10:36:00,"Investment bank analysts are pounding the table on these stocks, but are they right for your portfolio?",VRTX,0.05749,0.080024,Neutral
"Could Investing $10,000 In CRISPR Therapeutics Stock Make You a Millionaire?",https://www.fool.com/investing/2023/11/19/crispr-therapeutics-stock-make-you-a-millionaire/,2023-11-19 10:30:00,"The stock is trading below its peak, reached a couple of years ago.",VRTX,0.049526,0.08824,Neutral
"Barron's Weekend Stock Picks: Disney, Palantir And Cisco's Calamitous Outlook - Cisco Systems  ( NASDAQ:CSCO ) , Walt Disney  ( NYSE:DIS ) ",https://www.benzinga.com/news/23/11/35864021/barrons-weekend-stock-picks-disney-palantir-and-ciscos-calamitous-outlook,2023-11-19 01:18:08,"Benzinga reviews this weekend's top stories covered by Barron's. Here are the articles investors need to read. In ""Disney Now Faces Two Activist Investors,"" Carleton English writes that, now, two activist investors, ValueAct Capital and Trian Fund Management, are pressuring Walt Disney Co DIS to ...",VRTX,0.262522,-0.325941,Somewhat-Bearish
3 Monster Stocks in the Making,https://www.fool.com/investing/2023/11/18/3-monster-stocks-in-the-making/,2023-11-18 11:49:00,These stocks could grow much larger over the next few years.,VRTX,0.03792,0.043251,Neutral
You Don't Have to Pick a Winner in Biotech. Here's Why.,https://www.fool.com/investing/2023/11/18/you-dont-have-to-pick-biotech-winner-heres-why/,2023-11-18 10:00:00,"If you invest over the long term, you'll increase your chances of victory.",VRTX,0.056943,0.093937,Neutral
United Kingdom MHRA authorised Vertex and CRISPR Therapeutics's gene edited therapy for sickle cell disease and thalassemia,https://www.financialexpress.com/healthcare/pharma-healthcare/united-kingdom-mhra-authorised-vertex-and-crispr-therapeuticss-gene-edited-therapy-for-sickle-cell-disease-and-thalassemia/3310191/,2023-11-17 17:02:41,"Vertex Pharmaceuticals Incorporated and CRISPR Therapeutics announced on Thursday that the United Kingdom ( U.K. ) Medicines and Healthcare products Regulatory Agency ( MHRA ) has granted conditional marketing authorization for CASGEVY ( exagamglogene autotemcel [exa-cel] ) , a CRISPR/Cas9 ...",VRTX,0.104228,0.105417,Neutral
Why CRISPR Therapeutics Stock Is Jumping Again Today,https://www.fool.com/investing/2023/11/17/why-crispr-therapeutics-stock-is-jumping-again-tod/,2023-11-17 16:12:15,The stock continues to enjoy momentum from a key regulatory approval.,VRTX,0.275867,0.306885,Somewhat-Bullish
"Williams-Sonoma, Uber And 2 Other Stocks Insiders Are Selling - Seagate Tech Hldgs  ( NASDAQ:STX ) , Uber Technologies  ( NYSE:UBER ) ",https://www.benzinga.com/news/23/11/35847310/williams-sonoma-uber-and-2-other-stocks-insiders-are-selling,2023-11-17 13:26:18,"The Nasdaq 100 closed higher by 0.1% on Thursday. Investors, meanwhile, focused on some notable insider trades. When insiders sell shares, it could be a preplanned sale, or could indicate their concern in the company's prospects or that they view the stock as being overpriced.",VRTX,0.406526,0.175011,Somewhat-Bullish
"The Zacks Analyst Blog Highlights Arcellx, Bristol Myers Squibb, Solid Biosciences, Vertex Pharmaceuticals and CRISPR Therapeutics",https://www.zacks.com/stock/news/2185763/the-zacks-analyst-blog-highlights-arcellx-bristol-myers-squibb-solid-biosciences-vertex-pharmaceuticals-and-crispr-therapeutics,2023-11-17 11:00:00,"Arcellx, Bristol Myers Squibb, Solid Biosciences, Vertex Pharmaceuticals and CRISPR Therapeutics are included in this Analyst Blog.",VRTX,0.197011,0.022826,Neutral
Why Is Vertex  ( VRTX )  Down 6.4% Since Last Earnings Report?,https://www.zacks.com/stock/news/2194322/why-is-vertex-vrtx-down-64-since-last-earnings-report,2023-12-06 16:30:37,Vertex (VRTX) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.,VRTX,0.046273,-0.003989,Neutral
"Vertex Pharmaceuticals Clears Technical Benchmark, Hitting 80-Plus RS Rating",https://www.investors.com/ibd-data-stories/vertex-pharmaceuticals-clears-technical-benchmark-hitting-80-plus-rs-rating/,2023-12-06 08:00:00,"Vertex Pharmaceuticals ( VRTX ) saw a welcome improvement to its Relative Strength ( RS ) Rating on Wednesday, rising from 77 to 82. X When looking for the best stocks to buy and watch, one factor to watch closely is relative price strength.",VRTX,0.511256,0.78108,Bullish
CRISPR  ( CRSP )  to Focus on Next-Generation CAR T Pipeline,https://www.zacks.com/stock/news/2193794/crispr-crsp-to-focus-on-next-generation-car-t-pipeline,2023-12-05 18:15:00,"Based on early data from ongoing clinical studies, CRISPR (CRSP) has decided to focus on the development of its next-generation CAR T pipeline and discontinue its first-generation CAR T candidates.",VRTX,0.094576,0.035504,Neutral
Here's How Much $100 Invested In Vertex Pharmaceuticals 15 Years Ago Would Be Worth Today - Vertex Pharmaceuticals  ( NASDAQ:VRTX ) ,https://www.benzinga.com/news/23/12/36096228/heres-how-much-100-invested-in-vertex-pharmaceuticals-15-years-ago-would-be-worth-today,2023-12-05 16:30:22,"Vertex Pharmaceuticals VRTX has outperformed the market over the past 15 years by 7.91% on an annualized basis producing an average annual return of 19.33%. Currently, Vertex Pharmaceuticals has a market capitalization of $90.07 billion.",VRTX,0.980595,0.386944,Bullish
1 Promising Stock Down 66% That Could Skyrocket in 2024,https://www.fool.com/investing/2023/12/05/1-promising-stock-down-66-that-could-skyrocket-in/,2023-12-05 12:00:00,Financial results aren't what matters most right now for this company.,VRTX,0.051003,0.13707,Neutral
Better Growth Stock: CRISPR Therapeutics vs. Invitae,https://www.fool.com/investing/2023/12/05/better-growth-stock-crispr-therapeutics-vs-invitae/,2023-12-05 10:00:00,One of these stocks may be riskier than the other...,VRTX,0.056143,0.129021,Neutral
Crispr gene editing technology could transform medicine | FT Tech,https://www.ft.com/video/5053951c-1c3f-41fc-a0d3-bdf1a35aa9b6,2023-12-05 04:01:44,You can enable subtitles ( captions ) in the video player It's been barely a decade since two researchers came up with a plan to edit DNA in order to disrupt genetic disorders.,VRTX,0.102013,0.101518,Neutral
CRISPR Therapeutics Announces Updates to Immuno-Oncology Pipeline and Expansion into Autoimmune Disease,https://www.globenewswire.com/news-release/2023/12/04/2790468/0/en/CRISPR-Therapeutics-Announces-Updates-to-Immuno-Oncology-Pipeline-and-Expansion-into-Autoimmune-Disease.html,2023-12-04 21:15:00,"-Based on preliminary data from ongoing clinical trials, focusing on next-generation CAR T product candidates, CTX112 targeting CD19 and CTX131 targeting ...",VRTX,0.022579,0.115488,Neutral
Looking Into Vertex Pharmaceuticals's Recent Short Interest - Vertex Pharmaceuticals  ( NASDAQ:VRTX ) ,https://www.benzinga.com/short-sellers/23/12/36076383/looking-into-vertex-pharmaceuticalss-recent-short-interest,2023-12-04 19:00:24,"Vertex Pharmaceuticals's VRTX short percent of float has fallen 3.96% since its last report. The company recently reported that it has 2.51 million shares sold short, which is 0.97% of all regular shares that are available for trading.",VRTX,0.221819,0.083071,Neutral
GSK vs. VRTX: Which Stock Should Value Investors Buy Now?,https://www.zacks.com/stock/news/2193083/gsk-vs-vrtx-which-stock-should-value-investors-buy-now,2023-12-04 16:40:11,GSK vs. VRTX: Which Stock Is the Better Value Option?,VRTX,0.699089,0.529246,Bullish
You Don't Have to Pick a Winner in Gene-Editing. Do This Instead.,https://www.fool.com/investing/2023/12/04/you-dont-have-to-pick-a-winner-in-gene-editing-do/,2023-12-04 13:30:00,"The gene-editing revolution is unfolding at a record pace. Still, risks abound, and picking individual stocks may not be the wisest approach.",VRTX,0.204072,0.239476,Somewhat-Bullish
A Bull Market Is Coming. Here Are 3 Stocks You'll Absolutely Want to Own.,https://www.fool.com/investing/2023/12/04/a-bull-market-is-coming-here-are-3-stocks-youll-ab/,2023-12-04 10:51:00,These stocks are already big winners in 2023 and should keep their momentum going in a new bull market.,VRTX,0.119235,0.21208,Somewhat-Bullish
Where Will Vertex Pharmaceuticals Be in 10 Years?,https://www.fool.com/investing/2023/12/04/where-will-vertex-pharmaceuticals-be-in-10-years/,2023-12-04 10:30:00,Vertex shares have soared 400% over the past decade.,VRTX,0.101154,0.176507,Somewhat-Bullish
"If You Invested $5,000 in CRISPR Therapeutics in January, This Is How Much You Would Have Today",https://www.fool.com/investing/2023/12/04/if-you-invested-5000-in-crispr-therapeutics-in-jan/,2023-12-04 10:00:00,CRISPR Therapeutics' shares advanced in the double-digits this year.,VRTX,0.05749,0.0,Neutral
3 No-Brainer Growth Stocks to Buy in December,https://www.fool.com/investing/2023/12/03/3-no-brainer-growth-stocks-to-buy-in-december/,2023-12-03 11:54:00,No analysis paralysis is required with these great stocks.,VRTX,0.158259,-0.054183,Neutral
"Got $5,000? These Are 2 of the Best Growth Stocks to Buy Right Now",https://www.fool.com/investing/2023/12/03/got-5000-best-growth-stocks-buy-right-now/,2023-12-03 10:53:00,The one thing these two stocks have in common is tremendous growth prospects.,VRTX,0.109206,0.302414,Somewhat-Bullish
"CASGEVY Gets Bahrain approval for treatment, marking it second country in the world",https://www.benzinga.com/pressreleases/23/12/g36058548/casgevy-gets-bahrain-approval-for-treatment-marking-it-second-country-in-the-world,2023-12-02 17:59:21,"MANAMA, Bahrain, Dec. 02, 2023 ( GLOBE NEWSWIRE ) -- Bahrain has become the second country in the world and the first in the Middle East to approve the use of CASGEVY ( exagamglogene autotemcel ) for the treatment of patients with sickle cell disease and transfusion-dependent beta-thalassemia.",VRTX,0.091162,0.076813,Neutral
An Important History Lesson for Gene-Editing Investors,https://www.fool.com/investing/2023/12/02/an-important-history-lesson-for-gene-editing-inves/,2023-12-02 13:30:00,Gene editing holds tremendous promise for patients and investors alike. But the road to success won't be easy.,VRTX,0.040691,0.050122,Neutral
5 Top Stocks to Buy Before 2024,https://www.fool.com/investing/2023/12/02/5-top-stocks-to-buy-before-2024/,2023-12-02 10:00:00,These stocks have room to run -- next year and over the long term.,VRTX,0.075397,0.147665,Neutral
"Lululemon, Toll Brothers, Broadcom And November Jobs: Investing Action Plan",https://www.investors.com/research/investing-action-plan/lululemon-stock-toll-brothers-broadcom-and-november-jobs-investing-action-plan/,2023-12-01 22:53:00,"Lululemon, Toll Brothers, Broadcom And November Jobs: Investing ... Investor's Business Daily ...",VRTX,0.076765,0.119475,Neutral
Is iShares Biotechnology ETF  ( IBB )  a Strong ETF Right Now?,https://www.zacks.com/stock/news/2191965/is-ishares-biotechnology-etf-ibb-a-strong-etf-right-now,2023-12-01 11:20:06,Smart Beta ETF report for ...,VRTX,0.122269,0.068311,Neutral
Could CRISPR Therapeutics Become the Next Vertex Pharmaceuticals?,https://www.fool.com/investing/2023/12/01/could-crispr-therapeutics-become-the-next-vertex/,2023-12-01 11:15:00,It's not as long a shot as some might think.,VRTX,0.330286,0.240925,Somewhat-Bullish
Looking for Growth? 2 Top Stocks to Buy Hand Over Fist,https://www.fool.com/investing/2023/12/01/looking-for-growth-2-top-stocks-to-buy/,2023-12-01 10:15:00,These stocks offer enormous long-term growth potential.,VRTX,0.055236,0.054864,Neutral
"The Zacks Analyst Blog Highlights Avidity, Bristol Myers Squibb, Vertex, Arcturus and BioVie",https://www.zacks.com/stock/news/2191938/the-zacks-analyst-blog-highlights-avidity-bristol-myers-squibb-vertex-arcturus-and-biovie,2023-12-01 10:09:00,"Avidity, Bristol Myers Squibb, Vertex, Arcturus and BioVie are included in this Analyst Blog.",VRTX,0.160099,0.102954,Neutral
"Biotech Stock Roundup: RNA Up on BMY Deal Expansion, BIVI Down on Setback & More",https://www.zacks.com/stock/news/2191567/biotech-stock-roundup-rna-up-on-bmy-deal-expansion-bivi-down-on-setback-more,2023-11-30 15:33:00,"Regulatory and pipeline updates from Avidity Biosciences, Inc. (RNA) and BioVie (BIVI) are in the spotlight this week.",VRTX,0.129284,0.150144,Somewhat-Bullish
Stocks Flashing Renewed Technical Strength: Vertex Pharmaceuticals,https://www.investors.com/ibd-data-stories/stocks-flashing-renewed-technical-strength-vertex-pharmaceuticals-3/,2023-11-30 08:00:00,"The Relative Strength ( RS ) Rating for Vertex Pharmaceuticals ( VRTX ) entered a new percentile Thursday, with a rise from 78 to 81. X When looking for the best stocks to buy and watch, one factor to watch closely is relative price strength.",VRTX,0.647749,0.327287,Somewhat-Bullish
Health Canada Grants Market Authorization for KALYDECO  ( ivacaftor )  for Eligible Children With Cystic Fibrosis Ages 2 Months and Older,https://www.newswire.ca/news-releases/health-canada-grants-market-authorization-for-kalydeco-r-ivacaftor-for-eligible-children-with-cystic-fibrosis-ages-2-months-and-older-836626413.html,2023-11-29 18:59:00,Health Canada Grants Market Authorization for KALYDECO ( ivacaftor ) for Eligible Children With Cystic Fibrosis Ages ... Canada ...,VRTX,0.129983,0.116245,Neutral
What's Next For Crispr After Its 'Historic' Gene-Editing Approval?,https://www.investors.com/research/the-new-america/crsp-stock-what-is-next-as-shares-fly-on-a-historic-crispr-gene-editing-approval/,2023-11-29 13:00:00,CRSP Stock: What's Next As Shares Fly On A 'Historic' CRISPR ... Investor's Business Daily ...,VRTX,0.0699,0.152805,Somewhat-Bullish
"Arcturus'  ( ARCT )  CF Drug Gets FDA's Orphan Status, Stock Up",https://www.zacks.com/stock/news/2190147/arcturus-arct-cf-drug-gets-fdas-orphan-status-stock-up,2023-11-28 12:56:00,"Arcturus (ARCT) rises 8% as the FDA grants Orphan Drug Designation for its product candidate, ARCT-032, for the treatment of cystic fibrosis.",VRTX,0.211191,0.083487,Neutral
The CRISPR Era Is Here,https://www.theatlantic.com/health/archive/2023/11/crispr-sickle-cell-disease-cure/676151/,2023-11-27 18:38:54,The First CRISPR Therapy Is Here The Atlantic ...,VRTX,0.023035,0.188574,Somewhat-Bullish
3 Biotech Stocks To Watch Before December 2023,https://stockmarket.com/featured/3-biotech-stocks-to-watch-before-december-2023-2023-11-27,2023-11-27 15:38:43,"The biotechnology sector is a dynamic and innovative field that combines biological sciences with technology. It encompasses a range of companies focusing on medical research, pharmaceuticals, and genetic engineering. These companies work on groundbreaking treatments, vaccines, and technologies.",VRTX,0.296582,-0.075704,Neutral
5 Stocks You Can Confidently Invest $500 In Right Now,https://www.fool.com/investing/2023/11/27/5-stocks-you-can-confidently-invest-500-in-now/,2023-11-27 10:30:00,These companies could significantly grow your investment over the long haul.,VRTX,0.089629,0.0,Neutral
CRISPR Therapeutics Just Made History. So Why Did Its Stock Fall?,https://www.fool.com/investing/2023/12/16/crispr-therapeutics-just-made-history-so-why-did/,2023-12-16 14:45:00,"The benefits from its first drug launch will trickle in slowly, at least at first.",VRTX,0.110717,0.044829,Neutral
3 Fantastic Stocks That Could Enjoy a Santa Claus Rally,https://www.fool.com/investing/2023/12/16/3-fantastic-stocks-that-could-enjoy-a-santa-claus/,2023-12-16 11:55:00,These stocks could bring investors more than just a lump of coal for Christmas.,VRTX,0.081001,0.084485,Neutral
Here's the 1 Key Reason You Might Want to Buy CRISPR Therapeutics Stock on the Dip,https://www.fool.com/investing/2023/12/16/key-reason-buy-crispr-therapeutics-stock/,2023-12-16 10:53:00,This biotech could have more winners on the way.,VRTX,0.119235,0.200668,Somewhat-Bullish
"Down 30% in a Week, What in the World Is Going On With Bluebird Bio Stock?",https://www.fool.com/investing/2023/12/15/down-30-in-a-week-what-in-the-world-is-going-on-wi/,2023-12-15 16:14:00,An expected big win is rapidly turning into a defeat.,VRTX,0.102231,-0.033876,Neutral
Market Surges To 2023 Highs As Fed Pivots Toward Rate Cuts: Weekly Review,https://www.investors.com/news/stock-market-rally-surges-to-2023-highs-as-fed-pivots-toward-rate-cuts-weekly-review/,2023-12-15 15:54:00,"The stock market rally raced higher in a powerful, broad advance as the Federal Reserve signaled it could cut rates three times in 2024. The Dow Jones hit a record high while the S&P 500, Nasdaq composite, S&P MidCap 400 and small-cap Russell 2023 all set 2023 bests. Treasury yields plunged.",VRTX,0.119532,-0.108167,Neutral
Where Will CRISPR Therapeutics Be in 5 Years?,https://www.fool.com/investing/2023/12/15/where-will-crispr-therapeutics-be-in-5-years/,2023-12-15 14:30:00,Does the recent approval make the stock a no-brainer buy?,VRTX,0.105141,0.14288,Neutral
Twist Bioscience  ( TWST )  Soars 12.5%: Is Further Upside Left in the Stock?,https://www.zacks.com/stock/news/2198479/twist-bioscience-twst-soars-125-is-further-upside-left-in-the-stock,2023-12-15 13:11:00,Twist Bioscience (TWST) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might help the stock continue moving higher in the near term.,VRTX,0.360752,0.0,Neutral
"After This Landmark Win, Is CRISPR Therapeutics a Buy?",https://www.fool.com/investing/2023/12/15/after-this-landmark-win-is-crispr-a-buy/,2023-12-15 10:30:00,CRISPR Therapeutics stock already has advanced in the double digits this year.,VRTX,0.06211,0.192152,Somewhat-Bullish
"Ironwood Pharm Cl A Clears Technical Benchmark, Hitting 80-Plus RS Rating",https://www.investors.com/ibd-data-stories/ironwood-pharm-cl-a-clears-technical-benchmark-hitting-80-plus-rs-rating-2/,2023-12-15 08:00:00,"Ironwood Pharm Cl A ( IRWD ) saw a positive improvement to its Relative Strength ( RS ) Rating on Friday, rising from 66 to 80. X As you try to find the best stocks to buy and watch, be sure to pay attention to relative price strength.",VRTX,0.353059,0.0,Neutral
Xenon Pharmaceuticals Trying To Close In On Key Technical Measure,https://www.investors.com/ibd-data-stories/xenon-pharmaceuticals-trying-to-close-in-on-key-technical-measure/,2023-12-15 08:00:00,"In a welcome move, Xenon Pharmaceuticals ( XENE ) saw its Relative Strength Rating improve from 63 to 71 on Friday. X When looking for the best stocks to buy and watch, one factor to watch closely is relative price strength. IBD's unique rating identifies market leadership with a 1 ( worst ) ...",VRTX,0.343279,0.0,Neutral
Stocks Showing Rising Market Leadership: Editas Medicine Earns 87 RS Rating,https://www.investors.com/ibd-data-stories/stocks-showing-rising-market-leadership-editas-medicine-earns-87-rs-rating-2/,2023-12-15 08:00:00,"When putting together your watch list, look for stocks with an 80 or higher RS Rating. Editas Medicine ( EDIT ) just met that criteria with a new score of 87. As you try to find the best stocks to buy and watch, be sure to pay attention to relative price strength.",VRTX,0.338582,0.0,Neutral
Stock Upgrades: Vericel Shows Rising Relative Strength,https://www.investors.com/ibd-data-stories/stock-upgrades-vericel-shows-rising-relative-strength-4/,2023-12-15 08:00:00,"Vericel ( VCEL ) saw a positive improvement to its Relative Strength ( RS ) Rating on Friday, with an upgrade from 76 to 83. X When looking for the best stocks to buy and watch, keep a close on eye on relative price strength.",VRTX,0.305058,0.0,Neutral
Vertex Pharmaceuticals  ( VRTX )  Outpaces Stock Market Gains: What You Should Know,https://www.zacks.com/stock/news/2198296/vertex-pharmaceuticals-vrtx-outpaces-stock-market-gains-what-you-should-know,2023-12-14 22:45:17,"The latest trading day saw Vertex Pharmaceuticals (VRTX) settling at $406.60, representing a +0.38% change from its previous close.",VRTX,0.543535,0.318843,Somewhat-Bullish
"Neuropathy Pain Treatment Market size to grow by USD 5.84 billion from 2023 to 2028, North America accounts for 33 ... - PR Newswire",https://www.prnewswire.com/news-releases/neuropathy-pain-treatment-market-size-to-grow-by-usd-5-84-billion-from-2023-to-2028--north-america-accounts-for-33-of-market-growth--technavio-302015282.html,2023-12-14 22:15:00,"Neuropathy Pain Treatment Market size to grow by USD 5.84 billion from 2023 to 2028, North America accounts for 33 ... PR ...",VRTX,0.078099,0.0,Neutral
Promising new gene therapies for sickle cell are out of reach in countries where they're needed most,https://apnews.com/article/sickle-cell-gene-therapy-crispr-global-0a76d10be53462d57e9d3cc07d15fc02,2023-12-14 15:55:06,"Gautam Dongre's two children in India and Pascazia Mazeze's son in Tanzania live with an inherited blood disorder that turns blood cells into instruments of pain. Now that new gene therapies promise a cure for their sickle cell disease, Dongre says he's ""praying the treatment should come to us.""",VRTX,0.026328,0.006495,Neutral
"The Zacks Analyst Blog Highlights bluebird, Editas Medicine, Beam Therapeutics and Intellia Therapeutics",https://www.zacks.com/stock/news/2198066/the-zacks-analyst-blog-highlights-bluebird-editas-medicine-beam-therapeutics-and-intellia-therapeutics,2023-12-14 15:36:00,"bluebird, Editas Medicine, Beam Therapeutics and Intellia Therapeutics are part of the Zacks top Analyst Blog.",VRTX,0.03443,0.071953,Neutral
"Biotech Stock Roundup: BLUE, CRSP & VRTX Get Gene Therapy Nod, ACAD Up on Patent News",https://www.zacks.com/stock/news/2198026/biotech-stock-roundup-blue-crsp-vrtx-get-gene-therapy-nod-acad-up-on-patent-news,2023-12-14 14:55:00,bluebird (BLUE) and Vertex (VRTX) are in the spotlight this week on approval of therapies and pipeline news.,VRTX,0.142989,0.144851,Neutral
"Editas  ( EDIT )  Licenses Cas9 Tool to Vertex, Stock Up 6%",https://www.zacks.com/stock/news/2197854/editas-edit-licenses-cas9-tool-to-vertex-stock-up-6,2023-12-14 13:32:00,"Editas (EDIT) stock rises 6% on a non-exclusive agreement with Vertex Pharmaceuticals to license its Cas9 gene-editing technology for the development of the latter's gene therapy drug, Casgevy.",VRTX,0.112008,0.094706,Neutral
Vertex  ( VRTX )  Hits Record High on Non-Opioid Pain Drug Data,https://www.zacks.com/stock/news/2197830/vertex-vrtx-hits-record-high-on-non-opioid-pain-drug-data,2023-12-14 13:17:00,"Vertex (VRTX) stock hits a 52-week high after announcing encouraging data from a phase II study on non-opioid pain medicine, VX-548, for treating painful diabetic peripheral neuropathy.",VRTX,0.214462,-0.122114,Neutral
Futures: What To Do As Rally Runs,https://www.investors.com/market-trend/stock-market-today/dow-jones-futures-rise-market-rally-runs-on-fed-rate-cut-shift/,2023-12-14 11:42:00,Dow Jones Futures Rise As Market Rally Runs On Fed Rate-Cut Shift. What To Do Now Investor's Business Daily ...,VRTX,0.058759,0.0,Neutral
Vertex  ( VRTX )  Soars 13.2%: Is Further Upside Left in the Stock?,https://www.zacks.com/stock/news/2197712/vertex-vrtx-soars-132-is-further-upside-left-in-the-stock,2023-12-14 11:12:00,Vertex (VRTX) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions could translate into further price increase in the near term.,VRTX,0.272788,0.286913,Somewhat-Bullish
InnovationRx: Tough Road Ahead For Bluebird's Gene Therapy,https://www.forbes.com/sites/alexknapp/2023/12/13/innovationrx-tough-road-ahead-for-bluebirds-gene-therapy/,2023-12-13 23:33:29,"InnovationRx is your weekly digest of healthcare news. To get it in your inbox, subscribe here. Last Friday marked a biotech milestone as the Food and Drug Administration approved two Cripsr-based gene therapies for the treatment of sickle cell disease.",VRTX,0.069798,0.067246,Neutral
Dow Hits New High In Fed-Led Rally; Adobe Falls Late,https://www.investors.com/market-trend/stock-market-today/dow-jones-hits-record-high-as-fed-sees-three-rate-cuts-markets-bet-on-six-adobe-falls-late/,2023-12-13 21:53:00,Dow Jones Hits Record High As Fed Sees Three Rate Cuts. Markets Bet On Six. Adobe Falls Late Investor's Business Daily ...,VRTX,0.05986,0.0,Neutral
Why Vertex Stock Is Soaring Today,https://www.fool.com/investing/2023/12/13/why-vertex-stock-is-soaring-today/,2023-12-13 19:08:23,The drugmaker's non-opioid painkiller is showing promise in a select set of patients.,VRTX,0.386477,-0.011075,Neutral
Why Is Vertex Pharmaceuticals  ( VRTX )  Stock Surging Today? - Vertex Pharmaceuticals  ( NASDAQ:VRTX ) ,https://www.benzinga.com/general/biotech/23/12/36216498/vertexs-non-opioid-diabetes-associated-nerve-pain-treatment-candidate-aces-mid-stage-trial,2023-12-13 17:30:11,"Vertex Pharmaceuticals Incorporated VRTX released results from its Phase 2 dose-ranging study of VX-548 ( non-opioid pain medicine ) for diabetic peripheral neuropathy, a type of nerve damage caused by high blood sugar. VX-548 was generally well tolerated at all doses tested in the study.",VRTX,0.382925,-0.222795,Somewhat-Bearish
Vertex's stock heads for all-time high as non-opioid painkiller shows promise,https://www.marketwatch.com/story/vertexs-stock-heads-for-all-time-high-as-non-opioid-painkiller-shows-promise-3a42c530,2023-12-13 17:03:00,Vertex Pharmaceuticals' stock was on track for an all-time high Wednesday after the company released new data on its experimental non-opioid pain medicine.,VRTX,0.252987,-0.072374,Neutral
Dow Jones Flat Ahead Of Fed; Magnificent Seven Mixed As Tesla Falls,https://www.investors.com/market-trend/stock-market-today/dow-jones-flat-ahead-of-fed-magnificent-seven-mixed-as-tesla-falls/,2023-12-13 16:09:00,Dow Jones Flat Ahead Of Fed. Magnificent Seven Mixed As Tesla Falls Investor's Business Daily ...,VRTX,0.1172,0.014299,Neutral
"Vertex's non-opioid drug reduces nerve pain in trial, shares hit record high",https://www.reuters.com/business/healthcare-pharmaceuticals/vertexs-neuropathic-pain-treatment-succeeds-mid-stage-trial-2023-12-13/,2023-12-13 15:37:00,"A sign hangs in front of the world headquarters of Vertex Pharmaceuticals in Boston, Massachusetts, U.S., October 23, 2019. REUTERS/Brian Snyder/File Photo Acquire Licensing Rights",VRTX,0.220809,-0.247035,Somewhat-Bearish
1 Biotech Stock That Could Be the Next Amgen,https://www.fool.com/investing/2023/12/13/1-biotech-stock-that-could-be-the-next-amgen/,2023-12-13 15:15:00,The emergence of genomic medicine as a viable modality could transform this midcap biotech into the next Amgen.,VRTX,0.147818,0.199185,Somewhat-Bullish
Editas Medicine and Vertex Pharmaceuticals Enter into Non-exclusive License Agreement for Cas9,https://www.globenewswire.com/news-release/2023/12/13/2795602/0/en/Editas-Medicine-and-Vertex-Pharmaceuticals-Enter-into-Non-exclusive-License-Agreement-for-Cas9.html,2023-12-13 14:00:00,Vertex Pharmaceuticals to obtain a non-exclusive license for Cas9 for ...,VRTX,0.128822,0.128686,Neutral
"Vertex Rallies, Flashes Bullish Signal On Phase 2 Results For Opioid Alternative",https://www.investors.com/news/technology/vertex-stock-flashes-bullish-signal-on-phase-2-results-for-opioid-alternative/,2023-12-13 13:46:00,Vertex Pharmaceuticals ( VRTX ) reported positive Phase 2 study results for a pain drug to treat diabetic peripheral neuropathy ( DPN ) early Wednesday. Vertex stock rallied more than 7% premarket and flashed a bullish signal to clear a downtrend.,VRTX,0.345674,0.41427,Bullish
Better Growth Stock: Vertex Pharmaceuticals or Exact Sciences?,https://www.fool.com/investing/2023/12/13/better-growth-stock-vertex-pharmaceuticals-or-exac/,2023-12-13 13:45:00,"Both of these biotech stocks have been market-beaters over the prior 10 years. One stock, however, is a better buy right now.",VRTX,0.099066,0.145429,Neutral
3 Biotechs With Promising Gene Therapies in the Spotlight,https://www.zacks.com/stock/news/2197203/3-biotechs-with-promising-gene-therapies-in-the-spotlight,2023-12-13 13:06:00,"The recent FDA approval of two gene therapies has put the focus on biotechs like EDIT, BEAM and NTLA, which have promising candidates in their pipeline.",VRTX,0.03642,0.086097,Neutral
Thalassaemia International Federation applauds FDA approval of SCD gene therapies,https://www.financialexpress.com/healthcare/news-healthcare/thalassaemia-international-federation-applauds-fda-approval-of-scd-gene-therapies/3337598/,2023-12-13 09:37:15,"The US Food and Drug Administration ( FDA ) simultaneously approved two innovative gene therapies for individuals with sickle cell anaemia last week, offering substantial hope for a radical treatment of this severe haematological disorder.",VRTX,0.081552,-0.010457,Neutral
What FDA Approval Means For CRSP Stock,https://www.investors.com/news/technology/crsp-stock-what-fda-approval-means-for-future-of-medicine/,2023-12-12 21:03:00,CRSP Stock: What FDA's Historic Gene Editing Approval Means For The Future Of Medicine Investor's Business Daily ...,VRTX,0.133692,0.176462,Somewhat-Bullish
AbbVie Just Followed Pfizer's Big Move. Here's What It Means For Investors,https://www.fool.com/investing/2023/12/12/abbvie-just-followed-pfizers-big-move-heres-what/,2023-12-12 15:15:00,It's making a major acquisition to beef up a key area of its pipeline.,VRTX,0.051551,0.103893,Neutral
Could Intellia Therapeutics Become the Next CRISPR Therapeutics?,https://www.fool.com/investing/2023/12/12/could-intellia-become-the-next-crispr-therapeutics/,2023-12-12 11:00:00,Intellia is approaching the finish line.,VRTX,0.051663,0.094949,Neutral
A Closer Look at CRISPR Therapeutics's Options Market Dynamics - CRISPR Therapeutics  ( NASDAQ:CRSP ) ,https://www.benzinga.com/markets/options/23/12/36182007/a-closer-look-at-crispr-therapeuticss-options-market-dynamics,2023-12-11 18:16:04,"Financial giants have made a conspicuous bearish move on CRISPR Therapeutics. Our analysis of options history for CRISPR Therapeutics CRSP revealed 19 unusual trades. Delving into the details, we found 42% of traders were bullish, while 57% showed bearish tendencies.",VRTX,0.077845,0.155314,Somewhat-Bullish
Why CRISPR Stock Keeps Falling,https://www.fool.com/investing/2023/12/11/why-crispr-stock-keeps-falling/,2023-12-11 17:41:31,CRISPR just scored its first FDA victory -- but profits remain years away.,VRTX,0.159569,0.10866,Neutral
"BLUE, CRSP & VRTX Down Despite FDA Nod to SCD Therapies",https://www.zacks.com/stock/news/2196355/blue-crsp-vrtx-down-despite-fda-nod-to-scd-therapies,2023-12-11 17:24:00,The FDA approves two one-time gene therapies for treating sickle cell disease. One of them utilizes the Nobel prize-winning CRISPR/Cas9 gene-editing technology.,VRTX,0.123209,0.0,Neutral
bluebird  ( BLUE )  Down Despite FDA Nod to Gene Therapy for SCD,https://www.zacks.com/stock/news/2196255/bluebird-blue-down-despite-fda-nod-to-gene-therapy-for-scd,2023-12-11 16:08:00,"bluebird (BLUE) receives FDA approval for its third gene therapy. However, the label carries a black box warning, on which its shares have slumped.",VRTX,0.107736,0.072703,Neutral
"CRISPR  ( CRSP ) , Vertex Fall Despite FDA Nod to SCD Drug Casgevy",https://www.zacks.com/stock/news/2196180/crispr-crsp-vertex-fall-despite-fda-nod-to-scd-drug-casgevy,2023-12-11 14:51:00,"CRISPR (CRSP) and Vertex announce the FDA approval of the first-ever CRISPR-based gene-editing therapy, Casgevy, for the treatment of sickle cell disease.",VRTX,0.173022,0.161686,Somewhat-Bullish
CRISPR Therapeutics and Dollar General have been highlighted as Zacks Bull and Bear of the Day,https://www.zacks.com/stock/news/2196025/crispr-therapeutics-and-dollar-general-have-been-highlighted-as-zacks-bull-and-bear-of-the-day,2023-12-11 13:37:00,CRISPR Therapeutics and Dollar General are part of the Zacks Bull and Bear of the Day article.,VRTX,0.012631,0.011913,Neutral
Daily: Ohtani Scores Biggest Deal In U.S. Team Sports History,https://www.forbes.com/sites/daniellechemtob/2023/12/11/forbes-daily-ohtani-scores-biggest-deal-in-us-team-sports-history/,2023-12-11 13:20:49,"This is a published version of the Forbes Daily newsletter, you can sign-up to get Forbes Daily in your inbox here. While WeWork may have collapsed, the demand for coworking space hasn't gone away.",VRTX,0.020439,0.159704,Somewhat-Bullish
Is CRISPR Therapeutics a Good Stock to Buy Following Approval of Its First Drug?,https://www.fool.com/investing/2023/12/11/is-crispr-therapeutics-a-good-stock-to-buy-followi/,2023-12-11 10:43:00,A simultaneous pair of approvals from the U.S. Food and Drug Administration gives investors new factors to consider.,VRTX,0.136113,-0.080881,Neutral
Bull of the Day: CRISPR Therapeutics  ( CRSP ) ,https://www.zacks.com/commentary/2195863/bull-of-the-day-crispr-therapeutics-crsp,2023-12-11 10:20:00,FDA approval for revolutionary Sickle Cell Disease gene-editing treatment promises a bright future ...,VRTX,0.083833,0.081281,Neutral
3 Unstoppable Stocks to Buy Right Now,https://www.fool.com/investing/2023/12/10/3-unstoppable-stocks-to-buy-right-now/,2023-12-10 11:56:00,These stocks could be just the ticket for investors seeking strong growth.,VRTX,0.171181,0.189008,Somewhat-Bullish
Vertex Pharmaceuticals Just Proved Something Big to Investors. Time to Buy?,https://www.fool.com/investing/2023/12/10/vertex-pharmaceuticals-just-proved-something-big/,2023-12-10 10:45:00,The big biotech's shares have been on the rise this year.,VRTX,0.098659,0.181705,Somewhat-Bullish
"The FDA just approved the first gene editing therapy for sickle cell anemia, but it'll cost $2.2 million per person",https://www.businessinsider.com/gene-therapy-for-sickle-cell-anemia-costs-millions-fda-2023-12,2023-12-09 20:12:00,First FDA approved gene therapies for sickle cell anemia cost millions - Business Insider ...,VRTX,0.095138,0.209731,Somewhat-Bullish
"Forget the ""Magnificent Seven"": Buy This Stock Instead",https://www.fool.com/investing/2023/12/09/forget-magnificent-seven-buy-this-stock-instead/,2023-12-09 15:07:00,It's hard to go wrong with this high-flying drugmaker.,VRTX,0.237745,0.246479,Somewhat-Bullish
2 Superior Growth Stocks Up 23% and 105% in 2023 to Buy Now and Hold for Years,https://www.fool.com/investing/2023/12/09/2-superior-growth-stocks-up-23-and-105-this-year/,2023-12-09 14:36:00,"These businesses are on different growth trajectories, but both are leaders in their respective industries with untold potential ahead.",VRTX,0.088309,0.040798,Neutral
Rally Ready To Run? 5 Stocks In Buy Zones As Tesla Sets Up,https://www.investors.com/market-trend/stock-market-today/dow-jones-futures-market-looks-ready-to-run-again-5-stocks-in-buy-zones-as-tesla-sets-up/,2023-12-08 21:58:00,"Dow Jones futures will open Sunday evening, along with S&P 500 futures and Nasdaq futures. The Federal Reserve meeting looms as investors look for an shift toward rate cuts. The stock market rally enjoyed modest weekly gains, with the major indexes reversing higher after Wednesday.",VRTX,0.078611,-0.00311,Neutral
La FDA aprueba las primeras terapias gnicas para tratar a pacientes con anemia de clulas falciformes,https://www.prnewswire.com/news-releases/la-fda-aprueba-las-primeras-terapias-genicas-para-tratar-a-pacientes-con-anemia-de-celulas-falciformes-805174011.html,2023-12-08 20:35:00,"SILVER SPRING, Md., 8 de diciembre de 2023 /PRNewswire-HISPANIC PR WIRE/ -- Hoy, la Administracin de Alimentos y Medicamentos de los Estados Unidos ( FDA, por sus siglas en ingls ) aprob dos tratamientos importantes, Casgevy y Lyfgenia, que representan las primeras terapias gnicas basadas en ...",VRTX,0.021446,0.0,Neutral
First CRISPR Sickle Cell Patient 'Reborn': FDA Approves Treatment,https://www.forbes.com/sites/ellenmatloff/2023/12/08/first-crispr-sickle-cell-patient-reborn-fda-approves-treatment/,2023-12-08 18:59:00,"Updated, Dec. 8: The Food and Drug Administration on Friday approved the first drug to treat patients with sickle cell disease using the Nobel Prize-winning CRISPR gene-editing therapy. Casgevy ( also known as Exa-cel ) is manufactured by Vertex Pharmaceuticals in Boston and CRISPR Therapeutics ...",VRTX,0.03178,0.093983,Neutral
Vertex/CRISPR price sickle cell disease gene therapy at $2.2 mln,https://www.reuters.com/business/healthcare-pharmaceuticals/vertexcrispr-price-sickle-cell-disease-gene-therapy-22-mln-2023-12-08/,2023-12-08 18:58:56,Vertex/CRISPR price sickle cell disease gene therapy at ...,VRTX,0.514619,0.384461,Bullish
Boston Medical Center to Offer First FDA-Approved Gene Therapy Treatment Program for Sickle Cell Disease,https://www.prnewswire.com/news-releases/boston-medical-center-to-offer-first-fda-approved-gene-therapy-treatment-program-for-sickle-cell-disease-302010397.html,2023-12-08 18:50:00,"Renowned, Expert Care Team to Deliver Transformative New Therapy to Eligible Adult Patients Suffering from Sickle Cell Disease",VRTX,0.16849,0.250014,Somewhat-Bullish
"FDA Approves First Gene-Editing Cell Therapy For Sickle Cell Disease, An Inherited Blood Disorder - CRISPR Therapeutics  ( NASDAQ:CRSP ) , bluebird bio  ( NASDAQ:BLUE ) , Vertex Pharmaceuticals  ( NASDAQ:VRTX ) ",https://www.benzinga.com/general/biotech/23/12/36156713/fda-approves-first-gene-editing-cell-therapy-for-sickle-cell-disease-an-inherited-blood-disorder,2023-12-08 18:35:29,"The FDA has approved Casgevy and Lyfgenia, representing the first cell-based gene therapies for sickle cell disease in patients 12 years and older. Both products are made from the patient's blood stem cells, which are modified and given back as a one-time, single-dose infusion as part of a ...",VRTX,0.369685,0.163069,Somewhat-Bullish
FDA approves 2 gene therapies for sickle cell. One is the first to use the editing tool CRISPR,https://apnews.com/article/sickle-cell-fda-approval-vertex-crispr-8d85279d7de0c60888d37afbfa06d39e,2023-12-08 18:33:45,Two gene therapies for sickle cell disease approved in US The Associated Press ...,VRTX,0.039096,0.100142,Neutral
"Indexes Near 2023 Highs; AMD, Google Jump On AI: Weekly Review",https://www.investors.com/news/stock-market-rally-nears-2023-highs-amd-google-jump-on-ai-push-weekly-review/,2023-12-08 18:16:00,"Indexes Near 2023 Highs. AMD, Google Jump On AI: Weekly Review Investor's Business Daily ...",VRTX,0.059488,0.144348,Neutral
"Crispr Therapeutics, Vertex get FDA approval for breakthrough gene-editing treatment",https://www.marketwatch.com/story/crispr-therapeutics-vertex-get-fda-approval-for-breakthrough-gene-editing-treatment-30ae7842,2023-12-08 17:03:00,Crispr Therapeutics and Vertex Pharmaceuticals got U.S. regulatory approval for a sickle-cell disease treatment based on the gene-editing technology Crispr.,VRTX,0.17715,0.168366,Somewhat-Bullish
US approves two gene therapies for sickle cell disease,https://www.reuters.com/business/healthcare-pharmaceuticals/us-approves-two-gene-therapies-sickle-cell-disease-2023-12-08/,2023-12-08 16:21:00,"Signage is seen outside of the Food and Drug Administration ( FDA ) headquarters in White Oak, Maryland, U.S., August 29, 2020. REUTERS/Andrew Kelly Acquire Licensing Rights Dec 8 ( Reuters ) - The U.S.",VRTX,0.179788,0.207222,Somewhat-Bullish
"U.S. approves first gene-editing treatment, Casgevy, for sickle cell disease",https://www.cnbc.com/2023/12/08/casgevy-first-crispr-gene-editing-treatment-approved-in-us.html,2023-12-08 16:19:27,"Casgevy uses Nobel Prize-winning technology CRISPR to treat sickle cell disease, a blood disorder that affects about 100,000 Americans.",VRTX,0.071145,0.170161,Somewhat-Bullish
Crispr Near Buy Point With FDA Gene-Editing Approval Seen,https://www.investors.com/news/technology/crispr-stock-rises-ahead-of-expected-fda-approval-of-gene-editing-treatment/,2023-12-08 14:35:00,Crispr Stock Rises Ahead Of Expected FDA Approval Of Gene-Editing Treatment Investor's Business Daily ...,VRTX,0.447528,0.0,Neutral
"FDA expected to approve first CRISPR gene-editing treatment, bringing hope to thousands with sickle cell disease",https://www.cnn.com/2023/12/08/health/first-crispr-gene-editing-treatment-sickle-cell-disease-scn/index.html,2023-12-08 14:15:00,"Before Johnny Lubin got a potentially life-changing experimental treatment at the age of 13, he recalls, he had one main concern. ""I was worrying that I might get, like, superpowers,"" said Johnny, now 15, who lives in Trumbull, Connecticut, about 60 miles north of New York City.",VRTX,0.021897,0.092794,Neutral
CRISPR Therapeutics Just Slashed Its Staff by 10%. Should Shareholders Be Worried?,https://www.fool.com/investing/2023/12/08/crispr-therapeutics-just-slashed-its-staff-by-10/,2023-12-08 13:15:00,"The timing of the cuts is setting off alarm bells, but the situation is under control.",VRTX,0.055109,0.034005,Neutral
FDA Approves First Crispr Treatment That Might Cure Sickle Cell,https://www.forbes.com/sites/roberthart/2023/12/08/fda-approves-first-crispr-treatment-that-might-cure-sickle-cell/,2023-12-08 12:24:27,FDA Could Approve First Crispr Treatment Today That Might Cure Sickle Cell Forbes ...,VRTX,0.049629,-0.011,Neutral
FDA Could Approve First Crispr Treatment Today That Might Cure Sickle Cell,https://www.forbes.com/sites/roberthart/2023/12/08/fda-could-approve-first-crispr-treatment-today-that-might-cure-sickle-cell/,2023-12-08 12:24:27,"The Food and Drug Administration on Friday is poised to approve a new therapy based on Crispr gene editing to treat sickle cell disease, which would mark the first time a treatment using the technology has secured a regulatory green light in the U.S. amid hopes the revolutionary tool will emerge ...",VRTX,0.049221,-0.01,Neutral
CRISPR Therapeutics's Options: A Look at What the Big Money is Thinking - CRISPR Therapeutics  ( NASDAQ:CRSP ) ,https://www.benzinga.com/markets/options/23/12/36140245/crispr-therapeuticss-options-a-look-at-what-the-big-money-is-thinking,2023-12-07 18:33:44,"Investors with a lot of money to spend have taken a bearish stance on CRISPR Therapeutics CRSP. We noticed this today when the positions showed up on publicly available options history that we track here at Benzinga. Whether these are institutions or just wealthy individuals, we don't know.",VRTX,0.080728,0.156035,Somewhat-Bullish
U.S. poised to approve first gene-editing treatment in breakthrough for sickle cell patients,https://www.cnbc.com/2023/12/07/crispr-gene-editing-treatment-us-approval.html,2023-12-07 14:10:12,The U.S. Food and Drug Administration is expected to approve exa-cel for sickle cell disease in what would become the first marketed medicine to use CRISPR.,VRTX,0.03448,-0.040476,Neutral
These 2 Stocks Could Be About to Soar: Are They Buys?,https://www.fool.com/investing/2023/12/07/these-2-stocks-could-be-about-to-soar-are-they-buy/,2023-12-07 13:45:00,One thing is for certain -- both of these companies are innovators.,VRTX,0.045655,0.184139,Somewhat-Bullish
This Newly Discovered Risk Could Be a Big Headache for Vertex Pharmaceuticals and CRISPR Therapeutics,https://www.fool.com/investing/2023/12/07/new-risk-headache-vertex-pharma-crispr-stock/,2023-12-07 10:30:00,Shareholders will do well to prepare themselves for how regulators might react.,VRTX,0.080188,0.135427,Neutral
"5 Unstoppable Trends to Invest $1,000 in for 2024",https://www.fool.com/investing/2023/12/07/5-unstoppable-trends-to-invest-1000-in-for-2024/,2023-12-07 10:21:00,These next-big-thing trends represent some of the most exciting moneymaking opportunities for investors next year.,VRTX,0.054545,0.193873,Somewhat-Bullish
Unpacking the Latest Options Trading Trends in CRISPR Therapeutics - CRISPR Therapeutics  ( NASDAQ:CRSP ) ,https://www.benzinga.com/markets/options/23/12/36389306/unpacking-the-latest-options-trading-trends-in-crispr-therapeutics,2023-12-26 19:00:42,"Whales with a lot of money to spend have taken a noticeably bullish stance on CRISPR Therapeutics. Looking at options history for CRISPR Therapeutics CRSP we detected 9 trades. If we consider the specifics of each trade, it is accurate to state that 55% of the investors opened trades with ...",VRTX,0.075635,0.154823,Somewhat-Bullish
Should You Invest in Bluebird Bio Right Now?,https://www.fool.com/investing/2023/12/26/should-you-invest-in-bluebird-bio-right-now/,2023-12-26 13:00:00,"After two December share price crashes, there's no evident cure for Bluebird Bio's ills.",VRTX,0.176287,-0.143111,Neutral
The Nine Breakthroughs of the Year,https://www.theatlantic.com/ideas/archive/2023/12/scientific-breakthroughs-2023-list/676952/,2023-12-25 11:00:00,"This is Work in Progress, a newsletter about work, technology, and how to solve some of America's biggest problems. Sign up here. The theme of my second-annual Breakthroughs of the Year is the long road of progress. My top breakthrough is Casgevy, a gene-editing treatment for sickle-cell anemia.",VRTX,0.013379,-0.030885,Neutral
3 Top Stocks to Buy Hand Over Fist Before the End of 2023,https://www.fool.com/investing/2023/12/25/3-top-stocks-to-buy-hand-over-fist-before-the-end/,2023-12-25 10:54:00,These are ideal stocks to buy sooner rather than later.,VRTX,0.11983,0.274234,Somewhat-Bullish
"If You Invested $10,000 in Bluebird Bio In 2021, This Is How Much You Would Have Today",https://www.fool.com/investing/2023/12/24/if-you-invested-10000-in-bluebird-bio-in-2018-this/,2023-12-24 12:39:00,Can things get better for this struggling stock?,VRTX,0.070517,-0.112057,Neutral
Editas Just Caught a Break Thanks to Vertex Pharmaceuticals,https://www.fool.com/investing/2023/12/23/editas-just-caught-a-break-thanks-to-vertex-pharma/,2023-12-23 13:02:00,"Editas isn't out of the woods yet, but it's better off than before.",VRTX,0.155451,0.1941,Somewhat-Bullish
1 Green Flag and 1 Red Flag for Bluebird Bio Stock,https://www.fool.com/investing/2023/12/23/1-green-flag-and-1-red-flag-for-bluebird-bio-stock/,2023-12-23 12:30:00,The stock has been in the news lately.,VRTX,0.060541,0.058,Neutral
5 Top Stocks to Buy With Your End-of-the-Year Bonus,https://www.fool.com/investing/2023/12/23/5-top-stocks-to-buy-with-your-bonus/,2023-12-23 10:00:00,Your bonus could become the gift that keeps on giving.,VRTX,0.077593,0.147103,Neutral
Could CRISPR Therapeutics Stock Help You Become a Millionaire?,https://www.fool.com/investing/2023/12/22/could-crispr-therapeutics-stock-help-you-become-a/,2023-12-22 22:02:00,There are plenty of reasons to be optimistic about CRISPR's future.,VRTX,0.071145,0.198471,Somewhat-Bullish
Looking At CRISPR Therapeutics's Recent Unusual Options Activity - CRISPR Therapeutics  ( NASDAQ:CRSP ) ,https://www.benzinga.com/markets/options/23/12/36369249/looking-at-crispr-therapeuticss-recent-unusual-options-activity,2023-12-22 20:17:00,"Deep-pocketed investors have adopted a bearish approach towards CRISPR Therapeutics CRSP, and it's something market players shouldn't ignore. Our tracking of public options records at Benzinga unveiled this significant move today.",VRTX,0.069294,0.15373,Somewhat-Bullish
Market Whales and Their Recent Bets on VRTX Options - Vertex Pharmaceuticals  ( NASDAQ:VRTX ) ,https://www.benzinga.com/markets/options/23/12/36368906/market-whales-and-their-recent-bets-on-vrtx-options,2023-12-22 19:45:46,Whales with a lot of money to spend have taken a noticeably bearish stance on Vertex Pharmaceuticals. Looking at options history for Vertex Pharmaceuticals VRTX we detected 11 trades.,VRTX,0.679474,-0.052565,Neutral
"Biotech stocks set for a rebound in 2024, analysts say",https://www.marketwatch.com/story/biotech-stocks-set-for-a-rebound-in-2024-analysts-say-24df6236,2023-12-22 16:06:00,"A more favorable interest-rate outlook, an uptick in deals, and innovations in key areas like cancer and immunology are setting up biotech for a brighter 2024, analysts say.",VRTX,0.089129,-0.1576,Somewhat-Bearish
Could Sarepta Therapeutics Be the Next Vertex Pharmaceuticals Stock?,https://www.fool.com/investing/2023/12/22/could-sarepta-therapeutics-be-the-next-vertex/,2023-12-22 15:15:00,"Both develop medicines for rare diseases, and each aims to conquer a niche market.",VRTX,0.172713,0.105122,Neutral
3 Money-Saving Tricks for Investing in Biotech Stocks in 2024,https://www.fool.com/investing/2023/12/22/3-money-saving-tricks-for-investing-in-biotech/,2023-12-22 13:45:00,Doing a little math and doing a little extra research can make a big difference.,VRTX,0.041466,0.074833,Neutral
"The Zacks Analyst Blog Highlights Alphabet, Comcast, NextEra, Vertex and Eni",https://www.zacks.com/stock/news/2201362/the-zacks-analyst-blog-highlights-alphabet-comcast-nextera-vertex-and-eni,2023-12-22 11:00:00,"Alphabet, Comcast, NextEra, Vertex and Eni are included in this Analyst Blog.",VRTX,0.135347,0.039353,Neutral
"Up More Than 60% in 2023, Is It Too Late to Buy This Soaring Biotech Stock?",https://www.fool.com/investing/2023/12/22/up-more-than-60-in-2023-is-it-too-late-to-buy-this/,2023-12-22 10:27:00,The FDA's recent approval of CRISPR Therapeutics' first therapy is a step in the right direction.,VRTX,0.191549,0.062591,Neutral
Stocks To Watch: Roivant Sciences Sees Relative Strength Rating Jump To 83,https://www.investors.com/ibd-data-stories/stocks-to-watch-roivant-sciences-sees-relative-strength-rating-jump-to-83/,2023-12-22 08:00:00,"Roivant Sciences ( ROIV ) had its Relative Strength ( RS ) Rating upgraded from 77 to 83 Friday. X When looking for the best stocks to buy and watch, one factor to watch closely is relative price strength.",VRTX,0.395012,0.0,Neutral
Immunocore Holdings ADR Sees RS Rating Rise To 75,https://www.investors.com/ibd-data-stories/immunocore-holdings-adr-sees-rs-rating-rise-to-75/,2023-12-22 08:00:00,"On Friday, Immunocore Holdings ADR ( IMCR ) earned a positive adjustment to its Relative Strength ( RS ) Rating, from 69 to 75. X As you try to find the best stocks to buy and watch, be sure to pay attention to relative price strength.",VRTX,0.316846,0.0,Neutral
How Is The Market Feeling About Vertex Pharmaceuticals? - Vertex Pharmaceuticals  ( NASDAQ:VRTX ) ,https://www.benzinga.com/short-sellers/23/12/36342428/how-is-the-market-feeling-about-vertex-pharmaceuticals,2023-12-21 13:30:20,"Vertex Pharmaceuticals's VRTX short percent of float has risen 7.22% since its last report. The company recently reported that it has 2.69 million shares sold short, which is 1.04% of all regular shares that are available for trading.",VRTX,0.221819,0.155473,Somewhat-Bullish
6 Words That Explain Why CRISPR Stock Isn't Soaring Despite the Recent FDA Approval for Its Gene-Editing Therapy,https://www.fool.com/investing/2023/12/21/6-words-that-explain-why-crispr-stock-isnt-soaring/,2023-12-21 13:30:00,Should you buy CRISPR's stock on the dip?,VRTX,0.07423,0.25769,Somewhat-Bullish
Is Vertex Pharmaceuticals Sitting on a Gold Mine?,https://www.fool.com/investing/2023/12/21/is-vertex-pharmaceuticals-sitting-on-a-gold-mine/,2023-12-21 10:00:00,Vertex shares have climbed about 40% this year.,VRTX,0.101367,0.26303,Somewhat-Bullish
Vertex Pharmaceuticals  ( VRTX )  Stock Moves -0.72%: What You Should Know,https://www.zacks.com/stock/news/2200748/vertex-pharmaceuticals-vrtx-stock-moves--072-what-you-should-know,2023-12-20 22:45:21,"In the latest trading session, Vertex Pharmaceuticals (VRTX) closed at $400.25, marking a -0.72% move from the previous day.",VRTX,0.523451,0.221771,Somewhat-Bullish
bluebird  ( BLUE )  Stock Down on Raising Additional Capital,https://www.zacks.com/stock/news/2200724/bluebird-blue-stock-down-on-raising-additional-capital,2023-12-20 18:18:00,bluebird (BLUE) issues shares to raise capital to support the commercialization and manufacturing of its three approved gene therapies. Its shares are down on the dilution of equity.,VRTX,0.140485,0.0756,Neutral
3 Reasons to Buy CRISPR Therapeutics Stock Like There's No Tomorrow,https://www.fool.com/investing/2023/12/20/3-reasons-to-buy-crispr-therapeutics-stock/,2023-12-20 10:00:00,CRISPR Therapeutics stock has increased in the double digits this year.,VRTX,0.061949,0.140056,Neutral
"Vertex Pharmaceuticals  ( NASDAQ:VRTX )  Downgraded by StockNews.com to ""Buy""",https://www.defenseworld.net/2023/12/20/vertex-pharmaceuticals-nasdaqvrtx-downgraded-by-stocknews-com-to-buy.html,2023-12-20 08:20:42,StockNews.com lowered shares of Vertex Pharmaceuticals ( NASDAQ:VRTX - Free Report ) from a strong-buy rating to a buy rating in a research report report published on Tuesday morning.,VRTX,0.716023,0.421723,Bullish
Xenon Pharmaceuticals Getting Closer To Key Technical Measure,https://www.investors.com/ibd-data-stories/xenon-pharmaceuticals-getting-closer-to-key-technical-measure/,2023-12-20 08:00:00,"Xenon Pharmaceuticals ( XENE ) had its Relative Strength ( RS ) Rating upgraded from 69 to 74 Wednesday -- a welcome improvement, but still below the 80 or higher score you prefer to see. When you're researching the best stocks to buy and watch, be sure to pay attention to relative price ...",VRTX,0.380012,0.0,Neutral
Stocks To Watch: Kura Oncology Sees RS Rating Jump To 85,https://www.investors.com/ibd-data-stories/stocks-to-watch-kura-oncology-sees-rs-rating-jump-to-85/,2023-12-20 08:00:00,"On Wednesday, Kura Oncology ( KURA ) reached a key performance benchmark, seeing its Relative Strength ( RS ) Rating jump into the 80-plus percentile with an improvement to 85, up from 79 the day before. X When looking for the best stocks to buy and watch, one factor to watch closely is ...",VRTX,0.366061,0.0,Neutral
Stock Upgrades: Editas Medicine Shows Rising Relative Strength,https://www.investors.com/ibd-data-stories/stock-upgrades-editas-medicine-shows-rising-relative-strength-6/,2023-12-20 08:00:00,"On Wednesday, Editas Medicine ( EDIT ) earned a positive adjustment to its Relative Strength ( RS ) Rating, from 88 to 91. X When looking for the best stocks to buy and watch, keep a close on eye on relative price strength. IBD's unique rating identifies price performance with a 1 ( worst ) ...",VRTX,0.345674,0.131373,Neutral
Arvinas Shows Rising Price Performance With Jump To 92 RS Rating,https://www.investors.com/ibd-data-stories/arvinas-shows-rising-price-performance-with-jump-to-92-rs-rating/,2023-12-20 08:00:00,"Arvinas ( ARVN ) saw a positive improvement to its Relative Strength ( RS ) Rating on Wednesday, rising from 89 to 92. X When looking for the best stocks to buy and watch, one factor to watch closely is relative price strength.",VRTX,0.343279,0.130676,Neutral
Structure Therap ADR Scores Relative Strength Rating Upgrade; Hits Key Benchmark,https://www.investors.com/ibd-data-stories/structure-therap-adr-scores-relative-strength-rating-upgrade-hits-key-benchmark/,2023-12-20 08:00:00,Structure Therap ADR Scores Relative Strength Rating Upgrade. Hits Key Benchmark Investor's Business Daily ...,VRTX,0.340915,0.0,Neutral
Stock Upgrades: Recursion Pharm Shows Rising Relative Strength,https://www.investors.com/ibd-data-stories/stock-upgrades-recursion-pharm-shows-rising-relative-strength/,2023-12-20 08:00:00,"When considering what names to put on your watch list, look for stocks with an 80 or higher RS Rating. Recursion Pharm ( RXRX ) is one stock that just reached the mark, now earning a score of 85. X When looking for the best stocks to buy and watch, one factor to watch closely is relative price ...",VRTX,0.327366,0.0,Neutral
Stocks To Watch: Mirum Pharmaceuticals Sees RS Rating Rise To 87,https://www.investors.com/ibd-data-stories/stocks-to-watch-mirum-pharmaceuticals-sees-rs-rating-rise-to-87/,2023-12-20 08:00:00,"The Relative Strength ( RS ) Rating for Mirum Pharmaceuticals ( MIRM ) climbed into a new percentile Wednesday, with an increase from 80 to 87. X When looking for the best stocks to buy and watch, one factor to watch closely is relative price strength.",VRTX,0.308891,0.0,Neutral
$1000 Invested In Vertex Pharmaceuticals 20 Years Ago Would Be Worth This Much Today - Vertex Pharmaceuticals  ( NASDAQ:VRTX ) ,https://www.benzinga.com/news/23/12/36306828/1000-invested-in-vertex-pharmaceuticals-20-years-ago-would-be-worth-this-much-today,2023-12-19 15:32:32,"Vertex Pharmaceuticals VRTX has outperformed the market over the past 20 years by 12.73% on an annualized basis producing an average annual return of 20.32%. Currently, Vertex Pharmaceuticals has a market capitalization of $103.67 billion.",VRTX,0.980595,0.386944,Bullish
Better Growth Stock: Archer Aviation or Prime Medicine?,https://www.fool.com/investing/2023/12/19/better-growth-stock-archer-aviation-or-prime-medic/,2023-12-19 15:30:00,Which of these innovation-themed growth stocks is the better buy?,VRTX,0.059049,0.125,Neutral
Charles River's  ( CRL )  Memphis Site Achieves Crucial Approval,https://www.zacks.com/stock/news/2199833/charles-rivers-crl-memphis-site-achieves-crucial-approval,2023-12-19 13:01:00,Charles River (CRL) reaches an important milestone in cell therapy manufacturing collaboration with Vertex Pharmaceuticals.,VRTX,0.143415,0.072807,Neutral
3 Healthcare Stocks That Could Help Make You a Millionaire,https://www.fool.com/investing/2023/12/19/3-healthcare-stocks-could-help-make-you-rich/,2023-12-19 10:00:00,These stocks each have reached an important turning point that could signal growth ahead.,VRTX,0.05339,0.294926,Somewhat-Bullish
"The Zacks Analyst Blog Highlights Novo Nordisk, Eli Lilly, Vertex Pharmaceuticals, Regeneron and GSK",https://www.zacks.com/stock/news/2199740/the-zacks-analyst-blog-highlights-novo-nordisk-eli-lilly-vertex-pharmaceuticals-regeneron-and-gsk,2023-12-19 09:34:00,"Novo Nordisk, Eli Lilly, Vertex Pharmaceuticals, Regeneron and GSK are included in this Analyst Blog.",VRTX,0.067347,0.08218,Neutral
"Vivos Therapeutics Clears Key Benchmark, Hitting 90-Plus RS Rating",https://www.investors.com/ibd-data-stories/vivos-therapeutics-clears-key-benchmark-hitting-90-plus-rs-rating/,2023-12-19 08:00:00,"On Tuesday, Vivos Therapeutics ( VVOS ) earned a positive adjustment to its Relative Strength ( RS ) Rating, from 81 to 93. X When looking for the best stocks to buy and watch, one factor to watch closely is relative price strength.",VRTX,0.323078,0.129183,Neutral
Celldex Therapeutics Earns Relative Strength Rating Upgrade,https://www.investors.com/ibd-data-stories/celldex-therapeutics-earns-relative-strength-rating-upgrade-2/,2023-12-19 08:00:00,"Celldex Therapeutics ( CLDX ) saw a welcome improvement to its Relative Strength ( RS ) Rating on Tuesday, with an increase from 67 to 72. When looking for the best stocks to buy and watch, one factor to watch closely is relative price strength.",VRTX,0.316846,0.0,Neutral
"Vertex  ( VRTX ) , CRISPR Get Positive CHMP Opinion for Gene-Therapy",https://www.zacks.com/stock/news/2199442/vertex-vrtx-crispr-get-positive-chmp-opinion-for-gene-therapy,2023-12-18 14:58:00,"Vertex (VRTX) and CRISPR get a positive CHMP opinion, recommending the conditional approval of Casgevy for the treatment of SCD and TDT.",VRTX,0.182162,0.149685,Neutral
3 Biotech Stocks Most Wall Street Analysts Are Bullish About,https://www.zacks.com/stock/news/2199324/3-biotech-stocks-most-wall-street-analysts-are-bullish-about,2023-12-18 14:01:00,"Here we present three biotech stocks, CRSP, ITCI and DVAX, which most analysts on Wall Street are optimistic about. These companies have upside potential for 2024, backed by strong fundamentals.",VRTX,0.037563,0.202684,Somewhat-Bullish
5 Big Drug Stocks That May Continue to Outperform in 2024,https://www.zacks.com/stock/news/2199316/5-big-drug-stocks-that-may-continue-to-outperform-in-2024,2023-12-18 13:54:00,"Novo Nordisk (NVO), Eli Lilly (LLY), Vertex Pharmaceuticals (VRTX), Regeneron (REGN) and GSK (GSK) have been performing well this year. These stocks are poised to keep the momentum alive in 2024.",VRTX,0.046588,0.141465,Neutral
2 Stocks Profiting From Unstoppable Trends That Could Make You Rich,https://www.fool.com/investing/2023/12/18/2-stocks-that-could-make-you-rich/,2023-12-18 10:30:00,It's important to choose companies involved in trends that have long-term potential.,VRTX,0.126784,0.223686,Somewhat-Bullish
Stocks With Rising Relative Price Strength: Arcturus Therapeutics,https://www.investors.com/ibd-data-stories/stocks-with-rising-relative-price-strength-arcturus-therapeutics-2/,2023-12-18 08:00:00,"Arcturus Therapeutics ( ARCT ) had its Relative Strength ( RS ) Rating upgraded from 88 to 91 Monday. X When looking for the best stocks to buy and watch, one factor to watch closely is relative price strength.",VRTX,0.363388,0.136437,Neutral
"2 Stocks That Could Turn $1,000 Into $3,500 in 10 Years",https://www.fool.com/investing/2023/12/17/2-stocks-that-could-turn-1000-into-3500-in-10-year/,2023-12-17 13:45:00,These businesses are exciting and can also lead to outsized long-term returns.,VRTX,0.098054,0.157483,Somewhat-Bullish
It's Been An Abysmal Two Years. But Biotech Is Looking Up.,https://www.investors.com/news/technology/biotech-stocks-pharma-heat-up-in-2024-as-buyouts-obesity-ai-drive-excitement/,2024-01-05 14:00:00,"Biotech Stocks, Pharma Heat Up In 2024 As Buyouts, Obesity And AI Drive Excitement Investor's Business Daily ...",VRTX,0.02379,0.067127,Neutral
2 Biotech Stocks With Huge Catalysts in 2024,https://www.fool.com/investing/2024/01/05/2-biotech-stocks-with-huge-catalysts-in-2024/,2024-01-05 10:34:00,Important clinical-trial readouts on the way could send these stocks soaring in early 2024.,VRTX,0.160633,0.150694,Somewhat-Bullish
Stran & Company Appoints Ian Thomas Wall as Chief Information Officer,https://www.globenewswire.com/news-release/2024/01/04/2804023/0/en/Stran-Company-Appoints-Ian-Thomas-Wall-as-Chief-Information-Officer.html,2024-01-04 14:00:00,"Quincy, MA, Jan. 04, 2024 ( GLOBE NEWSWIRE ) -- Stran & Company, Inc. ( ""Stran"" or the ""Company"" ) ( NASDAQ: SWAG. SWAGW ) , a leading outsourced marketing solutions provider that leverages its promotional products and loyalty incentive expertise, announces that it has appointed Ian Thomas Wall ...",VRTX,0.04794,0.073616,Neutral
"The Best Stocks to Invest $1,000 in Right Now",https://www.fool.com/investing/2024/01/04/the-best-stocks-to-invest-1000-in-right-now/,2024-01-04 14:00:00,It's not too late to get in on these market beaters.,VRTX,0.168099,0.264564,Somewhat-Bullish
Here's Why 2024 Could Be a Big Year for CRISPR Therapeutics,https://www.fool.com/investing/2024/01/04/heres-why-2024-could-be-a-big-year-for-crispr-ther/,2024-01-04 10:00:00,CRISPR Therapeutics' shares climbed considerably last year -- but more gains could be just ahead.,VRTX,0.061949,0.062005,Neutral
StockNews.com Downgrades Vertex Pharmaceuticals  ( NASDAQ:VRTX )  to Buy,https://www.defenseworld.net/2024/01/04/stocknews-com-downgrades-vertex-pharmaceuticals-nasdaqvrtx-to-buy.html,2024-01-04 06:24:45,"Vertex Pharmaceuticals ( NASDAQ:VRTX - Get Free Report ) was downgraded by equities research analysts at StockNews.com from a ""strong-buy"" rating to a ""buy"" rating in a research note issued to investors on Thursday.",VRTX,0.735169,0.465748,Bullish
InnovationRx: TikTok's Parent Company Is Moving Into Pharma,https://www.forbes.com/sites/katiejennings/2024/01/03/innovationrx-tiktoks-parent-company-is-moving-into-pharma/,2024-01-03 22:54:26,"InnovationRx is your weekly digest of healthcare news. To get it in your inbox, subscribe here.",VRTX,0.062597,0.072015,Neutral
Vertex Pharmaceuticals  ( VRTX )  Stock Moves -0.05%: What You Should Know,https://www.zacks.com/stock/news/2205305/vertex-pharmaceuticals-vrtx-stock-moves--005-what-you-should-know,2024-01-03 22:50:17,"Vertex Pharmaceuticals (VRTX) concluded the recent trading session at $410.71, signifying a -0.05% move from its prior day's close.",VRTX,0.571903,0.262764,Somewhat-Bullish
Voyager  ( VYGR )  Gains on Gene Therapy Deal With Novartis,https://www.zacks.com/stock/news/2205112/voyager-vygr-gains-on-gene-therapy-deal-with-novartis,2024-01-03 16:15:00,Voyager (VYGR) enters into a capsid license agreement with Novartis for Huntington's disease and spinal muscular atrophy. The infusion of cash will extend the company's cash runway.,VRTX,0.059785,0.073998,Neutral
Is Invesco Biotechnology & Genome ETF  ( PBE )  a Strong ETF Right Now?,https://www.zacks.com/stock/news/2204768/is-invesco-biotechnology-genome-etf-pbe-a-strong-etf-right-now,2024-01-03 11:20:07,Smart Beta ETF report for ...,VRTX,0.116631,0.066983,Neutral
January Has Been 1 of the Worst Months for the S&P 500 Over the Last 20 Years. Here Are 3 Stocks to Buy Anyway.,https://www.fool.com/investing/2024/01/03/january-worst-month-sp-500-stocks-buy/,2024-01-03 10:50:00,"These stocks are smart picks to buy now, regardless of whether the S&P 500 stocks start off 2024 poorly.",VRTX,0.126784,0.139505,Neutral
A Closer Look at CRISPR Therapeutics's Options Market Dynamics - CRISPR Therapeutics  ( NASDAQ:CRSP ) ,https://www.benzinga.com/markets/options/24/01/36456642/a-closer-look-at-crispr-therapeuticss-options-market-dynamics,2024-01-02 18:01:16,"High-rolling investors have positioned themselves bearish on CRISPR Therapeutics CRSP, and it's important for retail traders to take note. \This activity came to our attention today through Benzinga's tracking of publicly available options data.",VRTX,0.073546,0.154411,Somewhat-Bullish
Editas  ( EDIT )  Stock Gains 23% in the Past 6 Months: Here's Why,https://www.zacks.com/stock/news/2204495/editas-edit-stock-gains-23-in-the-past-6-months-heres-why,2024-01-02 15:15:00,"Editas (EDIT) shares have gained 23% in the past six months, driven by encouraging findings from the EDIT-301 studies in SCD and TDT, along with a licensing deal for its CAS9 gene-editing tool with Vertex.",VRTX,0.089629,0.121267,Neutral
"""Murder In Boston"" Reopens The City's Troubled History Of Race Relations: One Path Forward",https://www.forbes.com/sites/sachinjain/2024/01/01/murder-in-boston-reopens-the-citys-troubled-history-of-race-relations-one-path-forward/,2024-01-01 17:41:37,"Charles Stuart shot his pregnant wife Carol and himself on the way out of a birthing class at the Brigham and Women's Hospital. When Stuart, a white man, called 911 for assistance, he implicated a fictitious ""black man"" who fled into Boston's Mission Hill neighborhood.",VRTX,0.027667,0.155307,Somewhat-Bullish
3 No-Brainer Growth Stocks to Buy for Less Than $100,https://www.fool.com/investing/2024/01/01/3-no-brainer-growth-stocks-to-buy-for-less-than-10/,2024-01-01 14:05:00,These businesses have promising futures and make for great investment options today.,VRTX,0.061949,0.117349,Neutral
Prediction: These 3 Stocks Will Soar in 2024,https://www.fool.com/investing/2024/01/01/prediction-these-3-stocks-will-soar-in-2024/,2024-01-01 11:50:00,Investors could enjoy an especially happy new year with these great stocks.,VRTX,0.121241,0.009226,Neutral
1 Cathie Wood Stock Worth Buying Hand Over Fist in 2024,https://www.fool.com/investing/2023/12/31/1-cathie-wood-stock-worth-buying-hand-over-fist-in/,2023-12-31 15:30:00,Ark Invest holds a hefty position in this gene-editing stock. Risk-tolerant investors may want to take a page from the fund's playbook on this name.,VRTX,0.147818,0.057218,Neutral
2 Gene-Editing Stocks That Might Be the Next CRISPR Therapeutics,https://www.fool.com/investing/2023/12/31/gene-editing-stocks-that-might-be-the-next-crispr/,2023-12-31 13:45:00,Curing rare inherited illnesses could be a lucrative business model.,VRTX,0.112269,0.157128,Somewhat-Bullish
"2023 in Review: Nvidia, Interest Rates, Taylor Swift",https://www.fool.com/investing/2023/12/30/2023-in-review-nvidia-interest-rates-taylor-swift/,2023-12-30 13:00:00,And a little bit of real estate insight.,VRTX,0.006353,0.099553,Neutral
3 Stocks That Could Be Monster Winners in 2024,https://www.fool.com/investing/2023/12/30/3-stocks-that-could-be-monster-winners-in-2024/,2023-12-30 11:50:00,Don't be surprised if these three stocks take off in the new year.,VRTX,0.088799,0.2227,Somewhat-Bullish
"Want $1 Million in Retirement? Invest $300,000 in These 3 Stocks and Wait a Decade.",https://www.fool.com/investing/2023/12/30/1-million-retirement-invest-stocks-wait-decade/,2023-12-30 10:50:00,These stocks offer attractive risk-reward profiles.,VRTX,0.098255,0.082414,Neutral
2 Exceptional Growth Stocks Up 42% and 66% to Buy Right Now,https://www.fool.com/investing/2023/12/29/2-exceptional-growth-stocks-up-42-and-66-to-buy/,2023-12-29 12:00:00,"It's been a crazy year across sectors, but winners remain.",VRTX,0.113062,0.059546,Neutral
"Gene Editing, Obesity Drugs And Long-Living Dogs: The Year In Biotech",https://www.forbes.com/sites/alexknapp/2023/12/29/gene-editing-obesity-drugs-and-long-living-dogs-the-year-in-biotech/,2023-12-29 11:30:00,"ike a lot of sectors, the biopharma industry kicked off a tumultuous year with a number of shakeups. Big and small biotech companies alike saw thousands of layoffs, not to mention significant leadership changes. In the startup landscape, one big change has been a strategic shift among investors.",VRTX,0.029184,0.06454,Neutral
"Casgevy approval unlikely to be followed up by another CRISPR drug in near future, says GlobalData",https://www.financialexpress.com/healthcare/pharma-healthcare/casgevy-approval-unlikely-to-be-followed-up-by-another-crispr-drug-in-near-future-says-globaldata/3349959/,2023-12-29 01:30:00,"Vertex Pharmaceuticals and CRISPR Therapeutics made history last month by gaining approval for the first CRISPR-based drug, exagamglogene autotemcel ( Casgevy ) .",VRTX,0.158519,0.150224,Somewhat-Bullish
Vertex Pharmaceuticals  ( VRTX )  Beats Stock Market Upswing: What Investors Need to Know,https://www.zacks.com/stock/news/2203367/vertex-pharmaceuticals-vrtx-beats-stock-market-upswing-what-investors-need-to-know,2023-12-28 22:50:19,"In the most recent trading session, Vertex Pharmaceuticals (VRTX) closed at $409.27, indicating a +0.3% shift from the previous trading day.",VRTX,0.468029,0.264644,Somewhat-Bullish
Decoding Vertex Pharmaceuticals's Options Activity: What's the Big Picture? - Vertex Pharmaceuticals  ( NASDAQ:VRTX ) ,https://www.benzinga.com/markets/options/23/12/36402803/decoding-vertex-pharmaceuticalss-options-activity-whats-the-big-picture,2023-12-27 19:16:08,"High-rolling investors have positioned themselves bearish on Vertex Pharmaceuticals VRTX, and it's important for retail traders to take note. \This activity came to our attention today through Benzinga's tracking of publicly available options data.",VRTX,0.777061,0.12708,Neutral
3 Reasons to Buy Vertex Pharmaceuticals Stock Like There's No Tomorrow,https://www.fool.com/investing/2023/12/27/3-reasons-to-buy-vertex-pharmaceuticals-stock-like/,2023-12-27 11:45:00,"With a new medicine on the market and plenty of money, Vertex is in great shape.",VRTX,0.13347,0.299724,Somewhat-Bullish
3 Monster Stocks to Buy Without Any Hesitation,https://www.fool.com/investing/2023/12/27/3-monster-stocks-to-buy-without-any-hesitation/,2023-12-27 10:50:00,These are easy choices for investors seeking market-beating long-term gains.,VRTX,0.109455,0.08296,Neutral
Vertex Pharmaceuticals  ( NASDAQ:VRTX )  Upgraded at StockNews.com,https://www.defenseworld.net/2023/12/27/vertex-pharmaceuticals-nasdaqvrtx-upgraded-at-stocknews-com.html,2023-12-27 06:18:43,"Vertex Pharmaceuticals ( NASDAQ:VRTX - Get Free Report ) was upgraded by analysts at StockNews.com from a ""buy"" rating to a ""strong-buy"" rating in a research report issued on Wednesday. Several other research analysts also recently weighed in on the stock.",VRTX,0.791081,0.472297,Bullish
Here's Why CRISPR Therapeutics Stock Rose 54% Last Year,https://www.fool.com/investing/2024/01/15/heres-why-crispr-therapeutics-stock-rose-54-last-y/,2024-01-15 21:56:00,Key regulatory developments sent this biotech stock higher.,VRTX,0.139669,0.117333,Neutral
"Down 88%, Could Editas Medicine Be a Good Investment Now?",https://www.fool.com/investing/2024/01/15/down-88-could-editas-medicine-be-a-good-investment/,2024-01-15 10:19:00,"The past few years have been difficult ones, but shares of the gene editor are far more attractive now that a CRISPR medicine has passed regulatory hurdles.",VRTX,0.24289,0.207009,Somewhat-Bullish
What Does It Mean for Investors if CRISPR Therapeutics Gets Bought Out in 2024?,https://www.fool.com/investing/2024/01/14/what-does-it-mean-if-crispr-gets-bought-out/,2024-01-14 18:30:00,An acquisition could be both a blessing and a curse for long-term investors.,VRTX,0.053035,0.170688,Somewhat-Bullish
My 3 Highest-Conviction Growth Stocks to Buy in 2024,https://www.fool.com/investing/2024/01/14/my-3-highest-conviction-growth-stocks-to-buy-in-20/,2024-01-14 15:13:00,"Simply put, these stocks inspire confidence.",VRTX,0.096866,0.071053,Neutral
3 Growth Stocks to Buy That Could Be Massive Long-Term Winners,https://www.fool.com/investing/2024/01/14/3-growth-stocks-to-buy-that-could-be-massive-long/,2024-01-14 14:00:00,These stocks appear to have what it takes to keep up their winning ways.,VRTX,0.116067,0.159005,Somewhat-Bullish
My 5 Top Growth Stocks to Buy Hand Over Fist for 2024,https://www.fool.com/investing/2024/01/14/my-5-top-growth-stocks-to-buy-for-2024/,2024-01-14 10:10:00,2024 could be a year of growth.,VRTX,0.036756,0.277177,Somewhat-Bullish
Want to Get Richer? 2 Stocks to Buy and Hold for 10 Years,https://www.fool.com/investing/2024/01/13/want-to-get-richer-2-stocks-to-buy-and-hold-for-10/,2024-01-13 13:00:00,These companies are leaders in their respective fields.,VRTX,0.116914,0.081648,Neutral
3 Unstoppable Stocks to Buy in 2024,https://www.fool.com/investing/2024/01/13/3-unstoppable-stocks-to-buy-in-2024/,2024-01-13 12:48:00,These stocks appear to be on a clear path to continued growth.,VRTX,0.349945,0.133208,Neutral
Cathie Wood Goes Bargain Hunting: 3 Stocks She Bought This Week,https://www.fool.com/investing/2024/01/13/cathie-wood-bargain-hunts-3-stocks-she-bought/,2024-01-13 10:20:00,These companies could stand out thanks to game-changing technology.,VRTX,0.04583,0.174802,Somewhat-Bullish
"Uber, Abbott Laboratories, Vertex Pharmaceuticals And More On CNBC's 'Final Trades' - Abbott Laboratories  ( NYSE:ABT ) , Uber Technologies  ( NYSE:UBER ) ",https://www.benzinga.com/trading-ideas/long-ideas/24/01/36606668/uber-abbott-laboratories-vertex-pharmaceuticals-and-more-on-cnbcs-final-trades,2024-01-12 13:51:03,"On CNBC's ""Halftime Report Final Trades,"" Joshua Brown of Ritholtz Wealth Management said Uber Technologies, Inc. UBER shares hit an all-time high on Thursday above the Feb. 2021 high. He remains long on the stock and still loves it.",VRTX,0.436009,0.618511,Bullish
"Arena BioWorks Launches as a Privately Funded, Fully Independent Biomedical Institute to Shorten the Path from Insight to Therapeutics",https://www.prnewswire.com/news-releases/arena-bioworks-launches-as-a-privately-funded-fully-independent-biomedical-institute-to-shorten-the-path-from-insight-to-therapeutics-302033563.html,2024-01-12 11:30:00,"Arena BioWorks Launches as a Privately Funded, Fully Independent Biomedical Institute to Shorten the Path from ... PR ...",VRTX,0.019026,0.055053,Neutral
Unpacking the Latest Options Trading Trends in Vertex Pharmaceuticals - Vertex Pharmaceuticals  ( NASDAQ:VRTX ) ,https://www.benzinga.com/markets/options/24/01/36598743/unpacking-the-latest-options-trading-trends-in-vertex-pharmaceuticals,2024-01-11 17:46:48,"Whales with a lot of money to spend have taken a noticeably bearish stance on Vertex Pharmaceuticals. Looking at options history for Vertex Pharmaceuticals VRTX we detected 8 trades. If we consider the specifics of each trade, it is accurate to state that 25% of the investors opened trades with ...",VRTX,0.592095,0.028215,Neutral
State Economics - Spotlight on New England: The Kiplinger Letter,https://www.kiplinger.com/personal-finance/job-search/state-economics-new-england-the-kiplinger-letter,2024-01-11 12:47:28,"After the 2023 boom, New England states see modest employment growth Kiplinger's Personal Finance ...",VRTX,0.047465,0.209683,Somewhat-Bullish
"Focal Segmental Glomerulosclerosis Market to Observe Impressive Growth by 2032, Predicts DelveInsight | Leading Companies - ACELYRIN, Genentech, ChemoCentryx, Travere Therapeutics, Boehringer Ingelheim, Chinook Therapeutics",https://www.prnewswire.com/news-releases/focal-segmental-glomerulosclerosis-market-to-observe-impressive-growth-by-2032-predicts-delveinsight--leading-companies---acelyrin-genentech-chemocentryx-travere-therapeutics-boehringer-ingelheim-chinook-therapeutics-302030785.html,2024-01-10 22:01:00,"Focal Segmental Glomerulosclerosis Market to Observe Impressive Growth by 2032, Predicts DelveInsight | Leading ... PR ...",VRTX,0.028321,0.038274,Neutral
2 Red Flags for Bluebird Bio Stock,https://www.fool.com/investing/2024/01/10/2-red-flags-for-bluebird-bio-stock/,2024-01-10 11:55:00,The biotech's struggles may continue.,VRTX,0.123526,-0.029978,Neutral
These 3 Stocks Have Beaten the S&P Average Return for Years and Are Likely to Continue That Trend,https://www.fool.com/investing/2024/01/10/these-3-stocks-have-beaten-the-sp-average-return-f/,2024-01-10 10:51:00,These winners seem likely to keep up their winning ways.,VRTX,0.110462,-0.147233,Neutral
ESG Is Under Fire. How These 5 Funds Still Beat the Market.,https://www.barrons.com/amp/articles/top-esg-funds-nvidia-active-f851057c,2024-01-10 07:30:00,The Top ESG Funds Held Nvidia and Other ...,VRTX,0.042122,0.195868,Somewhat-Bullish
Here's How Much You'd Have If You Invested $1000 in Vertex Pharmaceuticals a Decade Ago,https://www.zacks.com/stock/news/2207791/heres-how-much-youd-have-if-you-invested-1000-in-vertex-pharmaceuticals-a-decade-ago,2024-01-09 22:54:34,"Investing in certain stocks can pay off in the long run, especially if you hold on for a decade or more.",VRTX,0.422493,0.202301,Somewhat-Bullish
Vertex Pharmaceuticals  ( VRTX )  Ascends While Market Falls: Some Facts to Note,https://www.zacks.com/stock/news/2207797/vertex-pharmaceuticals-vrtx-ascends-while-market-falls-some-facts-to-note,2024-01-09 22:50:20,"In the most recent trading session, Vertex Pharmaceuticals (VRTX) closed at $421.01, indicating a +0.45% shift from the previous trading day.",VRTX,0.561606,0.216119,Somewhat-Bullish
What Makes Vertex Pharmaceuticals  ( VRTX )  a Strong Momentum Stock: Buy Now?,https://www.zacks.com/stock/news/2207704/what-makes-vertex-pharmaceuticals-vrtx-a-strong-momentum-stock-buy-now,2024-01-09 21:56:02,Does Vertex Pharmaceuticals (VRTX) have what it takes to be a top stock pick for momentum investors? Let's find out.,VRTX,0.596651,0.351022,Bullish
Should You Invest in the Invesco Biotechnology & Genome ETF  ( PBE ) ?,https://www.zacks.com/stock/news/2207718/should-you-invest-in-the-invesco-biotechnology-genome-etf-pbe,2024-01-09 21:54:49,Sector ETF report for ...,VRTX,0.128135,0.069783,Neutral
Biotech ETFs Stage Solid Comeback at the Start of 2024,https://www.zacks.com/stock/news/2207551/biotech-etfs-stage-solid-comeback-at-the-start-of-2024,2024-01-09 16:05:00,"The biotech space staged a strong comeback at the start of 2024, driven by multi-billion dollar deals, upbeat clinical results and cutting-edge medical advances like CRISPR gene-editing hitting prime-time.",VRTX,0.089129,0.084886,Neutral
A Look Into Vertex Pharmaceuticals Inc's Price Over Earnings - Vertex Pharmaceuticals  ( NASDAQ:VRTX ) ,https://www.benzinga.com/news/24/01/36557818/a-look-into-vertex-pharmaceuticals-incs-price-over-earnings,2024-01-09 14:45:15,"In the current session, the stock is trading at $419.65, after a 0.13% increase. Over the past month, Vertex Pharmaceuticals Inc. VRTX stock increased by 17.04%, and in the past year, by 43.26%.",VRTX,0.412298,0.116901,Neutral
Nuvation Bio Announces Appointment of Dr. Robert Mashal to its Board of Directors,https://investingnews.com/nuvation-bio-announces-appointment-of-dr-robert-mashal-to-its-board-of-directors/,2024-01-08 22:14:51,"Nuvation Bio Inc. ( NYSE: NUVB ) , a biopharmaceutical company tackling some of the greatest unmet needs in oncology by developing differentiated and novel therapeutic candidates, today announced the appointment of Robert Mashal, M.D. to its Board of Directors.",VRTX,0.095899,-0.008432,Neutral
MaxCyte Announces Preliminary Unaudited Fourth Quarter and Full Year 2023 Financial Results,https://www.globenewswire.com/news-release/2024/01/08/2805839/0/en/MaxCyte-Announces-Preliminary-Unaudited-Fourth-Quarter-and-Full-Year-2023-Financial-Results.html,2024-01-08 21:05:00,"ROCKVILLE, MD, January 8, 2024 - MaxCyte, Inc., ( NASDAQ: MXCT.",VRTX,0.039353,0.252586,Somewhat-Bullish
MaxCyte Announces Preliminary Unaudited Fourth Quarter and Full Year 2023 Financial Results,https://www.globenewswire.com/news-release/2024/01/08/2805846/0/en/MaxCyte-Announces-Preliminary-Unaudited-Fourth-Quarter-and-Full-Year-2023-Financial-Results.html,2024-01-08 21:05:00,"ROCKVILLE, Md., Jan. 08, 2024 ( GLOBE NEWSWIRE ) -- MaxCyte, Inc., ( NASDAQ: MXCT. LSE: MXCT ) , a leading, cell-engineering focused company providing enabling platform technologies to advance the discovery, development and commercialization of next-generation cell therapeutics and innovative ...",VRTX,0.039224,0.252519,Somewhat-Bullish
MaxCyte Announces Preliminary Unaudited Fourth Quarter and Full Year 2023 Financial Results - MaxCyte  ( NASDAQ:MXCT ) ,https://www.benzinga.com/pressreleases/24/01/g36544610/maxcyte-announces-preliminary-unaudited-fourth-quarter-and-full-year-2023-financial-results,2024-01-08 21:05:00,"ROCKVILLE, Md., Jan. 08, 2024 ( GLOBE NEWSWIRE ) -- MaxCyte, Inc., MXCTMXCT ) ) , a leading, cell-engineering focused company providing enabling platform technologies to advance the discovery, development and commercialization of next-generation cell therapeutics and innovative bioprocessing ...",VRTX,0.038843,0.252315,Somewhat-Bullish
"$1000 Invested In This Stock 15 Years Ago Would Be Worth $14,000 Today - Vertex Pharmaceuticals  ( NASDAQ:VRTX ) ",https://www.benzinga.com/news/24/01/36539655/1000-invested-in-this-stock-15-years-ago-would-be-worth-14-000-today,2024-01-08 17:30:15,"Vertex Pharmaceuticals VRTX has outperformed the market over the past 15 years by 6.9% on an annualized basis producing an average annual return of 18.8%. Currently, Vertex Pharmaceuticals has a market capitalization of $106.68 billion.",VRTX,0.980595,0.386944,Bullish
Will Vertex  ( VRTX )  Beat Estimates Again in Its Next Earnings Report?,https://www.zacks.com/stock/news/2207133/will-vertex-vrtx-beat-estimates-again-in-its-next-earnings-report,2024-01-08 17:10:11,Vertex (VRTX) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.,VRTX,0.173958,0.210994,Somewhat-Bullish
PBYI vs. VRTX: Which Stock Is the Better Value Option?,https://www.zacks.com/stock/news/2207091/pbyi-vs-vrtx-which-stock-is-the-better-value-option,2024-01-08 16:40:12,Investors interested in Medical - Biomedical and Genetics stocks are likely familiar with Puma Biotech ( PBYI Quick QuotePBYI - ) and Vertex Pharmaceuticals ( VRTX Quick QuoteVRTX - ) . But which of these two stocks offers value investors a better bang for their buck right now?,VRTX,0.68471,0.522443,Bullish
Editas Medicine Highlights 2024 Anticipated Milestones and Strategic Priorities at the J.P. Morgan Healthcare Conference - Editas Medicine  ( NASDAQ:EDIT ) ,https://www.benzinga.com/pressreleases/24/01/g36532383/editas-medicine-highlights-2024-anticipated-milestones-and-strategic-priorities-at-the-j-p-morgan-,2024-01-08 13:15:00,"Anticipated 2024 milestones include: present reni-cel clinical data updates mid-year and year-end, initiate the RUBY clinical trial adolescent cohort, establish in vivo preclinical proof-of-concept for an undisclosed indication, and continue to sublicense foundational IP",VRTX,0.04531,0.102362,Neutral
Editas Medicine Highlights 2024 Anticipated Milestones and Strategic Priorities at the J.P. Morgan Healthcare Conference,https://www.globenewswire.com/news-release/2024/01/08/2805430/0/en/Editas-Medicine-Highlights-2024-Anticipated-Milestones-and-Strategic-Priorities-at-the-J-P-Morgan-Healthcare-Conference.html,2024-01-08 13:15:00,"Anticipated 2024 milestones include: present reni-cel clinical data updates mid-year and year-end, initiate the RUBY clinical trial adolescent cohort, establish in vivo preclinical proof-of-concept for an undisclosed indication, and continue to sublicense foundational IP ...",VRTX,0.031079,0.051041,Neutral
Better Gene-Editing Stock: Editas Medicine vs. Intellia Therapeutics,https://www.fool.com/investing/2024/01/08/better-gene-editing-stock-editas-medicine-vs-intel/,2024-01-08 12:45:00,These two are at very different stages of the clinical trials process.,VRTX,0.056674,0.075978,Neutral
"The Ultimate Growth Stock to Buy With $1,000 Right Now",https://www.fool.com/investing/2024/01/08/the-ultimate-growth-stock-to-buy-with-1000-now/,2024-01-08 10:00:00,"The stock, trading for about $60, has plenty of room to run.",VRTX,0.055751,0.138,Neutral
Clarivate Identifies Thirteen Potential Blockbuster Drugs and Gamechangers in Annual Drugs to Watch Report,https://www.prnewswire.com/news-releases/clarivate-identifies-thirteen-potential-blockbuster-drugs-and-gamechangers-in-annual-drugs-to-watch-report-302027294.html,2024-01-08 08:00:00,"Therapeutic advancements for sickle cell disease, RSV, breast cancer, Crohn's and other ailments poised to advance patient health despite urgent challenges facing life science companies",VRTX,0.020266,0.0,Neutral
Clarivate Identifies Thirteen Potential Blockbuster Drugs and Gamechangers in Annual Drugs to Watch Report,https://www.newswire.ca/news-releases/clarivate-identifies-thirteen-potential-blockbuster-drugs-and-gamechangers-in-annual-drugs-to-watch-report-802561925.html,2024-01-08 08:00:00,"Therapeutic advancements for sickle cell disease, RSV, breast cancer, Crohn's and other ailments poised to advance patient health despite urgent challenges facing life science companies",VRTX,0.020266,0.0,Neutral
5 Top Stocks to Buy in January,https://www.fool.com/investing/2024/01/07/5-top-stocks-to-buy-in-january/,2024-01-07 10:45:00,Start the year off right by investing in these quality businesses.,VRTX,0.086478,0.156576,Somewhat-Bullish
Is Vertex Pharmaceuticals Stock a Buy Now?,https://www.fool.com/investing/2024/01/06/is-vertex-pharmaceuticals-stock-a-buy-now/,2024-01-06 13:45:00,The biotech's prospects keep improving.,VRTX,0.475618,0.430073,Bullish
Where Will Vertex Pharmaceuticals Be in 10 Years?,https://www.fool.com/investing/2024/01/25/where-will-vertex-pharmaceuticals-be-in-10-years/,2024-01-25 17:00:00,"As the adage goes, winners keep winning.",VRTX,0.359014,0.36705,Bullish
Could Sarepta Therapeutics Become the Next Vertex Pharmaceuticals?,https://www.fool.com/investing/2024/01/25/could-sarepta-therapeutics-become-the-next-vertex/,2024-01-25 14:45:00,It's always tough to be compared to a giant.,VRTX,0.217834,0.100139,Neutral
"Slow Market Penetration For Biogen's Another Alzheimer's Drug: UBS Highlights Risks, Forecasts - Biogen  ( NASDAQ:BIIB ) ",https://www.benzinga.com/analyst-ratings/analyst-color/24/01/36766392/slow-market-penetration-for-biogens-another-alzheimers-drug-ubs-highlights-risks-fo,2024-01-24 19:55:14,"UBS has downgraded Biogen Inc BIIB, noting inflection for its second Alzheimer's drug Leqembi ( lecanemab ) will take longer than anticipated.",VRTX,0.214937,0.122634,Neutral
PBYI or VRTX: Which Is the Better Value Stock Right Now?,https://www.zacks.com/stock/news/2215148/pbyi-or-vrtx-which-is-the-better-value-stock-right-now,2024-01-24 16:40:10,PBYI vs. VRTX: Which Stock Is the Better Value Option?,VRTX,0.614479,0.526631,Bullish
Where Will CRISPR Therapeutics Be in 5 Years?,https://www.fool.com/investing/2024/01/24/where-will-crispr-therapeutics-be-in-5-years/,2024-01-24 14:45:00,The company could maintain the momentum it gained last year.,VRTX,0.116914,0.117678,Neutral
Wall Street Bulls Look Optimistic About Vertex  ( VRTX ) : Should You Buy?,https://www.zacks.com/stock/news/2214956/wall-street-bulls-look-optimistic-about-vertex-vrtx-should-you-buy,2024-01-24 14:30:05,"According to the average brokerage recommendation (ABR), one should invest in Vertex (VRTX). It is debatable whether this highly sought-after metric is effective because Wall Street analysts' recommendations tend to be overly optimistic. Would it be worth investing in the stock?",VRTX,0.05387,0.14275,Neutral
"Netflix To Rally Around 18%? Here Are 10 Top Analyst Forecasts For Wednesday - Endava  ( NYSE:DAVA ) , Apellis Pharmaceuticals  ( NASDAQ:APLS ) ",https://www.benzinga.com/news/24/01/36755283/netflix-to-rally-around-18-here-are-10-top-analyst-forecasts-for-wednesday,2024-01-24 12:18:30,"Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our analyst ratings page. Keybanc raised Texas Instruments Incorporated TXN price target from $180 to $200.",VRTX,0.242084,-0.037199,Neutral
2 Super Stocks You'll Wish 5 Years From Now That You'd Bought Today,https://www.fool.com/investing/2024/01/24/2-super-stocks-youll-wish-youd-bought-today-5-year/,2024-01-24 10:15:00,These powerhouse stocks still have plenty of growth catalysts to tap into over the coming years.,VRTX,0.094762,0.152512,Somewhat-Bullish
Vertex Pharmaceuticals  ( VRTX )  Stock Dips While Market Gains: Key Facts,https://www.zacks.com/stock/news/2214594/vertex-pharmaceuticals-vrtx-stock-dips-while-market-gains-key-facts,2024-01-23 22:50:19,"Vertex Pharmaceuticals (VRTX) reachead $439.70 at the closing of the latest trading day, reflecting a -0.09% change compared to its last close.",VRTX,0.656549,0.350752,Bullish
A Look Into Vertex Pharmaceuticals Inc's Price Over Earnings - Vertex Pharmaceuticals  ( NASDAQ:VRTX ) ,https://www.benzinga.com/insights/news/24/01/36742045/a-look-into-vertex-pharmaceuticals-incs-price-over-earnings,2024-01-23 16:45:17,"In the current market session, Vertex Pharmaceuticals Inc. VRTX stock price is at $438.11, after a 0.45% drop. However, over the past month, the company's stock spiked by 7.36%, and in the past year, by 38.81%.",VRTX,0.428632,-0.048765,Neutral
1 Setback and 1 Opportunity for CRISPR Therapeutics Stock,https://www.fool.com/investing/2024/01/23/1-setback-and-1-opportunity-for-crispr-therapeutic/,2024-01-23 14:30:00,"Despite A bump in the road, the biotech's future looks sunny.",VRTX,0.111747,0.108935,Neutral
A New S&P 500 Bull Market Just Began: 3 No-Brainer Stocks to Buy Hand Over Fist,https://www.fool.com/investing/2024/01/22/sp-500-bull-market-no-brainer-stocks-to-buy/,2024-01-22 19:23:00,These stocks seem likely to keep up their winning ways.,VRTX,0.108466,-0.089797,Neutral
Highlights From the 2024 JPMorgan Health Care Conference,https://www.fool.com/investing/2024/01/22/highlights-from-the-2024-jpmorgan-health-care-conf/,2024-01-22 18:39:00,"Weight loss drugs are taking center spotlight, but other developing treatments could change how we live.",VRTX,0.009887,-0.122802,Neutral
Here's How Much $1000 Invested In Vertex Pharmaceuticals 10 Years Ago Would Be Worth Today - Vertex Pharmaceuticals  ( NASDAQ:VRTX ) ,https://www.benzinga.com/insights/news/24/01/36719767/heres-how-much-1000-invested-in-vertex-pharmaceuticals-10-years-ago-would-be-worth-today,2024-01-22 17:00:37,"Vertex Pharmaceuticals VRTX has outperformed the market over the past 10 years by 8.29% on an annualized basis producing an average annual return of 18.73%. Currently, Vertex Pharmaceuticals has a market capitalization of $112.76 billion.",VRTX,0.980595,0.386944,Bullish
"If You Invested $10,000 in Vertex Pharmaceuticals in 2018, This Is How Much You Would Have Today",https://www.fool.com/investing/2024/01/22/if-you-invested-10000-in-vertex-pharma-2018/,2024-01-22 14:00:00,Has investing in Vertex been a better option than just putting your money in the S&P 500?,VRTX,0.195287,0.17001,Somewhat-Bullish
Cathie Wood's ARKK ETF Is Taking On Water. The Reason Is Simple.,https://www.investors.com/news/cathie-wood-flagship-arkk-etf-is-taking-on-water-due-to-coinbase-tesla/,2024-01-22 12:51:00,"Cathie Wood Flagship ARKK ETF Is Taking On Water Due To Coinbase, Tesla, These Stocks Investor's Business Daily ...",VRTX,0.075279,0.161923,Somewhat-Bullish
Could CRISPR Therapeutics Stock Help You Become a Millionaire?,https://www.fool.com/investing/2024/01/22/could-crispr-therapeutics-help-make-you-rich/,2024-01-22 10:05:00,CRISPR Therapeutics shares have soared 39% over the past three months.,VRTX,0.055881,0.105888,Neutral
Could Editas Medicine Become the Next CRISPR Therapeutics?,https://www.fool.com/investing/2024/01/21/could-editas-medicine-become-the-next-crispr/,2024-01-21 14:37:00,"The similarities between the pair are striking, but it might not be enough.",VRTX,0.047654,0.080991,Neutral
Better Growth Stock: Intellia Therapeutics vs. CRISPR Therapeutics,https://www.fool.com/investing/2024/01/21/better-growth-stock-intellia-vs-crispr/,2024-01-21 13:00:00,Both companies are going to continue doing high-impact science in 2024.,VRTX,0.049526,0.10518,Neutral
2 Smart Growth Stocks to Buy Hand Over Fist in 2024,https://www.fool.com/investing/2024/01/21/2-smart-growth-stocks-to-buy-hand-over-fist/,2024-01-21 12:15:00,These businesses are on paths to extremely bright futures.,VRTX,0.079,0.02992,Neutral
3 Unstoppable Growth Stocks That Can Make You Richer in 2024,https://www.fool.com/investing/2024/01/20/3-unstoppable-growth-stocks-that-can-make-you-rich/,2024-01-20 17:50:00,These big winners of 2023 could keep their momentum going in the new year.,VRTX,0.121343,0.028017,Neutral
These 2 Phenomenal Growth Stocks Can Make You Richer in 2024,https://www.fool.com/investing/2024/01/20/these-2-phenomenal-growth-stocks-can-make-you-rich/,2024-01-20 11:55:00,One market-beating stock and one beaten-down stock look like tempting buys for very different reasons.,VRTX,0.102741,0.123755,Neutral
3 High-Flying Stocks That Could Soar Even More in 2024,https://www.fool.com/investing/2024/01/20/3-high-flying-stocks-that-could-soar-even-more-in/,2024-01-20 11:50:00,These big winners could keep the momentum going.,VRTX,0.044222,0.26179,Somewhat-Bullish
Postoperative Acute Pain Market to Grow Immensely at a CAGR of 7.9% During the Study Period  ( 2019-2032 )  | DelveInsight,https://www.prnewswire.com/news-releases/postoperative-acute-pain-market-to-grow-immensely-at-a-cagr-of-7-9-during-the-study-period-20192032--delveinsight-302039152.html,2024-01-19 22:30:00,Postoperative Acute Pain Market to Grow Immensely at a CAGR of 7.9% During the Study Period ( 2019-2032 ... PR ...,VRTX,0.073924,-0.042775,Neutral
"Alpha-1 Antitrypsin Deficiency Market to Register Incremental Growth by 2032, Assesses DelveInsight | Key Companies - Kamada Pharmaceuticals, Arrowhead Pharmaceuticals, Takeda, Mereo BioPharma, AstraZeneca, Inhibrx, Novo Nordisk",https://www.prnewswire.com/news-releases/alpha-1-antitrypsin-deficiency-market-to-register-incremental-growth-by-2032-assesses-delveinsight--key-companies---kamada-pharmaceuticals-arrowhead-pharmaceuticals-takeda-mereo-biopharma-astrazeneca-inhibrx-novo-nordisk-302038155.html,2024-01-18 22:01:00,"Alpha-1 Antitrypsin Deficiency Market to Register Incremental Growth by 2032, Assesses DelveInsight | Key ... PR ...",VRTX,0.071357,0.032536,Neutral
List Price Of Ozempic And Other Drugs Reportedly Rise: Here's What That Means For Consumers,https://www.forbes.com/sites/ariannajohnson/2024/01/18/list-price-of-ozempic-and-other-drugs-reportedly-rise-heres-what-that-means-for-consumers/,2024-01-18 19:49:30,"Almost 800 medications-including Ozempic and Mounjaro-had a median list price increase of 4.5% this month, according to a Wall Street Journal report, meaning copays may increase for consumers.",VRTX,0.113329,0.068214,Neutral
"Biotech Stock Roundup: VRTX/CRSP Gene Therapy Label Expansion, ALLK Falls on Update",https://www.zacks.com/stock/news/2212227/biotech-stock-roundup-vrtxcrsp-gene-therapy-label-expansion-allk-falls-on-update,2024-01-18 15:21:00,"Vertex (VRTX), CRSP and Allakos are in the spotlight on regulatory and pipeline updates.",VRTX,0.123526,0.137767,Neutral
Charles River's  ( CRL )  New Launch to Boost Gene Therapy Programs,https://www.zacks.com/stock/news/2212039/charles-rivers-crl-new-launch-to-boost-gene-therapy-programs,2024-01-18 14:10:00,Charles River's (CRL) latest offering is likely to complete a comprehensive range of off-the-shelf plasmid products and simplify gene therapy supply chains with immediate availability.,VRTX,0.060694,0.040071,Neutral
Vertex Pharmaceuticals  ( VRTX )  Declines More Than Market: Some Information for Investors,https://www.zacks.com/stock/news/2211744/vertex-pharmaceuticals-vrtx-declines-more-than-market-some-information-for-investors,2024-01-17 22:50:17,"Vertex Pharmaceuticals (VRTX) concluded the recent trading session at $433.76, signifying a -0.85% move from its prior day's close.",VRTX,0.55992,0.204315,Somewhat-Bullish
"Beta-thalassemia Market to Witness Upsurge in Growth During the Study Period  ( 2019-2032 ) , Evaluates DelveInsight | Leading Companies - Vertex Pharmaceuticals, CRISPR Therapeutics, Agios Pharmaceuticals, Celgene, Forma Therapeutics",https://www.prnewswire.com/news-releases/beta-thalassemia-market-to-witness-upsurge-in-growth-during-the-study-period-20192032-evaluates-delveinsight--leading-companies---vertex-pharmaceuticals-crispr-therapeutics-agios-pharmaceuticals-celgene-forma-therapeutics-302034997.html,2024-01-17 22:01:00,"Beta-thalassemia Market to Witness Upsurge in Growth During the Study Period ( 2019-2032 ) , Evaluates DelveInsight ... PR ...",VRTX,0.027257,0.096627,Neutral
Market Whales and Their Recent Bets on VRTX Options - Vertex Pharmaceuticals  ( NASDAQ:VRTX ) ,https://www.benzinga.com/markets/options/24/01/36666930/market-whales-and-their-recent-bets-on-vrtx-options,2024-01-17 20:00:41,"Investors with a lot of money to spend have taken a bullish stance on Vertex Pharmaceuticals VRTX. We noticed this today when the trades showed up on publicly available options history that we track here at Benzinga. Whether these are institutions or just wealthy individuals, we don't know.",VRTX,0.623976,0.156892,Somewhat-Bullish
"Vertex  ( VRTX ) , CRSP's Casgevy Gets FDA Nod for Thalassemia",https://www.zacks.com/stock/news/2211622/vertex-vrtx-crsps-casgevy-gets-fda-nod-for-thalassemia,2024-01-17 17:04:00,This is the second approval granted to Vertex (VRTX)/CRISPR's (CRSP) gene therapy Casgevy and comes just a month after the FDA approved the therapy for sickle cell disease.,VRTX,0.241684,0.091496,Neutral
"The Best Stock to Invest $1,000 in Right Now",https://www.fool.com/investing/2024/01/17/the-best-stock-to-invest-1000-in-right-now/,2024-01-17 10:50:00,This stock has what it takes to be a big winner.,VRTX,0.121037,0.238791,Somewhat-Bullish
FDA Approves New CRISPR Gene-Editing Treatment,https://www.forbes.com/sites/jamesfarrell/2024/01/16/fda-approves-new-crispr-gene-editing-treatment/,2024-01-16 22:59:05,"The Food and Drug Administration approved the use of Casgevy, a therapy from Vertex Pharmaceuticals and CRISPR Therapeutics that uses CRISPR gene-editing to treat the serious blood disorder transfusion-dependent beta thalassemia-marking the second major U.S. regulatory approval for the emerging ...",VRTX,0.102013,0.109846,Neutral
CRISPR Therapeutics Announces U.S. Food and Drug Administration  ( FDA )  Approval of CASGEVY  ( exagamglogene autotemcel )  for the Treatment of Transfusion-Dependent Beta Thalassemia - CRISPR Therapeutics  ( NASDAQ:CRSP ) ,https://www.benzinga.com/pressreleases/24/01/g36649789/crispr-therapeutics-announces-u-s-food-and-drug-administration-fda-approval-of-casgevy-exagamgloge,2024-01-16 21:01:00,"- Approximately 1,000 patients in the U.S. 12 years of age and older are now eligible for this one-time treatment- ZUG, Switzerland and BOSTON, Jan. 16, 2024 ( GLOBE NEWSWIRE ) -- CRISPR Therapeutics CRSP, a biopharmaceutical company focused on creating transformative gene-based medicines for ...",VRTX,0.11894,0.096945,Neutral
Vertex's Warpath Continues With A Second Crispr Gene-Editing OK,https://www.investors.com/news/technology/crsp-stock-dips-despite-snagging-a-second-gene-editing-ok-vrtx-stock-continues-on-its-warpath/,2024-01-16 20:21:00,CRSP Stock Dips Despite Snagging A Second Gene-Editing OK. VRTX Stock Continues On Its Warpath Investor's Business Daily ...,VRTX,0.47147,-0.076163,Neutral
"These 2 Stocks Carry a Lot of Risk, but Their Upside Is Huge",https://www.fool.com/investing/2024/01/16/these-2-stocks-carry-lot-of-risk-but-their-upside/,2024-01-16 13:15:00,These risky stocks can deliver big returns for investors.,VRTX,0.045569,-0.012901,Neutral
Got $100? 2 Top Cathie Wood Stocks to Buy and Hold.,https://www.fool.com/investing/2024/02/04/got-100-2-top-cathie-wood-stocks-to-buy-and-hold/,2024-02-04 19:35:00,These stocks are steals right now.,VRTX,0.060694,0.077001,Neutral
Vertex Pharmaceuticals May Be About to Solve a Common Health Problem. Is the Stock a Buy?,https://www.fool.com/investing/2024/02/02/vertex-to-solve-common-health-problem/,2024-02-02 21:12:00,Vertex shares recently reached an all-time high.,VRTX,0.119235,0.327133,Somewhat-Bullish
"Stocks Handle Huge Earnings, Fed, Jobs Report: Weekly Review",https://www.investors.com/news/stock-market-handles-huge-earnings-week-fed-powell-jobs-report-weekly-review/,2024-02-02 17:15:00,"Stock Market Handles Huge Earnings Week, Fed's Powell, Jobs Report: Weekly Review Investor's Business Daily ...",VRTX,0.049835,-0.069943,Neutral
Vertex  ( VRTX )  to Report Q4 Earnings: What's in the Cards?,https://www.zacks.com/stock/news/2220380/vertex-vrtx-to-report-q4-earnings-whats-in-the-cards,2024-02-02 15:47:00,"On Vertex's (VRTX) fourth-quarter 2023 earnings call, investors' focus is likely to be on the sales numbers of its lead drug, Trikafta/Kaftrio, and progress with other pipeline candidates.",VRTX,0.194632,0.0,Neutral
InnovationRx: Show Me The Healthcare Savings,https://www.forbes.com/sites/katiejennings/2024/02/01/innovationrx-welltheory-healthcare-savings/,2024-02-01 15:00:12,"InnovationRx is your weekly digest of healthcare news. To get it in your inbox, subscribe here. here were a whopping two healthtech startups that hit billion-dollar valuations in 2023, compared to 52 unicorns minted during the two years prior, according to a PitchBook analysis.",VRTX,0.041323,0.11689,Neutral
"EnteroBiotix Strengthens its Executive Team, Appoints COO and CFO",https://www.benzinga.com/pressreleases/24/02/g36882398/enterobiotix-strengthens-its-executive-team-appoints-coo-and-cfo,2024-02-01 08:27:28,"GLASGOW, Scotland, Feb. 01, 2024 ( GLOBE NEWSWIRE ) -- EnteroBiotix Limited ( ""EBX"" ) , a clinical stage biopharmaceutical company with the premier platform for full-spectrum microbiome therapeutics, today announced the appointments of Dr James Barnes as Chief Operating Officer ( ""COO"" ) and ...",VRTX,0.083251,0.066094,Neutral
Vertex's  ( VRTX )  Non-Opioid Pain Drug Meets Primary Goal,https://www.zacks.com/stock/news/2218984/vertexs-vrtx-non-opioid-pain-drug-meets-primary-goal,2024-01-31 17:18:00,"Three late-stage studies data show that Vertex's (VRTX) experimental non-opioid drug reduced pain across a 48-hour period. Based on this data, VRTX intends to submit an FDA filing by mid-2024.",VRTX,0.211652,-0.012561,Neutral
Check Out What Whales Are Doing With VRTX - Vertex Pharmaceuticals  ( NASDAQ:VRTX ) ,https://www.benzinga.com/insights/options/24/01/36869793/check-out-what-whales-are-doing-with-vrtx,2024-01-31 16:01:24,"Financial giants have made a conspicuous bearish move on Vertex Pharmaceuticals. Our analysis of options history for Vertex Pharmaceuticals VRTX revealed 9 unusual trades. Delving into the details, we found 33% of traders were bullish, while 66% showed bearish tendencies.",VRTX,0.68471,-0.101506,Neutral
Stay Ahead of the Game With Vertex  ( VRTX )  Q4 Earnings: Wall Street's Insights on Key Metrics,https://www.zacks.com/stock/news/2218636/stay-ahead-of-the-game-with-vertex-vrtx-q4-earnings-wall-streets-insights-on-key-metrics,2024-01-31 14:15:17,"Beyond analysts' top -and-bottom-line estimates for Vertex (VRTX), evaluate projections for some of its key metrics to gain a better insight into how the business might have performed for the quarter ended December 2023.",VRTX,0.227007,0.195855,Somewhat-Bullish
"Jim Cramer Says It's 'Still Not Too Late' To Buy This Energy Stock - CRISPR Therapeutics  ( NASDAQ:CRSP ) , DigitalOcean Holdings  ( NYSE:DOCN ) ",https://www.benzinga.com/trading-ideas/long-ideas/24/01/36860627/jim-cramer-says-its-still-not-too-late-to-buy-this-energy-stock,2024-01-31 12:57:43,"On CNBC's ""Mad Money Lightning Round,"" Jim Cramer said he is taking a ""hard pass"" on Surgery Partners, Inc. SGRY. ""That industry has been up and down and up and down,"" he added. Surgery Partners recently reaffirmed its 2023 adjusted EBITDA guidance of $436 million to $440 million and revenue ...",VRTX,0.111488,0.093442,Neutral
Why Vertex Pharmaceuticals Stock Topped the Market Today,https://www.fool.com/investing/2024/01/30/why-vertex-pharmaceuticals-stock-topped-the-market/,2024-01-31 00:10:16,The company reported that it met its primary endpoint in a study for its non-opioid pain drug.,VRTX,0.272788,0.493625,Bullish
Vertex non-opioid painkiller shows positive results in critical late-stage trial on acute pain,https://www.cnbc.com/2024/01/30/vertex-non-opioid-painkiller-shows-positive-late-stage-trial-results.html,2024-01-30 21:31:25,The trial results bring the biotech company one step closer to developing a drug that can provide strong pain relief without the addictive potential of opioids.,VRTX,0.077593,-0.126738,Neutral
Charles River  ( CRL )  Launches Animal-Free Endotoxin Test,https://www.zacks.com/stock/news/2218218/charles-river-crl-launches-animal-free-endotoxin-test,2024-01-30 18:39:00,Charles River's (CRL) latest launch expands on Charles River's existing Trillium rCR vial product.,VRTX,0.051221,0.038965,Neutral
Exelixis  ( EXEL )  Reports Next Week: Wall Street Expects Earnings Growth,https://www.zacks.com/stock/news/2217975/exelixis-exel-reports-next-week-wall-street-expects-earnings-growth,2024-01-30 15:00:58,Exelixis (EXEL) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.,VRTX,0.087985,0.038079,Neutral
Why Is Vertex Pharmaceuticals Stock Sliding Today? - Vertex Pharmaceuticals  ( NASDAQ:VRTX ) ,https://www.benzinga.com/general/biotech/24/01/36846814/why-is-vertex-pharmaceuticals-stock-sliding-today,2024-01-30 14:51:07,"Tuesday, Vertex Pharmaceuticals Incorporated VRTX announced results from its Phase 3 program ( two Phase 3 trials ) for the selective NaV1.8 inhibitor, VX-548, for moderate-to-severe acute pain.",VRTX,0.331765,-0.022013,Neutral
Vertex Skids - Its Opioid Alternative Is 'Not A Game-Changer',https://www.investors.com/news/technology/vrtx-stock-skids-its-alternative-to-opioids-is-not-a-game-changer-says-analyst/,2024-01-30 14:41:00,"Vertex Pharmaceuticals' ( VRTX ) alternative to opioids in pain treatment is ""not a game-changer,"" an analyst said Tuesday as VRTX stock slipped on the company's Phase 3 test results.",VRTX,0.666827,-0.470915,Bearish
Is CRISPR Therapeutics a Buy in the New Bull Market?,https://www.fool.com/investing/2024/01/30/is-crispr-therapeutics-a-buy-in-new-bull-market/,2024-01-30 10:02:00,CRISPR Therapeutics is a specialist in the hot technology of gene editing.,VRTX,0.055881,0.22298,Somewhat-Bullish
Vertex Pharmaceuticals  ( VRTX )  Laps the Stock Market: Here's Why,https://www.zacks.com/stock/news/2217475/vertex-pharmaceuticals-vrtx-laps-the-stock-market-heres-why,2024-01-29 22:50:18,"Vertex Pharmaceuticals (VRTX) closed at $435.82 in the latest trading session, marking a +1.31% move from the prior day.",VRTX,0.556576,0.379114,Bullish
2 Under-the-Radar Stocks With Incredible Upside Potential,https://www.fool.com/investing/2024/01/28/2-under-the-radar-stocks-with-incredible-upside/,2024-01-28 13:45:00,It's also important to consider their downsides.,VRTX,0.060848,0.113628,Neutral
Cathie Wood Goes Bargain Hunting: 3 Stocks She Bought Last Week,https://www.fool.com/investing/2024/01/28/cathie-wood-bargain-hunts-3-stocks-she-bought/,2024-01-28 10:10:00,Wood added to her existing positions in these three exciting companies.,VRTX,0.046006,0.254375,Somewhat-Bullish
Here's My Top Growth Stock to Buy Right Now,https://www.fool.com/investing/2024/01/27/heres-my-top-growth-stock-to-buy-right-now/,2024-01-27 16:50:00,There doesn't appear to be a weak link with this great stock.,VRTX,0.095138,0.133342,Neutral
3 Magnificent Stocks to Buy and Hold Forever,https://www.fool.com/investing/2024/01/27/3-magnificent-stocks-to-buy-and-hold-forever/,2024-01-27 12:54:00,Many investors will want to consider owning these stocks for a long time.,VRTX,0.16849,0.001473,Neutral
"If You Invested $1,000 in Bluebird Bio in 2019, This Is How Much You Would Have Today",https://www.fool.com/investing/2024/01/27/if-you-invested-1000-in-bluebird-bio-in-2019/,2024-01-27 12:28:00,The answer hardly inspires confidence.,VRTX,0.135347,0.058736,Neutral
